data_2l1t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l1t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -60.98 -45.34 95.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.948 -1.095 . . . . 0.0 110.028 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 3.38 16.72 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.181 0.42 . . . . 0.0 113.556 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.225 -1.75 . . . . 0.0 110.116 166.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.85 -46.29 2.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.363 1.065 . . . . 0.0 111.3 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.4 155.69 22.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.721 1.609 . . . . 0.0 107.575 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -144.35 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -60.8 -15.17 27.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.253 1.821 . . . . 0.0 115.524 -170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 mp -130.84 1.35 4.35 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 110.29 -173.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.98 165.8 23.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 155.68 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.32 144.69 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 106.374 -167.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -63.79 166.65 6.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.969 0.508 . . . . 0.0 110.058 160.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.3 mt -142.0 49.27 1.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.76 1.624 . . . . 0.0 109.563 -170.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -58.6 103.31 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 121.024 1.738 . . . . 0.0 109.003 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 82.4 t -95.66 119.32 43.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 121.633 2.015 . . . . 0.0 106.296 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.58 118.78 6.48 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.505 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -141.65 109.15 5.61 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.9 -1.125 . . . . 0.0 108.209 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -125.24 95.41 4.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -154.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 -167.45 14.46 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.646 1.117 . . . . 0.0 112.163 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.82 145.38 51.97 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.961 0.904 . . . . 0.0 108.596 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.68 145.9 31.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 167.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.1 32.52 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 165.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.43 158.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.034 1.734 . . . . 0.0 107.521 166.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -131.4 -30.75 1.67 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 112.372 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.7 m -145.55 130.72 18.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.264 1.826 . . . . 0.0 106.532 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 tp -131.71 123.18 27.19 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.397 1.479 . . . . 0.0 107.715 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.72 84.74 2.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 -122.06 17.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.68 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.3 p -68.27 -12.42 60.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 117.627 0.714 . . . . 0.0 112.657 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 tp -106.29 139.06 41.39 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 110.36 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.18 168.05 16.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 164.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -133.58 138.51 46.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.775 2.03 . . . . 0.0 109.302 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.95 162.87 25.76 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.734 1.614 . . . . 0.0 110.938 -160.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.41 24.23 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.4 mt 53.14 -171.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.956 0.902 . . . . 0.0 111.936 -168.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 124.462 1.105 . . . . 0.0 113.241 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.85 171.08 17.26 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.407 2.738 . . . . 0.0 112.899 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.63 156.43 52.79 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.149 1.9 . . . . 0.0 111.15 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -66.51 170.97 11.34 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.265 2.644 . . . . 0.0 109.783 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 p30 53.95 1.29 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 m -101.03 -48.0 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.694 0.679 . . . . 0.0 110.404 -163.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.23 144.67 56.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -141.51 163.63 32.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.396 0.678 . . . . 0.0 110.395 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 62.9 mt-10 -73.36 -5.96 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.799 1.239 . . . . 0.0 113.691 -167.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.98 28.83 2.79 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.33 136.14 57.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 167.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.48 125.89 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 165.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 t -124.22 135.39 53.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.645 1.212 . . . . 0.0 108.977 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.43 156.62 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 112.385 -2.189 . . . . 0.0 106.709 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.2 p -151.01 133.51 15.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.551 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -137.87 146.13 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.501 1.12 . . . . 0.0 109.201 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -96.37 132.58 41.73 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -141.14 95.62 2.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 43.78 42.43 6.22 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 118.853 2.301 . . . . 0.0 118.853 159.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.73 -40.54 0.2 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 121.01 2.405 . . . . 0.0 112.341 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.0 -178.18 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.105 0.955 . . . . 0.0 109.327 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 113.17 22.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 55.5 m -89.44 108.33 19.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.8 158.2 29.38 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.63 136.86 22.37 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.11 158.6 32.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 -179.56 39.1 Favored Glycine 0 N--CA 1.443 -0.871 0 O-C-N 121.131 -0.98 . . . . 0.0 112.118 -171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -127.19 162.13 26.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -32.13 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.603 0.761 . . . . 0.0 110.415 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.26 -66.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.29 2.236 . . . . 0.0 113.42 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.9 m -152.13 95.89 2.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.092 1.315 . . . . 0.0 108.232 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.481 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 1.7 tp -70.06 162.13 28.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -132.87 -41.8 0.92 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.347 -0.845 . . . . 0.0 109.681 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -148.81 172.9 13.9 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -61.12 -6.0 1.77 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.809 2.043 . . . . 0.0 112.465 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -139.66 -11.53 1.17 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.559 2.344 . . . . 0.0 114.606 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -123.71 125.31 44.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -167.11 158.65 12.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.84 176.01 9.97 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.405 1.482 . . . . 0.0 110.849 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.67 150.21 13.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.97 113.8 18.29 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.842 1.257 . . . . 0.0 108.473 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.8 133.0 45.24 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.288 1.835 . . . . 0.0 108.749 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.07 158.38 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.103 1.361 . . . . 0.0 110.327 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.78 80.17 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 119.215 -0.769 . . . . 0.0 112.417 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 59.38 166.78 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.103 2.561 . . . . 0.0 114.009 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -104.39 113.76 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.992 0.917 . . . . 0.0 110.446 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -55.41 -36.8 66.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.922 -1.111 . . . . 0.0 111.099 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.23 -14.45 76.73 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.255 -0.747 . . . . 0.0 113.108 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -75.12 -12.16 60.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.345 1.572 . . . . 0.0 110.744 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -118.72 -45.82 2.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.301 1.44 . . . . 0.0 110.439 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -95.7 116.39 28.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.491 1.116 . . . . 0.0 109.621 171.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 167.63 16.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 109.529 166.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.33 -18.45 55.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.558 0.743 . . . . 0.0 112.941 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.0 mt -127.28 14.09 7.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.088 1.355 . . . . 0.0 109.983 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.79 171.81 8.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.721 0.809 . . . . 0.0 109.827 173.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -108.76 149.74 28.6 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.44 157.51 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.658 1.183 . . . . 0.0 111.381 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -72.88 158.41 35.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.549 1.14 . . . . 0.0 112.048 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -131.24 60.94 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.001 1.72 . . . . 0.0 109.391 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m -78.73 110.11 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.931 -1.105 . . . . 0.0 108.424 174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.52 133.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.345 1.458 . . . . 0.0 108.375 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 147.85 46.19 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.06 1.3 . . . . 0.0 110.217 173.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.327 -0.386 0 C-N-CA 126.058 1.743 . . . . 0.0 108.038 169.837 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -95.36 157.18 16.01 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 163.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.27 125.15 15.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 163.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.77 -171.8 14.16 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 166.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -116.9 162.89 17.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.53 157.1 46.39 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.491 156.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.92 140.97 40.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 157.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.95 158.2 5.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.3 p -136.92 -28.74 0.94 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 m -154.57 124.02 6.49 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tt -143.98 129.76 19.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.651 1.114 . . . . 0.0 110.251 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -144.22 104.26 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.94 -131.29 44.33 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.196 0.903 . . . . 0.0 112.205 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.39 37.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.754 1.222 . . . . 0.0 112.111 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.14 117.36 9.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.784 1.234 . . . . 0.0 107.937 162.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.4 155.82 20.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 156.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -118.93 147.77 43.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.608 1.963 . . . . 0.0 108.778 164.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.67 166.5 13.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 110.478 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.3 65.41 1.25 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.537 0.735 . . . . 0.0 110.089 162.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt 45.3 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.329 3.051 . . . . 0.0 116.081 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 C-N-CA 123.929 0.892 . . . . 0.0 111.186 159.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.41 169.92 16.01 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.405 2.07 . . . . 0.0 110.564 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.58 154.8 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.951 1.101 . . . . 0.0 110.586 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -63.42 168.54 11.11 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.086 1.857 . . . . 0.0 108.935 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.77 5.96 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.2 m -108.48 -47.04 3.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.958 1.303 . . . . 0.0 110.844 -163.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -64.85 138.2 58.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.958 0.903 . . . . 0.0 109.182 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -137.1 158.98 43.22 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -74.14 -8.61 56.77 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -164.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.13 22.52 4.23 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 126.235 1.874 . . . . 0.0 109.422 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 125.72 24.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.02 135.88 54.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 164.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.51 163.59 35.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.849 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.78 153.43 39.54 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 160.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.51 145.33 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 p -147.7 146.32 29.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.78 143.55 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.066 0.946 . . . . 0.0 110.272 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.57 74.74 8.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.561 1.945 . . . . 0.0 111.365 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.254 3.4 t -97.65 100.87 12.27 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.388 -0.82 . . . . 0.0 109.435 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.52 33.98 3.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.514 2.483 . . . . 0.0 116.392 161.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.26 -65.97 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -167.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -171.18 -164.57 0.36 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.175 2.19 . . . . 0.0 107.822 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -76.95 94.32 3.93 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 134.9 54.76 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 155.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.13 161.23 36.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.8 t -157.46 175.71 13.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -114.71 156.38 24.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.8 178.3 40.0 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 120.455 -1.403 . . . . 0.0 111.697 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.78 159.04 36.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 166.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -58.7 -30.89 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.005 0.522 . . . . 0.0 111.984 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 65.69 -61.57 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.479 2.312 . . . . 0.0 111.161 -171.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -147.11 126.98 13.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.242 2.217 . . . . 0.0 105.658 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.55 157.11 16.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.4 ttm-85 -124.8 -44.43 1.95 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.869 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.37 176.38 11.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.8 -1.6 0.92 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.799 0.84 . . . . 0.0 112.325 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -130.78 -13.9 3.63 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.564 1.546 . . . . 0.0 113.579 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.64 136.74 46.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 108.6 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -175.45 166.02 3.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.366 1.066 . . . . 0.0 109.696 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.37 177.62 5.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.053 1.341 . . . . 0.0 110.671 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.07 127.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.149 1.379 . . . . 0.0 108.782 157.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -74.13 137.89 43.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 156.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -99.05 136.75 38.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.48 138.04 48.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.946 0.879 . . . . 0.0 111.93 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -107.47 3.06 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.17 142.53 7.26 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 126.155 1.782 . . . . 0.0 106.315 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.04 134.67 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 C--O 1.236 0.346 0 CA-C-N 119.161 0.892 . . . . 0.0 110.592 179.762 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -64.77 -39.25 93.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.246 -1.534 . . . . 0.0 109.539 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.67 -0.98 74.68 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.962 -169.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -85.85 -17.06 36.68 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.203 1.001 . . . . 0.0 111.038 163.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -105.91 -53.51 2.63 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.029 0.931 . . . . 0.0 110.442 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.44 155.72 22.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.98 153.63 43.2 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -63.03 -18.03 62.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -165.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.55 8.52 5.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.73 1.612 . . . . 0.0 110.223 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -73.87 169.39 17.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.796 -1.19 . . . . 0.0 108.905 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.81 17.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.689 170.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.29 165.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.515 1.126 . . . . 0.0 109.846 164.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.55 177.75 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.883 2.473 . . . . 0.0 112.266 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 mt -138.21 22.56 2.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.818 1.644 . . . . 0.0 115.113 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -62.8 106.74 0.85 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.957 1.708 . . . . 0.0 110.572 -167.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.9 t -99.12 139.77 20.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.639 1.575 . . . . 0.0 109.188 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -74.51 121.17 21.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 161.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 N--CA 1.433 -1.321 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 160.513 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.386 0.613 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -130.41 139.29 50.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.09 147.75 50.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.615 0.722 . . . . 0.0 110.271 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.75 -162.81 15.27 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -131.79 162.79 29.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.21 161.67 41.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 156.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 140.19 41.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 156.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.2 mt -69.25 158.61 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 161.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.6 p -131.96 -31.28 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.444 1.898 . . . . 0.0 111.96 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.14 145.17 31.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 tp -161.81 101.62 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -121.49 78.67 1.46 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.755 1.622 . . . . 0.0 106.875 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.04 -117.85 10.37 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 14.1 p -64.82 -0.48 1.5 Allowed 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 115.817 -2.039 . . . . 0.0 113.914 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -127.04 137.47 53.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.95 1.25 . . . . 0.0 108.193 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.59 166.6 23.9 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.048 0.939 . . . . 0.0 108.527 168.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -129.49 149.44 51.26 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.784 1.634 . . . . 0.0 108.402 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.77 171.37 8.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.573 1.949 . . . . 0.0 110.94 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.66 58.5 1.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.477 1.132 . . . . 0.0 111.229 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 mt 47.72 -169.87 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.663 1.985 . . . . 0.0 114.407 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.617 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.61 164.84 34.38 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.402 2.735 . . . . 0.0 112.586 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.83 160.76 35.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.866 1.711 . . . . 0.0 111.587 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.98 159.58 24.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.568 2.179 . . . . 0.0 112.313 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 44.79 32.69 0.84 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.873 2.069 . . . . 0.0 112.213 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 m -111.64 -56.72 2.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.363 1.065 . . . . 0.0 108.155 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.47 127.52 30.05 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -127.65 159.68 33.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.61 -3.92 17.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.35 19.1 4.34 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.772 2.129 . . . . 0.0 110.881 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.97 131.09 49.55 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.33 123.42 25.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.42 163.8 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.274 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.39 131.08 43.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.02 0.928 . . . . 0.0 108.852 -173.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.48 139.82 19.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -140.91 156.83 46.01 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.085 0.857 . . . . 0.0 110.283 159.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 p -160.86 149.13 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.197 1.799 . . . . 0.0 107.166 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -88.1 120.82 29.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 t -151.07 119.48 6.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.66 -162.44 47.85 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -159.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.27 2.08 22.48 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.867 1.223 . . . . 0.0 114.662 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.33 172.82 12.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.958 1.379 . . . . 0.0 110.767 -174.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.9 168.74 18.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.11 153.03 49.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 154.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.27 155.63 50.31 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.6 t -144.86 156.52 44.05 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 155.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -99.21 150.19 22.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.83 41.59 Favored Glycine 0 CA--C 1.523 0.593 0 O-C-N 120.958 -1.088 . . . . 0.0 110.911 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -128.02 169.15 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.648 0.779 . . . . 0.0 109.005 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.18 -35.35 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.131 0.973 . . . . 0.0 112.837 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 65.92 -54.14 0.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.764 2.426 . . . . 0.0 113.707 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -150.27 139.39 21.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.745 1.218 . . . . 0.0 108.264 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -115.77 152.29 33.55 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.52 -52.96 0.72 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.532 -169.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.54 174.93 7.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 159.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -55.5 -30.85 61.41 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.041 1.337 . . . . 0.0 111.821 166.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -104.27 -11.66 17.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -132.24 124.02 28.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 120.535 1.516 . . . . 0.0 108.596 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -162.4 166.29 25.27 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.536 1.148 . . . . 0.0 110.45 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.84 179.78 5.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.753 1.221 . . . . 0.0 110.209 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.71 133.7 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.435 1.494 . . . . 0.0 108.677 164.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -108.39 111.72 23.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.379 1.472 . . . . 0.0 107.674 174.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.5 mt -71.94 144.71 48.83 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.241 1.417 . . . . 0.0 107.563 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.59 153.65 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.557 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.32 -106.96 0.65 Allowed Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 125.721 1.629 . . . . 0.0 109.077 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.59 168.98 23.84 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.4 1.48 . . . . 0.0 110.825 -167.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.47 156.27 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.018 0.927 . . . . 0.0 109.749 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.55 0 C-N-CA 124.752 1.221 . . . . 0.0 110.296 150.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 C--O 1.222 -0.385 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -54.59 -39.99 68.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.092 1.315 . . . . 0.0 111.606 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.18 -6.06 55.92 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.478 1.037 . . . . 0.0 112.717 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.45 -16.89 55.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.16 -1.2 . . . . 0.0 111.373 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.78 -27.8 5.74 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.723 1.209 . . . . 0.0 110.422 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.83 144.25 50.73 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.445 1.117 . . . . 0.0 111.992 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.62 156.01 49.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.597 -173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 15' ' ' GLN . 1.5 pm0 -62.13 -17.31 57.46 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.49 13.41 8.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 118.884 0.765 . . . . 0.0 109.416 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.73 167.68 21.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.163 0.585 . . . . 0.0 109.575 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.64 147.77 32.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.859 0.864 . . . . 0.0 108.981 170.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -141.5 165.93 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.767 0.827 . . . . 0.0 111.099 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.23 165.55 24.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.043 1.737 . . . . 0.0 112.231 165.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -138.34 19.67 2.75 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.13 116.94 1.7 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.238 -161.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.5 116.05 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -64.21 133.61 53.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.657 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.2 mt . . . . . 0 C--O 1.238 0.477 0 C-N-CA 125.818 1.647 . . . . 0.0 107.031 173.393 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.6 150.22 26.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.97 125.52 15.79 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 126.583 1.953 . . . . 0.0 106.003 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.97 -174.82 23.03 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -118.57 159.21 23.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.75 156.5 40.42 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 118.581 0.628 . . . . 0.0 110.986 161.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.12 130.78 35.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 125.177 1.548 . . . . 0.0 108.008 160.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.89 159.79 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 158.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -132.4 -36.76 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.244 1.418 . . . . 0.0 110.932 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 m -145.77 138.27 25.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.743 1.217 . . . . 0.0 107.735 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.26 124.71 15.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.525 0.73 . . . . 0.0 109.145 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -135.8 81.01 1.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.115 1.366 . . . . 0.0 108.057 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.63 -118.61 5.07 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 166.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p -64.71 -3.79 3.6 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 126.426 1.89 . . . . 0.0 113.019 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.04 134.86 53.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.739 1.215 . . . . 0.0 110.816 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.45 163.56 29.41 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.139 1.375 . . . . 0.0 110.404 167.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -128.19 118.75 23.9 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.852 1.661 . . . . 0.0 110.127 170.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -87.32 165.18 15.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.858 1.663 . . . . 0.0 112.086 167.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.69 35.82 2.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.147 1.779 . . . . 0.0 111.529 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 mt 52.04 -169.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.476 1.91 . . . . 0.0 113.383 -169.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 . . . . . 0 C--O 1.235 0.34 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 173.48 9.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.846 2.364 . . . . 0.0 111.03 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.63 154.5 48.27 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.121 1.214 . . . . 0.0 110.027 162.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.31 174.45 11.48 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.151 2.567 . . . . 0.0 109.514 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.88 38.16 2.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 113.695 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -132.14 -52.31 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.323 1.449 . . . . 0.0 109.558 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.03 149.1 33.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 110.837 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 155.54 46.59 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.276 0.63 . . . . 0.0 110.879 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.8 -2.61 30.72 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.34 20.99 2.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 126.122 1.82 . . . . 0.0 109.664 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.49 25.93 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.06 130.55 41.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.65 138.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.444 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -109.5 130.63 55.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.514 0.726 . . . . 0.0 109.415 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.25 146.14 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.1 p -146.05 159.77 42.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 110.228 160.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.6 p -164.89 151.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.613 1.565 . . . . 0.0 107.841 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -79.0 108.21 12.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 166.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -144.13 152.57 41.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.62 4.58 7.12 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.644 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.87 2.08 42.57 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.821 1.81 . . . . 0.0 114.16 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.76 166.51 26.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.638 1.719 . . . . 0.0 109.836 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.54 95.01 6.99 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 155.09 39.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 170.68 18.1 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.594 172.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 t -159.93 163.35 34.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -101.98 143.6 31.63 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 108.924 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.29 24.19 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.475 1.512 . . . . 0.0 111.933 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.78 174.4 11.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.417 1.087 . . . . 0.0 111.73 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.67 -43.24 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.462 1.105 . . . . 0.0 113.659 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.45 -45.6 0.31 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.377 2.671 . . . . 0.0 114.195 -166.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.0 m -154.63 136.02 14.14 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.668 1.587 . . . . 0.0 107.772 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -116.51 161.19 19.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 108.262 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -143.39 -30.43 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.336 -0.852 . . . . 0.0 111.972 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -149.93 179.86 7.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.904 2.082 . . . . 0.0 105.824 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.7 -8.71 29.72 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.675 -0.641 . . . . 0.0 111.528 162.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -131.57 -11.92 3.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -128.55 128.2 43.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -166.47 167.33 15.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.88 172.9 7.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.994 0.918 . . . . 0.0 109.527 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 pt -141.79 138.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 108.45 160.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -107.3 111.19 23.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 128.433 2.693 . . . . 0.0 104.819 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.17 149.28 37.32 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.246 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.74 165.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.421 1.488 . . . . 0.0 108.973 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.99 -113.55 5.74 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 126.843 2.164 . . . . 0.0 109.907 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.79 137.18 2.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.589 0.756 . . . . 0.0 112.101 -160.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.97 152.97 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.673 1.189 . . . . 0.0 109.42 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 . . . . . 0 C--O 1.236 0.382 0 O-C-N 120.792 -1.192 . . . . 0.0 109.294 174.668 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.05 -33.07 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.894 -1.129 . . . . 0.0 111.097 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 2.41 53.34 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.182 0.896 . . . . 0.0 113.695 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 11' ' ' ARG . 35.8 mtt85 -81.85 -16.33 51.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.178 1.489 . . . . 0.0 111.256 163.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.63 -37.23 2.92 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.056 1.342 . . . . 0.0 112.506 -172.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.04 159.56 14.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.247 1.019 . . . . 0.0 108.302 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -156.3 161.15 40.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.51 -21.88 66.17 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -163.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.2 mt -122.03 14.28 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 109.466 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.53 -174.0 1.58 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.528 0.517 . . . . 0.0 110.755 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -122.69 159.26 28.32 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 125.09 1.356 . . . . 0.0 109.898 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 m -146.28 155.32 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.557 1.143 . . . . 0.0 110.19 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.07 166.68 15.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.159 1.784 . . . . 0.0 110.853 157.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.2 6.23 2.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -158.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 m -49.95 105.44 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 127.327 2.251 . . . . 0.0 112.849 -155.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.99 132.01 35.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -77.99 120.61 23.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.238 0.481 0 C-N-CA 124.329 1.052 . . . . 0.0 109.587 170.498 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.0 0.905 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -131.46 146.53 52.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.697 2.399 . . . . 0.0 104.773 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.64 159.37 42.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 118.832 0.742 . . . . 0.0 109.634 165.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.25 -166.73 30.5 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 155.43 32.49 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.38 159.12 42.86 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 163.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.1 145.51 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.89 153.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.002 1.721 . . . . 0.0 107.332 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.7 p -128.98 -18.21 3.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.543 1.137 . . . . 0.0 112.336 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 m -164.53 157.85 17.55 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.44 1.896 . . . . 0.0 109.123 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.16 135.31 33.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.529 1.131 . . . . 0.0 109.482 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 67.8 1.35 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 0.0 112.05 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 -81.47 1.73 Allowed Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.199 -0.938 . . . . 0.0 113.388 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -114.64 45.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.836 1.254 . . . . 0.0 109.115 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -159.21 132.53 7.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.421 1.088 . . . . 0.0 108.169 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.4 154.63 51.41 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 168.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -114.83 149.23 37.39 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.241 1.016 . . . . 0.0 109.154 169.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.7 mt -137.61 165.14 27.07 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.433 1.493 . . . . 0.0 109.771 -169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -143.42 16.33 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 54.71 161.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.324 1.85 . . . . 0.0 113.183 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.196 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.242 0.708 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.46 169.17 17.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.376 2.051 . . . . 0.0 110.997 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.64 159.84 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 120.817 1.011 . . . . 0.0 110.278 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.39 159.53 49.83 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.034 1.823 . . . . 0.0 109.946 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 50.47 30.67 4.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.106 1.362 . . . . 0.0 111.652 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -131.66 -2.23 3.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.335 1.054 . . . . 0.0 111.577 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -104.16 144.86 31.02 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.564 -1.335 . . . . 0.0 108.595 159.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -154.64 161.1 41.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.979 0.8 . . . . 0.0 110.307 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -67.63 -0.39 3.9 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.14 15.78 3.96 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 126.601 2.048 . . . . 0.0 110.842 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.43 125.57 26.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.51 135.95 38.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 165.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -142.51 141.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 108.278 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 m -95.11 166.9 11.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 0.0 109.583 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 145.3 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.244 1.018 . . . . 0.0 108.584 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -144.95 153.26 41.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 109.009 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.59 151.99 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.076 1.35 . . . . 0.0 107.645 171.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -91.22 115.51 28.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 t -151.24 171.82 16.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 169.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.66 19.13 54.15 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.858 -1.151 . . . . 0.0 113.417 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.08 -9.98 29.56 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 118.818 1.309 . . . . 0.0 113.494 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.85 -177.44 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.503 1.921 . . . . 0.0 110.957 -171.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.1 tp -105.9 101.37 10.87 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.871 1.268 . . . . 0.0 109.381 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 80.5 m -75.99 136.36 40.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -148.49 162.53 39.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.248 167.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.7 t -155.49 -174.47 4.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.775 0.83 . . . . 0.0 111.269 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -133.57 133.79 42.51 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 129.064 2.945 . . . . 0.0 105.505 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.32 -171.21 25.92 Favored Glycine 0 N--CA 1.463 0.454 0 O-C-N 120.441 -1.412 . . . . 0.0 112.557 -170.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.69 175.37 9.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 0.0 109.439 174.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.69 -40.8 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 64.93 -47.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.375 2.27 . . . . 0.0 114.479 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.5 m -148.92 101.36 3.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.075 1.75 . . . . 0.0 107.72 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.34 173.61 9.29 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 120.588 -1.32 . . . . 0.0 109.573 174.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -51.97 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 150.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -142.16 176.65 8.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.44 -15.74 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 112.649 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -118.41 -21.05 8.22 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.937 1.695 . . . . 0.0 113.462 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -130.35 132.63 45.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 120.615 1.552 . . . . 0.0 108.949 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -171.2 170.2 6.14 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.575 0.547 . . . . 0.0 110.816 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.81 167.98 13.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.778 2.031 . . . . 0.0 110.431 164.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.96 141.16 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.048 1.339 . . . . 0.0 108.501 159.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 140.4 29.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.623 1.569 . . . . 0.0 107.955 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.83 142.65 28.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 164.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.07 164.33 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.028 0.531 . . . . 0.0 110.12 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.68 -109.18 2.76 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.352 1.453 . . . . 0.0 109.898 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.52 142.49 15.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.194 1.798 . . . . 0.0 108.655 -169.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.23 139.47 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-N 118.372 0.533 . . . . 0.0 110.483 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--O 1.224 -0.266 0 N-CA-C 111.059 0.022 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -61.67 -36.59 81.28 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.332 -0.855 . . . . 0.0 110.657 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -10.65 67.33 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.33 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -74.36 -21.13 59.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.514 1.657 . . . . 0.0 110.428 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -115.43 -39.2 3.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.388 -169.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -105.43 131.19 53.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.405 1.882 . . . . 0.0 108.132 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.51 165.55 18.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -79.84 -8.45 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -152.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.4 mt -127.74 -0.59 6.07 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.627 2.371 . . . . 0.0 108.173 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.4 145.67 41.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.354 0.0 OUTLIER -108.19 113.76 27.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -173.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 m -102.04 172.86 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.574 2.75 . . . . 0.0 107.333 -171.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.48 163.39 15.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.405 1.882 . . . . 0.0 112.422 173.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 mt -134.98 51.4 2.1 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.492 1.517 . . . . 0.0 113.693 -167.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.1 m -67.44 120.56 14.11 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.886 -1.759 . . . . 0.0 108.109 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 t -118.73 129.71 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.868 1.267 . . . . 0.0 108.276 167.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -70.37 127.59 33.28 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.349 -0.844 . . . . 0.0 109.622 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.335 0 C-N-CA 125.833 1.653 . . . . 0.0 108.606 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.236 0.388 0 CA-C-O 122.107 0.956 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -97.09 142.72 28.68 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 166.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.8 150.15 51.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 165.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.2 -165.52 30.23 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.282 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.93 147.9 51.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.943 1.297 . . . . 0.0 107.687 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.53 34.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 162.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.23 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.15 161.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 162.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -142.05 -13.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.068 0.937 . . . . 0.0 112.608 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 m -156.58 151.15 25.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.16 138.74 31.79 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.364 1.078 . . . . 0.0 109.563 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.83 79.53 1.74 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.762 2.025 . . . . 0.0 106.015 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.35 -106.34 0.35 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.327 1.441 . . . . 0.0 113.49 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.79 9.85 0.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.892 1.677 . . . . 0.0 114.389 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -132.1 129.25 39.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.128 0.877 . . . . 0.0 109.781 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.83 159.2 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 155.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -117.66 147.39 42.95 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.808 1.243 . . . . 0.0 108.145 160.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.74 169.5 9.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.623 1.969 . . . . 0.0 111.284 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -142.43 21.91 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 57.93 -178.06 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 0.0 114.854 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 127.64 2.376 . . . . 0.0 108.261 164.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.939 -0.553 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -67.54 172.11 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.006 2.471 . . . . 0.0 113.305 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.69 154.05 75.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.885 1.724 . . . . 0.0 112.128 167.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 170.1 19.29 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.278 3.319 . . . . 0.0 110.961 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 46.56 20.28 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.075 2.15 . . . . 0.0 113.891 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.5 m -116.91 -57.24 2.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.81 121.98 13.68 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 m -130.81 160.01 35.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.038 0.381 . . . . 0.0 110.65 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.76 -13.36 62.34 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -166.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.51 30.82 3.22 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.636 2.065 . . . . 0.0 108.06 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.05 141.23 56.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 169.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 134.16 35.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 171.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.21 157.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.678 -169.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.18 107.67 7.36 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.27 148.89 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 163.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -145.54 144.84 30.76 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 155.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.92 163.24 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 166.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -108.75 74.56 0.92 Allowed 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 161.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 t -82.54 166.35 19.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 166.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.13 24.37 6.67 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 156.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 28.81 70.52 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.169 1.484 . . . . 0.0 114.443 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.16 44.42 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 121.725 2.762 . . . . 0.0 112.579 169.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 98.69 11.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.4 p -91.38 70.07 5.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 126.421 1.888 . . . . 0.0 108.263 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -85.64 132.63 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 2.9 t -149.04 167.85 24.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.092 0.557 . . . . 0.0 109.504 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -115.6 143.59 45.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.54 -176.54 22.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.273 1.892 . . . . 0.0 111.27 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -128.45 167.48 16.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.359 1.063 . . . . 0.0 108.265 161.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.96 -31.12 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.59 -55.68 0.53 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.491 2.316 . . . . 0.0 112.797 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.5 m -150.09 117.88 6.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.128 2.171 . . . . 0.0 106.341 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.0 tp -82.94 160.49 22.05 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -130.79 -47.99 1.04 Allowed 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 167.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -143.15 176.96 8.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.09 -11.89 59.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.723 0.809 . . . . 0.0 110.537 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -117.46 -39.63 3.15 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.708 1.603 . . . . 0.0 114.091 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -105.95 128.74 54.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -169.39 172.59 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.34 0.656 . . . . 0.0 109.747 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.29 179.15 4.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.504 1.122 . . . . 0.0 111.462 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.8 pt -146.32 129.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 159.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -76.38 122.99 25.28 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 160.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.54 131.94 34.96 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 169.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.04 177.19 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.723 1.209 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.94 -10.45 52.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 116.847 1.499 . . . . 0.0 116.847 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.0 129.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 129.691 3.197 . . . . 0.0 110.086 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 112.33 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -92.18 -51.58 5.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.099 1.318 . . . . 0.0 111.839 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 -17.22 69.83 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.098 0.832 . . . . 0.0 113.138 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -68.06 -15.53 63.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -111.73 -56.56 2.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -84.44 119.15 24.8 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.27 156.94 16.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -22.09 7.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.067 1.747 . . . . 0.0 113.551 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.68 1.45 4.44 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.561 1.544 . . . . 0.0 112.363 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 162.65 25.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 159.19 17.44 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.536 169.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.45 -173.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.25 159.02 15.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.872 2.069 . . . . 0.0 107.742 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.65 54.18 1.71 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.146 1.339 . . . . 0.0 110.56 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -59.33 116.82 4.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.07 135.47 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -74.41 119.1 18.15 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.8 mt . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.239 0.526 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -125.77 157.4 37.57 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 162.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -140.81 144.05 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.705 0.684 . . . . 0.0 110.333 164.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.32 -163.44 12.12 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.555 1.55 . . . . 0.0 110.664 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.04 153.96 43.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.48 147.57 23.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.29 145.58 27.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 167.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.12 159.57 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.216 1.406 . . . . 0.0 107.658 162.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p -136.14 -36.75 0.73 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.586 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -144.94 140.7 28.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.786 2.034 . . . . 0.0 106.089 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.43 119.83 10.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -116.29 0.98 13.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.306 1.043 . . . . 0.0 111.805 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.38 -108.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 p -75.02 30.57 0.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.251 1.025 . . . . 0.0 112.461 170.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -153.71 109.08 3.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.556 0.742 . . . . 0.0 110.628 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.05 162.03 13.22 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 163.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -127.4 138.97 53.13 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.459 1.904 . . . . 0.0 108.619 165.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.36 169.23 10.81 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.355 1.862 . . . . 0.0 112.599 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -137.71 22.22 2.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.9 mt 53.66 -173.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.875 1.67 . . . . 0.0 113.621 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 125.579 1.552 . . . . 0.0 110.187 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.92 167.49 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.289 1.326 . . . . 0.0 111.463 170.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.72 155.51 62.98 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.199 2.599 . . . . 0.0 112.993 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.32 160.76 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.518 2.812 . . . . 0.0 111.142 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.93 3.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.487 2.315 . . . . 0.0 113.89 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.3 m -97.35 -43.56 7.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.611 -1.306 . . . . 0.0 109.567 -166.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -62.36 143.55 56.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.94 0.791 . . . . 0.0 109.36 166.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -146.06 163.68 34.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.268 1.027 . . . . 0.0 108.275 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.07 -3.07 40.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.033 0.921 . . . . 0.0 113.316 -165.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.04 30.37 2.56 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.467 1.984 . . . . 0.0 108.508 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.21 126.21 26.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 164.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.08 135.99 49.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 164.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -147.27 157.45 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 112.408 -2.178 . . . . 0.0 107.625 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 151.85 48.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.336 -1.478 . . . . 0.0 110.331 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.53 121.41 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 124.333 1.053 . . . . 0.0 108.681 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.32 92.63 2.2 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 124.01 0.819 . . . . 0.0 110.014 -166.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.58 143.63 37.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.818 1.247 . . . . 0.0 108.92 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -95.19 102.53 14.34 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 t -152.24 157.97 42.18 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.861 0.755 . . . . 0.0 109.63 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.17 40.91 92.37 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.243 -0.911 . . . . 0.0 112.233 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.9 3.85 37.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.282 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.69 177.02 8.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.951 1.875 . . . . 0.0 112.55 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.31 115.27 30.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.274 1.029 . . . . 0.0 108.387 171.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.22 112.76 24.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 127.547 2.339 . . . . 0.0 104.897 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 128.38 42.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.0 t -134.34 168.27 19.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.779 0.8 . . . . 0.0 109.831 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -106.88 157.69 17.57 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.467 1.507 . . . . 0.0 107.59 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.82 179.42 45.2 Favored Glycine 0 CA--C 1.524 0.625 0 O-C-N 121.656 -0.652 . . . . 0.0 113.58 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 162.72 34.1 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.414 173.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.51 -36.14 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.95 1.3 . . . . 0.0 113.928 -170.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 73.52 -66.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.394 2.278 . . . . 0.0 111.176 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -138.09 133.97 34.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.54 157.9 18.04 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -136.6 -56.06 0.74 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.038 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -123.49 168.93 11.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.95 -6.74 13.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.16 0.984 . . . . 0.0 111.104 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.04 -14.25 8.9 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -129.81 119.79 23.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -163.62 169.47 18.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.76 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.94 178.84 5.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.326 1.05 . . . . 0.0 111.01 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.6 pt -147.08 141.81 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 160.59 14.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 159.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.2 mt -117.39 128.72 55.31 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 106.193 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.83 154.51 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.1 0.864 . . . . 0.0 110.458 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.28 -111.67 3.69 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -170.45 136.11 1.28 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.205 1.402 . . . . 0.0 109.467 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.67 154.8 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 126.826 2.05 . . . . 0.0 111.847 164.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 127.99 2.516 . . . . 0.0 105.142 167.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -55.06 -39.61 69.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.922 0.889 . . . . 0.0 110.17 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -13.07 61.3 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.286 0.469 . . . . 0.0 112.967 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -69.37 -22.77 63.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.551 1.175 . . . . 0.0 110.951 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -123.08 -24.32 4.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.949 1.299 . . . . 0.0 114.346 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -111.67 106.56 15.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.23 160.7 18.37 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.433 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.88 -19.66 65.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.973 2.109 . . . . 0.0 114.484 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 mt -124.92 2.28 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.849 1.26 . . . . 0.0 111.074 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -70.43 175.83 4.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.313 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -113.46 144.71 42.36 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.63 132.99 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.185 0.994 . . . . 0.0 108.401 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -53.01 157.32 1.78 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.916 0.78 . . . . 0.0 109.434 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.63 4.15 15.96 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -166.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.27 95.95 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 113.212 -154.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.17 123.19 44.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 108.367 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.25 137.89 55.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.539 1.063 . . . . 0.0 108.757 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.9 0.88 . . . . 0.0 108.642 179.117 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.238 0.456 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -126.14 139.42 53.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -135.21 137.41 42.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 162.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.52 -178.17 16.81 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.423 1.487 . . . . 0.0 110.195 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -101.46 150.41 23.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.22 161.71 38.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 162.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.01 155.59 17.05 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 154.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 92.7 mt -71.12 161.04 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.129 1.772 . . . . 0.0 106.265 161.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -134.39 -26.24 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.52 1.128 . . . . 0.0 112.099 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.6 m -154.73 157.06 37.46 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.46 1.504 . . . . 0.0 108.336 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.45 144.3 29.58 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -142.05 83.19 1.83 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.19 2.196 . . . . 0.0 107.894 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.73 -110.54 3.38 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.949 0.785 . . . . 0.0 112.691 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 22.9 p -72.64 -4.6 32.0 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 116.506 -1.711 . . . . 0.0 113.169 175.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -117.26 136.27 53.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.684 1.129 . . . . 0.0 108.469 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.18 164.13 27.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.216 1.406 . . . . 0.0 109.377 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -125.53 142.59 51.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 109.541 167.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.14 170.32 8.6 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.765 1.626 . . . . 0.0 112.002 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -141.21 22.69 2.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.58 1.552 . . . . 0.0 115.069 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.2 mt 51.81 -169.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.045 1.338 . . . . 0.0 112.514 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.341 0.223 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -66.11 175.16 5.03 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.69 1.594 . . . . 0.0 112.078 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.31 152.99 80.31 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 109.28 -1.085 . . . . 0.0 109.28 158.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.31 176.7 9.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.973 2.449 . . . . 0.0 111.261 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 p30 52.13 13.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.911 2.484 . . . . 0.0 115.042 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.3 m -121.35 -24.4 5.45 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.506 -0.747 . . . . 0.0 111.611 -164.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.8 mt -80.22 141.55 35.5 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 m -127.26 165.98 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.52 1.928 . . . . 0.0 110.423 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -79.01 -2.52 40.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.532 1.133 . . . . 0.0 113.284 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.26 20.62 2.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 126.597 2.046 . . . . 0.0 109.714 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.78 132.9 52.37 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -75.48 138.01 41.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 165.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.84 167.69 21.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 126.267 1.827 . . . . 0.0 109.496 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -128.89 134.2 48.18 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.838 -1.164 . . . . 0.0 109.582 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.08 170.43 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.417 1.487 . . . . 0.0 109.753 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.57 137.87 5.96 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.96 142.94 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 109.198 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -90.19 112.13 23.53 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -150.36 154.07 37.15 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 119.507 1.049 . . . . 0.0 110.419 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.86 -155.34 7.04 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -163.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.99 53.16 4.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.254 -1.303 . . . . 0.0 111.999 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -163.26 175.78 10.59 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.531 1.665 . . . . 0.0 112.768 162.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.54 145.51 28.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 156.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.402 ' SG ' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -118.14 83.82 2.07 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 127.737 2.415 . . . . 0.0 104.825 170.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -85.13 139.19 31.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.68 176.84 10.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 123.644 0.59 . . . . 0.0 110.58 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -105.57 168.81 8.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.045 1.338 . . . . 0.0 107.512 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.29 -179.99 40.53 Favored Glycine 0 C--N 1.334 0.454 0 O-C-N 120.759 -1.213 . . . . 0.0 112.76 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -128.03 169.91 13.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.47 1.508 . . . . 0.0 108.001 160.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.0 t -68.44 -40.26 81.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 118.861 0.755 . . . . 0.0 112.871 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 65.71 -43.92 0.37 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.801 2.04 . . . . 0.0 114.337 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -153.79 133.4 12.93 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.074 -1.641 . . . . 0.0 109.524 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.89 159.72 17.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.372 0.669 . . . . 0.0 109.33 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -138.05 -50.09 0.58 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.365 -0.835 . . . . 0.0 109.957 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.79 173.4 11.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.4 -6.46 14.52 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.753 0.821 . . . . 0.0 111.798 169.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -117.62 -18.28 9.74 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -130.98 127.85 39.2 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -168.82 166.76 11.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 109.815 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.81 174.95 7.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.631 1.173 . . . . 0.0 110.184 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -142.98 137.49 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 109.02 158.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 43' ' ' SER . 11.9 tpp180 -91.65 123.6 35.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 160.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.84 140.88 38.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 109.893 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.05 158.62 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.886 1.274 . . . . 0.0 110.954 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.54 53.64 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 125.791 1.662 . . . . 0.0 115.821 165.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.14 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.561 3.544 . . . . 0.0 111.98 -173.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.402 HG12 ' SG ' ' A' ' 77' ' ' CYS . 2.6 t -73.55 137.57 23.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 CA-C-N 121.32 1.873 . . . . 0.0 114.436 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.275 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -54.19 -41.73 68.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.619 0.767 . . . . 0.0 109.51 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -5.01 66.55 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.037 0.827 . . . . 0.0 113.834 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -88.22 -10.11 50.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.99 1.395 . . . . 0.0 111.588 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -117.93 -42.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.515 1.526 . . . . 0.0 109.592 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -99.45 146.81 25.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.08 1.352 . . . . 0.0 108.132 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -143.7 158.11 43.91 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -55.61 -20.12 12.59 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 126.453 1.901 . . . . 0.0 115.392 -164.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.2 mt -126.69 5.9 6.76 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -179.66 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.991 0.814 . . . . 0.0 110.587 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 129.36 56.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.715 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 m -118.75 140.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.68 162.45 13.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.945 0.898 . . . . 0.0 110.291 170.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.82 45.18 2.77 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.892 0.877 . . . . 0.0 109.811 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 m -65.01 125.26 24.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.9 t -131.95 127.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.024 1.729 . . . . 0.0 108.176 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 143.9 57.58 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.963 0.801 . . . . 0.0 109.778 172.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.9 mt . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.723 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 121.837 0.827 . . . . 0.0 113.203 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.93 149.57 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -150.35 123.16 8.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.61 -178.74 16.54 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.632 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.7 161.61 13.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 166.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.26 160.53 43.63 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.213 1.805 . . . . 0.0 109.622 161.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.98 135.6 33.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.89 153.74 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 159.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -131.52 -39.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.683 1.193 . . . . 0.0 110.279 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.4 m -152.9 123.49 7.27 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.97 1.308 . . . . 0.0 108.191 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 142.86 50.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.576 1.15 . . . . 0.0 109.645 -171.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -135.23 -169.81 2.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.754 1.622 . . . . 0.0 109.276 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.48 95.38 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -163.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -140.09 34.75 1.92 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.286 1.834 . . . . 0.0 108.376 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 146.33 36.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.28 168.59 19.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -130.83 142.86 50.41 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.514 1.926 . . . . 0.0 107.505 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -174.73 3.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.666 1.587 . . . . 0.0 109.894 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.7 mt 57.76 -177.37 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.628 1.571 . . . . 0.0 112.434 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.64 169.95 14.87 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.708 2.272 . . . . 0.0 112.061 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -57.25 154.57 33.85 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.394 1.396 . . . . 0.0 111.41 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.48 169.1 16.37 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.41 2.073 . . . . 0.0 109.093 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.17 44.79 6.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.0 m -138.75 -54.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.896 0.879 . . . . 0.0 109.195 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.78 137.95 58.16 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.678 171.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -147.16 160.88 41.92 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -69.94 -2.25 11.94 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -163.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.49 17.1 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 126.102 1.81 . . . . 0.0 111.137 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.67 28.22 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.88 129.94 38.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.86 159.36 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.128 -172.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.63 104.96 5.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.82 160.46 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.63 137.46 21.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.99 144.62 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.164 0.986 . . . . 0.0 109.231 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -86.33 111.15 20.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -156.99 150.71 24.53 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.57 -56.14 1.65 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.098 1.332 . . . . 0.0 110.936 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.92 -9.48 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.716 1.627 . . . . 0.0 112.933 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.29 174.61 7.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.186 1.493 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.8 tp -81.04 99.1 8.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -70.74 110.05 5.31 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 164.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 146.12 25.51 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.7 m -134.03 144.0 48.42 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.931 168.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.85 146.26 30.97 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.66 -177.52 22.96 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.23 0.919 . . . . 0.0 111.077 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -131.02 161.06 32.8 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 162.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.02 -31.08 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.29 -60.89 0.36 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.135 1.774 . . . . 0.0 111.139 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.4 m -153.27 122.73 6.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.799 2.04 . . . . 0.0 107.121 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tp -91.6 156.04 17.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -130.06 -46.68 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 111.502 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 5.7 m-20 -138.3 -178.73 5.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.231 1.812 . . . . 0.0 107.273 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -21.22 9.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.891 1.676 . . . . 0.0 111.434 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -122.07 -53.98 1.93 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 125.518 1.527 . . . . 0.0 111.214 -163.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.525 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 32.2 mt-30 -85.67 133.47 34.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.784 0.72 . . . . 0.0 109.493 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -166.94 164.04 16.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 109.012 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.78 176.21 8.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.605 0.762 . . . . 0.0 109.927 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -152.73 127.63 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.778 1.631 . . . . 0.0 110.219 164.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.13 125.39 34.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 164.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.58 137.96 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.6 164.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 120.657 1.571 . . . . 0.0 113.354 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.1 -117.6 10.87 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 127.544 2.497 . . . . 0.0 107.525 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -145.53 153.58 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.69 1.596 . . . . 0.0 108.113 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.6 t -55.93 152.69 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.347 1.859 . . . . 0.0 110.438 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.675 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -56.55 -42.38 78.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.539 1.535 . . . . 0.0 110.779 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.78 0.13 86.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.0 0.809 . . . . 0.0 113.524 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -84.43 -15.99 44.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.283 1.042 . . . . 0.0 111.207 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -116.21 -45.76 2.83 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.851 0.751 . . . . 0.0 111.367 -169.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.97 155.56 18.05 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.92 155.76 41.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -50.05 -27.41 5.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.727 3.211 . . . . 0.0 116.628 -168.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.49 1.51 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.608 1.163 . . . . 0.0 111.459 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.57 174.54 7.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 110.107 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -112.55 152.02 29.33 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.29 -0.881 . . . . 0.0 111.124 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.02 136.33 47.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.512 1.525 . . . . 0.0 107.181 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.01 164.55 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.5 mt -129.72 6.72 5.16 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -158.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.84 90.98 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.588 2.355 . . . . 0.0 112.841 -157.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.73 128.59 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -70.83 111.84 6.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.662 0.665 . . . . 0.0 109.613 165.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.49 ' HB2' ' H ' ' A' ' 30' ' ' SER . 2.5 mm? . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.319 0 CA-C-O 123.333 1.54 . . . . 0.0 114.588 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -136.6 102.7 5.0 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.156 1.382 . . . . 0.0 107.583 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 158.55 15.4 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.053 169.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -170.05 42.79 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 140.71 50.03 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.418 1.887 . . . . 0.0 108.486 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.43 155.13 50.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.969 0.804 . . . . 0.0 110.477 160.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.86 144.92 28.1 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.5 mt -70.77 157.68 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.065 1.346 . . . . 0.0 107.576 162.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -137.18 -56.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.745 2.018 . . . . 0.0 109.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -121.16 157.22 30.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.008 1.323 . . . . 0.0 109.176 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tt -153.64 118.63 5.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.07 94.65 3.08 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.203 1.401 . . . . 0.0 108.117 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.66 -127.38 43.21 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 p -71.24 36.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.994 1.397 . . . . 0.0 112.615 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -147.51 124.24 11.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.02 165.59 12.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 157.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -126.88 146.17 50.39 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 126.325 1.85 . . . . 0.0 108.297 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -138.24 157.9 45.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.709 1.604 . . . . 0.0 109.498 -159.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.42 26.71 2.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.3 mt 51.19 -165.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.97 1.308 . . . . 0.0 111.276 -171.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 C-N-CA 124.119 0.967 . . . . 0.0 111.776 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.34 170.75 10.3 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.383 2.722 . . . . 0.0 112.217 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.51 154.58 73.84 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.271 1.314 . . . . 0.0 109.286 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.62 161.03 47.51 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 122.72 2.28 . . . . 0.0 111.786 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 47.0 33.84 2.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.426 1.89 . . . . 0.0 112.051 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -128.56 -18.96 3.84 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.298 -0.876 . . . . 0.0 111.855 -171.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 mt -76.01 143.26 41.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.803 0.729 . . . . 0.0 109.284 155.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -141.4 168.77 18.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.364 1.466 . . . . 0.0 108.81 159.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -69.23 -3.76 15.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.443 1.497 . . . . 0.0 114.722 -170.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.44 -2.79 25.94 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 117.851 -1.527 . . . . 0.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.36 131.14 49.31 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.587 1.694 . . . . 0.0 109.188 -164.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -85.56 72.89 10.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.25 1.5 . . . . 0.0 108.48 -167.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.03 154.13 7.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.884 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -134.18 128.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.05 0.94 . . . . 0.0 108.852 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -95.15 175.66 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.694 1.597 . . . . 0.0 110.208 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.0 p -154.71 162.08 41.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.019 1.327 . . . . 0.0 107.829 152.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 p -157.33 143.06 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.747 0.703 . . . . 0.0 109.676 159.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -90.29 117.14 28.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.8 t -136.52 170.38 16.16 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.263 1.425 . . . . 0.0 107.685 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 58.44 -107.66 1.21 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.82 32.17 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.482 1.515 . . . . 0.0 111.952 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.52 -170.11 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.055 1.342 . . . . 0.0 108.789 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.88 122.03 43.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.412 1.485 . . . . 0.0 110.317 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.11 129.1 51.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.44 164.39 25.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.773 1.169 . . . . 0.0 108.345 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.7 t -149.67 148.17 28.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.4 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -79.84 144.3 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.302 1.441 . . . . 0.0 108.043 168.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.11 -169.61 16.46 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.229 -0.919 . . . . 0.0 112.078 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -138.07 168.9 18.76 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 106.73 163.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.88 -27.5 37.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 67.91 -62.85 0.34 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.946 1.699 . . . . 0.0 113.369 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 m -149.32 129.26 13.43 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.569 1.947 . . . . 0.0 106.601 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.97 140.03 43.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -115.2 -52.89 2.66 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.838 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -137.45 169.72 17.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -18.14 57.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.059 0.543 . . . . 0.0 111.978 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -110.41 -15.86 13.83 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.799 172.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -120.48 123.3 42.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.805 1.638 . . . . 0.0 109.127 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -165.77 165.42 18.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.474 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 176.03 8.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.705 1.202 . . . . 0.0 110.596 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.9 pt -144.75 148.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.306 1.442 . . . . 0.0 109.048 155.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 ttp85 -116.37 112.38 21.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.734 1.614 . . . . 0.0 109.286 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.3 mt -75.59 126.25 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.848 1.659 . . . . 0.0 108.571 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.77 161.87 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 111.108 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.12 8.51 87.41 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.072 -1.404 . . . . 0.0 115.039 167.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.28 135.63 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.433 2.693 . . . . 0.0 111.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -86.65 127.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 120.163 1.347 . . . . 0.0 109.767 171.133 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.74 -47.6 77.64 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.609 -1.307 . . . . 0.0 110.895 -166.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.63 6.19 33.39 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 124.065 0.841 . . . . 0.0 113.537 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -84.95 -13.87 49.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.762 1.281 . . . . 0.0 110.65 166.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.419 ' HE2' ' CG1' ' A' ' 100' ' ' VAL . 8.1 m-30 -123.74 -35.78 2.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.807 1.643 . . . . 0.0 112.965 -170.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 24.3 m-85 -108.49 122.17 46.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -172.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.54 159.6 16.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -60.32 -14.09 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.642 2.777 . . . . 0.0 114.203 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 mt -133.84 13.42 4.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.934 1.694 . . . . 0.0 109.911 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -97.36 163.91 12.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 127.008 2.123 . . . . 0.0 109.852 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -118.74 143.17 47.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.133 -0.98 . . . . 0.0 111.58 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.94 139.89 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.576 2.35 . . . . 0.0 104.721 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.58 156.06 24.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.264 172.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 mt -132.01 93.72 3.34 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -80.32 90.02 5.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 t -85.31 102.11 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -55.02 120.96 7.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 117.21 -1.376 . . . . 0.0 109.708 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.921 0 C-N-CA 124.081 0.953 . . . . 0.0 112.419 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 122.049 0.928 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -95.55 103.68 15.56 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 -172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.2 109.21 19.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.53 164.52 12.16 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.303 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 138.9 43.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.18 34.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.34 148.91 24.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.2 mt -72.95 160.62 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.886 1.675 . . . . 0.0 108.761 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.1 p -133.45 -32.22 1.17 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.672 2.389 . . . . 0.0 111.294 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 m -151.55 142.98 23.49 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 42' ' ' GLY . 1.4 tp -141.18 114.28 8.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 110.646 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.31 32.19 5.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.872 0.869 . . . . 0.0 112.941 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.415 ' H ' ' HG ' ' A' ' 40' ' ' LEU . . . 115.13 -113.09 2.86 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -67.98 22.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.365 1.466 . . . . 0.0 111.735 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' GLY . 2.8 tm? -148.83 126.78 11.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.58 163.63 22.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -124.97 146.14 49.54 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 127.264 2.226 . . . . 0.0 107.866 170.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.5 mt -138.88 161.35 37.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.092 1.495 . . . . 0.0 110.433 -156.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -146.33 36.47 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.8 mt 54.25 -174.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.335 -1.478 . . . . 0.0 113.847 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.185 0 O-C-N 121.982 -0.449 . . . . 0.0 112.012 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 119.085 -0.484 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.23 165.33 29.01 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.841 2.36 . . . . 0.0 111.158 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.11 160.01 24.1 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.351 1.367 . . . . 0.0 110.961 171.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.92 160.49 11.85 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.515 2.143 . . . . 0.0 110.853 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 56.3 35.88 26.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.311 1.444 . . . . 0.0 111.411 -171.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.72 -40.25 1.22 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -172.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.1 mt -73.06 140.21 47.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -138.68 165.18 27.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.831 0.852 . . . . 0.0 109.702 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 58.9 mt-10 -70.79 -2.23 14.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.431 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.26 2.26 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 120.659 -1.275 . . . . 0.0 110.129 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.5 132.43 53.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 165.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.37 116.83 16.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 166.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.53 140.48 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.53 116.43 22.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -165.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 79' ' ' CYS . 2.5 m -72.93 162.28 4.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 C-N-CA 124.045 0.938 . . . . 0.0 109.822 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -160.12 141.29 12.36 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.619 1.568 . . . . 0.0 112.031 150.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.91 158.3 10.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.165 1.386 . . . . 0.0 109.521 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -92.25 121.43 33.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.524 1.53 . . . . 0.0 107.428 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 t -150.47 160.54 43.7 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.26 -117.93 3.07 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.03 20.63 5.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.343 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.51 172.34 17.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.445 2.123 . . . . 0.0 110.293 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.89 115.81 28.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.71 150.52 20.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -157.01 134.97 11.0 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 106.93 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' H ' HG23 ' A' ' 68' ' ' VAL . 27.9 t -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 107.173 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.13 152.68 44.84 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.68 -175.95 23.16 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.755 -1.215 . . . . 0.0 111.618 -172.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -129.21 172.33 11.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.01 0.924 . . . . 0.0 109.218 163.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.0 t -68.62 -32.44 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.5 -65.53 0.2 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.885 1.674 . . . . 0.0 111.993 -172.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -145.33 126.49 14.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.142 1.377 . . . . 0.0 108.072 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 2.8 tp -86.31 165.11 16.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.797 0.839 . . . . 0.0 109.156 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -137.24 -43.71 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.783 0.72 . . . . 0.0 112.643 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -141.58 177.25 8.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.9 -6.06 7.5 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.48 -1.387 . . . . 0.0 111.884 169.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -138.9 -1.82 1.76 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -127.85 134.88 49.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 120.32 1.418 . . . . 0.0 107.282 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.54 166.43 2.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.8 178.9 6.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.563 0.745 . . . . 0.0 110.627 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.6 pt -147.43 134.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.654 1.181 . . . . 0.0 111.109 160.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -90.72 127.37 36.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.079 0.952 . . . . 0.0 108.665 165.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -84.85 131.02 34.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.26 171.19 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 119.472 1.033 . . . . 0.0 111.463 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.35 13.31 64.91 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.998 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.6 163.69 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.418 3.887 . . . . 0.0 113.577 -173.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.419 ' CG1' ' HE2' ' A' ' 12' ' ' TYR . 1.1 p -112.1 127.67 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.907 2.483 . . . . 0.0 110.625 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 167.904 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -57.41 -48.23 79.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.421 1.464 . . . . 0.0 110.963 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -15.73 65.49 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 119.301 -0.722 . . . . 0.0 113.417 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -71.15 -21.04 62.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.591 1.195 . . . . 0.0 111.305 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 1.2 m-85 -112.03 -51.4 2.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.379 0.672 . . . . 0.0 109.539 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.14 161.75 27.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -145.42 161.08 40.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.527 -0.733 . . . . 0.0 112.07 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.86 -22.84 62.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.69 9.05 8.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.233 1.413 . . . . 0.0 111.072 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.47 174.97 1.49 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.384 0.611 . . . . 0.0 110.02 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 30.2 mtpt -116.7 146.03 43.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 109.042 166.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.56 156.76 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 109.826 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.12 141.57 28.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.936 2.094 . . . . 0.0 109.441 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.9 mt -130.98 70.99 1.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.881 1.273 . . . . 0.0 113.459 -162.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -60.98 133.58 56.24 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.043 -1.036 . . . . 0.0 108.277 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -126.71 121.11 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 164.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -62.56 137.23 58.22 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 120.52 1.509 . . . . 0.0 108.941 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 171.454 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 121.838 0.828 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -80.9 154.2 27.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.18 141.76 37.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 157.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.95 174.17 24.43 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 164.24 12.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.19 160.14 43.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.785 -1.197 . . . . 0.0 110.465 161.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 147.17 28.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 157.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.1 mt -79.43 157.46 4.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -130.56 -32.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.536 1.535 . . . . 0.0 111.36 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.9 m -152.23 155.14 37.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.066 1.746 . . . . 0.0 108.878 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.2 tp -147.25 112.61 5.57 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.179 1.391 . . . . 0.0 108.671 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -133.16 94.22 3.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 51.88 -131.3 36.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.404 -0.664 . . . . 0.0 111.794 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 p -74.66 43.59 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.422 1.889 . . . . 0.0 110.839 173.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.25 107.83 3.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.849 -0.532 . . . . 0.0 111.732 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.67 165.51 11.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 165.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -126.83 148.63 49.95 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.588 1.555 . . . . 0.0 108.0 164.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 mt -135.9 172.25 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.124 1.769 . . . . 0.0 109.272 -165.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -151.03 27.22 0.7 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 mt 52.25 -174.15 0.03 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.36 1.864 . . . . 0.0 113.024 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 125.822 1.649 . . . . 0.0 106.952 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.56 175.23 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.753 2.302 . . . . 0.0 112.391 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -58.97 154.76 42.66 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 121.106 1.204 . . . . 0.0 110.55 160.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -65.63 174.66 5.15 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.604 2.869 . . . . 0.0 110.156 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.2 p30 52.69 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.4 m -110.09 -31.34 7.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 111.193 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -69.59 139.61 53.68 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.101 -0.999 . . . . 0.0 110.085 168.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.02 156.71 45.98 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.26 . . . . 0.0 110.049 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.71 -1.7 14.76 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -168.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.12 18.26 4.76 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.113 1.816 . . . . 0.0 111.215 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.61 141.01 58.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.67 63.79 1.25 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 123.674 1.702 . . . . 0.0 111.663 -163.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 m -68.38 162.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.014 -1.903 . . . . 0.0 112.039 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 169.17 9.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.584 1.154 . . . . 0.0 109.787 173.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.89 123.75 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 125.478 1.511 . . . . 0.0 109.565 168.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -121.64 141.87 50.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.963 0.789 . . . . 0.0 110.607 162.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.4 146.79 15.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.85 2.06 . . . . 0.0 106.337 162.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 76.6 m95 -87.77 143.05 27.36 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 163.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 t -137.5 173.68 11.4 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.01 -98.62 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.753 2.121 . . . . 0.0 112.683 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.8 22.38 2.82 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.322 1.915 . . . . 0.0 111.927 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.71 174.73 11.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.049 1.924 . . . . 0.0 114.024 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.8 tm? -115.61 122.77 46.61 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.151 1.381 . . . . 0.0 110.738 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.86 81.45 1.77 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.099 1.36 . . . . 0.0 110.074 -168.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -99.25 128.22 45.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.57 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.3 t -128.17 172.44 11.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.726 0.81 . . . . 0.0 110.021 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.21 160.19 16.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.125 1.77 . . . . 0.0 108.702 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.69 -169.32 29.15 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -144.12 160.72 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.638 1.975 . . . . 0.0 109.1 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.274 51.3 t -62.52 -31.84 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 70.23 -66.11 0.29 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.107 2.163 . . . . 0.0 114.937 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -155.71 97.16 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.796 1.638 . . . . 0.0 108.915 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tp -79.09 152.89 30.57 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.18 -58.76 1.53 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.239 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 30.0 m-20 -127.15 -173.54 2.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.24 -8.35 45.07 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.966 -1.084 . . . . 0.0 111.123 166.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -131.91 -44.89 0.95 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 112.574 -169.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 31.6 mt-30 -91.7 133.38 35.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -167.29 164.2 15.33 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.162 0.585 . . . . 0.0 109.724 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.85 175.31 10.79 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.25 1.42 . . . . 0.0 110.807 172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.46 148.17 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.391 1.076 . . . . 0.0 109.188 156.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.24 114.96 26.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.595 2.758 . . . . 0.0 107.606 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.64 147.09 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.495 1.043 . . . . 0.0 108.573 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.83 146.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 122.335 1.064 . . . . 0.0 109.758 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.74 -141.85 31.28 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -166.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.32 138.37 29.45 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.666 1.186 . . . . 0.0 110.838 -165.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.406 ' CG1' ' CE2' ' A' ' 12' ' ' TYR . 1.4 p -85.34 129.85 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.044 1.738 . . . . 0.0 111.662 171.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 125.914 1.686 . . . . 0.0 106.703 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.245 0.545 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -105.62 -47.71 3.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.439 1.495 . . . . 0.0 109.804 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.95 10.38 3.18 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.734 1.635 . . . . 0.0 113.363 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -90.85 -14.7 31.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.358 1.863 . . . . 0.0 112.484 165.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -121.52 -39.04 2.69 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.994 1.318 . . . . 0.0 112.329 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -93.16 154.35 18.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -143.76 155.8 44.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -57.61 -21.7 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 126.279 1.832 . . . . 0.0 113.661 -170.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -124.39 6.47 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.019 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -72.16 169.0 17.01 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.508 -1.37 . . . . 0.0 110.865 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -99.79 153.31 19.23 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.04 148.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.379 1.871 . . . . 0.0 106.039 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.65 161.77 29.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.761 0.825 . . . . 0.0 111.274 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -133.37 41.68 3.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.935 0.894 . . . . 0.0 112.487 -163.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 m -66.62 100.7 0.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.4 t -94.47 113.24 28.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -57.56 107.21 0.42 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-N 120.535 1.516 . . . . 0.0 109.334 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 126.168 1.787 . . . . 0.0 107.808 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.715 0 CA-C-O 121.647 0.737 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -110.48 148.4 32.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 164.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -132.79 141.37 48.46 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.926 0.89 . . . . 0.0 110.429 166.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.15 -168.42 26.18 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.568 1.556 . . . . 0.0 110.73 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.2 m -129.26 148.85 51.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.64 162.08 32.91 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 162.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.26 144.65 25.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.04 153.53 8.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 163.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.3 p -130.89 -40.19 1.19 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.776 1.231 . . . . 0.0 110.398 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -140.88 154.51 46.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.873 2.069 . . . . 0.0 107.695 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.75 134.8 20.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -154.23 95.06 1.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.905 1.682 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 -110.8 3.29 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.861 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.5 p -100.09 36.26 1.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.597 1.198 . . . . 0.0 110.449 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.36 131.64 22.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.22 28.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -122.11 147.16 46.48 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.791 1.637 . . . . 0.0 108.154 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -140.2 156.73 46.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.898 1.679 . . . . 0.0 109.691 -163.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -143.53 35.89 1.31 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 mt 50.89 -170.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.9 1.28 . . . . 0.0 111.3 -171.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 126.227 1.811 . . . . 0.0 112.963 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 168.12 19.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.193 1.929 . . . . 0.0 110.152 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.94 155.76 66.17 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 120.986 1.124 . . . . 0.0 110.041 164.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.06 174.88 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.014 2.476 . . . . 0.0 108.293 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.99 23.51 12.64 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.986 -1.071 . . . . 0.0 111.34 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.4 m -137.59 -43.85 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.457 1.503 . . . . 0.0 110.182 -167.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 mt -70.96 135.65 48.02 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 120.126 1.33 . . . . 0.0 109.349 169.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.7 m -132.77 163.91 27.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.084 0.954 . . . . 0.0 111.046 168.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.96 -0.05 12.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.026 1.33 . . . . 0.0 114.178 -170.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.2 10.86 7.31 Favored Glycine 0 C--N 1.321 -0.283 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.428 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 128.19 34.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 71.22 1.41 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.076 1.417 . . . . 0.0 109.844 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.6 m -82.87 136.17 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.779 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.84 120.42 41.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.907 0.883 . . . . 0.0 109.157 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.93 155.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.3 p -142.76 155.66 44.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 153.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -150.87 150.88 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 164.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -100.06 120.5 39.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -156.74 157.04 34.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.2 42.36 62.66 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.944 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.8 -22.87 5.39 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.077 0.938 . . . . 0.0 113.733 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.8 164.17 16.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.892 1.346 . . . . 0.0 112.055 -158.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 tp -84.73 102.02 12.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.7 m -88.55 123.45 33.06 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.31 158.56 42.64 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 167.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 41.9 t -148.83 141.97 24.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.296 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.36 149.95 46.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 110.141 173.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.62 -167.48 20.31 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.602 -1.311 . . . . 0.0 112.747 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -139.49 178.96 6.84 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.156 1.782 . . . . 0.0 110.269 166.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.03 -46.01 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.989 1.315 . . . . 0.0 113.234 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 64.7 -58.87 0.24 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.627 2.371 . . . . 0.0 115.23 -167.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -132.44 133.63 44.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -104.8 162.58 13.18 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -139.02 -37.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 120.843 -1.161 . . . . 0.0 113.853 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.77 -175.7 4.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 164.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -68.51 1.69 2.92 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.189 -0.944 . . . . 0.0 112.457 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -134.06 -18.32 2.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -121.24 138.02 54.42 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.364 1.438 . . . . 0.0 107.221 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -172.68 164.13 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.951 0.9 . . . . 0.0 109.602 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.95 172.12 12.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.484 1.114 . . . . 0.0 109.344 168.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 pt -139.97 143.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.326 1.05 . . . . 0.0 109.156 153.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 130.55 46.06 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.685 1.194 . . . . 0.0 107.794 163.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.1 mt -87.44 135.09 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.85 157.23 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 122.33 1.062 . . . . 0.0 109.529 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.98 -109.67 2.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -165.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.6 166.5 31.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -96.47 148.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 1 C-N-CA 133.179 4.591 . . . . 0.0 110.79 154.579 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 . . . . . 0 C--O 1.237 0.4 0 C-N-CA 127.616 2.366 . . . . 0.0 107.346 160.936 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -62.52 -37.79 87.44 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.96 -0.462 . . . . 0.0 110.415 -170.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.41 44.07 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.26 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 mtt-85 -84.52 -16.15 43.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.66 1.23 . . . . 0.0 110.164 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -116.53 -45.85 2.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.184 1.794 . . . . 0.0 109.98 -172.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -91.4 168.39 11.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.282 1.033 . . . . 0.0 108.237 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -148.85 169.54 20.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.692 0.797 . . . . 0.0 109.183 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -71.23 -20.73 62.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.98 14.13 7.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.1 0.96 . . . . 0.0 109.138 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -177.18 2.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.092 1.757 . . . . 0.0 110.542 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.99 33.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 120.926 -1.108 . . . . 0.0 111.042 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.67 144.86 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.529 1.131 . . . . 0.0 108.441 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.45 158.6 29.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.295 1.438 . . . . 0.0 109.934 167.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.8 mt -130.8 55.45 1.84 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.145 1.378 . . . . 0.0 109.72 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -69.06 130.26 42.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.38 130.42 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -71.17 114.6 9.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.778 1.627 . . . . 0.0 109.103 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 124.208 1.956 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -132.05 147.27 52.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -139.02 130.41 27.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.55 -168.77 13.3 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.227 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 142.32 45.22 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.063 1.345 . . . . 0.0 107.808 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.68 153.93 51.77 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 164.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.79 38.81 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 156.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.5 mt -68.63 158.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 160.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.1 p -135.88 -18.52 1.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.779 1.632 . . . . 0.0 112.122 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 m -157.6 148.6 21.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -144.48 122.56 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -135.68 74.64 1.52 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.592 1.957 . . . . 0.0 107.953 -173.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.56 -123.78 29.84 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.6 p -77.1 34.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.777 1.288 . . . . 0.0 111.97 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.7 125.01 8.78 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.8 162.46 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -129.3 147.52 51.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.684 1.194 . . . . 0.0 110.452 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.62 173.45 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.68 1.592 . . . . 0.0 112.51 -167.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.37 19.95 1.37 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mt 55.51 -171.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.861 0.864 . . . . 0.0 112.943 -169.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 C-N-CA 126.005 1.722 . . . . 0.0 109.903 165.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.88 167.77 18.76 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.107 3.205 . . . . 0.0 112.996 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.12 154.23 71.78 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 121.204 1.269 . . . . 0.0 109.994 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.01 170.45 20.08 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.192 2.595 . . . . 0.0 110.765 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.47 -3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 128.211 2.605 . . . . 0.0 116.503 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.2 m -101.32 -24.34 14.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.025 1.33 . . . . 0.0 112.046 -161.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.5 mt -78.92 149.26 32.42 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 120.97 -1.082 . . . . 0.0 108.845 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.75 163.24 34.6 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.553 1.141 . . . . 0.0 108.447 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -70.67 -2.04 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 37.48 1.5 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 135.87 57.21 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 162.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.18 125.78 29.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 166.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.98 136.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.565 1.146 . . . . 0.0 109.616 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.63 131.83 41.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.82 154.71 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.7 p -145.29 146.98 31.87 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 157.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.5 p -149.87 147.75 15.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.239 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -89.38 117.98 28.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.0 t -151.17 169.86 20.86 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.62 -117.61 3.56 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -163.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.35 60.89 0.63 Allowed Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.97 -175.59 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.482 1.513 . . . . 0.0 109.053 176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.5 101.85 10.99 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.029 1.732 . . . . 0.0 108.933 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -71.71 107.9 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.74 133.56 39.7 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 165.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.21 133.2 47.44 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.51 152.25 28.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.91 -171.43 33.84 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.16 167.14 21.22 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.9 -27.49 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 65.03 -64.16 0.17 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.129 1.772 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -149.36 110.25 4.32 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.319 2.247 . . . . 0.0 105.294 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tp -81.36 153.93 26.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 167.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -120.25 -71.36 0.74 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.03 179.48 3.94 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.116 1.766 . . . . 0.0 108.494 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.76 -2.3 0.22 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.421 2.688 . . . . 0.0 113.698 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -157.22 -38.13 0.07 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.1 -1.0 . . . . 0.0 113.151 -159.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.28 127.73 45.32 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -171.62 176.44 3.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.112 0.965 . . . . 0.0 109.308 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.19 179.92 4.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.338 1.055 . . . . 0.0 112.234 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -150.2 124.62 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.213 1.805 . . . . 0.0 111.654 167.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 114.18 26.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.25 1.42 . . . . 0.0 107.648 168.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -78.02 135.01 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.89 1.276 . . . . 0.0 108.129 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 m -136.89 167.65 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.163 0.585 . . . . 0.0 111.121 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.93 15.61 80.91 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 118.502 -1.165 . . . . 0.0 114.616 164.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.22 165.23 0.19 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.815 2.046 . . . . 0.0 111.006 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -116.59 137.45 50.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -72.91 -50.03 26.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.791 -1.193 . . . . 0.0 110.141 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.32 -24.05 77.38 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.547 0.612 . . . . 0.0 113.0 -164.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -61.79 -21.24 64.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.518 172.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -113.6 -40.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.034 1.334 . . . . 0.0 111.49 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.67 112.06 24.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.536 1.534 . . . . 0.0 108.606 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.18 157.49 19.34 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.605 0.566 . . . . 0.0 109.932 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.0 -27.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.522 2.729 . . . . 0.0 113.859 163.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.37 41.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.241 1.416 . . . . 0.0 108.561 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -113.0 159.9 18.66 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.462 1.105 . . . . 0.0 108.96 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 148.12 32.94 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.065 -1.022 . . . . 0.0 110.404 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.47 155.3 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.337 1.055 . . . . 0.0 108.763 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 161.09 5.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.238 0.615 . . . . 0.0 110.839 162.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.73 44.46 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.588 2.355 . . . . 0.0 108.303 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.2 m -68.2 114.59 6.82 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.47 104.73 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -50.12 114.54 1.12 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 165.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB2' ' H ' ' A' ' 30' ' ' SER . 84.7 mt . . . . . 0 CA--C 1.512 -0.518 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 25' ' ' LEU 0.315 1.2 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.64 166.69 23.31 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 105.933 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -152.59 154.95 36.42 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.04 11.52 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -133.67 151.71 51.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.9 151.0 39.25 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 167.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 145.57 26.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 166.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.0 156.32 7.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 168.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 p -132.8 -22.79 2.07 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.926 2.09 . . . . 0.0 111.819 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -157.05 132.82 9.41 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.537 1.535 . . . . 0.0 108.237 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -126.74 146.72 50.12 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.404 1.081 . . . . 0.0 108.621 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -161.8 88.11 0.69 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.229 1.012 . . . . 0.0 111.633 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.26 -125.92 37.0 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.1 p -80.48 45.0 0.74 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.041 0.92 . . . . 0.0 110.903 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tp -153.05 129.34 10.53 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.53 149.82 51.69 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -114.45 132.42 56.26 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.21 1.404 . . . . 0.0 108.73 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.31 156.06 34.66 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.044 1.338 . . . . 0.0 109.9 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -137.91 23.98 2.83 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -169.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 mt 51.37 140.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 130.671 3.589 . . . . 0.0 115.58 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.238 0.495 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.42 170.7 17.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.373 2.049 . . . . 0.0 112.317 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.54 154.19 74.84 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.15 1.9 . . . . 0.0 111.09 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.51 167.48 25.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.973 2.449 . . . . 0.0 111.424 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 49.23 26.22 1.45 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.904 2.081 . . . . 0.0 111.966 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.1 m -122.8 -55.79 1.79 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.115 1.366 . . . . 0.0 108.021 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.17 130.27 41.44 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 168.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 m -143.11 163.6 32.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -78.18 0.73 23.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.412 1.085 . . . . 0.0 113.713 -164.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.62 21.67 3.05 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 124.9 21.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.59 117.29 11.93 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.22 153.68 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 124.929 1.291 . . . . 0.0 107.843 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 p -125.71 130.46 51.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.105 0.866 . . . . 0.0 111.104 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.463 HG22 ' H ' ' A' ' 79' ' ' CYS . 2.6 m -81.28 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -165.75 131.38 2.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.326 2.25 . . . . 0.0 106.428 154.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.16 138.3 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 168.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -81.73 112.28 18.75 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 168.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -114.2 -166.09 1.07 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 168.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.78 127.49 14.69 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.66 2.53 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.22 -0.767 . . . . 0.0 111.413 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.7 174.19 11.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.908 1.354 . . . . 0.0 111.368 -154.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.59 117.74 23.92 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 173.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 15.0 p -99.55 122.16 42.21 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.71 162.12 32.81 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.463 ' H ' HG22 ' A' ' 68' ' ' VAL . 22.4 t -155.4 166.8 32.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.8 140.88 52.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.75 -175.57 22.11 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 123.552 0.596 . . . . 0.0 114.021 -160.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -133.35 163.84 28.43 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 166.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.3 t -65.17 -39.97 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.141 0.882 . . . . 0.0 111.961 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 64.9 -48.52 0.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.161 2.585 . . . . 0.0 113.921 -167.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 m -153.79 101.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.27 1.428 . . . . 0.0 107.685 -166.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 tp -81.9 161.63 23.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -133.85 -41.46 0.84 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.735 0.814 . . . . 0.0 111.792 171.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.37 173.63 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.706 2.002 . . . . 0.0 105.982 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.2 -10.2 1.85 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.975 2.11 . . . . 0.0 112.943 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -127.74 -24.4 3.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.839 1.656 . . . . 0.0 112.234 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -120.46 121.09 37.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -162.33 163.48 27.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.932 0.396 . . . . 0.0 110.038 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.11 171.55 10.17 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.029 171.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.3 pt -146.85 131.05 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.201 1.8 . . . . 0.0 108.638 163.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.32 119.48 31.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.47 125.83 29.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.93 158.24 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.13 -154.26 49.28 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -173.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 137.46 51.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.084 -2.058 . . . . 0.0 108.214 -171.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.52 149.62 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 . . . . . 0 C--O 1.234 0.251 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 164.883 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -59.4 -47.94 83.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 111.08 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.4 -16.61 71.62 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.792 0.71 . . . . 0.0 112.671 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -74.7 -10.54 59.63 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.72 -0.871 . . . . 0.0 111.525 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.492 ' HB3' ' HG ' ' A' ' 77' ' ' CYS . 3.3 m-30 -120.19 -40.93 2.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.331 1.452 . . . . 0.0 110.574 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -101.17 104.57 15.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -83.08 157.12 22.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 169.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -62.42 -15.13 47.5 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 127.286 2.234 . . . . 0.0 114.805 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.81 2.61 6.03 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.446 1.098 . . . . 0.0 111.203 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -71.43 178.83 3.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 111.712 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.81 157.61 18.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.427 1.091 . . . . 0.0 110.283 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.66 146.07 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 108.769 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -65.41 153.09 42.29 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.605 0.639 . . . . 0.0 109.387 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.83 51.39 1.53 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.328 0.651 . . . . 0.0 111.477 -165.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 112.96 4.39 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.131 -0.98 . . . . 0.0 110.294 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.64 109.6 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.029 1.332 . . . . 0.0 109.576 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -62.2 130.15 44.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.216 1.807 . . . . 0.0 109.941 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 124.493 1.117 . . . . 0.0 108.914 176.914 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -137.06 151.06 48.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 164.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.6 141.19 31.92 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.764 1.226 . . . . 0.0 108.186 166.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.23 -173.06 17.13 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.218 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.45 124.48 38.53 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.05 1.34 . . . . 0.0 107.637 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.77 149.95 45.57 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.672 1.989 . . . . 0.0 107.079 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.67 153.34 17.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.9 mt -75.19 162.62 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.625 1.57 . . . . 0.0 107.622 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.7 p -140.1 -40.85 0.43 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.986 1.715 . . . . 0.0 111.641 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 m -137.3 145.82 43.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tp -136.0 138.52 42.33 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.569 -1.332 . . . . 0.0 107.863 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -145.42 87.8 1.82 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.717 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.46 -119.04 16.84 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 124.37 0.986 . . . . 0.0 111.245 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 p -73.85 36.71 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.764 1.226 . . . . 0.0 111.795 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -145.16 134.95 23.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.568 -1.332 . . . . 0.0 107.725 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -131.24 163.25 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 161.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -122.07 140.85 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.155 1.782 . . . . 0.0 107.638 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.21 167.45 12.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.9 127.7 25.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.544 1.938 . . . . 0.0 108.29 162.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.2 mt -52.62 146.55 9.93 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 177.947 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.57 174.2 6.74 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.441 2.761 . . . . 0.0 110.775 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.84 158.11 44.49 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 120.81 1.007 . . . . 0.0 110.274 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.99 169.58 20.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.518 2.145 . . . . 0.0 111.105 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 56.12 13.7 1.26 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.402 1.881 . . . . 0.0 113.252 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.0 m -110.18 -53.25 2.7 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.834 1.253 . . . . 0.0 107.851 -166.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.88 150.25 20.77 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.403 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -144.15 163.4 33.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.685 0.794 . . . . 0.0 111.633 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -71.7 -7.8 50.22 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 10.43 7.58 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 124.696 1.141 . . . . 0.0 112.392 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.58 137.35 58.05 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.21 64.0 8.32 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.532 1.158 . . . . 0.0 111.487 -168.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.88 131.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -84.95 165.94 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.83 119.33 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 124.513 1.125 . . . . 0.0 109.565 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -121.57 145.45 47.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.981 0.912 . . . . 0.0 109.432 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -153.78 159.16 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 165.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -94.43 106.66 18.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 t -145.57 168.77 19.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.492 0.717 . . . . 0.0 109.216 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.8 28.26 38.56 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.599 -1.112 . . . . 0.0 113.202 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.08 6.36 88.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.27 1.414 . . . . 0.0 113.904 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 176.16 9.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 112.463 -166.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.4 tp -104.71 96.29 6.48 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.933 1.693 . . . . 0.0 107.967 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.492 ' HG ' ' HB3' ' A' ' 12' ' ' TYR . 26.2 p -80.16 140.0 36.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -146.05 112.53 5.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.662 -0.649 . . . . 0.0 111.801 168.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.3 t -107.63 172.4 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.931 0.872 . . . . 0.0 111.108 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.88 154.34 24.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.774 2.43 . . . . 0.0 107.472 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.74 -166.71 33.65 Favored Glycine 0 C--O 1.239 0.458 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.517 1.527 . . . . 0.0 109.761 173.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.2 t -70.51 -31.19 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.836 0.854 . . . . 0.0 112.658 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 68.88 -61.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.72 2.008 . . . . 0.0 112.704 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 m -146.21 115.51 7.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.142 2.177 . . . . 0.0 106.392 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.78 155.97 21.59 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -128.78 -58.34 1.16 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.714 -0.616 . . . . 0.0 110.636 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -123.24 172.67 8.45 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 107.114 170.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -7.87 25.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.929 0.492 . . . . 0.0 111.08 164.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.88 -7.4 8.98 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 125.507 1.523 . . . . 0.0 114.933 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.42 130.12 25.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -162.39 162.99 28.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 118.168 0.44 . . . . 0.0 110.123 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.44 178.49 8.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.488 0.715 . . . . 0.0 109.582 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 pt -142.45 157.2 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 125.122 1.369 . . . . 0.0 108.735 156.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.77 113.91 22.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.193 2.197 . . . . 0.0 106.138 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.99 149.73 44.7 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 174.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.987 0.915 . . . . 0.0 110.624 170.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.52 -111.81 2.63 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 126.354 1.93 . . . . 0.0 109.134 -170.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.28 21.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.53 1.932 . . . . 0.0 109.999 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.453 ' CG1' ' CE2' ' A' ' 12' ' ' TYR . 1.5 p -121.24 156.15 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.705 2.002 . . . . 0.0 110.673 172.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 128.628 2.771 . . . . 0.0 107.279 -161.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -39.34 82.04 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.364 -0.835 . . . . 0.0 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.42 -14.32 74.5 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 118.293 -1.282 . . . . 0.0 112.587 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.93 -40.93 95.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.014 1.907 . . . . 0.0 109.989 166.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -86.27 -46.38 10.39 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.265 -173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.18 105.47 17.63 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.496 1.118 . . . . 0.0 109.378 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -85.95 160.09 19.47 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 127.403 2.281 . . . . 0.0 110.31 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.28 -24.66 67.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -171.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -130.95 16.49 5.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.58 1.552 . . . . 0.0 109.342 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.407 HE21 HG21 ' A' ' 70' ' ' VAL . 3.8 mt-30 -66.05 171.95 4.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 165.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 159.48 16.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 167.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.17 164.49 29.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.75 159.6 30.02 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.397 167.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -120.28 45.48 2.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.579 1.081 . . . . 0.0 109.981 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 m -71.11 95.02 1.18 Allowed 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.71 130.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.307 0.958 . . . . 0.0 109.017 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -70.85 121.23 17.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 109.214 168.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.948 0.88 . . . . 0.0 109.024 171.492 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -84.8 158.6 20.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.7 1.2 . . . . 0.0 108.224 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.41 144.76 22.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.449 0.7 . . . . 0.0 109.993 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 -168.36 31.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.414 0.531 . . . . 0.0 112.256 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 133.32 56.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.548 1.539 . . . . 0.0 108.721 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.15 39.35 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 162.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.1 147.81 40.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.406 1.082 . . . . 0.0 109.003 164.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.6 mt -75.35 159.02 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.858 1.663 . . . . 0.0 106.83 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.7 p -141.89 -33.17 0.5 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.301 1.84 . . . . 0.0 112.325 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.43 137.05 12.17 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.789 -1.194 . . . . 0.0 110.971 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -135.28 141.19 45.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 126.234 1.814 . . . . 0.0 107.627 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -159.77 93.61 1.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.27 -135.92 36.97 Favored Glycine 0 C--O 1.229 -0.184 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.27 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.83 2.052 . . . . 0.0 113.176 170.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 tp -140.35 118.42 11.92 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 119.408 1.004 . . . . 0.0 109.825 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.38 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -128.5 135.83 49.97 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.938 2.095 . . . . 0.0 108.283 170.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.62 177.23 5.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.017 1.727 . . . . 0.0 111.328 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -148.15 131.27 16.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.923 2.489 . . . . 0.0 107.054 167.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.33 157.46 4.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.836 1.654 . . . . 0.0 112.716 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.34 0.162 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 161.96 43.03 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.781 1.654 . . . . 0.0 110.264 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -63.49 162.08 28.93 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 120.82 1.014 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.19 150.12 32.83 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.272 2.648 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 60.49 9.69 2.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.382 2.273 . . . . 0.0 114.074 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.9 m -88.6 -57.35 2.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.354 1.862 . . . . 0.0 111.542 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.95 131.27 50.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -122.98 159.05 29.15 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.65 0.78 . . . . 0.0 110.425 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.25 -5.1 25.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.553 0.741 . . . . 0.0 112.511 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.72 14.69 7.15 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-O 117.588 -1.673 . . . . 0.0 112.25 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.25 133.07 54.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.845 1.322 . . . . 0.0 107.624 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -83.83 110.83 18.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.48 133.86 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.241 0.616 . . . . 0.0 110.497 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.48 137.32 34.7 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.074 0.95 . . . . 0.0 108.569 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.6 126.11 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 124.29 1.036 . . . . 0.0 109.108 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 p -112.5 152.0 29.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.407 HG21 HE21 ' A' ' 17' ' ' GLN . 7.7 p -151.24 142.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 153.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -83.66 121.42 27.24 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.81 148.21 33.77 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.16 -89.47 0.33 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.866 1.222 . . . . 0.0 113.132 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.37 5.94 1.91 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.919 0.771 . . . . 0.0 112.97 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.99 177.28 9.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.212 1.506 . . . . 0.0 111.847 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.2 117.43 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 166.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.66 118.09 35.44 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -133.65 135.5 44.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.1 t -135.24 176.42 8.68 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.402 1.081 . . . . 0.0 108.867 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.04 147.38 45.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.85 -170.62 24.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.297 0.951 . . . . 0.0 111.165 -174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -134.13 172.62 12.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.856 1.662 . . . . 0.0 109.116 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -69.36 -35.57 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.913 1.233 . . . . 0.0 113.123 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.52 -62.23 0.44 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.821 2.048 . . . . 0.0 112.665 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -143.62 121.89 12.28 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.202 2.201 . . . . 0.0 106.422 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.42 160.53 18.29 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -123.15 -52.98 1.84 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.397 168.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.28 169.55 17.47 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.024 1.73 . . . . 0.0 107.648 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -4.74 1.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 112.37 170.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -128.47 -14.88 4.64 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 126.017 1.727 . . . . 0.0 113.575 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -138.99 124.98 19.9 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -170.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -165.73 165.79 18.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.49 173.58 11.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.467 1.107 . . . . 0.0 110.543 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.93 148.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.87 1.668 . . . . 0.0 107.997 154.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -113.54 125.35 54.09 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 125.011 1.324 . . . . 0.0 107.802 168.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.91 144.16 27.81 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.777 1.631 . . . . 0.0 106.781 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.79 146.98 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.777 0.717 . . . . 0.0 111.834 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.78 -99.08 0.32 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 126.069 1.795 . . . . 0.0 109.197 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 164.94 35.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 112.558 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -106.28 150.68 8.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.877 2.471 . . . . 0.0 110.199 160.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 125.431 1.492 . . . . 0.0 107.255 150.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.07 -38.45 86.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.015 1.28 . . . . 0.0 111.005 -171.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.36 1.51 65.17 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.85 0.738 . . . . 0.0 112.96 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -83.89 -4.42 58.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.577 1.689 . . . . 0.0 110.636 164.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.464 ' HB3' ' HG ' ' A' ' 77' ' ' CYS . 1.0 OUTLIER -118.26 -49.48 2.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.255 1.422 . . . . 0.0 107.957 -178.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -98.92 105.09 17.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.896 1.278 . . . . 0.0 107.575 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -103.95 161.06 14.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.273 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -154.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.75 10.44 7.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.41 1.884 . . . . 0.0 111.008 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -65.28 172.58 3.04 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -108.28 153.87 22.61 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.455 -0.778 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.94 158.05 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.732 1.213 . . . . 0.0 110.482 166.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -74.04 161.71 29.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.39 2.276 . . . . 0.0 111.669 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.96 49.66 1.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.73 1.612 . . . . 0.0 112.769 -167.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 m -66.74 108.8 2.62 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.244 -1.535 . . . . 0.0 109.514 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.81 124.3 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.092 1.757 . . . . 0.0 108.875 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -64.85 124.07 21.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt . . . . . 0 N--CA 1.468 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 112.715 175.874 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -86.58 152.84 22.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 164.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.8 132.44 14.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.14 -170.86 21.21 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.517 1.532 . . . . 0.0 109.625 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.31 162.43 13.68 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.099 1.36 . . . . 0.0 108.289 171.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.0 172.28 13.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.959 0.904 . . . . 0.0 110.185 157.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.84 145.53 28.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.83 1.332 . . . . 0.0 108.559 163.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.3 mt -71.51 157.76 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.842 2.057 . . . . 0.0 106.97 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 p -140.91 -46.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.502 1.121 . . . . 0.0 112.362 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -135.94 136.06 40.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.248 1.419 . . . . 0.0 107.933 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -145.66 137.4 25.22 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 123.161 1.457 . . . . 0.0 110.218 -175.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.08 93.02 1.78 Allowed 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.641 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.24 -110.24 0.84 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.174 1.368 . . . . 0.0 111.535 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.405 ' HB2' ' HD2' ' A' ' 95' ' ' ARG . 57.8 p -68.08 -7.26 27.97 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.009 1.724 . . . . 0.0 115.62 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.34 114.02 20.74 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 120.233 1.379 . . . . 0.0 111.063 -173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.1 157.81 16.61 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 163.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -122.4 142.23 50.74 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.151 2.18 . . . . 0.0 109.239 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.4 mt -135.05 154.78 51.58 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.767 1.227 . . . . 0.0 110.089 -163.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.68 33.26 4.03 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 49.12 -174.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.437 1.895 . . . . 0.0 114.494 -169.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.512 -0.482 0 C-N-CA 124.049 0.94 . . . . 0.0 111.748 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 C--O 1.237 0.431 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.05 171.18 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.3 2.0 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -57.15 154.52 33.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.129 1.219 . . . . 0.0 109.418 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.59 164.88 29.36 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.773 1.649 . . . . 0.0 109.59 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 p30 56.18 21.48 5.27 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.93 1.692 . . . . 0.0 114.079 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.3 m -124.49 -11.74 7.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.734 0.814 . . . . 0.0 111.124 -168.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.67 140.36 29.53 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.396 1.453 . . . . 0.0 110.672 156.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -146.33 160.12 42.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.023 0.929 . . . . 0.0 111.785 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.97 -2.0 6.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.56 1.944 . . . . 0.0 115.338 -172.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.16 2.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 125.25 1.405 . . . . 0.0 110.661 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.68 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.3 122.16 31.5 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 m -140.7 154.74 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 110.26 -166.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.24 150.83 41.76 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.4 -0.812 . . . . 0.0 110.068 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.55 120.05 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.32 1.048 . . . . 0.0 110.879 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -129.16 137.68 51.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -154.5 153.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -89.27 113.26 24.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.8 t -151.24 144.46 24.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.01 44.97 41.99 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.389 0.995 . . . . 0.0 111.44 -171.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.77 -15.86 2.1 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.447 1.499 . . . . 0.0 114.502 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.9 153.82 21.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.611 1.705 . . . . 0.0 110.715 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.3 tp -80.7 94.9 6.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.464 ' HG ' ' HB3' ' A' ' 12' ' ' TYR . 28.0 p -72.44 139.59 47.83 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.67 134.99 29.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.736 -0.603 . . . . 0.0 110.269 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.0 t -137.93 160.97 37.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 111.652 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.97 159.68 14.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.663 1.185 . . . . 0.0 109.05 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.92 -176.1 30.59 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.557 1.551 . . . . 0.0 111.439 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -130.34 171.17 13.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 161.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.79 -35.78 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.819 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 65.36 -59.91 0.26 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.262 2.225 . . . . 0.0 112.918 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 m -128.36 133.63 48.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -108.64 170.98 7.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 166.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -140.49 -47.47 0.42 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 116.734 -1.987 . . . . 0.0 115.996 152.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -131.11 167.43 19.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 171.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.21 6.14 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.737 1.615 . . . . 0.0 111.713 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.446 ' H ' ' C ' ' A' ' 88' ' ' ASP . 5.8 ptp180 -134.49 -19.74 1.87 Allowed 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.946 -1.721 . . . . 0.0 115.563 170.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -129.16 123.82 33.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 121.183 1.81 . . . . 0.0 108.197 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -166.79 177.72 6.31 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.61 0.364 . . . . 0.0 110.248 -172.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -108.62 175.66 5.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.291 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -145.22 130.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 125.38 1.472 . . . . 0.0 109.116 165.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD2' ' HB2' ' A' ' 43' ' ' SER . 18.3 tpt85 -87.48 114.16 23.84 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 125.902 1.681 . . . . 0.0 107.31 162.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.4 mt -68.89 135.07 50.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.85 148.45 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.169 0.985 . . . . 0.0 109.822 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.09 -107.44 2.06 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.23 168.39 27.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.045 1.338 . . . . 0.0 110.84 174.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -109.36 153.06 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 128.046 2.538 . . . . 0.0 111.167 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.906 0.86 . . . . 0.0 109.436 150.078 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -55.57 -37.76 68.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.947 -1.096 . . . . 0.0 110.574 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.87 -1.13 45.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.474 1.512 . . . . 0.0 112.736 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -72.67 -16.76 61.69 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.012 1.406 . . . . 0.0 111.626 165.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.53 -59.65 1.53 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.81 153.08 27.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.84 157.6 45.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -54.6 -22.56 13.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.943 1.697 . . . . 0.0 114.282 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.14 8.38 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 111.954 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.67 166.39 22.01 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.277 -0.89 . . . . 0.0 110.933 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -94.67 160.08 14.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.47 170.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.34 163.08 18.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.042 1.337 . . . . 0.0 109.24 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -80.23 158.5 26.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.455 0.702 . . . . 0.0 110.378 164.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.1 mt -127.53 51.5 1.91 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.689 1.595 . . . . 0.0 111.09 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -59.34 126.7 28.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.66 121.1 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -63.84 139.56 58.78 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.457 1.48 . . . . 0.0 108.746 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--O 1.235 0.293 0 C-N-CA 124.02 0.928 . . . . 0.0 112.421 179.008 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.437 -1.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -96.5 143.12 27.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 163.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.82 102.41 4.56 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.65 -171.71 15.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.364 0.983 . . . . 0.0 112.446 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -110.6 144.75 39.01 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.277 1.831 . . . . 0.0 107.938 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.96 161.8 36.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.548 -0.72 . . . . 0.0 111.034 157.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.57 137.95 32.52 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 113.964 -1.471 . . . . 0.0 107.594 159.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.64 155.04 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -136.02 -22.42 1.39 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.028 1.731 . . . . 0.0 112.185 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -153.55 152.62 31.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 120.923 -1.111 . . . . 0.0 108.104 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.3 tp -156.42 122.2 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -145.48 79.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . 73.96 -139.98 27.0 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -52.98 2.11 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 127.921 2.488 . . . . 0.0 114.617 168.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 42' ' ' GLY . 7.6 tp -117.25 132.27 56.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.999 1.727 . . . . 0.0 108.592 171.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.35 171.68 12.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 161.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -134.15 144.18 48.38 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.426 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.23 177.37 5.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.926 1.29 . . . . 0.0 110.042 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -144.02 32.27 1.25 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 mt 47.99 -173.1 0.01 OUTLIER 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.51 1.148 . . . . 0.0 112.77 -162.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.239 1.016 . . . . 0.0 108.27 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.241 0.619 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.66 167.19 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.667 1.578 . . . . 0.0 111.111 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.28 156.67 39.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.67 2.247 . . . . 0.0 111.445 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.69 162.97 16.77 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.018 2.478 . . . . 0.0 110.413 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 50.14 21.74 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 168.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.4 m -114.77 -30.93 6.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.075 0.95 . . . . 0.0 111.368 -168.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mt -73.84 145.68 44.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.041 1.336 . . . . 0.0 109.704 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -148.46 162.54 39.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.43 -1.93 12.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.178 1.391 . . . . 0.0 114.11 -168.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.62 6.98 9.67 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.153 1.835 . . . . 0.0 111.836 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.93 123.23 19.26 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.07 116.82 6.87 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.89 131.63 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 138.19 50.43 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.835 1.254 . . . . 0.0 108.297 -167.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.61 143.39 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 124.325 1.05 . . . . 0.0 109.098 -166.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.17 126.73 12.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 0.0 109.053 -174.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -152.26 161.45 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.287 1.435 . . . . 0.0 110.246 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -113.14 131.71 55.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.996 1.318 . . . . 0.0 110.238 -170.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -148.19 49.04 1.04 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 111.055 -163.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.63 -97.49 0.25 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.575 1.559 . . . . 0.0 109.407 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.82 0.29 9.98 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.83 1.681 . . . . 0.0 113.569 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.62 171.1 14.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.813 1.306 . . . . 0.0 111.937 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.78 109.66 21.33 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.208 2.203 . . . . 0.0 107.559 177.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -85.02 108.0 17.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.53 162.78 25.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 35.4 t -157.7 168.35 27.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.18 0.925 . . . . 0.0 109.631 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.02 152.66 18.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.222 1.809 . . . . 0.0 107.517 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.18 -177.86 37.95 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -138.62 165.2 27.52 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.482 1.113 . . . . 0.0 109.949 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.74 -34.48 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.65 -66.85 0.15 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.342 1.857 . . . . 0.0 112.656 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.0 m -142.25 117.34 10.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.921 2.488 . . . . 0.0 106.402 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tp -89.47 160.74 16.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -125.51 -56.12 1.51 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 90' ' ' ARG . 22.9 m-20 -148.39 175.61 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.71 23.31 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.198 1.399 . . . . 0.0 112.173 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 88' ' ' ASP . 28.2 ptt180 -147.03 -6.59 0.49 Allowed 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 166.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -138.6 131.15 28.99 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 120.585 1.539 . . . . 0.0 107.208 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -166.13 158.91 14.8 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.138 1.375 . . . . 0.0 109.412 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.49 175.63 10.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.917 1.287 . . . . 0.0 109.861 173.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.37 139.54 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.525 1.13 . . . . 0.0 108.408 158.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 43' ' ' SER . 14.4 tpp85 -93.93 111.77 23.53 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -72.55 139.54 47.59 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.61 139.59 50.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 123.708 0.63 . . . . 0.0 110.753 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.66 -88.97 1.18 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 124.441 1.02 . . . . 0.0 112.116 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 149.1 16.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.982 1.313 . . . . 0.0 110.119 -175.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.8 114.71 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 158.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -58.54 -46.63 86.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.468 0.707 . . . . 0.0 109.679 -168.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.61 -0.58 80.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.713 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -73.41 -28.86 62.23 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.573 1.686 . . . . 0.0 109.903 164.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -107.16 -41.68 5.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.295 1.038 . . . . 0.0 110.416 -168.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.26 116.38 30.36 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -94.94 154.39 17.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 -23.68 6.99 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 127.033 2.133 . . . . 0.0 114.102 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -129.67 8.72 5.38 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.77 1.628 . . . . 0.0 111.397 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.13 175.85 4.25 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.301 -0.874 . . . . 0.0 110.36 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HE3' ' CE1' ' A' ' 50' ' ' PHE . 47.3 mtpt -114.29 145.97 41.07 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.034 0.934 . . . . 0.0 108.588 168.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 153.02 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.823 0.849 . . . . 0.0 109.768 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -68.85 154.73 41.48 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.052 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.6 mt -129.6 21.91 5.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -158.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -52.51 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.346 1.458 . . . . 0.0 112.871 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.17 135.22 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.114 1.324 . . . . 0.0 108.13 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -82.1 125.08 30.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 124.341 1.056 . . . . 0.0 112.923 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.282 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -142.13 144.49 33.52 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.986 1.715 . . . . 0.0 108.563 173.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.86 136.76 48.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.24 -174.76 21.72 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.17 0.891 . . . . 0.0 110.896 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.09 146.55 45.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.309 1.043 . . . . 0.0 108.677 170.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.37 149.71 36.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.02 31.27 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.5 mt -75.32 155.93 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 164.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -133.91 -41.14 0.84 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.057 0.943 . . . . 0.0 111.759 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -141.56 153.76 45.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.835 1.254 . . . . 0.0 108.238 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 133.97 18.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -140.51 75.13 1.49 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.88 2.072 . . . . 0.0 107.589 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.95 -116.1 6.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.279 1.418 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.6 p -64.13 11.17 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.511 1.525 . . . . 0.0 114.966 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 117.1 11.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.17 166.28 15.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -128.82 155.92 44.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.33 1.052 . . . . 0.0 109.578 174.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.46 150.66 35.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.721 2.008 . . . . 0.0 108.227 -163.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -150.04 130.39 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 164.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -57.35 157.92 6.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.107 2.563 . . . . 0.0 113.087 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.462 ' CE1' ' HE3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 126.249 1.82 . . . . 0.0 112.113 -166.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 120.04 -0.028 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.63 167.19 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.948 2.432 . . . . 0.0 111.849 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -62.81 161.73 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.129 1.886 . . . . 0.0 112.427 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.05 158.72 46.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.022 1.815 . . . . 0.0 111.169 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 49.22 22.64 0.68 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.658 1.983 . . . . 0.0 113.902 171.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -94.68 -46.98 6.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.075 1.75 . . . . 0.0 109.146 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.92 155.24 40.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.644 1.577 . . . . 0.0 109.496 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -145.72 171.38 14.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.275 1.03 . . . . 0.0 108.273 158.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -73.13 -7.2 50.29 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -166.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.65 2.9 27.62 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 116.936 -2.036 . . . . 0.0 111.679 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.46 138.88 58.55 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.326 1.563 . . . . 0.0 107.936 -167.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.3 64.22 3.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.973 1.368 . . . . 0.0 109.303 -155.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.52 136.68 23.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.862 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -87.13 174.38 8.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 123.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.421 1.488 . . . . 0.0 109.395 170.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -118.95 152.7 35.87 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.025 0.829 . . . . 0.0 109.477 167.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.92 142.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 108.54 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.93 113.16 15.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -156.5 170.58 22.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 14.19 25.65 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.92 -0.933 . . . . 0.0 115.178 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 5.3 82.92 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.946 1.873 . . . . 0.0 115.03 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.76 -168.01 2.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.572 1.549 . . . . 0.0 108.491 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.6 tp -99.99 125.77 46.07 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 163.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.604 ' HG ' ' CG2' ' A' ' 100' ' ' VAL . 0.6 OUTLIER -92.32 141.02 29.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.37 1.468 . . . . 0.0 107.496 167.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -145.01 121.89 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 160.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.7 t -111.39 166.71 10.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.843 0.83 . . . . 0.0 109.09 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.14 133.07 55.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.84 -167.29 15.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 113.1 -165.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -137.37 171.0 15.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.519 1.528 . . . . 0.0 108.242 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.66 -30.18 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 72.24 -64.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.632 1.973 . . . . 0.0 111.531 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -148.35 123.64 10.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.455 2.302 . . . . 0.0 105.701 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.2 152.03 19.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 167.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.44 -47.46 2.34 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.234 0.614 . . . . 0.0 109.851 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -143.58 175.66 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -54.27 -20.95 7.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.29 11.24 4.55 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.86 115.24 13.42 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -163.3 168.42 20.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -173.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.74 178.63 6.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.099 1.76 . . . . 0.0 111.16 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 pt -144.05 145.84 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.979 1.311 . . . . 0.0 109.771 152.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.42 119.92 40.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 171.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.67 138.55 33.27 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.39 164.92 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.963 0.905 . . . . 0.0 109.857 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.55 8.61 63.38 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.408 -1.218 . . . . 0.0 115.426 165.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 62.83 143.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.436 2.295 . . . . 0.0 111.855 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.604 ' CG2' ' HG ' ' A' ' 77' ' ' CYS . 1.4 p -95.85 154.77 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 125.909 1.684 . . . . 0.0 110.182 170.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.445 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -70.07 84.73 0.52 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.899 1.279 . . . . 0.0 110.961 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 m -147.9 41.42 1.01 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.376 1.87 . . . . 0.0 109.423 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 44.87 62.34 2.13 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 128.006 2.522 . . . . 0.0 111.615 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.55 172.51 2.61 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.055 1.342 . . . . 0.0 112.512 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.4 -165.02 18.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.639 1.59 . . . . 0.0 110.447 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 m -137.0 -81.78 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.96 7.99 11.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.276 1.031 . . . . 0.0 111.123 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -60.98 -45.34 95.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.948 -1.095 . . . . 0.0 110.028 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 3.38 16.72 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.181 0.42 . . . . 0.0 113.556 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.225 -1.75 . . . . 0.0 110.116 166.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.85 -46.29 2.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.363 1.065 . . . . 0.0 111.3 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.4 155.69 22.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.721 1.609 . . . . 0.0 107.575 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -144.35 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -60.8 -15.17 27.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.253 1.821 . . . . 0.0 115.524 -170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 mp -130.84 1.35 4.35 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 110.29 -173.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.98 165.8 23.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 155.68 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.32 144.69 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 106.374 -167.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -63.79 166.65 6.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.969 0.508 . . . . 0.0 110.058 160.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.3 mt -142.0 49.27 1.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.76 1.624 . . . . 0.0 109.563 -170.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -58.6 103.31 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 121.024 1.738 . . . . 0.0 109.003 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 82.4 t -95.66 119.32 43.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 121.633 2.015 . . . . 0.0 106.296 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.58 118.78 6.48 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.9 87.77 2.87 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.62 65.07 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.441 -0.787 . . . . 0.0 113.311 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -95.12 -11.12 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.224 1.009 . . . . 0.0 112.913 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.89 -48.41 1.13 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.715 0.689 . . . . 0.0 111.252 -164.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.47 -112.89 0.54 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.684 1.612 . . . . 0.0 113.893 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.27 166.3 25.11 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 160.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -141.65 109.15 5.61 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.9 -1.125 . . . . 0.0 108.209 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -125.24 95.41 4.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -154.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 -167.45 14.46 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.646 1.117 . . . . 0.0 112.163 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.82 145.38 51.97 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.961 0.904 . . . . 0.0 108.596 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.68 145.9 31.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 167.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.1 32.52 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 165.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.43 158.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.034 1.734 . . . . 0.0 107.521 166.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -131.4 -30.75 1.67 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 112.372 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.7 m -145.55 130.72 18.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.264 1.826 . . . . 0.0 106.532 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 tp -131.71 123.18 27.19 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.397 1.479 . . . . 0.0 107.715 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.72 84.74 2.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 -122.06 17.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.68 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.3 p -68.27 -12.42 60.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 117.627 0.714 . . . . 0.0 112.657 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 tp -106.29 139.06 41.39 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 110.36 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.18 168.05 16.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 164.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -133.58 138.51 46.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.775 2.03 . . . . 0.0 109.302 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.95 162.87 25.76 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.734 1.614 . . . . 0.0 110.938 -160.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.41 24.23 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.4 mt 53.14 -171.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.956 0.902 . . . . 0.0 111.936 -168.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.0 -12.24 5.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.462 1.105 . . . . 0.0 113.241 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 179.18 179.51 48.73 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 120.967 -1.083 . . . . 0.0 111.167 -164.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.84 -9.09 57.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.445 1.098 . . . . 0.0 113.026 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.49 94.86 2.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.79 1.177 . . . . 0.0 108.247 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -129.05 154.97 80.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.923 2.089 . . . . 0.0 108.054 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.85 171.08 17.26 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.407 2.738 . . . . 0.0 112.899 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.63 156.43 52.79 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.149 1.9 . . . . 0.0 111.15 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -66.51 170.97 11.34 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.265 2.644 . . . . 0.0 109.783 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 p30 53.95 1.29 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 m -101.03 -48.0 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.694 0.679 . . . . 0.0 110.404 -163.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.23 144.67 56.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -141.51 163.63 32.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.396 0.678 . . . . 0.0 110.395 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 62.9 mt-10 -73.36 -5.96 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.799 1.239 . . . . 0.0 113.691 -167.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.98 28.83 2.79 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.33 136.14 57.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 167.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.48 125.89 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 165.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 t -124.22 135.39 53.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.645 1.212 . . . . 0.0 108.977 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.43 156.62 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 112.385 -2.189 . . . . 0.0 106.709 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.2 p -151.01 133.51 15.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.551 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -137.87 146.13 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.501 1.12 . . . . 0.0 109.201 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -96.37 132.58 41.73 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -141.14 95.62 2.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 43.78 42.43 6.22 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 118.853 2.301 . . . . 0.0 118.853 159.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.73 -40.54 0.2 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 121.01 2.405 . . . . 0.0 112.341 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.0 -178.18 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.105 0.955 . . . . 0.0 109.327 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 113.17 22.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 55.5 m -89.44 108.33 19.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.8 158.2 29.38 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.63 136.86 22.37 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.11 158.6 32.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 -179.56 39.1 Favored Glycine 0 N--CA 1.443 -0.871 0 O-C-N 121.131 -0.98 . . . . 0.0 112.118 -171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -127.19 162.13 26.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -32.13 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.603 0.761 . . . . 0.0 110.415 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.26 -66.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.29 2.236 . . . . 0.0 113.42 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.9 m -152.13 95.89 2.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.092 1.315 . . . . 0.0 108.232 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.481 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 1.7 tp -70.06 162.13 28.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -132.87 -41.8 0.92 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.347 -0.845 . . . . 0.0 109.681 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -148.81 172.9 13.9 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -61.12 -6.0 1.77 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.809 2.043 . . . . 0.0 112.465 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -139.66 -11.53 1.17 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.559 2.344 . . . . 0.0 114.606 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -123.71 125.31 44.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -167.11 158.65 12.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.84 176.01 9.97 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.405 1.482 . . . . 0.0 110.849 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.67 150.21 13.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.97 113.8 18.29 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.842 1.257 . . . . 0.0 108.473 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.8 133.0 45.24 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.288 1.835 . . . . 0.0 108.749 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.07 158.38 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.103 1.361 . . . . 0.0 110.327 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.78 80.17 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 119.215 -0.769 . . . . 0.0 112.417 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 59.38 166.78 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.103 2.561 . . . . 0.0 114.009 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -104.39 113.76 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 161.48 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.992 0.917 . . . . 0.0 110.446 169.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.04 76.5 5.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.164 2.186 . . . . 0.0 108.933 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.0 -44.1 66.6 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.775 -1.203 . . . . 0.0 112.34 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -121.3 161.35 22.17 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.357 1.863 . . . . 0.0 106.845 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.0 45.26 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 111.579 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 44.29 69.72 0.39 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.718 1.607 . . . . 0.0 110.402 169.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.18 83.37 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.526 1.53 . . . . 0.0 110.096 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -128.6 108.84 10.84 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 127.776 2.43 . . . . 0.0 104.728 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 C--O 1.254 1.311 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 161.187 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.4 ttp -131.62 13.46 4.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.078 1.351 . . . . 0.0 109.9 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -52.16 110.19 0.46 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 165.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.0 121.83 30.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 153.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.34 163.18 16.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.323 1.049 . . . . 0.0 109.314 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.08 68.23 0.7 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.413 1.006 . . . . 0.0 111.187 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.3 t -155.79 -15.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -6.66 10.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.814 1.643 . . . . 0.0 112.034 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -55.41 -36.8 66.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.922 -1.111 . . . . 0.0 111.099 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.23 -14.45 76.73 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.255 -0.747 . . . . 0.0 113.108 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -75.12 -12.16 60.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.345 1.572 . . . . 0.0 110.744 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -118.72 -45.82 2.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.301 1.44 . . . . 0.0 110.439 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -95.7 116.39 28.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.491 1.116 . . . . 0.0 109.621 171.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 167.63 16.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 109.529 166.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.33 -18.45 55.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.558 0.743 . . . . 0.0 112.941 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.0 mt -127.28 14.09 7.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.088 1.355 . . . . 0.0 109.983 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.79 171.81 8.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.721 0.809 . . . . 0.0 109.827 173.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -108.76 149.74 28.6 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.44 157.51 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.658 1.183 . . . . 0.0 111.381 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -72.88 158.41 35.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.549 1.14 . . . . 0.0 112.048 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -131.24 60.94 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.001 1.72 . . . . 0.0 109.391 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m -78.73 110.11 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.931 -1.105 . . . . 0.0 108.424 174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.52 133.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.345 1.458 . . . . 0.0 108.375 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 147.85 46.19 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.06 1.3 . . . . 0.0 110.217 173.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.2 mt -132.15 77.9 1.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.058 1.743 . . . . 0.0 108.038 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.3 30.6 69.23 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.116 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t70 74.99 -55.21 0.65 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.433 2.293 . . . . 0.0 112.578 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.0 p -71.28 -4.08 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 113.003 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.77 164.56 29.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.4 m -144.43 165.11 28.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 107.754 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -95.36 157.18 16.01 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 163.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.27 125.15 15.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 163.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.77 -171.8 14.16 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 166.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -116.9 162.89 17.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.53 157.1 46.39 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.491 156.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.92 140.97 40.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 157.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.95 158.2 5.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.3 p -136.92 -28.74 0.94 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 m -154.57 124.02 6.49 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tt -143.98 129.76 19.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.651 1.114 . . . . 0.0 110.251 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -144.22 104.26 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.94 -131.29 44.33 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.196 0.903 . . . . 0.0 112.205 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.39 37.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.754 1.222 . . . . 0.0 112.111 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.14 117.36 9.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.784 1.234 . . . . 0.0 107.937 162.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.4 155.82 20.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 156.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -118.93 147.77 43.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.608 1.963 . . . . 0.0 108.778 164.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.67 166.5 13.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 110.478 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.3 65.41 1.25 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.537 0.735 . . . . 0.0 110.089 162.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt 45.3 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.329 3.051 . . . . 0.0 116.081 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -110.35 179.47 4.08 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.929 0.892 . . . . 0.0 111.186 159.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.21 -12.57 26.95 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -159.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.19 -32.87 11.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 110.487 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.31 171.78 13.58 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.409 0.684 . . . . 0.0 111.24 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -164.62 155.58 13.1 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.938 2.095 . . . . 0.0 108.534 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.41 169.92 16.01 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.405 2.07 . . . . 0.0 110.564 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.58 154.8 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.951 1.101 . . . . 0.0 110.586 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -63.42 168.54 11.11 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.086 1.857 . . . . 0.0 108.935 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.77 5.96 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.2 m -108.48 -47.04 3.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.958 1.303 . . . . 0.0 110.844 -163.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -64.85 138.2 58.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.958 0.903 . . . . 0.0 109.182 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -137.1 158.98 43.22 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -74.14 -8.61 56.77 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -164.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.13 22.52 4.23 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 126.235 1.874 . . . . 0.0 109.422 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 125.72 24.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.02 135.88 54.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 164.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.51 163.59 35.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.849 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.78 153.43 39.54 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 160.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.51 145.33 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 p -147.7 146.32 29.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.78 143.55 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.066 0.946 . . . . 0.0 110.272 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.484 ' CH2' ' HG3' ' A' ' 106' ' ' ARG . 98.4 m95 -81.57 74.74 8.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.561 1.945 . . . . 0.0 111.365 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.254 3.4 t -97.65 100.87 12.27 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.388 -0.82 . . . . 0.0 109.435 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.52 33.98 3.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.514 2.483 . . . . 0.0 116.392 161.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.26 -65.97 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -167.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -171.18 -164.57 0.36 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.175 2.19 . . . . 0.0 107.822 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -76.95 94.32 3.93 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 134.9 54.76 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 155.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.13 161.23 36.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.8 t -157.46 175.71 13.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -114.71 156.38 24.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.8 178.3 40.0 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 120.455 -1.403 . . . . 0.0 111.697 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.78 159.04 36.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 166.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -58.7 -30.89 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.005 0.522 . . . . 0.0 111.984 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 65.69 -61.57 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.479 2.312 . . . . 0.0 111.161 -171.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -147.11 126.98 13.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.242 2.217 . . . . 0.0 105.658 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.55 157.11 16.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.4 ttm-85 -124.8 -44.43 1.95 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.869 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.37 176.38 11.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.8 -1.6 0.92 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.799 0.84 . . . . 0.0 112.325 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -130.78 -13.9 3.63 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.564 1.546 . . . . 0.0 113.579 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.64 136.74 46.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 108.6 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -175.45 166.02 3.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.366 1.066 . . . . 0.0 109.696 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.37 177.62 5.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.053 1.341 . . . . 0.0 110.671 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.07 127.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.149 1.379 . . . . 0.0 108.782 157.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -74.13 137.89 43.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 156.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -99.05 136.75 38.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.48 138.04 48.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.946 0.879 . . . . 0.0 111.93 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -107.47 3.06 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.17 142.53 7.26 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 126.155 1.782 . . . . 0.0 106.315 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.04 134.67 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -150.81 156.97 42.33 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.161 0.892 . . . . 0.0 110.592 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.32 136.65 52.11 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 166.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.67 -13.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.701 -1.142 . . . . 0.0 112.46 162.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -133.28 143.95 49.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.809 1.64 . . . . 0.0 110.095 -161.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -137.81 155.42 49.03 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.484 ' HG3' ' CH2' ' A' ' 71' ' ' TRP . 37.1 mtp180 -79.39 129.35 34.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.423 1.489 . . . . 0.0 109.065 -173.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -81.29 31.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.193 0.997 . . . . 0.0 112.141 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.03 20.58 3.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.193 1.397 . . . . 0.0 112.843 -168.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 128.092 2.557 . . . . 0.0 114.473 -173.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.9 mtp 53.67 -168.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.266 1.027 . . . . 0.0 109.822 -160.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m 66.43 -84.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.089 1.756 . . . . 0.0 112.878 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.9 -42.53 0.37 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 130.263 3.425 . . . . 0.0 114.495 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.13 -168.73 2.27 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 127.285 2.234 . . . . 0.0 108.84 173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.46 -96.92 0.11 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 9' ' ' TYR . 2.5 t 57.87 -176.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.431 1.115 . . . . 0.0 110.456 -168.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.26 0.27 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.046 2.139 . . . . 0.0 113.397 -169.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.447 ' H ' ' C ' ' A' ' 7' ' ' SER . 24.7 m-85 -64.77 -39.25 93.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.246 -1.534 . . . . 0.0 109.539 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.67 -0.98 74.68 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.962 -169.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -85.85 -17.06 36.68 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.203 1.001 . . . . 0.0 111.038 163.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -105.91 -53.51 2.63 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.029 0.931 . . . . 0.0 110.442 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.44 155.72 22.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.98 153.63 43.2 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -63.03 -18.03 62.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -165.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.55 8.52 5.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.73 1.612 . . . . 0.0 110.223 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -73.87 169.39 17.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.796 -1.19 . . . . 0.0 108.905 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.81 17.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.689 170.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.29 165.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.515 1.126 . . . . 0.0 109.846 164.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.55 177.75 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.883 2.473 . . . . 0.0 112.266 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 mt -138.21 22.56 2.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.818 1.644 . . . . 0.0 115.113 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -62.8 106.74 0.85 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.957 1.708 . . . . 0.0 110.572 -167.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.9 t -99.12 139.77 20.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.639 1.575 . . . . 0.0 109.188 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -74.51 121.17 21.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 161.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.7 84.45 1.93 Allowed 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.09 134.04 27.94 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 63.92 -5.96 0.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.61 2.764 . . . . 0.0 116.304 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 -33.41 4.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.596 -176.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.96 126.84 5.86 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 125.352 1.453 . . . . 0.0 111.902 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.31 161.34 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 111.831 -160.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -130.41 139.29 50.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.09 147.75 50.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.615 0.722 . . . . 0.0 110.271 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.75 -162.81 15.27 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -131.79 162.79 29.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.21 161.67 41.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 156.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 140.19 41.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 156.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.2 mt -69.25 158.61 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 161.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.6 p -131.96 -31.28 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.444 1.898 . . . . 0.0 111.96 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.14 145.17 31.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 tp -161.81 101.62 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -121.49 78.67 1.46 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.755 1.622 . . . . 0.0 106.875 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.04 -117.85 10.37 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 14.1 p -64.82 -0.48 1.5 Allowed 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 115.817 -2.039 . . . . 0.0 113.914 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -127.04 137.47 53.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.95 1.25 . . . . 0.0 108.193 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.59 166.6 23.9 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.048 0.939 . . . . 0.0 108.527 168.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -129.49 149.44 51.26 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.784 1.634 . . . . 0.0 108.402 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.77 171.37 8.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.573 1.949 . . . . 0.0 110.94 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.66 58.5 1.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.477 1.132 . . . . 0.0 111.229 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 mt 47.72 -169.87 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.663 1.985 . . . . 0.0 114.407 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 -18.61 3.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.72 126.3 3.68 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.152 0.882 . . . . 0.0 111.565 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 69.36 -50.76 0.61 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 130.215 3.406 . . . . 0.0 114.413 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.84 98.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.042 1.337 . . . . 0.0 107.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -129.6 152.38 79.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.516 0.727 . . . . 0.0 111.548 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.61 164.84 34.38 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.402 2.735 . . . . 0.0 112.586 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.83 160.76 35.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.866 1.711 . . . . 0.0 111.587 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.98 159.58 24.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.568 2.179 . . . . 0.0 112.313 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 44.79 32.69 0.84 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.873 2.069 . . . . 0.0 112.213 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 m -111.64 -56.72 2.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.363 1.065 . . . . 0.0 108.155 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.47 127.52 30.05 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -127.65 159.68 33.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.61 -3.92 17.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.35 19.1 4.34 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.772 2.129 . . . . 0.0 110.881 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.97 131.09 49.55 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.33 123.42 25.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.42 163.8 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.274 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.39 131.08 43.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.02 0.928 . . . . 0.0 108.852 -173.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.48 139.82 19.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -140.91 156.83 46.01 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.085 0.857 . . . . 0.0 110.283 159.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 p -160.86 149.13 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.197 1.799 . . . . 0.0 107.166 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -88.1 120.82 29.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 t -151.07 119.48 6.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.66 -162.44 47.85 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -159.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.27 2.08 22.48 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.867 1.223 . . . . 0.0 114.662 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.33 172.82 12.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.958 1.379 . . . . 0.0 110.767 -174.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.9 168.74 18.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.11 153.03 49.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 154.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.27 155.63 50.31 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.6 t -144.86 156.52 44.05 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 155.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -99.21 150.19 22.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.83 41.59 Favored Glycine 0 CA--C 1.523 0.593 0 O-C-N 120.958 -1.088 . . . . 0.0 110.911 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -128.02 169.15 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.648 0.779 . . . . 0.0 109.005 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.18 -35.35 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.131 0.973 . . . . 0.0 112.837 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 65.92 -54.14 0.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.764 2.426 . . . . 0.0 113.707 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -150.27 139.39 21.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.745 1.218 . . . . 0.0 108.264 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -115.77 152.29 33.55 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.52 -52.96 0.72 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.532 -169.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.54 174.93 7.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 159.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -55.5 -30.85 61.41 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.041 1.337 . . . . 0.0 111.821 166.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -104.27 -11.66 17.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -132.24 124.02 28.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 120.535 1.516 . . . . 0.0 108.596 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -162.4 166.29 25.27 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.536 1.148 . . . . 0.0 110.45 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.84 179.78 5.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.753 1.221 . . . . 0.0 110.209 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.71 133.7 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.435 1.494 . . . . 0.0 108.677 164.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -108.39 111.72 23.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.379 1.472 . . . . 0.0 107.674 174.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.5 mt -71.94 144.71 48.83 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.241 1.417 . . . . 0.0 107.563 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.59 153.65 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.557 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.32 -106.96 0.65 Allowed Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 125.721 1.629 . . . . 0.0 109.077 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.59 168.98 23.84 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.4 1.48 . . . . 0.0 110.825 -167.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.47 156.27 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.018 0.927 . . . . 0.0 109.749 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.92 162.33 35.75 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.752 1.221 . . . . 0.0 110.296 150.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.46 143.37 57.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 151.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.38 -6.03 5.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.252 175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -152.93 153.67 33.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.029 2.132 . . . . 0.0 107.398 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.38 161.74 31.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.285 1.402 . . . . 0.0 110.954 171.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -108.64 0.11 20.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.172 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -77.06 48.75 0.62 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.469 1.108 . . . . 0.0 112.099 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -127.49 18.26 6.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.128 2.571 . . . . 0.0 111.445 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 C-N-CA 127.254 2.222 . . . . 0.0 111.019 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.408 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.86 32.67 17.95 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.331 1.065 . . . . 0.0 111.699 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m 66.32 118.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.093 2.157 . . . . 0.0 110.827 -169.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.58 173.39 11.99 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.94 0.876 . . . . 0.0 110.589 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 58.55 171.51 0.06 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.396 2.278 . . . . 0.0 110.784 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.16 -84.39 0.19 Allowed Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m 174.99 -71.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.657 2.783 . . . . 0.0 104.185 159.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.89 -1.42 4.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 126.484 1.914 . . . . 0.0 110.156 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -54.59 -39.99 68.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.092 1.315 . . . . 0.0 111.606 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.18 -6.06 55.92 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.478 1.037 . . . . 0.0 112.717 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.45 -16.89 55.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.16 -1.2 . . . . 0.0 111.373 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.78 -27.8 5.74 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.723 1.209 . . . . 0.0 110.422 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.83 144.25 50.73 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.445 1.117 . . . . 0.0 111.992 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.62 156.01 49.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.597 -173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 15' ' ' GLN . 1.5 pm0 -62.13 -17.31 57.46 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.49 13.41 8.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 118.884 0.765 . . . . 0.0 109.416 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.73 167.68 21.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.163 0.585 . . . . 0.0 109.575 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.64 147.77 32.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.859 0.864 . . . . 0.0 108.981 170.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -141.5 165.93 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.767 0.827 . . . . 0.0 111.099 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.23 165.55 24.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.043 1.737 . . . . 0.0 112.231 165.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -138.34 19.67 2.75 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.13 116.94 1.7 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.238 -161.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.5 116.05 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -64.21 133.61 53.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.657 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.2 mt -128.68 82.8 2.11 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.818 1.647 . . . . 0.0 107.031 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.14 37.66 94.87 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 122.077 -0.39 . . . . 0.0 113.887 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.91 10.46 3.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.16 2.184 . . . . 0.0 113.514 158.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -154.3 -35.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.475 1.11 . . . . 0.0 110.047 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.78 2.72 31.0 Favored Glycine 0 C--O 1.22 -0.719 0 O-C-N 121.077 -1.014 . . . . 0.0 115.434 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -54.36 135.97 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.951 -161.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.6 150.22 26.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.97 125.52 15.79 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 126.583 1.953 . . . . 0.0 106.003 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.97 -174.82 23.03 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -118.57 159.21 23.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.75 156.5 40.42 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 118.581 0.628 . . . . 0.0 110.986 161.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.12 130.78 35.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 125.177 1.548 . . . . 0.0 108.008 160.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.89 159.79 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 158.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -132.4 -36.76 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.244 1.418 . . . . 0.0 110.932 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 m -145.77 138.27 25.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.743 1.217 . . . . 0.0 107.735 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.26 124.71 15.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.525 0.73 . . . . 0.0 109.145 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -135.8 81.01 1.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.115 1.366 . . . . 0.0 108.057 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.63 -118.61 5.07 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 166.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p -64.71 -3.79 3.6 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 126.426 1.89 . . . . 0.0 113.019 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.04 134.86 53.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.739 1.215 . . . . 0.0 110.816 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.45 163.56 29.41 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.139 1.375 . . . . 0.0 110.404 167.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -128.19 118.75 23.9 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.852 1.661 . . . . 0.0 110.127 170.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -87.32 165.18 15.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.858 1.663 . . . . 0.0 112.086 167.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.69 35.82 2.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.147 1.779 . . . . 0.0 111.529 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 mt 52.04 -169.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.476 1.91 . . . . 0.0 113.383 -169.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.45 123.17 35.42 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.94 -156.81 52.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 173.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.94 -0.5 57.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.141 0.977 . . . . 0.0 112.616 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -75.74 130.22 38.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.224 0.92 . . . . 0.0 108.761 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -151.65 157.68 34.51 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 124.078 0.951 . . . . 0.0 110.415 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 173.48 9.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.846 2.364 . . . . 0.0 111.03 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.63 154.5 48.27 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.121 1.214 . . . . 0.0 110.027 162.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.31 174.45 11.48 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.151 2.567 . . . . 0.0 109.514 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.88 38.16 2.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 113.695 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -132.14 -52.31 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.323 1.449 . . . . 0.0 109.558 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.03 149.1 33.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 110.837 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 155.54 46.59 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.276 0.63 . . . . 0.0 110.879 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.8 -2.61 30.72 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.34 20.99 2.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 126.122 1.82 . . . . 0.0 109.664 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.49 25.93 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.06 130.55 41.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.65 138.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.444 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -109.5 130.63 55.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.514 0.726 . . . . 0.0 109.415 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.25 146.14 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.1 p -146.05 159.77 42.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 110.228 160.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.6 p -164.89 151.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.613 1.565 . . . . 0.0 107.841 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -79.0 108.21 12.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 166.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -144.13 152.57 41.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.62 4.58 7.12 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.644 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.87 2.08 42.57 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.821 1.81 . . . . 0.0 114.16 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.76 166.51 26.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.638 1.719 . . . . 0.0 109.836 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.54 95.01 6.99 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 155.09 39.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 170.68 18.1 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.594 172.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 t -159.93 163.35 34.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -101.98 143.6 31.63 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 108.924 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.29 24.19 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.475 1.512 . . . . 0.0 111.933 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.78 174.4 11.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.417 1.087 . . . . 0.0 111.73 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.67 -43.24 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.462 1.105 . . . . 0.0 113.659 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.45 -45.6 0.31 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.377 2.671 . . . . 0.0 114.195 -166.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.0 m -154.63 136.02 14.14 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.668 1.587 . . . . 0.0 107.772 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -116.51 161.19 19.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 108.262 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -143.39 -30.43 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.336 -0.852 . . . . 0.0 111.972 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -149.93 179.86 7.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.904 2.082 . . . . 0.0 105.824 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.7 -8.71 29.72 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.675 -0.641 . . . . 0.0 111.528 162.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -131.57 -11.92 3.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -128.55 128.2 43.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -166.47 167.33 15.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.88 172.9 7.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.994 0.918 . . . . 0.0 109.527 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 pt -141.79 138.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 108.45 160.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -107.3 111.19 23.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 128.433 2.693 . . . . 0.0 104.819 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.17 149.28 37.32 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.246 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.74 165.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.421 1.488 . . . . 0.0 108.973 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.99 -113.55 5.74 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 126.843 2.164 . . . . 0.0 109.907 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.79 137.18 2.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.589 0.756 . . . . 0.0 112.101 -160.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.97 152.97 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.673 1.189 . . . . 0.0 109.42 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -160.89 163.74 31.75 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.792 -1.192 . . . . 0.0 109.294 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.15 124.25 26.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 -12.2 3.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 169.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -140.77 162.78 34.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.084 1.353 . . . . 0.0 109.609 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 179.55 166.29 1.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.638 1.975 . . . . 0.0 110.644 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -73.73 129.47 38.0 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -158.48 92.97 1.17 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.338 0.1 OUTLIER -136.88 34.33 2.63 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.658 -171.805 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 119.028 -0.873 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.0 tpt -69.38 -33.53 73.18 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.322 1.061 . . . . 0.0 108.986 160.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -133.71 173.93 10.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.192 2.597 . . . . 0.0 108.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 75.14 -179.1 0.17 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.306 2.642 . . . . 0.0 112.358 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.24 166.78 17.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.18 1.392 . . . . 0.0 111.267 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.84 170.32 29.95 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-O 122.485 1.047 . . . . 0.0 113.484 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -154.63 3.69 0.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.099 1.759 . . . . 0.0 110.78 -168.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.73 -5.96 48.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.48 -1.387 . . . . 0.0 111.476 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.05 -33.07 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.894 -1.129 . . . . 0.0 111.097 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 2.41 53.34 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.182 0.896 . . . . 0.0 113.695 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 11' ' ' ARG . 35.8 mtt85 -81.85 -16.33 51.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.178 1.489 . . . . 0.0 111.256 163.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.63 -37.23 2.92 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.056 1.342 . . . . 0.0 112.506 -172.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.04 159.56 14.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.247 1.019 . . . . 0.0 108.302 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -156.3 161.15 40.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.51 -21.88 66.17 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -163.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.2 mt -122.03 14.28 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 109.466 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.53 -174.0 1.58 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.528 0.517 . . . . 0.0 110.755 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -122.69 159.26 28.32 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 125.09 1.356 . . . . 0.0 109.898 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 m -146.28 155.32 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.557 1.143 . . . . 0.0 110.19 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.07 166.68 15.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.159 1.784 . . . . 0.0 110.853 157.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.2 6.23 2.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -158.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 m -49.95 105.44 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 127.327 2.251 . . . . 0.0 112.849 -155.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.99 132.01 35.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -77.99 120.61 23.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.76 68.65 0.85 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.329 1.052 . . . . 0.0 109.587 170.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 -167.35 50.51 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 122.099 0.833 . . . . 0.0 111.333 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -77.89 -13.01 60.03 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.14 1.376 . . . . 0.0 111.798 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -133.12 11.32 4.22 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.137 1.375 . . . . 0.0 113.772 -166.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.35 162.9 31.74 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.992 1.269 . . . . 0.0 112.045 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.53 170.76 20.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.0 0.905 . . . . 0.0 111.684 170.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -131.46 146.53 52.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.697 2.399 . . . . 0.0 104.773 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.64 159.37 42.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 118.832 0.742 . . . . 0.0 109.634 165.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.25 -166.73 30.5 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 155.43 32.49 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.38 159.12 42.86 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 163.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.1 145.51 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.89 153.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.002 1.721 . . . . 0.0 107.332 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.7 p -128.98 -18.21 3.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.543 1.137 . . . . 0.0 112.336 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 m -164.53 157.85 17.55 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.44 1.896 . . . . 0.0 109.123 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.16 135.31 33.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.529 1.131 . . . . 0.0 109.482 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 67.8 1.35 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 0.0 112.05 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 -81.47 1.73 Allowed Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.199 -0.938 . . . . 0.0 113.388 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -114.64 45.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.836 1.254 . . . . 0.0 109.115 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -159.21 132.53 7.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.421 1.088 . . . . 0.0 108.169 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.4 154.63 51.41 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 168.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -114.83 149.23 37.39 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.241 1.016 . . . . 0.0 109.154 169.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.7 mt -137.61 165.14 27.07 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.433 1.493 . . . . 0.0 109.771 -169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -143.42 16.33 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 54.71 161.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.324 1.85 . . . . 0.0 113.183 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -61.01 2.1 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.27 -176.31 28.07 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.92 -61.82 0.0 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 131.096 3.759 . . . . 0.0 114.63 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.73 155.71 35.25 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 165.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -165.72 161.63 13.36 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 127.23 2.212 . . . . 0.0 108.342 158.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.46 169.17 17.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.376 2.051 . . . . 0.0 110.997 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.64 159.84 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 120.817 1.011 . . . . 0.0 110.278 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.39 159.53 49.83 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.034 1.823 . . . . 0.0 109.946 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 50.47 30.67 4.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.106 1.362 . . . . 0.0 111.652 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -131.66 -2.23 3.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.335 1.054 . . . . 0.0 111.577 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -104.16 144.86 31.02 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.564 -1.335 . . . . 0.0 108.595 159.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -154.64 161.1 41.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.979 0.8 . . . . 0.0 110.307 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -67.63 -0.39 3.9 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.14 15.78 3.96 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 126.601 2.048 . . . . 0.0 110.842 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.43 125.57 26.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.51 135.95 38.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 165.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -142.51 141.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 108.278 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 m -95.11 166.9 11.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 0.0 109.583 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 145.3 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.244 1.018 . . . . 0.0 108.584 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -144.95 153.26 41.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 109.009 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.59 151.99 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.076 1.35 . . . . 0.0 107.645 171.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -91.22 115.51 28.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 t -151.24 171.82 16.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 169.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.66 19.13 54.15 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.858 -1.151 . . . . 0.0 113.417 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.08 -9.98 29.56 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 118.818 1.309 . . . . 0.0 113.494 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.85 -177.44 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.503 1.921 . . . . 0.0 110.957 -171.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.1 tp -105.9 101.37 10.87 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.871 1.268 . . . . 0.0 109.381 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 80.5 m -75.99 136.36 40.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -148.49 162.53 39.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.248 167.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.7 t -155.49 -174.47 4.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.775 0.83 . . . . 0.0 111.269 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -133.57 133.79 42.51 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 129.064 2.945 . . . . 0.0 105.505 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.32 -171.21 25.92 Favored Glycine 0 N--CA 1.463 0.454 0 O-C-N 120.441 -1.412 . . . . 0.0 112.557 -170.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.69 175.37 9.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 0.0 109.439 174.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.69 -40.8 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 64.93 -47.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.375 2.27 . . . . 0.0 114.479 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.5 m -148.92 101.36 3.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.075 1.75 . . . . 0.0 107.72 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.34 173.61 9.29 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 120.588 -1.32 . . . . 0.0 109.573 174.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -51.97 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 150.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -142.16 176.65 8.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.44 -15.74 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 112.649 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -118.41 -21.05 8.22 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.937 1.695 . . . . 0.0 113.462 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -130.35 132.63 45.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 120.615 1.552 . . . . 0.0 108.949 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -171.2 170.2 6.14 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.575 0.547 . . . . 0.0 110.816 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.81 167.98 13.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.778 2.031 . . . . 0.0 110.431 164.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.96 141.16 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.048 1.339 . . . . 0.0 108.501 159.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 140.4 29.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.623 1.569 . . . . 0.0 107.955 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.83 142.65 28.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 164.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.07 164.33 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.028 0.531 . . . . 0.0 110.12 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.68 -109.18 2.76 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.352 1.453 . . . . 0.0 109.898 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.52 142.49 15.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.194 1.798 . . . . 0.0 108.655 -169.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.23 139.47 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 169.3 17.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.372 0.533 . . . . 0.0 110.483 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -80.53 100.25 8.48 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.598 1.959 . . . . 0.0 107.429 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.49 -26.15 57.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.984 0.811 . . . . 0.0 112.29 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -145.52 158.49 43.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.175 1.39 . . . . 0.0 108.935 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -131.99 128.74 39.03 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.166 1.786 . . . . 0.0 107.482 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -66.8 157.7 32.26 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 156.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.21 70.72 0.76 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 163.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 56.63 11.05 0.8 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 127.382 2.273 . . . . 0.0 111.953 178.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.36 2.04 2.57 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -113.24 157.7 21.41 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.429 1.468 . . . . 0.0 108.546 170.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.92 165.76 26.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 0.0 107.534 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.0 146.27 26.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.23 -129.94 43.72 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m 174.66 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 128.662 2.785 . . . . 0.0 107.307 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -131.45 -7.64 3.72 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.922 0.889 . . . . 0.0 111.059 -167.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -61.67 -36.59 81.28 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.332 -0.855 . . . . 0.0 110.657 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -10.65 67.33 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.33 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -74.36 -21.13 59.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.514 1.657 . . . . 0.0 110.428 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -115.43 -39.2 3.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.388 -169.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -105.43 131.19 53.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.405 1.882 . . . . 0.0 108.132 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.51 165.55 18.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -79.84 -8.45 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -152.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.4 mt -127.74 -0.59 6.07 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.627 2.371 . . . . 0.0 108.173 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.4 145.67 41.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.354 0.0 OUTLIER -108.19 113.76 27.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -173.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 m -102.04 172.86 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.574 2.75 . . . . 0.0 107.333 -171.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.48 163.39 15.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.405 1.882 . . . . 0.0 112.422 173.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 mt -134.98 51.4 2.1 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.492 1.517 . . . . 0.0 113.693 -167.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.1 m -67.44 120.56 14.11 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.886 -1.759 . . . . 0.0 108.109 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 t -118.73 129.71 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.868 1.267 . . . . 0.0 108.276 167.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -70.37 127.59 33.28 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.349 -0.844 . . . . 0.0 109.622 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.85 62.65 0.61 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.833 1.653 . . . . 0.0 108.606 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.36 -170.04 54.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -75.38 -25.28 57.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 p -131.11 42.05 3.27 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.463 0.649 . . . . 0.0 109.923 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.72 169.05 42.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 163.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -173.27 162.36 4.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.107 0.956 . . . . 0.0 110.535 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -97.09 142.72 28.68 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 166.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.8 150.15 51.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 165.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.2 -165.52 30.23 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.282 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.93 147.9 51.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.943 1.297 . . . . 0.0 107.687 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.53 34.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 162.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.23 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.15 161.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 162.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -142.05 -13.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.068 0.937 . . . . 0.0 112.608 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 m -156.58 151.15 25.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.16 138.74 31.79 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.364 1.078 . . . . 0.0 109.563 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.83 79.53 1.74 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.762 2.025 . . . . 0.0 106.015 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.35 -106.34 0.35 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.327 1.441 . . . . 0.0 113.49 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.79 9.85 0.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.892 1.677 . . . . 0.0 114.389 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -132.1 129.25 39.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.128 0.877 . . . . 0.0 109.781 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.83 159.2 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 155.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -117.66 147.39 42.95 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.808 1.243 . . . . 0.0 108.145 160.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.74 169.5 9.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.623 1.969 . . . . 0.0 111.284 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -142.43 21.91 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 57.93 -178.06 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 0.0 114.854 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.9 174.68 10.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.64 2.376 . . . . 0.0 108.261 164.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.42 0.61 39.16 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 154.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.86 -32.12 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.583 2.753 . . . . 0.0 115.479 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -58.66 158.71 7.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.074 1.75 . . . . 0.0 110.622 166.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -155.0 163.1 25.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.523 0.602 . . . . 0.0 110.267 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -67.54 172.11 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.006 2.471 . . . . 0.0 113.305 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.69 154.05 75.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.885 1.724 . . . . 0.0 112.128 167.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 170.1 19.29 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.278 3.319 . . . . 0.0 110.961 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 46.56 20.28 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.075 2.15 . . . . 0.0 113.891 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.5 m -116.91 -57.24 2.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.81 121.98 13.68 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 m -130.81 160.01 35.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.038 0.381 . . . . 0.0 110.65 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.76 -13.36 62.34 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -166.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.51 30.82 3.22 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.636 2.065 . . . . 0.0 108.06 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.05 141.23 56.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 169.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 134.16 35.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 171.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.21 157.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.678 -169.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.18 107.67 7.36 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.27 148.89 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 163.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -145.54 144.84 30.76 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 155.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.92 163.24 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 166.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -108.75 74.56 0.92 Allowed 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 161.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 t -82.54 166.35 19.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 166.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.13 24.37 6.67 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 156.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 28.81 70.52 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.169 1.484 . . . . 0.0 114.443 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.16 44.42 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 121.725 2.762 . . . . 0.0 112.579 169.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 98.69 11.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.4 p -91.38 70.07 5.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 126.421 1.888 . . . . 0.0 108.263 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -85.64 132.63 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 2.9 t -149.04 167.85 24.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.092 0.557 . . . . 0.0 109.504 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -115.6 143.59 45.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.54 -176.54 22.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.273 1.892 . . . . 0.0 111.27 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -128.45 167.48 16.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.359 1.063 . . . . 0.0 108.265 161.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.96 -31.12 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.59 -55.68 0.53 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.491 2.316 . . . . 0.0 112.797 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.5 m -150.09 117.88 6.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.128 2.171 . . . . 0.0 106.341 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.0 tp -82.94 160.49 22.05 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -130.79 -47.99 1.04 Allowed 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 167.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -143.15 176.96 8.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.09 -11.89 59.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.723 0.809 . . . . 0.0 110.537 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -117.46 -39.63 3.15 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.708 1.603 . . . . 0.0 114.091 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -105.95 128.74 54.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -169.39 172.59 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.34 0.656 . . . . 0.0 109.747 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.29 179.15 4.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.504 1.122 . . . . 0.0 111.462 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.8 pt -146.32 129.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 159.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -76.38 122.99 25.28 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 160.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.54 131.94 34.96 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 169.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.04 177.19 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.723 1.209 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.94 -10.45 52.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 116.847 1.499 . . . . 0.0 116.847 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.0 129.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 129.691 3.197 . . . . 0.0 110.086 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 112.33 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.05 144.04 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -70.69 100.81 1.93 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -66.51 -25.53 66.73 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.03 -0.419 . . . . 0.0 110.612 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -150.59 164.42 36.07 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.037 1.735 . . . . 0.0 109.941 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -121.71 115.53 22.88 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.872 1.669 . . . . 0.0 107.514 166.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -74.41 114.12 12.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.59 51.73 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.261 1.425 . . . . 0.0 110.267 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -130.71 28.92 4.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.316 1.046 . . . . 0.0 110.927 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 166.796 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 CA-C-O 117.176 -1.902 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 30.5 ttm 76.95 66.48 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.652 1.981 . . . . 0.0 108.979 -160.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.04 169.91 14.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.398 1.479 . . . . 0.0 108.419 -167.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.43 21.94 5.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.919 1.288 . . . . 0.0 111.995 -166.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -137.75 -69.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.943 0.792 . . . . 0.0 111.107 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.76 38.59 0.65 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.998 0.817 . . . . 0.0 114.757 -167.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 168.38 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.707 1.203 . . . . 0.0 109.679 -171.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.33 10.17 0.43 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.217 1.407 . . . . 0.0 114.54 -166.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -92.18 -51.58 5.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.099 1.318 . . . . 0.0 111.839 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 -17.22 69.83 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.098 0.832 . . . . 0.0 113.138 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -68.06 -15.53 63.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -111.73 -56.56 2.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -84.44 119.15 24.8 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.27 156.94 16.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -22.09 7.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.067 1.747 . . . . 0.0 113.551 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.68 1.45 4.44 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.561 1.544 . . . . 0.0 112.363 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 162.65 25.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 159.19 17.44 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.536 169.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.45 -173.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.25 159.02 15.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.872 2.069 . . . . 0.0 107.742 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.65 54.18 1.71 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.146 1.339 . . . . 0.0 110.56 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -59.33 116.82 4.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.07 135.47 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -74.41 119.1 18.15 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.8 mt -112.63 84.17 1.94 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.84 90.4 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 116.907 -2.052 . . . . 0.0 113.471 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 75.55 -55.25 0.63 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.362 2.665 . . . . 0.0 110.81 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 t -51.92 -43.31 63.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 111.035 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.98 167.66 14.59 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 122.515 1.064 . . . . 0.0 110.896 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 176.55 8.85 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.549 164.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -125.77 157.4 37.57 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 162.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -140.81 144.05 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.705 0.684 . . . . 0.0 110.333 164.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.32 -163.44 12.12 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.555 1.55 . . . . 0.0 110.664 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.04 153.96 43.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.48 147.57 23.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.29 145.58 27.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 167.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.12 159.57 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.216 1.406 . . . . 0.0 107.658 162.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p -136.14 -36.75 0.73 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.586 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -144.94 140.7 28.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.786 2.034 . . . . 0.0 106.089 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.43 119.83 10.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -116.29 0.98 13.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.306 1.043 . . . . 0.0 111.805 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.38 -108.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 p -75.02 30.57 0.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.251 1.025 . . . . 0.0 112.461 170.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -153.71 109.08 3.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.556 0.742 . . . . 0.0 110.628 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.05 162.03 13.22 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 163.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -127.4 138.97 53.13 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.459 1.904 . . . . 0.0 108.619 165.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.36 169.23 10.81 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.355 1.862 . . . . 0.0 112.599 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -137.71 22.22 2.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.9 mt 53.66 -173.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.875 1.67 . . . . 0.0 113.621 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.49 113.2 10.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.579 1.552 . . . . 0.0 110.187 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.51 -125.26 9.23 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.71 7.04 3.77 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 111.807 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.54 154.14 34.81 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 163.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -158.66 159.9 29.52 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.856 1.662 . . . . 0.0 108.489 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.92 167.49 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.289 1.326 . . . . 0.0 111.463 170.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.72 155.51 62.98 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.199 2.599 . . . . 0.0 112.993 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.32 160.76 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.518 2.812 . . . . 0.0 111.142 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.93 3.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.487 2.315 . . . . 0.0 113.89 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.3 m -97.35 -43.56 7.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.611 -1.306 . . . . 0.0 109.567 -166.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -62.36 143.55 56.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.94 0.791 . . . . 0.0 109.36 166.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -146.06 163.68 34.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.268 1.027 . . . . 0.0 108.275 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.07 -3.07 40.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.033 0.921 . . . . 0.0 113.316 -165.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.04 30.37 2.56 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.467 1.984 . . . . 0.0 108.508 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.21 126.21 26.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 164.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.08 135.99 49.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 164.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -147.27 157.45 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 112.408 -2.178 . . . . 0.0 107.625 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 151.85 48.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.336 -1.478 . . . . 0.0 110.331 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.53 121.41 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 124.333 1.053 . . . . 0.0 108.681 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.32 92.63 2.2 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 124.01 0.819 . . . . 0.0 110.014 -166.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.58 143.63 37.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.818 1.247 . . . . 0.0 108.92 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -95.19 102.53 14.34 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 t -152.24 157.97 42.18 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.861 0.755 . . . . 0.0 109.63 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.17 40.91 92.37 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.243 -0.911 . . . . 0.0 112.233 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.9 3.85 37.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.282 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . . . -139.69 177.02 8.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.951 1.875 . . . . 0.0 112.55 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.31 115.27 30.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.274 1.029 . . . . 0.0 108.387 171.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.22 112.76 24.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 127.547 2.339 . . . . 0.0 104.897 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 128.38 42.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.0 t -134.34 168.27 19.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.779 0.8 . . . . 0.0 109.831 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -106.88 157.69 17.57 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.467 1.507 . . . . 0.0 107.59 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.82 179.42 45.2 Favored Glycine 0 CA--C 1.524 0.625 0 O-C-N 121.656 -0.652 . . . . 0.0 113.58 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 162.72 34.1 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.414 173.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.51 -36.14 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.95 1.3 . . . . 0.0 113.928 -170.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 73.52 -66.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.394 2.278 . . . . 0.0 111.176 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -138.09 133.97 34.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.54 157.9 18.04 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -136.6 -56.06 0.74 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.038 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -123.49 168.93 11.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.95 -6.74 13.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.16 0.984 . . . . 0.0 111.104 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.04 -14.25 8.9 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -129.81 119.79 23.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -163.62 169.47 18.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.76 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.94 178.84 5.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.326 1.05 . . . . 0.0 111.01 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.6 pt -147.08 141.81 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 160.59 14.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 159.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.2 mt -117.39 128.72 55.31 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 106.193 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.83 154.51 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.1 0.864 . . . . 0.0 110.458 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.28 -111.67 3.69 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -170.45 136.11 1.28 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.205 1.402 . . . . 0.0 109.467 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.67 154.8 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 126.826 2.05 . . . . 0.0 111.847 164.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.97 154.99 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.99 2.516 . . . . 0.0 105.142 167.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.49 112.7 5.47 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mt -105.68 -0.47 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.543 -0.723 . . . . 0.0 111.968 -172.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -158.78 169.3 24.69 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 128.104 2.562 . . . . 0.0 107.703 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 54.0 mtm-85 -122.11 162.52 21.12 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.763 0.825 . . . . 0.0 109.971 170.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.21 95.29 4.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.147 1.379 . . . . 0.0 107.411 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.19 107.89 12.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 166.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -140.4 21.71 2.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.092 0.957 . . . . 0.0 111.804 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.817 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 63.37 9.43 4.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 m 66.56 135.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.729 1.612 . . . . 0.0 109.845 -153.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.84 7.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.06 0.944 . . . . 0.0 108.518 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -161.98 -78.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -154.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.1 53.89 0.13 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 t -151.12 -3.65 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.097 1.359 . . . . 0.0 111.0 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -65.26 -6.52 9.87 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.75 -1.218 . . . . 0.0 111.6 159.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -55.06 -39.61 69.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.922 0.889 . . . . 0.0 110.17 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -13.07 61.3 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.286 0.469 . . . . 0.0 112.967 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -69.37 -22.77 63.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.551 1.175 . . . . 0.0 110.951 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -123.08 -24.32 4.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.949 1.299 . . . . 0.0 114.346 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -111.67 106.56 15.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.23 160.7 18.37 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.433 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.88 -19.66 65.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.973 2.109 . . . . 0.0 114.484 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 mt -124.92 2.28 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.849 1.26 . . . . 0.0 111.074 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -70.43 175.83 4.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.313 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -113.46 144.71 42.36 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.63 132.99 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.185 0.994 . . . . 0.0 108.401 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -53.01 157.32 1.78 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.916 0.78 . . . . 0.0 109.434 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.63 4.15 15.96 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -166.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.27 95.95 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 113.212 -154.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.17 123.19 44.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 108.367 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.25 137.89 55.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.539 1.063 . . . . 0.0 108.757 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.82 87.53 2.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.9 0.88 . . . . 0.0 108.642 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.17 17.31 79.55 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 121.613 -0.679 . . . . 0.0 111.841 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t0 75.19 -58.79 0.56 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.073 2.549 . . . . 0.0 111.086 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -68.71 -30.26 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.259 0.936 . . . . 0.0 111.841 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.77 158.89 24.41 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 169.0 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.161 1.384 . . . . 0.0 107.551 167.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -126.14 139.42 53.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -135.21 137.41 42.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 162.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.52 -178.17 16.81 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.423 1.487 . . . . 0.0 110.195 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -101.46 150.41 23.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.22 161.71 38.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 162.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.01 155.59 17.05 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 154.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 92.7 mt -71.12 161.04 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.129 1.772 . . . . 0.0 106.265 161.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -134.39 -26.24 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.52 1.128 . . . . 0.0 112.099 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.6 m -154.73 157.06 37.46 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.46 1.504 . . . . 0.0 108.336 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.45 144.3 29.58 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -142.05 83.19 1.83 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.19 2.196 . . . . 0.0 107.894 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.73 -110.54 3.38 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.949 0.785 . . . . 0.0 112.691 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 22.9 p -72.64 -4.6 32.0 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 116.506 -1.711 . . . . 0.0 113.169 175.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -117.26 136.27 53.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.684 1.129 . . . . 0.0 108.469 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.18 164.13 27.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.216 1.406 . . . . 0.0 109.377 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -125.53 142.59 51.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 109.541 167.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.14 170.32 8.6 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.765 1.626 . . . . 0.0 112.002 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -141.21 22.69 2.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.58 1.552 . . . . 0.0 115.069 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.2 mt 51.81 -169.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.045 1.338 . . . . 0.0 112.514 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 -13.98 7.13 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.95 -157.77 29.31 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -165.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -16.57 61.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.999 0.9 . . . . 0.0 112.937 -172.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.7 100.21 2.77 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -124.27 165.03 26.43 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.752 1.621 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -66.11 175.16 5.03 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.69 1.594 . . . . 0.0 112.078 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.31 152.99 80.31 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 109.28 -1.085 . . . . 0.0 109.28 158.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.31 176.7 9.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.973 2.449 . . . . 0.0 111.261 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 p30 52.13 13.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.911 2.484 . . . . 0.0 115.042 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.3 m -121.35 -24.4 5.45 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.506 -0.747 . . . . 0.0 111.611 -164.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.8 mt -80.22 141.55 35.5 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 m -127.26 165.98 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.52 1.928 . . . . 0.0 110.423 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -79.01 -2.52 40.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.532 1.133 . . . . 0.0 113.284 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.26 20.62 2.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 126.597 2.046 . . . . 0.0 109.714 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.78 132.9 52.37 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -75.48 138.01 41.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 165.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.84 167.69 21.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 126.267 1.827 . . . . 0.0 109.496 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -128.89 134.2 48.18 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.838 -1.164 . . . . 0.0 109.582 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.08 170.43 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.417 1.487 . . . . 0.0 109.753 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.57 137.87 5.96 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.96 142.94 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 109.198 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -90.19 112.13 23.53 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -150.36 154.07 37.15 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 119.507 1.049 . . . . 0.0 110.419 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.86 -155.34 7.04 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -163.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.99 53.16 4.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.254 -1.303 . . . . 0.0 111.999 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -163.26 175.78 10.59 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.531 1.665 . . . . 0.0 112.768 162.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.54 145.51 28.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 156.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.402 ' SG ' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -118.14 83.82 2.07 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 127.737 2.415 . . . . 0.0 104.825 170.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -85.13 139.19 31.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.68 176.84 10.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 123.644 0.59 . . . . 0.0 110.58 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -105.57 168.81 8.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.045 1.338 . . . . 0.0 107.512 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.29 -179.99 40.53 Favored Glycine 0 C--N 1.334 0.454 0 O-C-N 120.759 -1.213 . . . . 0.0 112.76 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -128.03 169.91 13.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.47 1.508 . . . . 0.0 108.001 160.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.0 t -68.44 -40.26 81.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 118.861 0.755 . . . . 0.0 112.871 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 65.71 -43.92 0.37 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.801 2.04 . . . . 0.0 114.337 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -153.79 133.4 12.93 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.074 -1.641 . . . . 0.0 109.524 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.89 159.72 17.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.372 0.669 . . . . 0.0 109.33 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -138.05 -50.09 0.58 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.365 -0.835 . . . . 0.0 109.957 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.79 173.4 11.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.4 -6.46 14.52 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.753 0.821 . . . . 0.0 111.798 169.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -117.62 -18.28 9.74 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -130.98 127.85 39.2 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -168.82 166.76 11.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 109.815 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.81 174.95 7.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.631 1.173 . . . . 0.0 110.184 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -142.98 137.49 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 109.02 158.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 43' ' ' SER . 11.9 tpp180 -91.65 123.6 35.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 160.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.84 140.88 38.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 109.893 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.05 158.62 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.886 1.274 . . . . 0.0 110.954 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.54 53.64 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 125.791 1.662 . . . . 0.0 115.821 165.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.14 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.561 3.544 . . . . 0.0 111.98 -173.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.402 HG12 ' SG ' ' A' ' 77' ' ' CYS . 2.6 t -73.55 137.57 23.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 52.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.32 1.873 . . . . 0.0 114.436 172.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 45.0 53.19 7.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.172 1.389 . . . . 0.0 112.283 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.42 -11.45 42.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.268 . . . . 0.0 112.193 -170.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.93 155.45 40.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 128.414 2.686 . . . . 0.0 106.163 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.28 164.61 27.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.188 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.4 ttp85 -84.0 163.11 20.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -143.75 44.2 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.49 0.586 . . . . 0.0 110.224 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 57.22 -0.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.474 1.91 . . . . 0.0 106.125 158.427 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.522 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.47 -60.54 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.648 1.979 . . . . 0.0 110.75 -161.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -141.08 67.66 1.35 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.093 1.357 . . . . 0.0 107.949 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.07 113.95 1.69 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 109.879 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.46 -16.07 63.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.358 1.463 . . . . 0.0 111.874 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.86 -169.82 28.13 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 124.785 1.183 . . . . 0.0 110.976 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.9 m -142.22 -79.79 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -1.96 7.06 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.623 0.769 . . . . 0.0 112.9 -175.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -54.19 -41.73 68.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.619 0.767 . . . . 0.0 109.51 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -5.01 66.55 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.037 0.827 . . . . 0.0 113.834 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -88.22 -10.11 50.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.99 1.395 . . . . 0.0 111.588 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -117.93 -42.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.515 1.526 . . . . 0.0 109.592 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -99.45 146.81 25.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.08 1.352 . . . . 0.0 108.132 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -143.7 158.11 43.91 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -55.61 -20.12 12.59 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 126.453 1.901 . . . . 0.0 115.392 -164.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.2 mt -126.69 5.9 6.76 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -179.66 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.991 0.814 . . . . 0.0 110.587 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 129.36 56.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.715 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 m -118.75 140.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.68 162.45 13.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.945 0.898 . . . . 0.0 110.291 170.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.82 45.18 2.77 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.892 0.877 . . . . 0.0 109.811 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 m -65.01 125.26 24.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.9 t -131.95 127.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.024 1.729 . . . . 0.0 108.176 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 143.9 57.58 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.963 0.801 . . . . 0.0 109.778 172.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.11 18.03 6.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.07 -103.0 0.27 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -130.08 -85.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 171.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p -79.56 63.74 4.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.36 2.664 . . . . 0.0 110.064 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.35 -95.22 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.13 167.4 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.455 2.302 . . . . 0.0 113.203 -165.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.93 149.57 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -150.35 123.16 8.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.61 -178.74 16.54 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.632 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.7 161.61 13.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 166.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.26 160.53 43.63 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.213 1.805 . . . . 0.0 109.622 161.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.98 135.6 33.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.89 153.74 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 159.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -131.52 -39.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.683 1.193 . . . . 0.0 110.279 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.4 m -152.9 123.49 7.27 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.97 1.308 . . . . 0.0 108.191 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 142.86 50.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.576 1.15 . . . . 0.0 109.645 -171.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -135.23 -169.81 2.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.754 1.622 . . . . 0.0 109.276 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.48 95.38 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -163.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -140.09 34.75 1.92 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.286 1.834 . . . . 0.0 108.376 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 146.33 36.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.28 168.59 19.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -130.83 142.86 50.41 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.514 1.926 . . . . 0.0 107.505 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -174.73 3.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.666 1.587 . . . . 0.0 109.894 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.7 mt 57.76 -177.37 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.628 1.571 . . . . 0.0 112.434 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.48 134.44 52.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 172.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.05 -134.33 29.39 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 121.645 0.58 . . . . 0.0 112.562 165.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.43 22.99 5.53 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.81 145.66 28.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -159.46 154.56 21.66 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 122.99 0.516 . . . . 0.0 110.697 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.64 169.95 14.87 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.708 2.272 . . . . 0.0 112.061 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -57.25 154.57 33.85 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.394 1.396 . . . . 0.0 111.41 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.48 169.1 16.37 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.41 2.073 . . . . 0.0 109.093 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.17 44.79 6.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.0 m -138.75 -54.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.896 0.879 . . . . 0.0 109.195 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.78 137.95 58.16 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.678 171.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -147.16 160.88 41.92 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -69.94 -2.25 11.94 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -163.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.49 17.1 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 126.102 1.81 . . . . 0.0 111.137 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.67 28.22 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.88 129.94 38.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.86 159.36 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.128 -172.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.63 104.96 5.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.82 160.46 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.63 137.46 21.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.99 144.62 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.164 0.986 . . . . 0.0 109.231 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -86.33 111.15 20.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -156.99 150.71 24.53 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.57 -56.14 1.65 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.098 1.332 . . . . 0.0 110.936 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.92 -9.48 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.716 1.627 . . . . 0.0 112.933 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.29 174.61 7.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.186 1.493 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.8 tp -81.04 99.1 8.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -70.74 110.05 5.31 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 164.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 146.12 25.51 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.7 m -134.03 144.0 48.42 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.931 168.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.85 146.26 30.97 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.66 -177.52 22.96 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.23 0.919 . . . . 0.0 111.077 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -131.02 161.06 32.8 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 162.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.02 -31.08 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.29 -60.89 0.36 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.135 1.774 . . . . 0.0 111.139 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.4 m -153.27 122.73 6.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.799 2.04 . . . . 0.0 107.121 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tp -91.6 156.04 17.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -130.06 -46.68 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 111.502 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 5.7 m-20 -138.3 -178.73 5.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.231 1.812 . . . . 0.0 107.273 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -21.22 9.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.891 1.676 . . . . 0.0 111.434 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -122.07 -53.98 1.93 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 125.518 1.527 . . . . 0.0 111.214 -163.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.525 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 32.2 mt-30 -85.67 133.47 34.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.784 0.72 . . . . 0.0 109.493 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -166.94 164.04 16.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 109.012 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.78 176.21 8.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.605 0.762 . . . . 0.0 109.927 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -152.73 127.63 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.778 1.631 . . . . 0.0 110.219 164.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.13 125.39 34.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 164.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.58 137.96 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.6 164.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 120.657 1.571 . . . . 0.0 113.354 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.1 -117.6 10.87 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 127.544 2.497 . . . . 0.0 107.525 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -145.53 153.58 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.69 1.596 . . . . 0.0 108.113 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.6 t -55.93 152.69 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.347 1.859 . . . . 0.0 110.438 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -143.41 157.2 44.65 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.37 128.86 37.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -12.29 3.83 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -132.2 156.09 47.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.337 1.426 . . . . 0.0 109.778 166.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.16 -16.66 12.97 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 124.175 0.99 . . . . 0.0 111.189 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -179.84 -164.46 0.06 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.237 2.215 . . . . 0.0 106.95 -172.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 60.96 55.38 3.14 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 123.462 1.601 . . . . 0.0 111.145 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.258 0.0 OUTLIER -78.68 26.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 128.497 2.719 . . . . 0.0 107.401 177.944 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -148.65 162.54 39.51 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.919 0.888 . . . . 0.0 109.683 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -158.63 99.67 1.59 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.3 -43.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.937 2.095 . . . . 0.0 106.715 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 56.33 49.6 14.84 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.995 1.718 . . . . 0.0 109.773 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.91 134.98 1.75 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-O 118.101 -1.389 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 9' ' ' TYR . 11.3 p 174.87 -69.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 112.735 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -59.68 9.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 1 C-N-CA 131.77 4.028 . . . . 0.0 114.365 -172.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 7' ' ' SER . 3.9 m-30 -56.55 -42.38 78.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.539 1.535 . . . . 0.0 110.779 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.78 0.13 86.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.0 0.809 . . . . 0.0 113.524 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -84.43 -15.99 44.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.283 1.042 . . . . 0.0 111.207 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -116.21 -45.76 2.83 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.851 0.751 . . . . 0.0 111.367 -169.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.97 155.56 18.05 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.92 155.76 41.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -50.05 -27.41 5.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.727 3.211 . . . . 0.0 116.628 -168.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.49 1.51 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.608 1.163 . . . . 0.0 111.459 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.57 174.54 7.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 110.107 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -112.55 152.02 29.33 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.29 -0.881 . . . . 0.0 111.124 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.02 136.33 47.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.512 1.525 . . . . 0.0 107.181 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.01 164.55 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.5 mt -129.72 6.72 5.16 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -158.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.84 90.98 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.588 2.355 . . . . 0.0 112.841 -157.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.73 128.59 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -70.83 111.84 6.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.662 0.665 . . . . 0.0 109.613 165.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.49 ' HB2' ' H ' ' A' ' 30' ' ' SER . 2.5 mm? -109.99 79.39 1.21 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.53 -161.69 50.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 166.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.013 0.925 . . . . 0.0 113.231 -154.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 t -151.32 2.7 0.42 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.687 0.676 . . . . 0.0 112.295 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.49 -104.03 2.89 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 120.052 1.296 . . . . 0.0 112.137 -164.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 74.62 158.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 1 C-N-CA 132.047 4.139 . . . . 0.0 114.588 177.956 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -136.6 102.7 5.0 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.156 1.382 . . . . 0.0 107.583 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 158.55 15.4 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.053 169.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -170.05 42.79 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 140.71 50.03 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.418 1.887 . . . . 0.0 108.486 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.43 155.13 50.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.969 0.804 . . . . 0.0 110.477 160.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.86 144.92 28.1 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.5 mt -70.77 157.68 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.065 1.346 . . . . 0.0 107.576 162.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -137.18 -56.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.745 2.018 . . . . 0.0 109.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -121.16 157.22 30.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.008 1.323 . . . . 0.0 109.176 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tt -153.64 118.63 5.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.07 94.65 3.08 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.203 1.401 . . . . 0.0 108.117 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.66 -127.38 43.21 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 p -71.24 36.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.994 1.397 . . . . 0.0 112.615 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -147.51 124.24 11.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.02 165.59 12.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 157.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -126.88 146.17 50.39 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 126.325 1.85 . . . . 0.0 108.297 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -138.24 157.9 45.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.709 1.604 . . . . 0.0 109.498 -159.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.42 26.71 2.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.3 mt 51.19 -165.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.97 1.308 . . . . 0.0 111.276 -171.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.27 153.49 47.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.119 0.967 . . . . 0.0 111.776 168.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.31 -118.63 5.46 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.756 1.646 . . . . 0.0 111.507 167.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.01 2.82 7.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.577 1.551 . . . . 0.0 111.226 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.05 141.32 47.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.05 155.55 24.54 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.297 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.34 170.75 10.3 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.383 2.722 . . . . 0.0 112.217 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.51 154.58 73.84 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.271 1.314 . . . . 0.0 109.286 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.62 161.03 47.51 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 122.72 2.28 . . . . 0.0 111.786 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 47.0 33.84 2.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.426 1.89 . . . . 0.0 112.051 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -128.56 -18.96 3.84 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.298 -0.876 . . . . 0.0 111.855 -171.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 mt -76.01 143.26 41.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.803 0.729 . . . . 0.0 109.284 155.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -141.4 168.77 18.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.364 1.466 . . . . 0.0 108.81 159.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -69.23 -3.76 15.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.443 1.497 . . . . 0.0 114.722 -170.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.44 -2.79 25.94 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 117.851 -1.527 . . . . 0.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.36 131.14 49.31 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.587 1.694 . . . . 0.0 109.188 -164.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -85.56 72.89 10.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.25 1.5 . . . . 0.0 108.48 -167.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.03 154.13 7.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.884 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -134.18 128.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.05 0.94 . . . . 0.0 108.852 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -95.15 175.66 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.694 1.597 . . . . 0.0 110.208 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.0 p -154.71 162.08 41.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.019 1.327 . . . . 0.0 107.829 152.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 p -157.33 143.06 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.747 0.703 . . . . 0.0 109.676 159.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -90.29 117.14 28.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.8 t -136.52 170.38 16.16 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.263 1.425 . . . . 0.0 107.685 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 58.44 -107.66 1.21 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.82 32.17 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.482 1.515 . . . . 0.0 111.952 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.52 -170.11 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.055 1.342 . . . . 0.0 108.789 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.88 122.03 43.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.412 1.485 . . . . 0.0 110.317 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.11 129.1 51.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.44 164.39 25.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.773 1.169 . . . . 0.0 108.345 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.7 t -149.67 148.17 28.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.4 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -79.84 144.3 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.302 1.441 . . . . 0.0 108.043 168.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.11 -169.61 16.46 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.229 -0.919 . . . . 0.0 112.078 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -138.07 168.9 18.76 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 106.73 163.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.88 -27.5 37.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 67.91 -62.85 0.34 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.946 1.699 . . . . 0.0 113.369 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 m -149.32 129.26 13.43 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.569 1.947 . . . . 0.0 106.601 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.97 140.03 43.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -115.2 -52.89 2.66 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.838 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -137.45 169.72 17.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -18.14 57.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.059 0.543 . . . . 0.0 111.978 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -110.41 -15.86 13.83 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.799 172.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -120.48 123.3 42.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.805 1.638 . . . . 0.0 109.127 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -165.77 165.42 18.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.474 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 176.03 8.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.705 1.202 . . . . 0.0 110.596 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.9 pt -144.75 148.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.306 1.442 . . . . 0.0 109.048 155.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 ttp85 -116.37 112.38 21.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.734 1.614 . . . . 0.0 109.286 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.3 mt -75.59 126.25 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.848 1.659 . . . . 0.0 108.571 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.77 161.87 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 111.108 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.12 8.51 87.41 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.072 -1.404 . . . . 0.0 115.039 167.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.28 135.63 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.433 2.693 . . . . 0.0 111.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -86.65 127.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -131.65 165.19 24.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.163 1.347 . . . . 0.0 109.767 171.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.78 92.33 4.18 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 170.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.73 -12.89 55.18 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.646 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -145.89 144.6 30.3 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.347 -162.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -115.34 -28.89 6.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.244 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -166.2 170.79 12.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.207 2.603 . . . . 0.0 106.849 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 49.16 0.33 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 120.033 3.346 . . . . 0.0 120.033 167.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 56.44 46.92 19.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.944 2.097 . . . . 0.0 112.797 -167.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 35.7 p90 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.075 173.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 CA-C-O 117.383 -1.787 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.4 ttm -63.83 -76.11 0.07 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 121.083 2.442 . . . . 0.0 108.865 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -69.42 95.92 0.85 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.57 -20.8 1.34 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.47 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 50.04 62.01 2.89 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.968 1.707 . . . . 0.0 112.129 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.0 160.93 10.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.983 2.23 . . . . 0.0 110.027 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.3 p -159.56 -172.1 3.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.993 1.317 . . . . 0.0 109.203 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.7 -14.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.53 2.332 . . . . 0.0 114.524 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.74 -47.6 77.64 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.609 -1.307 . . . . 0.0 110.895 -166.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.63 6.19 33.39 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 124.065 0.841 . . . . 0.0 113.537 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -84.95 -13.87 49.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.762 1.281 . . . . 0.0 110.65 166.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.419 ' HE2' ' CG1' ' A' ' 100' ' ' VAL . 8.1 m-30 -123.74 -35.78 2.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.807 1.643 . . . . 0.0 112.965 -170.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 24.3 m-85 -108.49 122.17 46.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -172.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.54 159.6 16.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -60.32 -14.09 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.642 2.777 . . . . 0.0 114.203 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 mt -133.84 13.42 4.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.934 1.694 . . . . 0.0 109.911 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -97.36 163.91 12.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 127.008 2.123 . . . . 0.0 109.852 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -118.74 143.17 47.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.133 -0.98 . . . . 0.0 111.58 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.94 139.89 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.576 2.35 . . . . 0.0 104.721 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.58 156.06 24.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.264 172.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 mt -132.01 93.72 3.34 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -80.32 90.02 5.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 t -85.31 102.11 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -55.02 120.96 7.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 117.21 -1.376 . . . . 0.0 109.708 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.5 2.38 15.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.081 0.953 . . . . 0.0 112.419 173.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 164.82 36.33 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.04 37.85 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.781 1.632 . . . . 0.0 113.579 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 p 59.8 16.57 5.71 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.929 -1.107 . . . . 0.0 111.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.18 -1.92 90.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 129.926 3.631 . . . . 0.0 114.309 -170.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -61.24 150.58 34.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.983 1.713 . . . . 0.0 109.351 -163.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -95.55 103.68 15.56 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 -172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.2 109.21 19.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.53 164.52 12.16 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.303 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 138.9 43.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.18 34.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.34 148.91 24.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.2 mt -72.95 160.62 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.886 1.675 . . . . 0.0 108.761 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.1 p -133.45 -32.22 1.17 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.672 2.389 . . . . 0.0 111.294 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 m -151.55 142.98 23.49 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 42' ' ' GLY . 1.4 tp -141.18 114.28 8.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 110.646 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.31 32.19 5.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.872 0.869 . . . . 0.0 112.941 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.415 ' H ' ' HG ' ' A' ' 40' ' ' LEU . . . 115.13 -113.09 2.86 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -67.98 22.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.365 1.466 . . . . 0.0 111.735 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' GLY . 2.8 tm? -148.83 126.78 11.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.58 163.63 22.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -124.97 146.14 49.54 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 127.264 2.226 . . . . 0.0 107.866 170.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.5 mt -138.88 161.35 37.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.092 1.495 . . . . 0.0 110.433 -156.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -146.33 36.47 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.8 mt 54.25 -174.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.335 -1.478 . . . . 0.0 113.847 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.36 -48.69 2.4 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.982 -0.449 . . . . 0.0 112.012 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.03 -167.44 11.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.956 1.265 . . . . 0.0 111.296 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.33 17.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.826 1.251 . . . . 0.0 112.67 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.96 104.32 0.69 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.497 1.519 . . . . 0.0 108.521 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -135.28 149.38 69.69 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 123.779 0.832 . . . . 0.0 109.948 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.23 165.33 29.01 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.841 2.36 . . . . 0.0 111.158 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.11 160.01 24.1 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.351 1.367 . . . . 0.0 110.961 171.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.92 160.49 11.85 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.515 2.143 . . . . 0.0 110.853 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 56.3 35.88 26.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.311 1.444 . . . . 0.0 111.411 -171.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.72 -40.25 1.22 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -172.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.1 mt -73.06 140.21 47.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -138.68 165.18 27.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.831 0.852 . . . . 0.0 109.702 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 58.9 mt-10 -70.79 -2.23 14.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.431 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.26 2.26 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 120.659 -1.275 . . . . 0.0 110.129 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.5 132.43 53.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 165.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.37 116.83 16.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 166.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.53 140.48 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.53 116.43 22.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -165.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 79' ' ' CYS . 2.5 m -72.93 162.28 4.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 C-N-CA 124.045 0.938 . . . . 0.0 109.822 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -160.12 141.29 12.36 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.619 1.568 . . . . 0.0 112.031 150.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.91 158.3 10.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.165 1.386 . . . . 0.0 109.521 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -92.25 121.43 33.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.524 1.53 . . . . 0.0 107.428 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 t -150.47 160.54 43.7 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.26 -117.93 3.07 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.03 20.63 5.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.343 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.51 172.34 17.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.445 2.123 . . . . 0.0 110.293 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.89 115.81 28.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.71 150.52 20.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -157.01 134.97 11.0 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 106.93 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.475 ' H ' HG23 ' A' ' 68' ' ' VAL . 27.9 t -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 107.173 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.13 152.68 44.84 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.68 -175.95 23.16 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.755 -1.215 . . . . 0.0 111.618 -172.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -129.21 172.33 11.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.01 0.924 . . . . 0.0 109.218 163.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.0 t -68.62 -32.44 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.5 -65.53 0.2 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.885 1.674 . . . . 0.0 111.993 -172.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -145.33 126.49 14.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.142 1.377 . . . . 0.0 108.072 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 2.8 tp -86.31 165.11 16.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.797 0.839 . . . . 0.0 109.156 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -137.24 -43.71 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.783 0.72 . . . . 0.0 112.643 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -141.58 177.25 8.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.9 -6.06 7.5 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.48 -1.387 . . . . 0.0 111.884 169.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -138.9 -1.82 1.76 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -127.85 134.88 49.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 120.32 1.418 . . . . 0.0 107.282 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.54 166.43 2.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.8 178.9 6.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.563 0.745 . . . . 0.0 110.627 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.6 pt -147.43 134.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.654 1.181 . . . . 0.0 111.109 160.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -90.72 127.37 36.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.079 0.952 . . . . 0.0 108.665 165.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -84.85 131.02 34.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.26 171.19 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 119.472 1.033 . . . . 0.0 111.463 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.35 13.31 64.91 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.998 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.6 163.69 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.418 3.887 . . . . 0.0 113.577 -173.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.419 ' CG1' ' HE2' ' A' ' 12' ' ' TYR . 1.1 p -112.1 127.67 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.907 2.483 . . . . 0.0 110.625 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 -131.0 162.53 29.56 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 167.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.0 106.15 3.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.22 -16.84 23.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.787 -1.102 . . . . 0.0 112.036 175.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -142.13 150.45 41.14 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.967 0.889 . . . . 0.0 110.613 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -126.71 179.29 5.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.876 1.671 . . . . 0.0 109.746 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.74 29.47 1.12 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 127.252 2.221 . . . . 0.0 105.845 -174.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -94.77 89.44 5.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -107.85 89.53 3.02 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.334 0.654 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.25 1.121 0 C-N-CA 126.448 1.899 . . . . 0.0 109.399 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.67 164.17 14.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.053 0.927 . . . . 0.0 109.912 166.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -130.15 1.83 4.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.19 1.796 . . . . 0.0 111.836 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.24 43.67 3.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.111 1.364 . . . . 0.0 109.96 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.45 161.01 37.5 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.638 1.175 . . . . 0.0 108.209 160.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.57 65.77 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 128.731 3.063 . . . . 0.0 106.37 170.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -130.86 -29.03 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.427 1.114 . . . . 0.0 113.483 -169.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -6.6 34.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.421 1.464 . . . . 0.0 114.732 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -57.41 -48.23 79.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.421 1.464 . . . . 0.0 110.963 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -15.73 65.49 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 119.301 -0.722 . . . . 0.0 113.417 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -71.15 -21.04 62.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.591 1.195 . . . . 0.0 111.305 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 1.2 m-85 -112.03 -51.4 2.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.379 0.672 . . . . 0.0 109.539 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.14 161.75 27.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -145.42 161.08 40.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.527 -0.733 . . . . 0.0 112.07 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.86 -22.84 62.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.69 9.05 8.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.233 1.413 . . . . 0.0 111.072 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.47 174.97 1.49 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.384 0.611 . . . . 0.0 110.02 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 30.2 mtpt -116.7 146.03 43.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 109.042 166.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.56 156.76 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 109.826 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.12 141.57 28.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.936 2.094 . . . . 0.0 109.441 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.9 mt -130.98 70.99 1.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.881 1.273 . . . . 0.0 113.459 -162.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -60.98 133.58 56.24 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.043 -1.036 . . . . 0.0 108.277 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 t -126.71 121.11 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 164.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -62.56 137.23 58.22 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 120.52 1.509 . . . . 0.0 108.941 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.0 mt -138.61 101.0 4.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 171.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.24 28.53 73.73 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.111 -0.993 . . . . 0.0 111.984 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 57.47 5.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.533 2.733 . . . . 0.0 114.873 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 p -149.43 -39.09 0.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.129 1.772 . . . . 0.0 109.835 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 7.72 4.55 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 126.885 2.183 . . . . 0.0 114.631 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -58.43 138.29 56.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.371 1.868 . . . . 0.0 111.333 -160.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -80.9 154.2 27.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.18 141.76 37.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 157.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.95 174.17 24.43 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 164.24 12.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.19 160.14 43.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.785 -1.197 . . . . 0.0 110.465 161.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 147.17 28.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 157.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.1 mt -79.43 157.46 4.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -130.56 -32.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.536 1.535 . . . . 0.0 111.36 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.9 m -152.23 155.14 37.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.066 1.746 . . . . 0.0 108.878 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.2 tp -147.25 112.61 5.57 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.179 1.391 . . . . 0.0 108.671 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -133.16 94.22 3.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 51.88 -131.3 36.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.404 -0.664 . . . . 0.0 111.794 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 p -74.66 43.59 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.422 1.889 . . . . 0.0 110.839 173.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.25 107.83 3.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.849 -0.532 . . . . 0.0 111.732 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.67 165.51 11.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 165.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -126.83 148.63 49.95 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.588 1.555 . . . . 0.0 108.0 164.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 mt -135.9 172.25 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.124 1.769 . . . . 0.0 109.272 -165.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -151.03 27.22 0.7 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.1 mt 52.25 -174.15 0.03 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.36 1.864 . . . . 0.0 113.024 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -131.78 126.84 35.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.822 1.649 . . . . 0.0 106.952 174.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.34 -132.88 42.68 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.524 0.514 . . . . 0.0 112.815 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.7 4.37 17.1 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 0.0 112.586 -171.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.06 53.49 1.44 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.622 1.569 . . . . 0.0 109.616 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -87.48 156.46 53.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 121.372 -0.83 . . . . 0.0 111.197 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.56 175.23 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.753 2.302 . . . . 0.0 112.391 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -58.97 154.76 42.66 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 121.106 1.204 . . . . 0.0 110.55 160.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -65.63 174.66 5.15 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.604 2.869 . . . . 0.0 110.156 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.2 p30 52.69 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.4 m -110.09 -31.34 7.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 111.193 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -69.59 139.61 53.68 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.101 -0.999 . . . . 0.0 110.085 168.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.02 156.71 45.98 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.26 . . . . 0.0 110.049 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.71 -1.7 14.76 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -168.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.12 18.26 4.76 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.113 1.816 . . . . 0.0 111.215 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.61 141.01 58.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.67 63.79 1.25 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 123.674 1.702 . . . . 0.0 111.663 -163.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 m -68.38 162.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.014 -1.903 . . . . 0.0 112.039 -171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 169.17 9.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.584 1.154 . . . . 0.0 109.787 173.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.89 123.75 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 125.478 1.511 . . . . 0.0 109.565 168.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -121.64 141.87 50.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.963 0.789 . . . . 0.0 110.607 162.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.4 146.79 15.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.85 2.06 . . . . 0.0 106.337 162.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 76.6 m95 -87.77 143.05 27.36 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 163.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 t -137.5 173.68 11.4 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.01 -98.62 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.753 2.121 . . . . 0.0 112.683 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.8 22.38 2.82 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.322 1.915 . . . . 0.0 111.927 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.71 174.73 11.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.049 1.924 . . . . 0.0 114.024 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.8 tm? -115.61 122.77 46.61 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.151 1.381 . . . . 0.0 110.738 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.86 81.45 1.77 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.099 1.36 . . . . 0.0 110.074 -168.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -99.25 128.22 45.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.57 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.3 t -128.17 172.44 11.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.726 0.81 . . . . 0.0 110.021 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.21 160.19 16.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.125 1.77 . . . . 0.0 108.702 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.69 -169.32 29.15 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -144.12 160.72 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.638 1.975 . . . . 0.0 109.1 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.274 51.3 t -62.52 -31.84 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 70.23 -66.11 0.29 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.107 2.163 . . . . 0.0 114.937 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -155.71 97.16 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.796 1.638 . . . . 0.0 108.915 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tp -79.09 152.89 30.57 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.18 -58.76 1.53 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.239 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 30.0 m-20 -127.15 -173.54 2.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.24 -8.35 45.07 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.966 -1.084 . . . . 0.0 111.123 166.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -131.91 -44.89 0.95 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 112.574 -169.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 31.6 mt-30 -91.7 133.38 35.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -167.29 164.2 15.33 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.162 0.585 . . . . 0.0 109.724 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.85 175.31 10.79 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.25 1.42 . . . . 0.0 110.807 172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.46 148.17 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.391 1.076 . . . . 0.0 109.188 156.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.24 114.96 26.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.595 2.758 . . . . 0.0 107.606 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.64 147.09 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.495 1.043 . . . . 0.0 108.573 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.83 146.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 122.335 1.064 . . . . 0.0 109.758 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.74 -141.85 31.28 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -166.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.32 138.37 29.45 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.666 1.186 . . . . 0.0 110.838 -165.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.406 ' CG1' ' CE2' ' A' ' 12' ' ' TYR . 1.4 p -85.34 129.85 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.044 1.738 . . . . 0.0 111.662 171.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.52 158.03 40.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.914 1.686 . . . . 0.0 106.703 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.16 97.76 0.74 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.3 mt -80.1 -9.1 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 120.951 -1.093 . . . . 0.0 111.341 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -154.94 156.01 35.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 127.207 2.203 . . . . 0.0 107.933 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -113.87 179.01 4.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.22 1.408 . . . . 0.0 107.785 166.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -129.94 129.15 43.45 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.07 90.71 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 163.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.358 0.0 OUTLIER -99.03 -4.08 33.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 169.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 127.39 2.276 . . . . 0.0 110.076 -172.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 72.2 mtm -144.68 65.46 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -167.37 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -155.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.13 157.32 46.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.577 1.151 . . . . 0.0 109.383 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 44.93 -158.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.216 1.806 . . . . 0.0 112.603 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.37 142.48 16.54 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 120.182 1.356 . . . . 0.0 112.365 -170.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t -144.3 175.97 9.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.945 2.098 . . . . 0.0 108.411 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 73.3 16.64 4.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.645 1.578 . . . . 0.0 110.538 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -105.62 -47.71 3.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.439 1.495 . . . . 0.0 109.804 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.95 10.38 3.18 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.734 1.635 . . . . 0.0 113.363 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -90.85 -14.7 31.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.358 1.863 . . . . 0.0 112.484 165.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -121.52 -39.04 2.69 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.994 1.318 . . . . 0.0 112.329 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -93.16 154.35 18.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -143.76 155.8 44.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -57.61 -21.7 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 126.279 1.832 . . . . 0.0 113.661 -170.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -124.39 6.47 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.019 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -72.16 169.0 17.01 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.508 -1.37 . . . . 0.0 110.865 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -99.79 153.31 19.23 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.04 148.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.379 1.871 . . . . 0.0 106.039 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.65 161.77 29.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.761 0.825 . . . . 0.0 111.274 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -133.37 41.68 3.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.935 0.894 . . . . 0.0 112.487 -163.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 m -66.62 100.7 0.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.4 t -94.47 113.24 28.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -57.56 107.21 0.42 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-N 120.535 1.516 . . . . 0.0 109.334 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.25 61.72 5.84 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.168 1.787 . . . . 0.0 107.808 171.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.48 7.21 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 75.09 -71.34 0.13 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.925 2.09 . . . . 0.0 112.871 161.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -63.98 -24.5 67.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.096 1.358 . . . . 0.0 111.892 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.06 174.1 22.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.56 172.23 8.29 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.438 1.095 . . . . 0.0 109.266 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -110.48 148.4 32.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 164.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -132.79 141.37 48.46 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.926 0.89 . . . . 0.0 110.429 166.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.15 -168.42 26.18 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.568 1.556 . . . . 0.0 110.73 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.2 m -129.26 148.85 51.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.64 162.08 32.91 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 162.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.26 144.65 25.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.04 153.53 8.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 163.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.3 p -130.89 -40.19 1.19 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.776 1.231 . . . . 0.0 110.398 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -140.88 154.51 46.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.873 2.069 . . . . 0.0 107.695 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.75 134.8 20.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -154.23 95.06 1.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.905 1.682 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 -110.8 3.29 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.861 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.5 p -100.09 36.26 1.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.597 1.198 . . . . 0.0 110.449 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.36 131.64 22.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.22 28.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -122.11 147.16 46.48 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.791 1.637 . . . . 0.0 108.154 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -140.2 156.73 46.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.898 1.679 . . . . 0.0 109.691 -163.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -143.53 35.89 1.31 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 mt 50.89 -170.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.9 1.28 . . . . 0.0 111.3 -171.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.04 -22.65 7.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.227 1.811 . . . . 0.0 112.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.76 -171.39 26.15 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -167.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.5 -67.98 0.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 128.337 2.655 . . . . 0.0 111.587 -169.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -128.73 159.88 34.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.128 2.571 . . . . 0.0 109.552 -163.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -158.37 163.17 25.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 110.34 -172.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 168.12 19.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.193 1.929 . . . . 0.0 110.152 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.94 155.76 66.17 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 120.986 1.124 . . . . 0.0 110.041 164.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.06 174.88 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.014 2.476 . . . . 0.0 108.293 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.99 23.51 12.64 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.986 -1.071 . . . . 0.0 111.34 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.4 m -137.59 -43.85 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.457 1.503 . . . . 0.0 110.182 -167.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 mt -70.96 135.65 48.02 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 120.126 1.33 . . . . 0.0 109.349 169.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.7 m -132.77 163.91 27.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.084 0.954 . . . . 0.0 111.046 168.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.96 -0.05 12.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.026 1.33 . . . . 0.0 114.178 -170.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.2 10.86 7.31 Favored Glycine 0 C--N 1.321 -0.283 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.428 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 128.19 34.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 71.22 1.41 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.076 1.417 . . . . 0.0 109.844 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.6 m -82.87 136.17 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.779 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.84 120.42 41.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.907 0.883 . . . . 0.0 109.157 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.93 155.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.3 p -142.76 155.66 44.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 153.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -150.87 150.88 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 164.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -100.06 120.5 39.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -156.74 157.04 34.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.2 42.36 62.66 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.944 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.8 -22.87 5.39 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.077 0.938 . . . . 0.0 113.733 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.8 164.17 16.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.892 1.346 . . . . 0.0 112.055 -158.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 tp -84.73 102.02 12.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.7 m -88.55 123.45 33.06 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.31 158.56 42.64 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 167.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 41.9 t -148.83 141.97 24.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.296 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.36 149.95 46.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 110.141 173.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.62 -167.48 20.31 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.602 -1.311 . . . . 0.0 112.747 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -139.49 178.96 6.84 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.156 1.782 . . . . 0.0 110.269 166.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.03 -46.01 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.989 1.315 . . . . 0.0 113.234 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 64.7 -58.87 0.24 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.627 2.371 . . . . 0.0 115.23 -167.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -132.44 133.63 44.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -104.8 162.58 13.18 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -139.02 -37.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 120.843 -1.161 . . . . 0.0 113.853 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.77 -175.7 4.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 164.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -68.51 1.69 2.92 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.189 -0.944 . . . . 0.0 112.457 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -134.06 -18.32 2.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -121.24 138.02 54.42 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.364 1.438 . . . . 0.0 107.221 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -172.68 164.13 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.951 0.9 . . . . 0.0 109.602 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.95 172.12 12.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.484 1.114 . . . . 0.0 109.344 168.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 pt -139.97 143.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.326 1.05 . . . . 0.0 109.156 153.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 130.55 46.06 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.685 1.194 . . . . 0.0 107.794 163.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.1 mt -87.44 135.09 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.85 157.23 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 122.33 1.062 . . . . 0.0 109.529 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.98 -109.67 2.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -165.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.6 166.5 31.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -96.47 148.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 1 C-N-CA 133.179 4.591 . . . . 0.0 110.79 154.579 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -137.97 171.38 14.51 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.616 2.366 . . . . 0.0 107.346 160.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -71.84 135.45 46.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 161.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.69 75.5 1.63 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.176 0.99 . . . . 0.0 109.289 173.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 77.08 173.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 131.222 3.809 . . . . 0.0 113.764 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.42 163.21 31.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 127.428 2.291 . . . . 0.0 110.899 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -99.75 -10.96 21.25 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -88.19 98.21 11.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -105.6 91.86 3.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.653 -1.165 . . . . 0.0 110.06 -168.585 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.195 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 39.6 mtp -143.59 106.15 4.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 p -166.93 30.54 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.428 1.491 . . . . 0.0 109.984 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 68.65 -23.64 0.14 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 129.684 3.194 . . . . 0.0 115.213 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.39 171.39 7.39 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.324 1.449 . . . . 0.0 111.933 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.67 -95.62 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 O-C-N 121.278 -0.889 . . . . 0.0 112.686 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.91 27.81 14.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.544 1.138 . . . . 0.0 112.144 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -9.41 15.62 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.101 -1.624 . . . . 0.0 111.889 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -62.52 -37.79 87.44 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.96 -0.462 . . . . 0.0 110.415 -170.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.41 44.07 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.26 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 mtt-85 -84.52 -16.15 43.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.66 1.23 . . . . 0.0 110.164 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -116.53 -45.85 2.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.184 1.794 . . . . 0.0 109.98 -172.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -91.4 168.39 11.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.282 1.033 . . . . 0.0 108.237 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -148.85 169.54 20.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.692 0.797 . . . . 0.0 109.183 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -71.23 -20.73 62.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.98 14.13 7.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.1 0.96 . . . . 0.0 109.138 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -177.18 2.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.092 1.757 . . . . 0.0 110.542 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.99 33.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 120.926 -1.108 . . . . 0.0 111.042 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.67 144.86 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.529 1.131 . . . . 0.0 108.441 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.45 158.6 29.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.295 1.438 . . . . 0.0 109.934 167.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.8 mt -130.8 55.45 1.84 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.145 1.378 . . . . 0.0 109.72 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -69.06 130.26 42.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.38 130.42 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -71.17 114.6 9.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.778 1.627 . . . . 0.0 109.103 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -110.79 79.15 1.17 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.36 -149.7 47.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.11 -14.26 14.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.304 1.042 . . . . 0.0 112.201 -164.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.99 7.46 3.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.155 1.382 . . . . 0.0 111.153 -169.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.34 -97.0 2.01 Favored Glycine 0 CA--C 1.501 -0.81 0 N-CA-C 106.494 -2.643 . . . . 0.0 106.494 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 m 50.8 170.05 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 111.61 -2.295 . . . . 0.0 112.961 -157.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -132.05 147.27 52.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -139.02 130.41 27.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.55 -168.77 13.3 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.227 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 142.32 45.22 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.063 1.345 . . . . 0.0 107.808 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.68 153.93 51.77 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 164.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.79 38.81 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 156.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.5 mt -68.63 158.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 160.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.1 p -135.88 -18.52 1.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.779 1.632 . . . . 0.0 112.122 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 m -157.6 148.6 21.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -144.48 122.56 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -135.68 74.64 1.52 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.592 1.957 . . . . 0.0 107.953 -173.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.56 -123.78 29.84 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.6 p -77.1 34.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.777 1.288 . . . . 0.0 111.97 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.7 125.01 8.78 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.8 162.46 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -129.3 147.52 51.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.684 1.194 . . . . 0.0 110.452 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.62 173.45 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.68 1.592 . . . . 0.0 112.51 -167.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.37 19.95 1.37 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mt 55.51 -171.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.861 0.864 . . . . 0.0 112.943 -169.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.83 148.78 52.31 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.005 1.722 . . . . 0.0 109.903 165.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.42 -111.0 2.84 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.642 1.115 . . . . 0.0 112.563 161.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.77 7.96 1.11 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.562 1.545 . . . . 0.0 111.163 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.97 146.4 46.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 163.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -173.87 149.59 1.55 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.513 1.925 . . . . 0.0 113.047 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.88 167.77 18.76 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.107 3.205 . . . . 0.0 112.996 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.12 154.23 71.78 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 121.204 1.269 . . . . 0.0 109.994 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.01 170.45 20.08 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.192 2.595 . . . . 0.0 110.765 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.47 -3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 128.211 2.605 . . . . 0.0 116.503 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.2 m -101.32 -24.34 14.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.025 1.33 . . . . 0.0 112.046 -161.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.5 mt -78.92 149.26 32.42 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 120.97 -1.082 . . . . 0.0 108.845 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.75 163.24 34.6 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.553 1.141 . . . . 0.0 108.447 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -70.67 -2.04 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 37.48 1.5 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 135.87 57.21 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 162.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.18 125.78 29.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 166.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.98 136.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.565 1.146 . . . . 0.0 109.616 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.63 131.83 41.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.82 154.71 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.7 p -145.29 146.98 31.87 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 157.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.5 p -149.87 147.75 15.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.239 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -89.38 117.98 28.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.0 t -151.17 169.86 20.86 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.62 -117.61 3.56 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -163.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.35 60.89 0.63 Allowed Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.97 -175.59 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.482 1.513 . . . . 0.0 109.053 176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.5 101.85 10.99 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.029 1.732 . . . . 0.0 108.933 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -71.71 107.9 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.74 133.56 39.7 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 165.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.21 133.2 47.44 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.51 152.25 28.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.91 -171.43 33.84 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.16 167.14 21.22 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.9 -27.49 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 65.03 -64.16 0.17 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.129 1.772 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -149.36 110.25 4.32 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.319 2.247 . . . . 0.0 105.294 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tp -81.36 153.93 26.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 167.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -120.25 -71.36 0.74 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.03 179.48 3.94 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.116 1.766 . . . . 0.0 108.494 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.76 -2.3 0.22 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.421 2.688 . . . . 0.0 113.698 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -157.22 -38.13 0.07 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.1 -1.0 . . . . 0.0 113.151 -159.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.28 127.73 45.32 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -171.62 176.44 3.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.112 0.965 . . . . 0.0 109.308 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.19 179.92 4.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.338 1.055 . . . . 0.0 112.234 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -150.2 124.62 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.213 1.805 . . . . 0.0 111.654 167.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 114.18 26.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.25 1.42 . . . . 0.0 107.648 168.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -78.02 135.01 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.89 1.276 . . . . 0.0 108.129 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 m -136.89 167.65 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.163 0.585 . . . . 0.0 111.121 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.93 15.61 80.91 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 118.502 -1.165 . . . . 0.0 114.616 164.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.22 165.23 0.19 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.815 2.046 . . . . 0.0 111.006 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -116.59 137.45 50.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.19 149.77 40.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.93 106.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.773 1.629 . . . . 0.0 106.96 162.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mt -104.6 -15.12 15.4 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.567 1.076 . . . . 0.0 112.196 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -135.48 160.9 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.51 174.33 8.74 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.434 ' C ' ' H ' ' A' ' 108' ' ' TYR . 16.8 ttt180 -91.71 19.48 6.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.679 1.127 . . . . 0.0 112.839 -169.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 75.39 -15.42 0.68 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.725 2.41 . . . . 0.0 112.194 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 106' ' ' ARG . 10.6 m-30 -83.21 14.29 3.6 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 127.213 2.205 . . . . 0.0 112.664 -175.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . 0.259 84.7 m-85 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 130.261 3.424 . . . . 0.0 112.476 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.43 96.47 1.06 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -176.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -176.68 153.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.716 1.606 . . . . 0.0 107.545 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.92 -42.64 0.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.664 0.785 . . . . 0.0 111.023 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -118.37 174.93 5.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.153 2.181 . . . . 0.0 108.073 -174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.35 84.74 1.09 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 t -133.6 -30.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.866 1.266 . . . . 0.0 110.018 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -49.29 1.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 131.501 3.921 . . . . 0.0 115.989 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -72.91 -50.03 26.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.791 -1.193 . . . . 0.0 110.141 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.32 -24.05 77.38 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.547 0.612 . . . . 0.0 113.0 -164.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -61.79 -21.24 64.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.518 172.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -113.6 -40.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.034 1.334 . . . . 0.0 111.49 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.67 112.06 24.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.536 1.534 . . . . 0.0 108.606 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.18 157.49 19.34 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.605 0.566 . . . . 0.0 109.932 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.0 -27.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.522 2.729 . . . . 0.0 113.859 163.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.37 41.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.241 1.416 . . . . 0.0 108.561 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -113.0 159.9 18.66 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.462 1.105 . . . . 0.0 108.96 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 148.12 32.94 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.065 -1.022 . . . . 0.0 110.404 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.47 155.3 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.337 1.055 . . . . 0.0 108.763 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 161.09 5.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.238 0.615 . . . . 0.0 110.839 162.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.73 44.46 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.588 2.355 . . . . 0.0 108.303 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.2 m -68.2 114.59 6.82 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.47 104.73 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -50.12 114.54 1.12 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 165.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB2' ' H ' ' A' ' 30' ' ' SER . 84.7 mt -106.33 79.95 1.44 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 167.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.54 -5.79 27.57 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.319 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.16 -4.73 2.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 130.253 3.421 . . . . 0.0 112.175 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.0 t -85.99 -25.49 25.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.849 0.86 . . . . 0.0 110.762 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.14 -75.03 0.73 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-O 122.57 1.094 . . . . 0.0 111.419 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 25' ' ' LEU 0.315 1.2 m 56.54 166.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.319 3.048 . . . . 0.0 114.946 -166.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.64 166.69 23.31 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 105.933 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -152.59 154.95 36.42 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.04 11.52 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -133.67 151.71 51.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.9 151.0 39.25 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 167.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 145.57 26.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 166.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.0 156.32 7.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 168.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 p -132.8 -22.79 2.07 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.926 2.09 . . . . 0.0 111.819 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -157.05 132.82 9.41 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.537 1.535 . . . . 0.0 108.237 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -126.74 146.72 50.12 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.404 1.081 . . . . 0.0 108.621 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -161.8 88.11 0.69 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.229 1.012 . . . . 0.0 111.633 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.26 -125.92 37.0 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.1 p -80.48 45.0 0.74 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.041 0.92 . . . . 0.0 110.903 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tp -153.05 129.34 10.53 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.53 149.82 51.69 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -114.45 132.42 56.26 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.21 1.404 . . . . 0.0 108.73 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.31 156.06 34.66 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.044 1.338 . . . . 0.0 109.9 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -137.91 23.98 2.83 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -169.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 mt 51.37 140.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 130.671 3.589 . . . . 0.0 115.58 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.31 3.55 27.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.97 -160.18 52.55 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -164.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.25 -70.08 0.17 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.471 2.708 . . . . 0.0 110.161 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.12 169.71 18.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.469 1.908 . . . . 0.0 110.012 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -151.86 161.44 29.49 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.67 1.588 . . . . 0.0 109.826 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.42 170.7 17.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.373 2.049 . . . . 0.0 112.317 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.54 154.19 74.84 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.15 1.9 . . . . 0.0 111.09 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.51 167.48 25.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.973 2.449 . . . . 0.0 111.424 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 49.23 26.22 1.45 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.904 2.081 . . . . 0.0 111.966 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.1 m -122.8 -55.79 1.79 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.115 1.366 . . . . 0.0 108.021 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.17 130.27 41.44 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 168.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 m -143.11 163.6 32.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -78.18 0.73 23.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.412 1.085 . . . . 0.0 113.713 -164.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.62 21.67 3.05 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 124.9 21.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.59 117.29 11.93 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.22 153.68 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 124.929 1.291 . . . . 0.0 107.843 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 p -125.71 130.46 51.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.105 0.866 . . . . 0.0 111.104 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.463 HG22 ' H ' ' A' ' 79' ' ' CYS . 2.6 m -81.28 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -165.75 131.38 2.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.326 2.25 . . . . 0.0 106.428 154.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.16 138.3 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 168.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -81.73 112.28 18.75 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 168.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -114.2 -166.09 1.07 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 168.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.78 127.49 14.69 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.66 2.53 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.22 -0.767 . . . . 0.0 111.413 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.7 174.19 11.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.908 1.354 . . . . 0.0 111.368 -154.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.59 117.74 23.92 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 173.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 15.0 p -99.55 122.16 42.21 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.71 162.12 32.81 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.463 ' H ' HG22 ' A' ' 68' ' ' VAL . 22.4 t -155.4 166.8 32.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.8 140.88 52.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.75 -175.57 22.11 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 123.552 0.596 . . . . 0.0 114.021 -160.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -133.35 163.84 28.43 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 166.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.3 t -65.17 -39.97 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.141 0.882 . . . . 0.0 111.961 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 64.9 -48.52 0.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.161 2.585 . . . . 0.0 113.921 -167.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 m -153.79 101.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.27 1.428 . . . . 0.0 107.685 -166.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 tp -81.9 161.63 23.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -133.85 -41.46 0.84 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.735 0.814 . . . . 0.0 111.792 171.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.37 173.63 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.706 2.002 . . . . 0.0 105.982 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.2 -10.2 1.85 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.975 2.11 . . . . 0.0 112.943 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -127.74 -24.4 3.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.839 1.656 . . . . 0.0 112.234 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -120.46 121.09 37.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -162.33 163.48 27.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.932 0.396 . . . . 0.0 110.038 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.11 171.55 10.17 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.029 171.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.3 pt -146.85 131.05 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.201 1.8 . . . . 0.0 108.638 163.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.32 119.48 31.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.47 125.83 29.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.93 158.24 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.13 -154.26 49.28 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -173.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 137.46 51.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.084 -2.058 . . . . 0.0 108.214 -171.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.52 149.62 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -145.91 158.73 43.85 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 164.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 77.81 2.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.41 -5.22 56.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.839 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.63 136.21 24.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.701 1.6 . . . . 0.0 108.994 -170.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -147.29 111.01 4.98 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.71 1.204 . . . . 0.0 109.284 -163.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 175.13 9.71 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.974 166.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 44.76 59.97 3.13 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.9 168.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.296 0.0 OUTLIER -106.78 -5.15 18.63 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.06 1.744 . . . . 0.0 114.272 -174.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.256 1.022 . . . . 0.0 109.906 171.081 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 23.8 ttt -71.51 77.55 0.79 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 165.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 t -144.31 -85.05 0.14 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.66 91.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 118.538 0.608 . . . . 0.0 111.142 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.9 t70 44.57 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.448 2.299 . . . . 0.0 114.581 168.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.12 79.64 0.27 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.479 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t 53.64 -153.23 0.28 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -106.33 11.74 30.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.844 1.258 . . . . 0.0 111.998 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -59.4 -47.94 83.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 111.08 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.4 -16.61 71.62 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.792 0.71 . . . . 0.0 112.671 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -74.7 -10.54 59.63 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.72 -0.871 . . . . 0.0 111.525 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.492 ' HB3' ' HG ' ' A' ' 77' ' ' CYS . 3.3 m-30 -120.19 -40.93 2.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.331 1.452 . . . . 0.0 110.574 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -101.17 104.57 15.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -83.08 157.12 22.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 169.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -62.42 -15.13 47.5 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 127.286 2.234 . . . . 0.0 114.805 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.81 2.61 6.03 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.446 1.098 . . . . 0.0 111.203 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -71.43 178.83 3.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 111.712 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.81 157.61 18.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.427 1.091 . . . . 0.0 110.283 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.66 146.07 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 108.769 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -65.41 153.09 42.29 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.605 0.639 . . . . 0.0 109.387 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.83 51.39 1.53 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.328 0.651 . . . . 0.0 111.477 -165.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 112.96 4.39 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.131 -0.98 . . . . 0.0 110.294 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.64 109.6 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.029 1.332 . . . . 0.0 109.576 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -62.2 130.15 44.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.216 1.807 . . . . 0.0 109.941 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.1 mt -116.67 54.23 0.86 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.493 1.117 . . . . 0.0 108.914 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.24 -162.41 46.04 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -164.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -84.81 -26.97 27.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.696 -0.885 . . . . 0.0 112.489 -166.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.45 68.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.11 140.05 2.78 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.07 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.758 1.223 . . . . 0.0 108.264 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -137.06 151.06 48.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 164.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.6 141.19 31.92 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.764 1.226 . . . . 0.0 108.186 166.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.23 -173.06 17.13 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.218 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.45 124.48 38.53 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.05 1.34 . . . . 0.0 107.637 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.77 149.95 45.57 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.672 1.989 . . . . 0.0 107.079 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.67 153.34 17.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.9 mt -75.19 162.62 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.625 1.57 . . . . 0.0 107.622 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.7 p -140.1 -40.85 0.43 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.986 1.715 . . . . 0.0 111.641 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 m -137.3 145.82 43.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tp -136.0 138.52 42.33 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.569 -1.332 . . . . 0.0 107.863 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -145.42 87.8 1.82 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.717 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.46 -119.04 16.84 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 124.37 0.986 . . . . 0.0 111.245 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 p -73.85 36.71 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.764 1.226 . . . . 0.0 111.795 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -145.16 134.95 23.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.568 -1.332 . . . . 0.0 107.725 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -131.24 163.25 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 161.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -122.07 140.85 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.155 1.782 . . . . 0.0 107.638 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.21 167.45 12.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.9 127.7 25.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.544 1.938 . . . . 0.0 108.29 162.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.2 mt -52.62 146.55 9.93 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -79.83 -71.13 0.47 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.95 39.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.986 1.279 . . . . 0.0 110.622 -168.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.46 -6.82 56.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.573 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.26 77.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 128.554 2.742 . . . . 0.0 111.588 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -107.09 154.01 40.65 Favored Pre-proline 0 C--O 1.243 0.728 0 C-N-CA 124.687 1.195 . . . . 0.0 108.949 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.57 174.2 6.74 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.441 2.761 . . . . 0.0 110.775 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.84 158.11 44.49 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 120.81 1.007 . . . . 0.0 110.274 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.99 169.58 20.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.518 2.145 . . . . 0.0 111.105 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 56.12 13.7 1.26 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.402 1.881 . . . . 0.0 113.252 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.0 m -110.18 -53.25 2.7 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.834 1.253 . . . . 0.0 107.851 -166.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.88 150.25 20.77 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.403 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -144.15 163.4 33.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.685 0.794 . . . . 0.0 111.633 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -71.7 -7.8 50.22 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 10.43 7.58 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 124.696 1.141 . . . . 0.0 112.392 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.58 137.35 58.05 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.21 64.0 8.32 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.532 1.158 . . . . 0.0 111.487 -168.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.88 131.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -84.95 165.94 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.83 119.33 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 124.513 1.125 . . . . 0.0 109.565 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -121.57 145.45 47.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.981 0.912 . . . . 0.0 109.432 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -153.78 159.16 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 165.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -94.43 106.66 18.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 t -145.57 168.77 19.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.492 0.717 . . . . 0.0 109.216 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.8 28.26 38.56 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.599 -1.112 . . . . 0.0 113.202 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.08 6.36 88.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.27 1.414 . . . . 0.0 113.904 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 176.16 9.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 112.463 -166.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.4 tp -104.71 96.29 6.48 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.933 1.693 . . . . 0.0 107.967 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.492 ' HG ' ' HB3' ' A' ' 12' ' ' TYR . 26.2 p -80.16 140.0 36.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -146.05 112.53 5.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.662 -0.649 . . . . 0.0 111.801 168.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.3 t -107.63 172.4 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.931 0.872 . . . . 0.0 111.108 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.88 154.34 24.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.774 2.43 . . . . 0.0 107.472 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.74 -166.71 33.65 Favored Glycine 0 C--O 1.239 0.458 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.517 1.527 . . . . 0.0 109.761 173.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.2 t -70.51 -31.19 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.836 0.854 . . . . 0.0 112.658 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 68.88 -61.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.72 2.008 . . . . 0.0 112.704 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 m -146.21 115.51 7.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.142 2.177 . . . . 0.0 106.392 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.78 155.97 21.59 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -128.78 -58.34 1.16 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.714 -0.616 . . . . 0.0 110.636 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -123.24 172.67 8.45 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 107.114 170.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -7.87 25.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.929 0.492 . . . . 0.0 111.08 164.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.88 -7.4 8.98 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 125.507 1.523 . . . . 0.0 114.933 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.42 130.12 25.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -162.39 162.99 28.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 118.168 0.44 . . . . 0.0 110.123 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.44 178.49 8.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.488 0.715 . . . . 0.0 109.582 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 pt -142.45 157.2 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 125.122 1.369 . . . . 0.0 108.735 156.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.77 113.91 22.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.193 2.197 . . . . 0.0 106.138 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.99 149.73 44.7 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 174.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.987 0.915 . . . . 0.0 110.624 170.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.52 -111.81 2.63 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 126.354 1.93 . . . . 0.0 109.134 -170.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.28 21.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.53 1.932 . . . . 0.0 109.999 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.453 ' CG1' ' CE2' ' A' ' 12' ' ' TYR . 1.5 p -121.24 156.15 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.705 2.002 . . . . 0.0 110.673 172.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 153.49 19.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.628 2.771 . . . . 0.0 107.279 -161.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -81.41 101.75 10.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.53 -31.78 72.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.45 -0.781 . . . . 0.0 111.075 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.53 162.65 34.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.734 1.613 . . . . 0.0 107.822 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -120.37 179.47 4.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.124 0.97 . . . . 0.0 109.13 166.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -129.67 177.79 6.97 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.38 6.14 24.1 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.114 1.365 . . . . 0.0 112.58 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -82.14 2.59 30.72 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.973 -1.079 . . . . 0.0 113.424 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 115.895 -2.002 . . . . 0.0 106.743 -154.318 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.617 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -171.08 -75.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.49 162.02 28.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.562 2.745 . . . . 0.0 109.6 170.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.01 96.6 4.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.949 1.7 . . . . 0.0 107.568 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -146.12 -46.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.437 0.695 . . . . 0.0 109.482 172.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.71 37.39 3.46 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.293 1.425 . . . . 0.0 112.594 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.8 t -140.37 -2.16 1.45 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.373 1.086 . . . . 0.0 113.376 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -89.47 1.9 55.25 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 126.136 1.774 . . . . 0.0 111.595 -173.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -39.34 82.04 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.364 -0.835 . . . . 0.0 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.42 -14.32 74.5 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 118.293 -1.282 . . . . 0.0 112.587 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.93 -40.93 95.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.014 1.907 . . . . 0.0 109.989 166.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -86.27 -46.38 10.39 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.265 -173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.18 105.47 17.63 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.496 1.118 . . . . 0.0 109.378 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -85.95 160.09 19.47 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 127.403 2.281 . . . . 0.0 110.31 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.28 -24.66 67.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -171.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -130.95 16.49 5.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.58 1.552 . . . . 0.0 109.342 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.407 HE21 HG21 ' A' ' 70' ' ' VAL . 3.8 mt-30 -66.05 171.95 4.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 165.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 159.48 16.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 167.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.17 164.49 29.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.75 159.6 30.02 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.397 167.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -120.28 45.48 2.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.579 1.081 . . . . 0.0 109.981 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 m -71.11 95.02 1.18 Allowed 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.71 130.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.307 0.958 . . . . 0.0 109.017 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -70.85 121.23 17.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 109.214 168.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.57 70.48 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.948 0.88 . . . . 0.0 109.024 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.35 -91.65 1.02 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 167.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.38 1.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.481 1.512 . . . . 0.0 112.615 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 t -138.98 2.64 2.15 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 111.587 -160.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.93 157.37 27.24 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.97 130.37 8.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.016 0.908 . . . . 0.0 110.07 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -84.8 158.6 20.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.7 1.2 . . . . 0.0 108.224 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.41 144.76 22.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.449 0.7 . . . . 0.0 109.993 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 -168.36 31.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.414 0.531 . . . . 0.0 112.256 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 133.32 56.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.548 1.539 . . . . 0.0 108.721 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.15 39.35 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 162.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.1 147.81 40.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.406 1.082 . . . . 0.0 109.003 164.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.6 mt -75.35 159.02 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.858 1.663 . . . . 0.0 106.83 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.7 p -141.89 -33.17 0.5 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.301 1.84 . . . . 0.0 112.325 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.43 137.05 12.17 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.789 -1.194 . . . . 0.0 110.971 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -135.28 141.19 45.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 126.234 1.814 . . . . 0.0 107.627 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -159.77 93.61 1.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.27 -135.92 36.97 Favored Glycine 0 C--O 1.229 -0.184 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.27 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.83 2.052 . . . . 0.0 113.176 170.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 tp -140.35 118.42 11.92 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 119.408 1.004 . . . . 0.0 109.825 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.38 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -128.5 135.83 49.97 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.938 2.095 . . . . 0.0 108.283 170.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.62 177.23 5.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.017 1.727 . . . . 0.0 111.328 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -148.15 131.27 16.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.923 2.489 . . . . 0.0 107.054 167.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.33 157.46 4.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.836 1.654 . . . . 0.0 112.716 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.11 -37.85 7.16 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.0 -50.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.159 0 O-C-N 120.247 -1.533 . . . . 0.0 114.211 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.27 99.94 7.3 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 123.473 1.606 . . . . 0.0 109.913 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 74.85 159.75 0.22 Allowed 'General case' 0 N--CA 1.415 -2.179 1 CA-C-N 107.406 -4.452 . . . . 0.0 109.83 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.24 157.6 49.13 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.711 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 161.96 43.03 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.781 1.654 . . . . 0.0 110.264 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -63.49 162.08 28.93 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 120.82 1.014 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.19 150.12 32.83 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.272 2.648 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 60.49 9.69 2.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.382 2.273 . . . . 0.0 114.074 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.9 m -88.6 -57.35 2.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.354 1.862 . . . . 0.0 111.542 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.95 131.27 50.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -122.98 159.05 29.15 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.65 0.78 . . . . 0.0 110.425 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.25 -5.1 25.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.553 0.741 . . . . 0.0 112.511 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.72 14.69 7.15 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-O 117.588 -1.673 . . . . 0.0 112.25 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.25 133.07 54.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.845 1.322 . . . . 0.0 107.624 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -83.83 110.83 18.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.48 133.86 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.241 0.616 . . . . 0.0 110.497 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.48 137.32 34.7 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.074 0.95 . . . . 0.0 108.569 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.6 126.11 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 124.29 1.036 . . . . 0.0 109.108 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 p -112.5 152.0 29.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.407 HG21 HE21 ' A' ' 17' ' ' GLN . 7.7 p -151.24 142.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 153.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -83.66 121.42 27.24 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.81 148.21 33.77 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.16 -89.47 0.33 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.866 1.222 . . . . 0.0 113.132 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.37 5.94 1.91 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.919 0.771 . . . . 0.0 112.97 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.99 177.28 9.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.212 1.506 . . . . 0.0 111.847 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.2 117.43 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 166.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.66 118.09 35.44 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -133.65 135.5 44.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.1 t -135.24 176.42 8.68 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.402 1.081 . . . . 0.0 108.867 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.04 147.38 45.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.85 -170.62 24.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.297 0.951 . . . . 0.0 111.165 -174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -134.13 172.62 12.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.856 1.662 . . . . 0.0 109.116 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -69.36 -35.57 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.913 1.233 . . . . 0.0 113.123 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.52 -62.23 0.44 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.821 2.048 . . . . 0.0 112.665 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -143.62 121.89 12.28 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.202 2.201 . . . . 0.0 106.422 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.42 160.53 18.29 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -123.15 -52.98 1.84 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.397 168.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.28 169.55 17.47 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.024 1.73 . . . . 0.0 107.648 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -4.74 1.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 112.37 170.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -128.47 -14.88 4.64 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 126.017 1.727 . . . . 0.0 113.575 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -138.99 124.98 19.9 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -170.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -165.73 165.79 18.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.49 173.58 11.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.467 1.107 . . . . 0.0 110.543 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.93 148.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.87 1.668 . . . . 0.0 107.997 154.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -113.54 125.35 54.09 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 125.011 1.324 . . . . 0.0 107.802 168.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.91 144.16 27.81 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.777 1.631 . . . . 0.0 106.781 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.79 146.98 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.777 0.717 . . . . 0.0 111.834 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.78 -99.08 0.32 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 126.069 1.795 . . . . 0.0 109.197 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 164.94 35.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 112.558 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -106.28 150.68 8.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.877 2.471 . . . . 0.0 110.199 160.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 173.94 11.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.431 1.492 . . . . 0.0 107.255 150.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.25 120.41 10.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 157.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.5 mt -94.37 -14.45 25.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.276 0.944 . . . . 0.0 111.763 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -153.14 156.82 39.35 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.806 1.642 . . . . 0.0 108.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.0 mtm-85 -121.5 167.45 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.35 1.46 . . . . 0.0 110.122 171.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.95 68.05 1.48 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -166.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.96 52.59 2.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.136 1.775 . . . . 0.0 109.142 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -143.65 53.57 1.32 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.571 1.549 . . . . 0.0 109.073 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.251 1.177 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.433 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.07 166.68 23.52 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.478 1.511 . . . . 0.0 108.637 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.1 m -54.6 -11.19 0.52 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.568 3.147 . . . . 0.0 117.686 -162.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.36 64.35 1.88 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.992 2.117 . . . . 0.0 110.18 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -38.99 37.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 128.359 2.664 . . . . 0.0 112.801 163.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.41 21.92 15.91 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.208 0.908 . . . . 0.0 112.167 -173.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 t -140.54 -11.52 1.04 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.352 1.861 . . . . 0.0 110.354 -166.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.82 -3.63 13.2 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.386 -1.446 . . . . 0.0 113.092 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.07 -38.45 86.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.015 1.28 . . . . 0.0 111.005 -171.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.36 1.51 65.17 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.85 0.738 . . . . 0.0 112.96 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -83.89 -4.42 58.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.577 1.689 . . . . 0.0 110.636 164.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.464 ' HB3' ' HG ' ' A' ' 77' ' ' CYS . 1.0 OUTLIER -118.26 -49.48 2.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.255 1.422 . . . . 0.0 107.957 -178.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -98.92 105.09 17.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.896 1.278 . . . . 0.0 107.575 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -103.95 161.06 14.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.273 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -154.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.75 10.44 7.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.41 1.884 . . . . 0.0 111.008 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -65.28 172.58 3.04 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -108.28 153.87 22.61 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.455 -0.778 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.94 158.05 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.732 1.213 . . . . 0.0 110.482 166.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -74.04 161.71 29.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.39 2.276 . . . . 0.0 111.669 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.96 49.66 1.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.73 1.612 . . . . 0.0 112.769 -167.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 m -66.74 108.8 2.62 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.244 -1.535 . . . . 0.0 109.514 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.81 124.3 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.092 1.757 . . . . 0.0 108.875 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -64.85 124.07 21.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -110.18 9.73 23.88 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 112.715 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.66 -173.13 28.7 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.24 -17.48 60.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.9 0.85 . . . . 0.0 109.123 164.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -125.8 25.03 6.97 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.208 2.203 . . . . 0.0 112.047 -164.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.54 153.51 21.93 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 m -143.32 144.1 31.96 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 163.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -86.58 152.84 22.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 164.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.8 132.44 14.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.14 -170.86 21.21 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.517 1.532 . . . . 0.0 109.625 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.31 162.43 13.68 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.099 1.36 . . . . 0.0 108.289 171.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.0 172.28 13.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.959 0.904 . . . . 0.0 110.185 157.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.84 145.53 28.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.83 1.332 . . . . 0.0 108.559 163.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.3 mt -71.51 157.76 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.842 2.057 . . . . 0.0 106.97 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 p -140.91 -46.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.502 1.121 . . . . 0.0 112.362 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -135.94 136.06 40.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.248 1.419 . . . . 0.0 107.933 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -145.66 137.4 25.22 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 123.161 1.457 . . . . 0.0 110.218 -175.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.08 93.02 1.78 Allowed 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.641 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.24 -110.24 0.84 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.174 1.368 . . . . 0.0 111.535 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.405 ' HB2' ' HD2' ' A' ' 95' ' ' ARG . 57.8 p -68.08 -7.26 27.97 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.009 1.724 . . . . 0.0 115.62 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.34 114.02 20.74 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 120.233 1.379 . . . . 0.0 111.063 -173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.1 157.81 16.61 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 163.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -122.4 142.23 50.74 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.151 2.18 . . . . 0.0 109.239 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.4 mt -135.05 154.78 51.58 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.767 1.227 . . . . 0.0 110.089 -163.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.68 33.26 4.03 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 49.12 -174.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.437 1.895 . . . . 0.0 114.494 -169.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 139.12 29.32 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.049 0.94 . . . . 0.0 111.748 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.8 -152.65 22.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -168.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.41 -7.98 17.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.18 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -54.75 143.4 25.48 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.253 0.621 . . . . 0.0 109.563 167.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -155.67 157.63 31.56 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 125.338 1.455 . . . . 0.0 108.839 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.05 171.18 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.3 2.0 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -57.15 154.52 33.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.129 1.219 . . . . 0.0 109.418 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.59 164.88 29.36 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.773 1.649 . . . . 0.0 109.59 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 p30 56.18 21.48 5.27 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.93 1.692 . . . . 0.0 114.079 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.3 m -124.49 -11.74 7.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.734 0.814 . . . . 0.0 111.124 -168.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.67 140.36 29.53 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.396 1.453 . . . . 0.0 110.672 156.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -146.33 160.12 42.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.023 0.929 . . . . 0.0 111.785 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.97 -2.0 6.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.56 1.944 . . . . 0.0 115.338 -172.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.16 2.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 125.25 1.405 . . . . 0.0 110.661 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.68 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.3 122.16 31.5 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 m -140.7 154.74 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 110.26 -166.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.24 150.83 41.76 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.4 -0.812 . . . . 0.0 110.068 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.55 120.05 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.32 1.048 . . . . 0.0 110.879 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -129.16 137.68 51.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -154.5 153.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -89.27 113.26 24.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.8 t -151.24 144.46 24.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.01 44.97 41.99 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.389 0.995 . . . . 0.0 111.44 -171.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.77 -15.86 2.1 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.447 1.499 . . . . 0.0 114.502 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.9 153.82 21.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.611 1.705 . . . . 0.0 110.715 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.3 tp -80.7 94.9 6.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.464 ' HG ' ' HB3' ' A' ' 12' ' ' TYR . 28.0 p -72.44 139.59 47.83 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.67 134.99 29.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.736 -0.603 . . . . 0.0 110.269 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.0 t -137.93 160.97 37.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 111.652 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.97 159.68 14.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.663 1.185 . . . . 0.0 109.05 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.92 -176.1 30.59 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.557 1.551 . . . . 0.0 111.439 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -130.34 171.17 13.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 161.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.79 -35.78 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.819 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 65.36 -59.91 0.26 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.262 2.225 . . . . 0.0 112.918 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 m -128.36 133.63 48.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -108.64 170.98 7.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 166.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -140.49 -47.47 0.42 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 116.734 -1.987 . . . . 0.0 115.996 152.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -131.11 167.43 19.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 171.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.21 6.14 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.737 1.615 . . . . 0.0 111.713 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.446 ' H ' ' C ' ' A' ' 88' ' ' ASP . 5.8 ptp180 -134.49 -19.74 1.87 Allowed 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.946 -1.721 . . . . 0.0 115.563 170.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -129.16 123.82 33.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 121.183 1.81 . . . . 0.0 108.197 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -166.79 177.72 6.31 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.61 0.364 . . . . 0.0 110.248 -172.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -108.62 175.66 5.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.291 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -145.22 130.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 125.38 1.472 . . . . 0.0 109.116 165.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD2' ' HB2' ' A' ' 43' ' ' SER . 18.3 tpt85 -87.48 114.16 23.84 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 125.902 1.681 . . . . 0.0 107.31 162.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.4 mt -68.89 135.07 50.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.85 148.45 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.169 0.985 . . . . 0.0 109.822 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.09 -107.44 2.06 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.23 168.39 27.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.045 1.338 . . . . 0.0 110.84 174.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -109.36 153.06 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 128.046 2.538 . . . . 0.0 111.167 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -149.09 172.21 15.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.906 0.86 . . . . 0.0 109.436 150.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -45.62 81.12 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.749 1 C-N-CA 132.363 4.265 . . . . 0.0 111.365 158.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.7 mt -74.7 -27.53 60.43 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 119.952 -1.717 . . . . 0.0 111.696 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.24 162.5 33.33 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.923 2.089 . . . . 0.0 108.16 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -135.06 168.99 18.12 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.737 1.615 . . . . 0.0 108.667 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -145.18 154.17 42.14 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 120.514 1.506 . . . . 0.0 109.61 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 52.36 24.41 2.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.198 0.999 . . . . 0.0 112.352 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 74.47 -5.5 2.09 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 131.492 3.917 . . . . 0.0 117.054 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.851 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 164.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.441 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -149.48 160.93 43.05 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.649 1.98 . . . . 0.0 107.442 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -139.79 121.17 15.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -173.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 47.46 34.89 3.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.961 1.304 . . . . 0.0 111.723 -172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.1 t70 69.5 -3.76 1.54 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.8 2.44 . . . . 0.0 114.856 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.91 92.08 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 O-C-N 121.016 -1.053 . . . . 0.0 111.541 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 t -157.27 -8.73 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.435 0.694 . . . . 0.0 111.936 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -60.73 -9.91 4.64 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.607 1.163 . . . . 0.0 111.225 160.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -55.57 -37.76 68.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.947 -1.096 . . . . 0.0 110.574 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.87 -1.13 45.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.474 1.512 . . . . 0.0 112.736 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -72.67 -16.76 61.69 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.012 1.406 . . . . 0.0 111.626 165.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.53 -59.65 1.53 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.81 153.08 27.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.84 157.6 45.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -54.6 -22.56 13.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.943 1.697 . . . . 0.0 114.282 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.14 8.38 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 111.954 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.67 166.39 22.01 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.277 -0.89 . . . . 0.0 110.933 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -94.67 160.08 14.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.47 170.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.34 163.08 18.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.042 1.337 . . . . 0.0 109.24 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -80.23 158.5 26.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.455 0.702 . . . . 0.0 110.378 164.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.1 mt -127.53 51.5 1.91 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.689 1.595 . . . . 0.0 111.09 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -59.34 126.7 28.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.66 121.1 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -63.84 139.56 58.78 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.457 1.48 . . . . 0.0 108.746 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.7 mt -118.1 11.52 13.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.02 0.928 . . . . 0.0 112.421 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.88 -105.81 0.72 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.23 -71.99 0.74 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -159.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -116.72 87.76 2.76 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.31 -102.23 0.18 Allowed Glycine 0 CA--C 1.498 -0.969 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 163.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 m 68.26 142.67 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 126.913 2.085 . . . . 0.0 110.824 -153.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -96.5 143.12 27.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 163.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.82 102.41 4.56 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.65 -171.71 15.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.364 0.983 . . . . 0.0 112.446 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -110.6 144.75 39.01 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.277 1.831 . . . . 0.0 107.938 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.96 161.8 36.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.548 -0.72 . . . . 0.0 111.034 157.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.57 137.95 32.52 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 113.964 -1.471 . . . . 0.0 107.594 159.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.64 155.04 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -136.02 -22.42 1.39 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.028 1.731 . . . . 0.0 112.185 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -153.55 152.62 31.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 120.923 -1.111 . . . . 0.0 108.104 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.3 tp -156.42 122.2 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -145.48 79.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 44' ' ' LEU . . . 73.96 -139.98 27.0 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -52.98 2.11 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 127.921 2.488 . . . . 0.0 114.617 168.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 42' ' ' GLY . 7.6 tp -117.25 132.27 56.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.999 1.727 . . . . 0.0 108.592 171.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.35 171.68 12.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 161.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -134.15 144.18 48.38 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.426 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.23 177.37 5.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.926 1.29 . . . . 0.0 110.042 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -144.02 32.27 1.25 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 mt 47.99 -173.1 0.01 OUTLIER 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.51 1.148 . . . . 0.0 112.77 -162.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.82 -60.66 1.5 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.239 1.016 . . . . 0.0 108.27 161.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.03 170.57 12.49 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -164.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 63.4 -70.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.893 2.077 . . . . 0.0 110.565 -169.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -71.65 142.09 49.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.76 1.224 . . . . 0.0 109.414 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -151.95 155.74 33.77 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.864 1.266 . . . . 0.0 107.817 152.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.66 167.19 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.667 1.578 . . . . 0.0 111.111 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.28 156.67 39.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.67 2.247 . . . . 0.0 111.445 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.69 162.97 16.77 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.018 2.478 . . . . 0.0 110.413 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 50.14 21.74 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 168.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.4 m -114.77 -30.93 6.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.075 0.95 . . . . 0.0 111.368 -168.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mt -73.84 145.68 44.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.041 1.336 . . . . 0.0 109.704 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -148.46 162.54 39.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.43 -1.93 12.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.178 1.391 . . . . 0.0 114.11 -168.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.62 6.98 9.67 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.153 1.835 . . . . 0.0 111.836 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.93 123.23 19.26 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.07 116.82 6.87 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.89 131.63 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 138.19 50.43 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.835 1.254 . . . . 0.0 108.297 -167.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.61 143.39 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 124.325 1.05 . . . . 0.0 109.098 -166.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.17 126.73 12.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 0.0 109.053 -174.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -152.26 161.45 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.287 1.435 . . . . 0.0 110.246 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -113.14 131.71 55.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.996 1.318 . . . . 0.0 110.238 -170.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -148.19 49.04 1.04 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 111.055 -163.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.63 -97.49 0.25 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.575 1.559 . . . . 0.0 109.407 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.82 0.29 9.98 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.83 1.681 . . . . 0.0 113.569 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.62 171.1 14.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.813 1.306 . . . . 0.0 111.937 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.78 109.66 21.33 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.208 2.203 . . . . 0.0 107.559 177.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -85.02 108.0 17.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.53 162.78 25.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 35.4 t -157.7 168.35 27.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.18 0.925 . . . . 0.0 109.631 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.02 152.66 18.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.222 1.809 . . . . 0.0 107.517 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.18 -177.86 37.95 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -138.62 165.2 27.52 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.482 1.113 . . . . 0.0 109.949 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.74 -34.48 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.65 -66.85 0.15 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.342 1.857 . . . . 0.0 112.656 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.0 m -142.25 117.34 10.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.921 2.488 . . . . 0.0 106.402 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tp -89.47 160.74 16.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -125.51 -56.12 1.51 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 90' ' ' ARG . 22.9 m-20 -148.39 175.61 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.71 23.31 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.198 1.399 . . . . 0.0 112.173 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 88' ' ' ASP . 28.2 ptt180 -147.03 -6.59 0.49 Allowed 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 166.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -138.6 131.15 28.99 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 120.585 1.539 . . . . 0.0 107.208 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -166.13 158.91 14.8 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.138 1.375 . . . . 0.0 109.412 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.49 175.63 10.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.917 1.287 . . . . 0.0 109.861 173.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.37 139.54 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.525 1.13 . . . . 0.0 108.408 158.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 43' ' ' SER . 14.4 tpp85 -93.93 111.77 23.53 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -72.55 139.54 47.59 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.61 139.59 50.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 123.708 0.63 . . . . 0.0 110.753 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.66 -88.97 1.18 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 124.441 1.02 . . . . 0.0 112.116 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 149.1 16.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.982 1.313 . . . . 0.0 110.119 -175.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.8 114.71 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 158.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.35 35.17 2.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 47.25 92.35 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.52 2.328 . . . . 0.0 114.247 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.86 -3.7 17.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -161.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -135.8 162.8 31.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -120.81 161.04 22.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.875 0.87 . . . . 0.0 110.274 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -101.04 137.08 39.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -134.59 62.65 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 119.566 1.075 . . . . 0.0 110.374 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 55.43 7.7 0.24 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 160.227 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -136.19 69.37 1.43 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.97 43.86 30.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.676 1.59 . . . . 0.0 112.3 168.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.48 91.51 2.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.211 1.005 . . . . 0.0 110.422 -172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.94 102.94 0.66 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.899 0.88 . . . . 0.0 109.972 171.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 82.78 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.162 -0.961 . . . . 0.0 112.557 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.7 m -136.7 6.83 2.97 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.83 -0.806 . . . . 0.0 111.309 159.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -82.93 -7.4 59.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.56 2.344 . . . . 0.0 113.525 -172.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -58.54 -46.63 86.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.468 0.707 . . . . 0.0 109.679 -168.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.61 -0.58 80.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.713 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -73.41 -28.86 62.23 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.573 1.686 . . . . 0.0 109.903 164.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -107.16 -41.68 5.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.295 1.038 . . . . 0.0 110.416 -168.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.26 116.38 30.36 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -94.94 154.39 17.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 -23.68 6.99 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 127.033 2.133 . . . . 0.0 114.102 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -129.67 8.72 5.38 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.77 1.628 . . . . 0.0 111.397 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.13 175.85 4.25 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.301 -0.874 . . . . 0.0 110.36 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HE3' ' CE1' ' A' ' 50' ' ' PHE . 47.3 mtpt -114.29 145.97 41.07 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.034 0.934 . . . . 0.0 108.588 168.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 153.02 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.823 0.849 . . . . 0.0 109.768 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -68.85 154.73 41.48 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.052 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.6 mt -129.6 21.91 5.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -158.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -52.51 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.346 1.458 . . . . 0.0 112.871 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.17 135.22 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.114 1.324 . . . . 0.0 108.13 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -82.1 125.08 30.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.18 13.81 24.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.341 1.056 . . . . 0.0 112.923 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.74 -144.55 15.43 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -83.73 -85.36 0.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.0 p -87.53 43.44 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.815 2.446 . . . . 0.0 111.566 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.09 -91.49 0.76 Allowed Glycine 0 C--N 1.334 0.426 0 O-C-N 121.211 -0.93 . . . . 0.0 110.864 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.282 0.0 OUTLIER 58.99 170.02 0.06 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.913 2.485 . . . . 0.0 114.462 -178.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -142.13 144.49 33.52 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.986 1.715 . . . . 0.0 108.563 173.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.86 136.76 48.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.24 -174.76 21.72 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.17 0.891 . . . . 0.0 110.896 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.09 146.55 45.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.309 1.043 . . . . 0.0 108.677 170.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.37 149.71 36.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.02 31.27 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.5 mt -75.32 155.93 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 164.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -133.91 -41.14 0.84 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.057 0.943 . . . . 0.0 111.759 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -141.56 153.76 45.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.835 1.254 . . . . 0.0 108.238 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 133.97 18.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -140.51 75.13 1.49 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.88 2.072 . . . . 0.0 107.589 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.95 -116.1 6.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.279 1.418 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.6 p -64.13 11.17 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.511 1.525 . . . . 0.0 114.966 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 117.1 11.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.17 166.28 15.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -128.82 155.92 44.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.33 1.052 . . . . 0.0 109.578 174.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.46 150.66 35.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.721 2.008 . . . . 0.0 108.227 -163.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -150.04 130.39 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 164.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -57.35 157.92 6.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.107 2.563 . . . . 0.0 113.087 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.462 ' CE1' ' HE3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -78.75 -70.19 0.51 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.249 1.82 . . . . 0.0 112.113 -166.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.76 131.68 1.25 Allowed Glycine 0 CA--C 1.524 0.639 0 O-C-N 120.502 -1.374 . . . . 0.0 109.68 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.38 -3.84 2.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.037 2.935 . . . . 0.0 113.871 -171.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.89 34.87 1.57 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.764 1.226 . . . . 0.0 112.144 -167.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.2 161.17 78.19 Favored Pre-proline 0 N--CA 1.473 0.708 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 159.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.63 167.19 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.948 2.432 . . . . 0.0 111.849 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -62.81 161.73 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.129 1.886 . . . . 0.0 112.427 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.05 158.72 46.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.022 1.815 . . . . 0.0 111.169 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 49.22 22.64 0.68 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.658 1.983 . . . . 0.0 113.902 171.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -94.68 -46.98 6.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.075 1.75 . . . . 0.0 109.146 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.92 155.24 40.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.644 1.577 . . . . 0.0 109.496 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -145.72 171.38 14.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.275 1.03 . . . . 0.0 108.273 158.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -73.13 -7.2 50.29 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -166.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.65 2.9 27.62 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 116.936 -2.036 . . . . 0.0 111.679 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.46 138.88 58.55 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.326 1.563 . . . . 0.0 107.936 -167.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.3 64.22 3.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.973 1.368 . . . . 0.0 109.303 -155.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.52 136.68 23.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.862 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -87.13 174.38 8.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 123.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.421 1.488 . . . . 0.0 109.395 170.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -118.95 152.7 35.87 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.025 0.829 . . . . 0.0 109.477 167.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.92 142.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 108.54 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.93 113.16 15.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -156.5 170.58 22.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 14.19 25.65 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.92 -0.933 . . . . 0.0 115.178 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 5.3 82.92 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.946 1.873 . . . . 0.0 115.03 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.76 -168.01 2.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.572 1.549 . . . . 0.0 108.491 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.6 tp -99.99 125.77 46.07 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 163.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.604 ' HG ' ' CG2' ' A' ' 100' ' ' VAL . 0.6 OUTLIER -92.32 141.02 29.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.37 1.468 . . . . 0.0 107.496 167.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -145.01 121.89 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 160.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.7 t -111.39 166.71 10.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.843 0.83 . . . . 0.0 109.09 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.14 133.07 55.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.84 -167.29 15.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 113.1 -165.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -137.37 171.0 15.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.519 1.528 . . . . 0.0 108.242 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.66 -30.18 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 72.24 -64.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.632 1.973 . . . . 0.0 111.531 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -148.35 123.64 10.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.455 2.302 . . . . 0.0 105.701 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.2 152.03 19.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 167.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.44 -47.46 2.34 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.234 0.614 . . . . 0.0 109.851 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -143.58 175.66 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -54.27 -20.95 7.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.29 11.24 4.55 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.86 115.24 13.42 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -163.3 168.42 20.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -173.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.74 178.63 6.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.099 1.76 . . . . 0.0 111.16 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 pt -144.05 145.84 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.979 1.311 . . . . 0.0 109.771 152.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.42 119.92 40.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 171.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.67 138.55 33.27 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.39 164.92 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.963 0.905 . . . . 0.0 109.857 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.55 8.61 63.38 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.408 -1.218 . . . . 0.0 115.426 165.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 62.83 143.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.436 2.295 . . . . 0.0 111.855 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.604 ' CG2' ' HG ' ' A' ' 77' ' ' CYS . 1.4 p -95.85 154.77 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 125.909 1.684 . . . . 0.0 110.182 170.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -150.4 -170.89 3.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -96.96 121.22 38.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.698 2.399 . . . . 0.0 105.884 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 -10.13 7.17 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -171.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -139.0 163.59 31.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.077 1.351 . . . . 0.0 107.928 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -135.01 172.49 12.94 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -64.08 169.09 4.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.334 0.588 . . . . 0.0 110.053 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -108.75 60.9 0.6 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 55.17 30.45 14.51 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.985 0.914 . . . . 0.0 112.117 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.907 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -60.98 -45.34 95.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.948 -1.095 . . . . 0.0 110.028 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 3.38 16.72 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.181 0.42 . . . . 0.0 113.556 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.225 -1.75 . . . . 0.0 110.116 166.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.85 -46.29 2.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.363 1.065 . . . . 0.0 111.3 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.4 155.69 22.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.721 1.609 . . . . 0.0 107.575 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -144.35 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.602 ' C ' HD12 ' A' ' 16' ' ' LEU . 9.3 tt0 -60.8 -15.17 27.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.253 1.821 . . . . 0.0 115.524 -170.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 15' ' ' GLN . 7.2 mp -130.84 1.35 4.35 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 110.29 -173.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.98 165.8 23.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 155.68 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.32 144.69 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 106.374 -167.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -63.79 166.65 6.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.969 0.508 . . . . 0.0 110.058 160.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.3 mt -142.0 49.27 1.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.76 1.624 . . . . 0.0 109.563 -170.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -58.6 103.31 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 121.024 1.738 . . . . 0.0 109.003 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 HG12 ' A' ' 66' ' ' VAL . 82.4 t -95.66 119.32 43.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 121.633 2.015 . . . . 0.0 106.296 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.58 118.78 6.48 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.505 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -141.65 109.15 5.61 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.9 -1.125 . . . . 0.0 108.209 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -125.24 95.41 4.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -154.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 -167.45 14.46 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.646 1.117 . . . . 0.0 112.163 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.82 145.38 51.97 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.961 0.904 . . . . 0.0 108.596 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.68 145.9 31.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 167.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.1 32.52 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 165.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.43 158.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.034 1.734 . . . . 0.0 107.521 166.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -131.4 -30.75 1.67 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 112.372 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.7 m -145.55 130.72 18.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.264 1.826 . . . . 0.0 106.532 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 tp -131.71 123.18 27.19 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.397 1.479 . . . . 0.0 107.715 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.72 84.74 2.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 -122.06 17.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.68 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.3 p -68.27 -12.42 60.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 117.627 0.714 . . . . 0.0 112.657 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 tp -106.29 139.06 41.39 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 110.36 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.18 168.05 16.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 164.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -133.58 138.51 46.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.775 2.03 . . . . 0.0 109.302 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.95 162.87 25.76 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.734 1.614 . . . . 0.0 110.938 -160.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.41 24.23 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.4 mt 53.14 -171.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.956 0.902 . . . . 0.0 111.936 -168.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 124.462 1.105 . . . . 0.0 113.241 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.85 171.08 17.26 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.407 2.738 . . . . 0.0 112.899 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.63 156.43 52.79 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.149 1.9 . . . . 0.0 111.15 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -66.51 170.97 11.34 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.265 2.644 . . . . 0.0 109.783 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 p30 53.95 1.29 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 m -101.03 -48.0 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.694 0.679 . . . . 0.0 110.404 -163.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.23 144.67 56.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -141.51 163.63 32.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.396 0.678 . . . . 0.0 110.395 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 62.9 mt-10 -73.36 -5.96 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.799 1.239 . . . . 0.0 113.691 -167.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.98 28.83 2.79 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.33 136.14 57.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 167.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.48 125.89 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 165.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG12 HG22 ' A' ' 23' ' ' VAL . 20.7 m -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 t -124.22 135.39 53.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.645 1.212 . . . . 0.0 108.977 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.43 156.62 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 112.385 -2.189 . . . . 0.0 106.709 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.59 ' HB2' HD21 ' A' ' 76' ' ' LEU . 21.2 p -151.01 133.51 15.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.551 164.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -137.87 146.13 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.501 1.12 . . . . 0.0 109.201 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -96.37 132.58 41.73 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -141.14 95.62 2.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 43.78 42.43 6.22 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 118.853 2.301 . . . . 0.0 118.853 159.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.73 -40.54 0.2 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 121.01 2.405 . . . . 0.0 112.341 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.0 -178.18 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.105 0.955 . . . . 0.0 109.327 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.01 113.17 22.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 55.5 m -89.44 108.33 19.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.8 158.2 29.38 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.63 136.86 22.37 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.11 158.6 32.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 -179.56 39.1 Favored Glycine 0 N--CA 1.443 -0.871 0 O-C-N 121.131 -0.98 . . . . 0.0 112.118 -171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -127.19 162.13 26.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -32.13 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.603 0.761 . . . . 0.0 110.415 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.26 -66.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.29 2.236 . . . . 0.0 113.42 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.9 m -152.13 95.89 2.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.092 1.315 . . . . 0.0 108.232 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 1.7 tp -70.06 162.13 28.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -132.87 -41.8 0.92 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.347 -0.845 . . . . 0.0 109.681 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -148.81 172.9 13.9 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -61.12 -6.0 1.77 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.809 2.043 . . . . 0.0 112.465 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -139.66 -11.53 1.17 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.559 2.344 . . . . 0.0 114.606 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -123.71 125.31 44.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -167.11 158.65 12.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.84 176.01 9.97 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.405 1.482 . . . . 0.0 110.849 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.67 150.21 13.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.97 113.8 18.29 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.842 1.257 . . . . 0.0 108.473 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.8 133.0 45.24 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.288 1.835 . . . . 0.0 108.749 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.07 158.38 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.103 1.361 . . . . 0.0 110.327 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.78 80.17 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 119.215 -0.769 . . . . 0.0 112.417 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 59.38 166.78 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.103 2.561 . . . . 0.0 114.009 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -104.39 113.76 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.992 0.917 . . . . 0.0 110.446 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -55.41 -36.8 66.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.922 -1.111 . . . . 0.0 111.099 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.23 -14.45 76.73 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.255 -0.747 . . . . 0.0 113.108 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -75.12 -12.16 60.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.345 1.572 . . . . 0.0 110.744 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.422 ' HA ' HG21 ' A' ' 72' ' ' THR . 3.2 m-85 -118.72 -45.82 2.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.301 1.44 . . . . 0.0 110.439 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -95.7 116.39 28.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.491 1.116 . . . . 0.0 109.621 171.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 167.63 16.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 109.529 166.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.33 -18.45 55.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.558 0.743 . . . . 0.0 112.941 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.0 mt -127.28 14.09 7.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.088 1.355 . . . . 0.0 109.983 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -69.79 171.81 8.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.721 0.809 . . . . 0.0 109.827 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -108.76 149.74 28.6 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.44 157.51 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.658 1.183 . . . . 0.0 111.381 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -72.88 158.41 35.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.549 1.14 . . . . 0.0 112.048 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -131.24 60.94 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.001 1.72 . . . . 0.0 109.391 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m -78.73 110.11 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.931 -1.105 . . . . 0.0 108.424 174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.52 133.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.345 1.458 . . . . 0.0 108.375 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 147.85 46.19 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.06 1.3 . . . . 0.0 110.217 173.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.327 -0.386 0 C-N-CA 126.058 1.743 . . . . 0.0 108.038 169.837 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -95.36 157.18 16.01 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 163.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.27 125.15 15.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 163.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.77 -171.8 14.16 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 166.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -116.9 162.89 17.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.53 157.1 46.39 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.491 156.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.92 140.97 40.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 157.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.95 158.2 5.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.3 p -136.92 -28.74 0.94 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 m -154.57 124.02 6.49 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tt -143.98 129.76 19.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.651 1.114 . . . . 0.0 110.251 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -144.22 104.26 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.94 -131.29 44.33 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.196 0.903 . . . . 0.0 112.205 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.39 37.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.754 1.222 . . . . 0.0 112.111 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.14 117.36 9.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.784 1.234 . . . . 0.0 107.937 162.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.4 155.82 20.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 156.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -118.93 147.77 43.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.608 1.963 . . . . 0.0 108.778 164.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.67 166.5 13.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 110.478 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.3 65.41 1.25 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.537 0.735 . . . . 0.0 110.089 162.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt 45.3 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.329 3.051 . . . . 0.0 116.081 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 C-N-CA 123.929 0.892 . . . . 0.0 111.186 159.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.41 169.92 16.01 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.405 2.07 . . . . 0.0 110.564 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.58 154.8 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.951 1.101 . . . . 0.0 110.586 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -63.42 168.54 11.11 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.086 1.857 . . . . 0.0 108.935 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.77 5.96 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.2 m -108.48 -47.04 3.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.958 1.303 . . . . 0.0 110.844 -163.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -64.85 138.2 58.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.958 0.903 . . . . 0.0 109.182 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -137.1 158.98 43.22 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -74.14 -8.61 56.77 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -164.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.13 22.52 4.23 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 126.235 1.874 . . . . 0.0 109.422 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 125.72 24.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.02 135.88 54.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 164.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.51 163.59 35.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.849 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.78 153.43 39.54 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 160.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.51 145.33 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 p -147.7 146.32 29.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.78 143.55 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.066 0.946 . . . . 0.0 110.272 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.57 74.74 8.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.561 1.945 . . . . 0.0 111.365 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 12' ' ' TYR 0.254 3.4 t -97.65 100.87 12.27 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.388 -0.82 . . . . 0.0 109.435 -170.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.52 33.98 3.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.514 2.483 . . . . 0.0 116.392 161.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.26 -65.97 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -167.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -171.18 -164.57 0.36 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.175 2.19 . . . . 0.0 107.822 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -76.95 94.32 3.93 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 134.9 54.76 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 155.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.13 161.23 36.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.8 t -157.46 175.71 13.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -114.71 156.38 24.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -164.8 178.3 40.0 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 120.455 -1.403 . . . . 0.0 111.697 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.817 HH11 HG21 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -128.78 159.04 36.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 166.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -58.7 -30.89 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.005 0.522 . . . . 0.0 111.984 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 65.69 -61.57 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.479 2.312 . . . . 0.0 111.161 -171.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -147.11 126.98 13.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.242 2.217 . . . . 0.0 105.658 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.55 157.11 16.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.4 ttm-85 -124.8 -44.43 1.95 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.869 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.37 176.38 11.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.8 -1.6 0.92 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.799 0.84 . . . . 0.0 112.325 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -130.78 -13.9 3.63 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.564 1.546 . . . . 0.0 113.579 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.64 136.74 46.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 108.6 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -175.45 166.02 3.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.366 1.066 . . . . 0.0 109.696 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.37 177.62 5.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.053 1.341 . . . . 0.0 110.671 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.07 127.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.149 1.379 . . . . 0.0 108.782 157.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -74.13 137.89 43.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 156.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -99.05 136.75 38.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.817 HG21 HH11 ' A' ' 82' ' ' ARG . 16.8 m -135.48 138.04 48.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.946 0.879 . . . . 0.0 111.93 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -107.47 3.06 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.17 142.53 7.26 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 126.155 1.782 . . . . 0.0 106.315 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.04 134.67 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 C--O 1.236 0.346 0 CA-C-N 119.161 0.892 . . . . 0.0 110.592 179.762 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -64.77 -39.25 93.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.246 -1.534 . . . . 0.0 109.539 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.67 -0.98 74.68 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.962 -169.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -85.85 -17.06 36.68 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.203 1.001 . . . . 0.0 111.038 163.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -105.91 -53.51 2.63 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.029 0.931 . . . . 0.0 110.442 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.44 155.72 22.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.98 153.63 43.2 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -63.03 -18.03 62.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -165.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.55 8.52 5.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.73 1.612 . . . . 0.0 110.223 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -73.87 169.39 17.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.796 -1.19 . . . . 0.0 108.905 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.81 17.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.689 170.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.29 165.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.515 1.126 . . . . 0.0 109.846 164.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.55 177.75 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.883 2.473 . . . . 0.0 112.266 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 23' ' ' VAL . 61.3 mt -138.21 22.56 2.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.818 1.644 . . . . 0.0 115.113 -174.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -62.8 106.74 0.85 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.957 1.708 . . . . 0.0 110.572 -167.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 66' ' ' VAL . 67.9 t -99.12 139.77 20.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.639 1.575 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -74.51 121.17 21.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 161.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 N--CA 1.433 -1.321 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 160.513 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.386 0.613 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -130.41 139.29 50.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.09 147.75 50.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.615 0.722 . . . . 0.0 110.271 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.75 -162.81 15.27 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -131.79 162.79 29.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.21 161.67 41.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 156.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 140.19 41.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 156.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.2 mt -69.25 158.61 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 161.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.6 p -131.96 -31.28 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.444 1.898 . . . . 0.0 111.96 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.14 145.17 31.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 tp -161.81 101.62 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -121.49 78.67 1.46 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.755 1.622 . . . . 0.0 106.875 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.04 -117.85 10.37 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 14.1 p -64.82 -0.48 1.5 Allowed 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 115.817 -2.039 . . . . 0.0 113.914 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -127.04 137.47 53.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.95 1.25 . . . . 0.0 108.193 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.59 166.6 23.9 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.048 0.939 . . . . 0.0 108.527 168.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -129.49 149.44 51.26 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.784 1.634 . . . . 0.0 108.402 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.77 171.37 8.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.573 1.949 . . . . 0.0 110.94 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.66 58.5 1.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.477 1.132 . . . . 0.0 111.229 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 mt 47.72 -169.87 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.663 1.985 . . . . 0.0 114.407 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.617 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.61 164.84 34.38 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.402 2.735 . . . . 0.0 112.586 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.83 160.76 35.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.866 1.711 . . . . 0.0 111.587 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.98 159.58 24.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.568 2.179 . . . . 0.0 112.313 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 44.79 32.69 0.84 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.873 2.069 . . . . 0.0 112.213 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 m -111.64 -56.72 2.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.363 1.065 . . . . 0.0 108.155 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.47 127.52 30.05 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -127.65 159.68 33.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.61 -3.92 17.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.35 19.1 4.34 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.772 2.129 . . . . 0.0 110.881 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.97 131.09 49.55 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.33 123.42 25.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.642 HG12 HG22 ' A' ' 23' ' ' VAL . 34.9 m -134.42 163.8 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.274 -176.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.39 131.08 43.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.02 0.928 . . . . 0.0 108.852 -173.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.48 139.82 19.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -140.91 156.83 46.01 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.085 0.857 . . . . 0.0 110.283 159.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 p -160.86 149.13 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.197 1.799 . . . . 0.0 107.166 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.403 ' CE2' HD13 ' A' ' 76' ' ' LEU . 92.6 m95 -88.1 120.82 29.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 t -151.07 119.48 6.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.66 -162.44 47.85 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -159.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.27 2.08 22.48 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.867 1.223 . . . . 0.0 114.662 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.33 172.82 12.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.958 1.379 . . . . 0.0 110.767 -174.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.403 HD13 ' CE2' ' A' ' 71' ' ' TRP . 23.5 tp -73.9 168.74 18.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.11 153.03 49.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 154.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.27 155.63 50.31 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HB2' HG22 ' A' ' 100' ' ' VAL . 17.6 t -144.86 156.52 44.05 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 155.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -99.21 150.19 22.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.83 41.59 Favored Glycine 0 CA--C 1.523 0.593 0 O-C-N 120.958 -1.088 . . . . 0.0 110.911 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -128.02 169.15 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.648 0.779 . . . . 0.0 109.005 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.18 -35.35 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.131 0.973 . . . . 0.0 112.837 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 65.92 -54.14 0.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.764 2.426 . . . . 0.0 113.707 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -150.27 139.39 21.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.745 1.218 . . . . 0.0 108.264 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -115.77 152.29 33.55 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.52 -52.96 0.72 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.532 -169.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.54 174.93 7.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 159.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -55.5 -30.85 61.41 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.041 1.337 . . . . 0.0 111.821 166.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -104.27 -11.66 17.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -132.24 124.02 28.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 120.535 1.516 . . . . 0.0 108.596 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -162.4 166.29 25.27 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.536 1.148 . . . . 0.0 110.45 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.84 179.78 5.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.753 1.221 . . . . 0.0 110.209 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.71 133.7 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.435 1.494 . . . . 0.0 108.677 164.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -108.39 111.72 23.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.379 1.472 . . . . 0.0 107.674 174.441 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.5 mt -71.94 144.71 48.83 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.241 1.417 . . . . 0.0 107.563 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.59 153.65 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.557 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.32 -106.96 0.65 Allowed Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 125.721 1.629 . . . . 0.0 109.077 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.59 168.98 23.84 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.4 1.48 . . . . 0.0 110.825 -167.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 79' ' ' CYS . 78.8 t -93.47 156.27 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.018 0.927 . . . . 0.0 109.749 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.55 0 C-N-CA 124.752 1.221 . . . . 0.0 110.296 150.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 C--O 1.222 -0.385 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -54.59 -39.99 68.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.092 1.315 . . . . 0.0 111.606 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.18 -6.06 55.92 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.478 1.037 . . . . 0.0 112.717 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.45 -16.89 55.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.16 -1.2 . . . . 0.0 111.373 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.78 -27.8 5.74 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.723 1.209 . . . . 0.0 110.422 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.83 144.25 50.73 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.445 1.117 . . . . 0.0 111.992 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.62 156.01 49.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.597 -173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.469 ' HG2' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -62.13 -17.31 57.46 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -174.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 15' ' ' GLN . 5.9 mp -124.49 13.41 8.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 118.884 0.765 . . . . 0.0 109.416 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.73 167.68 21.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.163 0.585 . . . . 0.0 109.575 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.64 147.77 32.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.859 0.864 . . . . 0.0 108.981 170.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -141.5 165.93 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.767 0.827 . . . . 0.0 111.099 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.23 165.55 24.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.043 1.737 . . . . 0.0 112.231 165.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -138.34 19.67 2.75 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.13 116.94 1.7 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.238 -161.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.5 116.05 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -64.21 133.61 53.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.657 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.2 mt . . . . . 0 C--O 1.238 0.477 0 C-N-CA 125.818 1.647 . . . . 0.0 107.031 173.393 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.6 150.22 26.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.97 125.52 15.79 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 126.583 1.953 . . . . 0.0 106.003 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.97 -174.82 23.03 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -118.57 159.21 23.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.75 156.5 40.42 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 118.581 0.628 . . . . 0.0 110.986 161.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.12 130.78 35.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 125.177 1.548 . . . . 0.0 108.008 160.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.89 159.79 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 158.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -132.4 -36.76 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.244 1.418 . . . . 0.0 110.932 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 m -145.77 138.27 25.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.743 1.217 . . . . 0.0 107.735 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.26 124.71 15.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.525 0.73 . . . . 0.0 109.145 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -135.8 81.01 1.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.115 1.366 . . . . 0.0 108.057 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.63 -118.61 5.07 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 166.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p -64.71 -3.79 3.6 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 126.426 1.89 . . . . 0.0 113.019 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.04 134.86 53.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.739 1.215 . . . . 0.0 110.816 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.45 163.56 29.41 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.139 1.375 . . . . 0.0 110.404 167.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -128.19 118.75 23.9 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.852 1.661 . . . . 0.0 110.127 170.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -87.32 165.18 15.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.858 1.663 . . . . 0.0 112.086 167.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.69 35.82 2.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.147 1.779 . . . . 0.0 111.529 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 mt 52.04 -169.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.476 1.91 . . . . 0.0 113.383 -169.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 . . . . . 0 C--O 1.235 0.34 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 173.48 9.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.846 2.364 . . . . 0.0 111.03 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.63 154.5 48.27 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.121 1.214 . . . . 0.0 110.027 162.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.31 174.45 11.48 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.151 2.567 . . . . 0.0 109.514 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.88 38.16 2.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 113.695 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -132.14 -52.31 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.323 1.449 . . . . 0.0 109.558 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.03 149.1 33.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 110.837 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 155.54 46.59 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.276 0.63 . . . . 0.0 110.879 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.8 -2.61 30.72 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.34 20.99 2.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 126.122 1.82 . . . . 0.0 109.664 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.49 25.93 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.06 130.55 41.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.65 138.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.444 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -109.5 130.63 55.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.514 0.726 . . . . 0.0 109.415 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.25 146.14 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.1 p -146.05 159.77 42.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 110.228 160.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.6 p -164.89 151.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.613 1.565 . . . . 0.0 107.841 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -79.0 108.21 12.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 166.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -144.13 152.57 41.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.62 4.58 7.12 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.644 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.87 2.08 42.57 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.821 1.81 . . . . 0.0 114.16 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.76 166.51 26.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.638 1.719 . . . . 0.0 109.836 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.54 95.01 6.99 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 155.09 39.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 170.68 18.1 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.594 172.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 t -159.93 163.35 34.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -101.98 143.6 31.63 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 108.924 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.29 24.19 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.475 1.512 . . . . 0.0 111.933 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.78 174.4 11.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.417 1.087 . . . . 0.0 111.73 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.67 -43.24 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.462 1.105 . . . . 0.0 113.659 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.45 -45.6 0.31 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.377 2.671 . . . . 0.0 114.195 -166.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.0 m -154.63 136.02 14.14 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.668 1.587 . . . . 0.0 107.772 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -116.51 161.19 19.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 108.262 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -143.39 -30.43 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.336 -0.852 . . . . 0.0 111.972 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -149.93 179.86 7.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.904 2.082 . . . . 0.0 105.824 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.7 -8.71 29.72 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.675 -0.641 . . . . 0.0 111.528 162.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -131.57 -11.92 3.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -128.55 128.2 43.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -166.47 167.33 15.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.88 172.9 7.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.994 0.918 . . . . 0.0 109.527 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 pt -141.79 138.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 108.45 160.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -107.3 111.19 23.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 128.433 2.693 . . . . 0.0 104.819 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.17 149.28 37.32 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.246 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.74 165.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.421 1.488 . . . . 0.0 108.973 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.99 -113.55 5.74 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 126.843 2.164 . . . . 0.0 109.907 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.79 137.18 2.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.589 0.756 . . . . 0.0 112.101 -160.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.97 152.97 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.673 1.189 . . . . 0.0 109.42 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 . . . . . 0 C--O 1.236 0.382 0 O-C-N 120.792 -1.192 . . . . 0.0 109.294 174.668 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.05 -33.07 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.894 -1.129 . . . . 0.0 111.097 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 2.41 53.34 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.182 0.896 . . . . 0.0 113.695 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.445 ' HG3' HH11 ' A' ' 11' ' ' ARG . 35.8 mtt85 -81.85 -16.33 51.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.178 1.489 . . . . 0.0 111.256 163.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.63 -37.23 2.92 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.056 1.342 . . . . 0.0 112.506 -172.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.04 159.56 14.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.247 1.019 . . . . 0.0 108.302 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -156.3 161.15 40.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.51 -21.88 66.17 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -163.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.2 mt -122.03 14.28 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 109.466 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.457 HE21 HG21 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -73.53 -174.0 1.58 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.528 0.517 . . . . 0.0 110.755 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -122.69 159.26 28.32 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 125.09 1.356 . . . . 0.0 109.898 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 m -146.28 155.32 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.557 1.143 . . . . 0.0 110.19 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.07 166.68 15.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.159 1.784 . . . . 0.0 110.853 157.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.2 6.23 2.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -158.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 m -49.95 105.44 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 127.327 2.251 . . . . 0.0 112.849 -155.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG22 HG12 ' A' ' 66' ' ' VAL . 25.9 t -89.99 132.01 35.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -77.99 120.61 23.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.238 0.481 0 C-N-CA 124.329 1.052 . . . . 0.0 109.587 170.498 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.0 0.905 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -131.46 146.53 52.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.697 2.399 . . . . 0.0 104.773 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.64 159.37 42.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 118.832 0.742 . . . . 0.0 109.634 165.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.25 -166.73 30.5 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 155.43 32.49 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.38 159.12 42.86 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 163.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.1 145.51 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.89 153.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.002 1.721 . . . . 0.0 107.332 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.7 p -128.98 -18.21 3.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.543 1.137 . . . . 0.0 112.336 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 m -164.53 157.85 17.55 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.44 1.896 . . . . 0.0 109.123 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.16 135.31 33.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.529 1.131 . . . . 0.0 109.482 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 67.8 1.35 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 0.0 112.05 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 -81.47 1.73 Allowed Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.199 -0.938 . . . . 0.0 113.388 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -114.64 45.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.836 1.254 . . . . 0.0 109.115 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -159.21 132.53 7.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.421 1.088 . . . . 0.0 108.169 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.4 154.63 51.41 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 168.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -114.83 149.23 37.39 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.241 1.016 . . . . 0.0 109.154 169.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.7 mt -137.61 165.14 27.07 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.433 1.493 . . . . 0.0 109.771 -169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -143.42 16.33 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 54.71 161.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.324 1.85 . . . . 0.0 113.183 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.196 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.242 0.708 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.46 169.17 17.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.376 2.051 . . . . 0.0 110.997 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.64 159.84 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 120.817 1.011 . . . . 0.0 110.278 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.39 159.53 49.83 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.034 1.823 . . . . 0.0 109.946 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 50.47 30.67 4.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.106 1.362 . . . . 0.0 111.652 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -131.66 -2.23 3.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.335 1.054 . . . . 0.0 111.577 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.752 ' HB3' HD21 ' A' ' 86' ' ' LEU . 9.3 mt -104.16 144.86 31.02 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.564 -1.335 . . . . 0.0 108.595 159.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -154.64 161.1 41.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.979 0.8 . . . . 0.0 110.307 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -67.63 -0.39 3.9 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.14 15.78 3.96 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 126.601 2.048 . . . . 0.0 110.842 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.43 125.57 26.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.51 135.95 38.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 165.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG12 HG22 ' A' ' 23' ' ' VAL . 17.9 m -142.51 141.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 108.278 -174.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 m -95.11 166.9 11.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 0.0 109.583 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 145.3 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.244 1.018 . . . . 0.0 108.584 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -144.95 153.26 41.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 109.009 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.457 HG21 HE21 ' A' ' 17' ' ' GLN . 8.9 p -157.59 151.99 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.076 1.35 . . . . 0.0 107.645 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -91.22 115.51 28.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 t -151.24 171.82 16.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 169.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.66 19.13 54.15 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.858 -1.151 . . . . 0.0 113.417 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.08 -9.98 29.56 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 118.818 1.309 . . . . 0.0 113.494 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.85 -177.44 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.503 1.921 . . . . 0.0 110.957 -171.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.1 tp -105.9 101.37 10.87 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.871 1.268 . . . . 0.0 109.381 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 80.5 m -75.99 136.36 40.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -148.49 162.53 39.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.248 167.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.7 t -155.49 -174.47 4.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.775 0.83 . . . . 0.0 111.269 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -133.57 133.79 42.51 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 129.064 2.945 . . . . 0.0 105.505 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.32 -171.21 25.92 Favored Glycine 0 N--CA 1.463 0.454 0 O-C-N 120.441 -1.412 . . . . 0.0 112.557 -170.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.69 175.37 9.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 0.0 109.439 174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.69 -40.8 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 64.93 -47.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.375 2.27 . . . . 0.0 114.479 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.5 m -148.92 101.36 3.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.075 1.75 . . . . 0.0 107.72 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -73.34 173.61 9.29 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 120.588 -1.32 . . . . 0.0 109.573 174.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.429 ' N ' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -138.2 -51.97 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 150.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -142.16 176.65 8.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.44 -15.74 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 112.649 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -118.41 -21.05 8.22 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.937 1.695 . . . . 0.0 113.462 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -130.35 132.63 45.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 120.615 1.552 . . . . 0.0 108.949 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.573 ' HB3' HD22 ' A' ' 86' ' ' LEU . 9.8 p90 -171.2 170.2 6.14 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.575 0.547 . . . . 0.0 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.81 167.98 13.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.778 2.031 . . . . 0.0 110.431 164.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.96 141.16 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.048 1.339 . . . . 0.0 108.501 159.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 140.4 29.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.623 1.569 . . . . 0.0 107.955 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.83 142.65 28.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 164.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.07 164.33 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.028 0.531 . . . . 0.0 110.12 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.68 -109.18 2.76 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.352 1.453 . . . . 0.0 109.898 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.52 142.49 15.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.194 1.798 . . . . 0.0 108.655 -169.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.23 139.47 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-N 118.372 0.533 . . . . 0.0 110.483 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--O 1.224 -0.266 0 N-CA-C 111.059 0.022 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -61.67 -36.59 81.28 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.332 -0.855 . . . . 0.0 110.657 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -10.65 67.33 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.33 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -74.36 -21.13 59.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.514 1.657 . . . . 0.0 110.428 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.563 ' HA ' HG21 ' A' ' 72' ' ' THR . 7.8 m-85 -115.43 -39.2 3.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.388 -169.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HE1' HG23 ' A' ' 70' ' ' VAL . 11.3 m-85 -105.43 131.19 53.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.405 1.882 . . . . 0.0 108.132 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.51 165.55 18.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -79.84 -8.45 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -152.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.4 mt -127.74 -0.59 6.07 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.627 2.371 . . . . 0.0 108.173 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.4 145.67 41.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.354 0.0 OUTLIER -108.19 113.76 27.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -173.241 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 HG22 ' A' ' 70' ' ' VAL . 25.7 m -102.04 172.86 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.574 2.75 . . . . 0.0 107.333 -171.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.48 163.39 15.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.405 1.882 . . . . 0.0 112.422 173.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 mt -134.98 51.4 2.1 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.492 1.517 . . . . 0.0 113.693 -167.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.1 m -67.44 120.56 14.11 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.886 -1.759 . . . . 0.0 108.109 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 t -118.73 129.71 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.868 1.267 . . . . 0.0 108.276 167.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -70.37 127.59 33.28 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.349 -0.844 . . . . 0.0 109.622 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.335 0 C-N-CA 125.833 1.653 . . . . 0.0 108.606 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.236 0.388 0 CA-C-O 122.107 0.956 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -97.09 142.72 28.68 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 166.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.8 150.15 51.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 165.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.2 -165.52 30.23 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.282 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.93 147.9 51.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.943 1.297 . . . . 0.0 107.687 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.53 34.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 162.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.23 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.15 161.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 162.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -142.05 -13.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.068 0.937 . . . . 0.0 112.608 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 m -156.58 151.15 25.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.16 138.74 31.79 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.364 1.078 . . . . 0.0 109.563 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.83 79.53 1.74 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.762 2.025 . . . . 0.0 106.015 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.35 -106.34 0.35 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.327 1.441 . . . . 0.0 113.49 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.79 9.85 0.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.892 1.677 . . . . 0.0 114.389 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -132.1 129.25 39.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.128 0.877 . . . . 0.0 109.781 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.83 159.2 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 155.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -117.66 147.39 42.95 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.808 1.243 . . . . 0.0 108.145 160.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.74 169.5 9.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.623 1.969 . . . . 0.0 111.284 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -142.43 21.91 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 57.93 -178.06 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 0.0 114.854 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 127.64 2.376 . . . . 0.0 108.261 164.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.939 -0.553 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -67.54 172.11 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.006 2.471 . . . . 0.0 113.305 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.69 154.05 75.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.885 1.724 . . . . 0.0 112.128 167.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 170.1 19.29 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.278 3.319 . . . . 0.0 110.961 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 46.56 20.28 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.075 2.15 . . . . 0.0 113.891 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.5 m -116.91 -57.24 2.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.81 121.98 13.68 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 m -130.81 160.01 35.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.038 0.381 . . . . 0.0 110.65 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.76 -13.36 62.34 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -166.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.51 30.82 3.22 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.636 2.065 . . . . 0.0 108.06 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.05 141.23 56.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 169.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 134.16 35.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 171.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.21 157.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.678 -169.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.18 107.67 7.36 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.27 148.89 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 163.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -145.54 144.84 30.76 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 155.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 19' ' ' VAL . 1.7 t -140.92 163.24 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 166.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -108.75 74.56 0.92 Allowed 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 161.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 12' ' ' TYR . 5.6 t -82.54 166.35 19.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 166.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.13 24.37 6.67 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 156.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 28.81 70.52 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.169 1.484 . . . . 0.0 114.443 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.16 44.42 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 121.725 2.762 . . . . 0.0 112.579 169.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 98.69 11.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.4 p -91.38 70.07 5.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 126.421 1.888 . . . . 0.0 108.263 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -85.64 132.63 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 2.9 t -149.04 167.85 24.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.092 0.557 . . . . 0.0 109.504 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -115.6 143.59 45.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.54 -176.54 22.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.273 1.892 . . . . 0.0 111.27 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -128.45 167.48 16.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.359 1.063 . . . . 0.0 108.265 161.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.96 -31.12 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.59 -55.68 0.53 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.491 2.316 . . . . 0.0 112.797 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.5 m -150.09 117.88 6.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.128 2.171 . . . . 0.0 106.341 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.0 tp -82.94 160.49 22.05 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -130.79 -47.99 1.04 Allowed 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 167.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -143.15 176.96 8.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.09 -11.89 59.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.723 0.809 . . . . 0.0 110.537 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -117.46 -39.63 3.15 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.708 1.603 . . . . 0.0 114.091 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -105.95 128.74 54.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -169.39 172.59 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.34 0.656 . . . . 0.0 109.747 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.29 179.15 4.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.504 1.122 . . . . 0.0 111.462 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.8 pt -146.32 129.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 159.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -76.38 122.99 25.28 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 160.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.54 131.94 34.96 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 169.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.04 177.19 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.723 1.209 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.94 -10.45 52.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 116.847 1.499 . . . . 0.0 116.847 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.0 129.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 129.691 3.197 . . . . 0.0 110.086 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 112.33 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -92.18 -51.58 5.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.099 1.318 . . . . 0.0 111.839 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 -17.22 69.83 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.098 0.832 . . . . 0.0 113.138 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -68.06 -15.53 63.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.511 ' HD2' ' HG ' ' A' ' 77' ' ' CYS . 4.5 m-85 -111.73 -56.56 2.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -84.44 119.15 24.8 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.27 156.94 16.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.503 ' C ' HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -53.42 -22.09 7.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.067 1.747 . . . . 0.0 113.551 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 15' ' ' GLN . 6.7 mp -130.68 1.45 4.44 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.561 1.544 . . . . 0.0 112.363 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 162.65 25.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 159.19 17.44 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.536 169.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.45 -173.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -92.25 159.02 15.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.872 2.069 . . . . 0.0 107.742 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.65 54.18 1.71 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.146 1.339 . . . . 0.0 110.56 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -59.33 116.82 4.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 66' ' ' VAL . 21.4 t -118.07 135.47 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -74.41 119.1 18.15 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 59' ' ' THR . 28.8 mt . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.239 0.526 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -125.77 157.4 37.57 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 162.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -140.81 144.05 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.705 0.684 . . . . 0.0 110.333 164.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.32 -163.44 12.12 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.555 1.55 . . . . 0.0 110.664 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.04 153.96 43.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.48 147.57 23.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.29 145.58 27.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 167.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.12 159.57 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.216 1.406 . . . . 0.0 107.658 162.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p -136.14 -36.75 0.73 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.586 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -144.94 140.7 28.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.786 2.034 . . . . 0.0 106.089 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.43 119.83 10.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -116.29 0.98 13.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.306 1.043 . . . . 0.0 111.805 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.38 -108.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 p -75.02 30.57 0.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.251 1.025 . . . . 0.0 112.461 170.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -153.71 109.08 3.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.556 0.742 . . . . 0.0 110.628 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.05 162.03 13.22 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 163.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -127.4 138.97 53.13 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.459 1.904 . . . . 0.0 108.619 165.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.36 169.23 10.81 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.355 1.862 . . . . 0.0 112.599 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -137.71 22.22 2.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 90' ' ' ARG . 7.9 mt 53.66 -173.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.875 1.67 . . . . 0.0 113.621 -171.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 125.579 1.552 . . . . 0.0 110.187 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.92 167.49 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.289 1.326 . . . . 0.0 111.463 170.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.72 155.51 62.98 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.199 2.599 . . . . 0.0 112.993 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.32 160.76 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.518 2.812 . . . . 0.0 111.142 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.93 3.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.487 2.315 . . . . 0.0 113.89 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.417 ' CG2' HD22 ' A' ' 25' ' ' LEU . 87.3 m -97.35 -43.56 7.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.611 -1.306 . . . . 0.0 109.567 -166.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 60' ' ' LEU . 15.2 mt -62.36 143.55 56.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.94 0.791 . . . . 0.0 109.36 166.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -146.06 163.68 34.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.268 1.027 . . . . 0.0 108.275 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.07 -3.07 40.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.033 0.921 . . . . 0.0 113.316 -165.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.04 30.37 2.56 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.467 1.984 . . . . 0.0 108.508 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.21 126.21 26.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 164.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.08 135.99 49.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 164.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.426 HG12 HG22 ' A' ' 23' ' ' VAL . 30.0 m -147.27 157.45 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 112.408 -2.178 . . . . 0.0 107.625 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 151.85 48.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.336 -1.478 . . . . 0.0 110.331 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.53 121.41 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 124.333 1.053 . . . . 0.0 108.681 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.32 92.63 2.2 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 124.01 0.819 . . . . 0.0 110.014 -166.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.58 143.63 37.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.818 1.247 . . . . 0.0 108.92 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -95.19 102.53 14.34 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 t -152.24 157.97 42.18 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.861 0.755 . . . . 0.0 109.63 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.17 40.91 92.37 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.243 -0.911 . . . . 0.0 112.233 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.9 3.85 37.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.282 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.69 177.02 8.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.951 1.875 . . . . 0.0 112.55 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.31 115.27 30.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.274 1.029 . . . . 0.0 108.387 171.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.511 ' HG ' ' HD2' ' A' ' 12' ' ' TYR . 0.5 OUTLIER -93.22 112.76 24.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 127.547 2.339 . . . . 0.0 104.897 174.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 128.38 42.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 8.0 t -134.34 168.27 19.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.779 0.8 . . . . 0.0 109.831 171.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -106.88 157.69 17.57 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.467 1.507 . . . . 0.0 107.59 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.82 179.42 45.2 Favored Glycine 0 CA--C 1.524 0.625 0 O-C-N 121.656 -0.652 . . . . 0.0 113.58 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 162.72 34.1 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.414 173.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.51 -36.14 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.95 1.3 . . . . 0.0 113.928 -170.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 73.52 -66.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.394 2.278 . . . . 0.0 111.176 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -138.09 133.97 34.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.54 157.9 18.04 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -136.6 -56.06 0.74 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.038 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -123.49 168.93 11.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.95 -6.74 13.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.16 0.984 . . . . 0.0 111.104 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.469 ' HB3' HD12 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -120.04 -14.25 8.9 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -129.81 119.79 23.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -163.62 169.47 18.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.76 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.94 178.84 5.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.326 1.05 . . . . 0.0 111.01 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.6 pt -147.08 141.81 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 160.59 14.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 159.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.2 mt -117.39 128.72 55.31 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 106.193 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.83 154.51 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.1 0.864 . . . . 0.0 110.458 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.28 -111.67 3.69 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -170.45 136.11 1.28 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.205 1.402 . . . . 0.0 109.467 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.4 p -58.67 154.8 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 126.826 2.05 . . . . 0.0 111.847 164.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 127.99 2.516 . . . . 0.0 105.142 167.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -55.06 -39.61 69.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.922 0.889 . . . . 0.0 110.17 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -13.07 61.3 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.286 0.469 . . . . 0.0 112.967 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -69.37 -22.77 63.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.551 1.175 . . . . 0.0 110.951 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -123.08 -24.32 4.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.949 1.299 . . . . 0.0 114.346 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -111.67 106.56 15.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.23 160.7 18.37 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.433 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.88 -19.66 65.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.973 2.109 . . . . 0.0 114.484 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 mt -124.92 2.28 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.849 1.26 . . . . 0.0 111.074 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -70.43 175.83 4.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.313 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -113.46 144.71 42.36 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.63 132.99 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.185 0.994 . . . . 0.0 108.401 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -53.01 157.32 1.78 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.916 0.78 . . . . 0.0 109.434 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.63 4.15 15.96 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -166.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.27 95.95 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 113.212 -154.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.17 123.19 44.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 108.367 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.25 137.89 55.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.539 1.063 . . . . 0.0 108.757 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.9 0.88 . . . . 0.0 108.642 179.117 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.238 0.456 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -126.14 139.42 53.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -135.21 137.41 42.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 162.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.52 -178.17 16.81 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.423 1.487 . . . . 0.0 110.195 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -101.46 150.41 23.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.22 161.71 38.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 162.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.01 155.59 17.05 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 154.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 92.7 mt -71.12 161.04 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.129 1.772 . . . . 0.0 106.265 161.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -134.39 -26.24 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.52 1.128 . . . . 0.0 112.099 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.6 m -154.73 157.06 37.46 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.46 1.504 . . . . 0.0 108.336 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.45 144.3 29.58 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -142.05 83.19 1.83 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.19 2.196 . . . . 0.0 107.894 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.73 -110.54 3.38 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.949 0.785 . . . . 0.0 112.691 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 p -72.64 -4.6 32.0 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 116.506 -1.711 . . . . 0.0 113.169 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -117.26 136.27 53.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.684 1.129 . . . . 0.0 108.469 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.18 164.13 27.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.216 1.406 . . . . 0.0 109.377 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -125.53 142.59 51.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 109.541 167.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.14 170.32 8.6 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.765 1.626 . . . . 0.0 112.002 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -141.21 22.69 2.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.58 1.552 . . . . 0.0 115.069 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 49' ' ' LEU . 7.2 mt 51.81 -169.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.045 1.338 . . . . 0.0 112.514 -169.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.341 0.223 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -66.11 175.16 5.03 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.69 1.594 . . . . 0.0 112.078 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.31 152.99 80.31 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 109.28 -1.085 . . . . 0.0 109.28 158.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.31 176.7 9.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.973 2.449 . . . . 0.0 111.261 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 p30 52.13 13.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.911 2.484 . . . . 0.0 115.042 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.3 m -121.35 -24.4 5.45 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.506 -0.747 . . . . 0.0 111.611 -164.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 89' ' ' ASP . 14.8 mt -80.22 141.55 35.5 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 m -127.26 165.98 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.52 1.928 . . . . 0.0 110.423 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -79.01 -2.52 40.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.532 1.133 . . . . 0.0 113.284 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.26 20.62 2.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 126.597 2.046 . . . . 0.0 109.714 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.78 132.9 52.37 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -75.48 138.01 41.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 165.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.84 167.69 21.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 126.267 1.827 . . . . 0.0 109.496 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -128.89 134.2 48.18 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.838 -1.164 . . . . 0.0 109.582 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.08 170.43 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.417 1.487 . . . . 0.0 109.753 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.57 137.87 5.96 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.96 142.94 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 109.198 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.444 ' CZ2' ' HG ' ' A' ' 76' ' ' LEU . 94.5 m95 -90.19 112.13 23.53 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -150.36 154.07 37.15 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 119.507 1.049 . . . . 0.0 110.419 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.86 -155.34 7.04 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -163.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.99 53.16 4.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.254 -1.303 . . . . 0.0 111.999 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -163.26 175.78 10.59 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.531 1.665 . . . . 0.0 112.768 162.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.444 ' HG ' ' CZ2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -84.54 145.51 28.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 156.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.591 ' SG ' HG11 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -118.14 83.82 2.07 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 127.737 2.415 . . . . 0.0 104.825 170.008 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -85.13 139.19 31.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.68 176.84 10.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 123.644 0.59 . . . . 0.0 110.58 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -105.57 168.81 8.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.045 1.338 . . . . 0.0 107.512 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.29 -179.99 40.53 Favored Glycine 0 C--N 1.334 0.454 0 O-C-N 120.759 -1.213 . . . . 0.0 112.76 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -128.03 169.91 13.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.47 1.508 . . . . 0.0 108.001 160.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.0 t -68.44 -40.26 81.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 118.861 0.755 . . . . 0.0 112.871 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 65.71 -43.92 0.37 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.801 2.04 . . . . 0.0 114.337 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -153.79 133.4 12.93 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.074 -1.641 . . . . 0.0 109.524 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.89 159.72 17.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.372 0.669 . . . . 0.0 109.33 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -138.05 -50.09 0.58 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.365 -0.835 . . . . 0.0 109.957 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.79 173.4 11.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.455 ' HA ' HD12 ' A' ' 60' ' ' LEU . 1.2 m-20 -66.4 -6.46 14.52 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.753 0.821 . . . . 0.0 111.798 169.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -117.62 -18.28 9.74 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -130.98 127.85 39.2 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -168.82 166.76 11.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 109.815 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.81 174.95 7.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.631 1.173 . . . . 0.0 110.184 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -142.98 137.49 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 109.02 158.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -91.65 123.6 35.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 160.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.84 140.88 38.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 109.893 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.05 158.62 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.886 1.274 . . . . 0.0 110.954 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.54 53.64 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 125.791 1.662 . . . . 0.0 115.821 165.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.14 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.561 3.544 . . . . 0.0 111.98 -173.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.591 HG11 ' SG ' ' A' ' 77' ' ' CYS . 2.6 t -73.55 137.57 23.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 CA-C-N 121.32 1.873 . . . . 0.0 114.436 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.275 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -54.19 -41.73 68.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.619 0.767 . . . . 0.0 109.51 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -5.01 66.55 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.037 0.827 . . . . 0.0 113.834 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -88.22 -10.11 50.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.99 1.395 . . . . 0.0 111.588 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' HD2' HG21 ' A' ' 100' ' ' VAL . 4.0 m-30 -117.93 -42.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.515 1.526 . . . . 0.0 109.592 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -99.45 146.81 25.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.08 1.352 . . . . 0.0 108.132 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -143.7 158.11 43.91 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -55.61 -20.12 12.59 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 126.453 1.901 . . . . 0.0 115.392 -164.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.2 mt -126.69 5.9 6.76 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -179.66 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.991 0.814 . . . . 0.0 110.587 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 129.36 56.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.715 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 m -118.75 140.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -63.68 162.45 13.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.945 0.898 . . . . 0.0 110.291 170.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.82 45.18 2.77 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.892 0.877 . . . . 0.0 109.811 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 m -65.01 125.26 24.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 66' ' ' VAL . 23.9 t -131.95 127.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.024 1.729 . . . . 0.0 108.176 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 143.9 57.58 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.963 0.801 . . . . 0.0 109.778 172.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 59' ' ' THR . 48.9 mt . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 121.837 0.827 . . . . 0.0 113.203 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.93 149.57 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -150.35 123.16 8.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.61 -178.74 16.54 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.632 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.7 161.61 13.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 166.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.26 160.53 43.63 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.213 1.805 . . . . 0.0 109.622 161.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.98 135.6 33.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.89 153.74 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 159.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -131.52 -39.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.683 1.193 . . . . 0.0 110.279 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.4 m -152.9 123.49 7.27 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.97 1.308 . . . . 0.0 108.191 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 142.86 50.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.576 1.15 . . . . 0.0 109.645 -171.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -135.23 -169.81 2.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.754 1.622 . . . . 0.0 109.276 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.48 95.38 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -163.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -140.09 34.75 1.92 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.286 1.834 . . . . 0.0 108.376 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 146.33 36.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.28 168.59 19.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -130.83 142.86 50.41 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.514 1.926 . . . . 0.0 107.505 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -174.73 3.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.666 1.587 . . . . 0.0 109.894 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.7 mt 57.76 -177.37 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.628 1.571 . . . . 0.0 112.434 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.64 169.95 14.87 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.708 2.272 . . . . 0.0 112.061 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -57.25 154.57 33.85 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.394 1.396 . . . . 0.0 111.41 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.48 169.1 16.37 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.41 2.073 . . . . 0.0 109.093 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.17 44.79 6.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.485 ' CG2' HD22 ' A' ' 25' ' ' LEU . 89.0 m -138.75 -54.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.896 0.879 . . . . 0.0 109.195 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.78 137.95 58.16 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.678 171.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -147.16 160.88 41.92 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 66.8 mt-10 -69.94 -2.25 11.94 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -163.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.49 17.1 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 126.102 1.81 . . . . 0.0 111.137 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.67 28.22 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.88 129.94 38.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 23' ' ' VAL . 35.8 m -134.86 159.36 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.128 -172.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.63 104.96 5.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.82 160.46 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.468 ' CB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -148.63 137.46 21.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.99 144.62 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.164 0.986 . . . . 0.0 109.231 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.451 ' CE2' HD13 ' A' ' 76' ' ' LEU . 81.7 m95 -86.33 111.15 20.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -156.99 150.71 24.53 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.57 -56.14 1.65 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.098 1.332 . . . . 0.0 110.936 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.92 -9.48 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.716 1.627 . . . . 0.0 112.933 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.29 174.61 7.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.186 1.493 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.468 HD11 ' CB ' ' A' ' 69' ' ' SER . 31.8 tp -81.04 99.1 8.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -70.74 110.05 5.31 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 164.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 146.12 25.51 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.672 ' SG ' HG22 ' A' ' 100' ' ' VAL . 24.7 m -134.03 144.0 48.42 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.931 168.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.85 146.26 30.97 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.66 -177.52 22.96 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.23 0.919 . . . . 0.0 111.077 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -131.02 161.06 32.8 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 162.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.02 -31.08 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.29 -60.89 0.36 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.135 1.774 . . . . 0.0 111.139 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.4 m -153.27 122.73 6.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.799 2.04 . . . . 0.0 107.121 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.483 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.4 tp -91.6 156.04 17.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -130.06 -46.68 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 111.502 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.475 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 5.7 m-20 -138.3 -178.73 5.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.231 1.812 . . . . 0.0 107.273 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -21.22 9.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.891 1.676 . . . . 0.0 111.434 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -122.07 -53.98 1.93 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 125.518 1.527 . . . . 0.0 111.214 -163.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.475 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 32.2 mt-30 -85.67 133.47 34.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.784 0.72 . . . . 0.0 109.493 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -166.94 164.04 16.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 109.012 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.78 176.21 8.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.605 0.762 . . . . 0.0 109.927 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -152.73 127.63 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.778 1.631 . . . . 0.0 110.219 164.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.13 125.39 34.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 164.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.58 137.96 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.6 164.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 120.657 1.571 . . . . 0.0 113.354 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.1 -117.6 10.87 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 127.544 2.497 . . . . 0.0 107.525 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -145.53 153.58 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.69 1.596 . . . . 0.0 108.113 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.672 HG22 ' SG ' ' A' ' 79' ' ' CYS . 85.6 t -55.93 152.69 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.347 1.859 . . . . 0.0 110.438 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.675 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.401 ' CD1' HG23 ' A' ' 100' ' ' VAL . 3.9 m-30 -56.55 -42.38 78.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.539 1.535 . . . . 0.0 110.779 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.78 0.13 86.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.0 0.809 . . . . 0.0 113.524 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -84.43 -15.99 44.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.283 1.042 . . . . 0.0 111.207 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -116.21 -45.76 2.83 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.851 0.751 . . . . 0.0 111.367 -169.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.97 155.56 18.05 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.92 155.76 41.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -50.05 -27.41 5.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.727 3.211 . . . . 0.0 116.628 -168.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.49 1.51 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.608 1.163 . . . . 0.0 111.459 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.57 174.54 7.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 110.107 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -112.55 152.02 29.33 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.29 -0.881 . . . . 0.0 111.124 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.02 136.33 47.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.512 1.525 . . . . 0.0 107.181 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.01 164.55 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.5 mt -129.72 6.72 5.16 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -158.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.84 90.98 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.588 2.355 . . . . 0.0 112.841 -157.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.73 128.59 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -70.83 111.84 6.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.662 0.665 . . . . 0.0 109.613 165.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.766 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.319 0 CA-C-O 123.333 1.54 . . . . 0.0 114.588 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -136.6 102.7 5.0 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.156 1.382 . . . . 0.0 107.583 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 158.55 15.4 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.053 169.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -170.05 42.79 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 140.71 50.03 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.418 1.887 . . . . 0.0 108.486 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.43 155.13 50.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.969 0.804 . . . . 0.0 110.477 160.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.86 144.92 28.1 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.5 mt -70.77 157.68 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.065 1.346 . . . . 0.0 107.576 162.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -137.18 -56.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.745 2.018 . . . . 0.0 109.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -121.16 157.22 30.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.008 1.323 . . . . 0.0 109.176 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tt -153.64 118.63 5.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.07 94.65 3.08 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.203 1.401 . . . . 0.0 108.117 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.66 -127.38 43.21 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 p -71.24 36.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.994 1.397 . . . . 0.0 112.615 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -147.51 124.24 11.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.02 165.59 12.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 157.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -126.88 146.17 50.39 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 126.325 1.85 . . . . 0.0 108.297 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -138.24 157.9 45.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.709 1.604 . . . . 0.0 109.498 -159.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.42 26.71 2.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 90' ' ' ARG . 8.3 mt 51.19 -165.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.97 1.308 . . . . 0.0 111.276 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 C-N-CA 124.119 0.967 . . . . 0.0 111.776 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.34 170.75 10.3 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.383 2.722 . . . . 0.0 112.217 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HG2' HG21 ' A' ' 59' ' ' THR . 59.3 Cg_endo -66.51 154.58 73.84 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.271 1.314 . . . . 0.0 109.286 171.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.62 161.03 47.51 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 122.72 2.28 . . . . 0.0 111.786 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 47.0 33.84 2.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.426 1.89 . . . . 0.0 112.051 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.444 HG21 ' HG2' ' A' ' 56' ' ' PRO . 95.1 m -128.56 -18.96 3.84 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.298 -0.876 . . . . 0.0 111.855 -171.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 mt -76.01 143.26 41.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.803 0.729 . . . . 0.0 109.284 155.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -141.4 168.77 18.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.364 1.466 . . . . 0.0 108.81 159.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -69.23 -3.76 15.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.443 1.497 . . . . 0.0 114.722 -170.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.44 -2.79 25.94 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 117.851 -1.527 . . . . 0.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.36 131.14 49.31 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.587 1.694 . . . . 0.0 109.188 -164.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -85.56 72.89 10.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.25 1.5 . . . . 0.0 108.48 -167.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.03 154.13 7.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.884 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -134.18 128.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.05 0.94 . . . . 0.0 108.852 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -95.15 175.66 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.694 1.597 . . . . 0.0 110.208 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' HD21 ' A' ' 76' ' ' LEU . 54.0 p -154.71 162.08 41.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.019 1.327 . . . . 0.0 107.829 152.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 p -157.33 143.06 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.747 0.703 . . . . 0.0 109.676 159.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 68.3 m95 -90.29 117.14 28.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.8 t -136.52 170.38 16.16 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.263 1.425 . . . . 0.0 107.685 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 58.44 -107.66 1.21 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.82 32.17 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.482 1.515 . . . . 0.0 111.952 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.52 -170.11 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.055 1.342 . . . . 0.0 108.789 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.6 tm? -116.88 122.03 43.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.412 1.485 . . . . 0.0 110.317 172.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.11 129.1 51.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.44 164.39 25.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.773 1.169 . . . . 0.0 108.345 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.7 t -149.67 148.17 28.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.4 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -79.84 144.3 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.302 1.441 . . . . 0.0 108.043 168.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.11 -169.61 16.46 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.229 -0.919 . . . . 0.0 112.078 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -138.07 168.9 18.76 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 106.73 163.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.88 -27.5 37.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 67.91 -62.85 0.34 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.946 1.699 . . . . 0.0 113.369 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 m -149.32 129.26 13.43 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.569 1.947 . . . . 0.0 106.601 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.97 140.03 43.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -115.2 -52.89 2.66 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.838 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -137.45 169.72 17.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -18.14 57.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.059 0.543 . . . . 0.0 111.978 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.48 ' HA ' HD12 ' A' ' 49' ' ' LEU . 7.4 ptp180 -110.41 -15.86 13.83 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.799 172.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -120.48 123.3 42.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.805 1.638 . . . . 0.0 109.127 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -165.77 165.42 18.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.474 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 176.03 8.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.705 1.202 . . . . 0.0 110.596 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.9 pt -144.75 148.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.306 1.442 . . . . 0.0 109.048 155.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 ttp85 -116.37 112.38 21.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.734 1.614 . . . . 0.0 109.286 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.3 mt -75.59 126.25 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.848 1.659 . . . . 0.0 108.571 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.77 161.87 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 111.108 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.12 8.51 87.41 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.072 -1.404 . . . . 0.0 115.039 167.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.28 135.63 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.433 2.693 . . . . 0.0 111.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.401 HG23 ' CD1' ' A' ' 9' ' ' TYR . 7.8 t -86.65 127.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 120.163 1.347 . . . . 0.0 109.767 171.133 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.74 -47.6 77.64 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.609 -1.307 . . . . 0.0 110.895 -166.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.63 6.19 33.39 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 124.065 0.841 . . . . 0.0 113.537 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -84.95 -13.87 49.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.762 1.281 . . . . 0.0 110.65 166.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.454 ' HB3' HG21 ' A' ' 72' ' ' THR . 8.1 m-30 -123.74 -35.78 2.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.807 1.643 . . . . 0.0 112.965 -170.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 24.3 m-85 -108.49 122.17 46.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -172.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.54 159.6 16.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -60.32 -14.09 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.642 2.777 . . . . 0.0 114.203 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 mt -133.84 13.42 4.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.934 1.694 . . . . 0.0 109.911 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -97.36 163.91 12.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 127.008 2.123 . . . . 0.0 109.852 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -118.74 143.17 47.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.133 -0.98 . . . . 0.0 111.58 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.94 139.89 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.576 2.35 . . . . 0.0 104.721 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.519 ' O ' HD23 ' A' ' 21' ' ' LEU . 5.6 t-20 -62.58 156.06 24.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.264 172.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 20' ' ' ASN . 2.9 mt -132.01 93.72 3.34 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -80.32 90.02 5.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 t -85.31 102.11 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -55.02 120.96 7.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 117.21 -1.376 . . . . 0.0 109.708 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.921 0 C-N-CA 124.081 0.953 . . . . 0.0 112.419 173.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.565 ' HA ' HD22 ' A' ' 25' ' ' LEU . 3.6 m . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 122.049 0.928 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 25' ' ' LEU . 83.3 t80 -95.55 103.68 15.56 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 -172.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.2 109.21 19.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.53 164.52 12.16 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.303 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 138.9 43.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.18 34.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.34 148.91 24.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.2 mt -72.95 160.62 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.886 1.675 . . . . 0.0 108.761 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.1 p -133.45 -32.22 1.17 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.672 2.389 . . . . 0.0 111.294 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 m -151.55 142.98 23.49 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tp -141.18 114.28 8.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 110.646 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.31 32.19 5.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.872 0.869 . . . . 0.0 112.941 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 -113.09 2.86 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -67.98 22.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.365 1.466 . . . . 0.0 111.735 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 93' ' ' ALA . 2.8 tm? -148.83 126.78 11.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.58 163.63 22.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.413 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 43.9 m95 -124.97 146.14 49.54 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 127.264 2.226 . . . . 0.0 107.866 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.5 mt -138.88 161.35 37.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.092 1.495 . . . . 0.0 110.433 -156.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -146.33 36.47 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 49' ' ' LEU . 8.8 mt 54.25 -174.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.335 -1.478 . . . . 0.0 113.847 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.185 0 O-C-N 121.982 -0.449 . . . . 0.0 112.012 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 119.085 -0.484 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.23 165.33 29.01 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.841 2.36 . . . . 0.0 111.158 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.11 160.01 24.1 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.351 1.367 . . . . 0.0 110.961 171.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.92 160.49 11.85 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.515 2.143 . . . . 0.0 110.853 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 56.3 35.88 26.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.311 1.444 . . . . 0.0 111.411 -171.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -130.72 -40.25 1.22 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -172.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.1 mt -73.06 140.21 47.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -138.68 165.18 27.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.831 0.852 . . . . 0.0 109.702 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.604 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 58.9 mt-10 -70.79 -2.23 14.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.431 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.26 2.26 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 120.659 -1.275 . . . . 0.0 110.129 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.5 132.43 53.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 165.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.37 116.83 16.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 166.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.53 140.48 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.53 116.43 22.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -165.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.528 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.5 m -72.93 162.28 4.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 C-N-CA 124.045 0.938 . . . . 0.0 109.822 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -160.12 141.29 12.36 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.619 1.568 . . . . 0.0 112.031 150.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.91 158.3 10.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.165 1.386 . . . . 0.0 109.521 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -92.25 121.43 33.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.524 1.53 . . . . 0.0 107.428 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 12' ' ' TYR . 9.8 t -150.47 160.54 43.7 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.26 -117.93 3.07 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.03 20.63 5.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.343 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.51 172.34 17.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.445 2.123 . . . . 0.0 110.293 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.89 115.81 28.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.71 150.52 20.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -157.01 134.97 11.0 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 106.93 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 27.9 t -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 107.173 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.13 152.68 44.84 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -150.68 -175.95 23.16 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.755 -1.215 . . . . 0.0 111.618 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -129.21 172.33 11.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.01 0.924 . . . . 0.0 109.218 163.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.0 t -68.62 -32.44 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.5 -65.53 0.2 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.885 1.674 . . . . 0.0 111.993 -172.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -145.33 126.49 14.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.142 1.377 . . . . 0.0 108.072 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.604 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 2.8 tp -86.31 165.11 16.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.797 0.839 . . . . 0.0 109.156 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -137.24 -43.71 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.783 0.72 . . . . 0.0 112.643 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -141.58 177.25 8.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.9 -6.06 7.5 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.48 -1.387 . . . . 0.0 111.884 169.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.6 ptt180 -138.9 -1.82 1.76 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -127.85 134.88 49.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 120.32 1.418 . . . . 0.0 107.282 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.54 166.43 2.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -89.8 178.9 6.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.563 0.745 . . . . 0.0 110.627 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.6 pt -147.43 134.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.654 1.181 . . . . 0.0 111.109 160.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -90.72 127.37 36.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.079 0.952 . . . . 0.0 108.665 165.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -84.85 131.02 34.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG22 ' HA2' ' A' ' 81' ' ' GLY . 27.4 m -137.26 171.19 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 119.472 1.033 . . . . 0.0 111.463 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.35 13.31 64.91 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.998 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.6 163.69 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.418 3.887 . . . . 0.0 113.577 -173.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.1 p -112.1 127.67 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.907 2.483 . . . . 0.0 110.625 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 167.904 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -57.41 -48.23 79.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.421 1.464 . . . . 0.0 110.963 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -15.73 65.49 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 119.301 -0.722 . . . . 0.0 113.417 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -71.15 -21.04 62.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.591 1.195 . . . . 0.0 111.305 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 1.2 m-85 -112.03 -51.4 2.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.379 0.672 . . . . 0.0 109.539 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.14 161.75 27.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -145.42 161.08 40.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.527 -0.733 . . . . 0.0 112.07 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.86 -22.84 62.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.69 9.05 8.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.233 1.413 . . . . 0.0 111.072 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.47 174.97 1.49 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.384 0.611 . . . . 0.0 110.02 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 30.2 mtpt -116.7 146.03 43.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 109.042 166.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.56 156.76 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 109.826 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.12 141.57 28.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.936 2.094 . . . . 0.0 109.441 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.9 mt -130.98 70.99 1.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.881 1.273 . . . . 0.0 113.459 -162.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -60.98 133.58 56.24 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.043 -1.036 . . . . 0.0 108.277 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.681 HG22 HG12 ' A' ' 66' ' ' VAL . 10.2 t -126.71 121.11 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -62.56 137.23 58.22 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 120.52 1.509 . . . . 0.0 108.941 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 171.454 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 121.838 0.828 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -80.9 154.2 27.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.18 141.76 37.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 157.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.95 174.17 24.43 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 164.24 12.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.19 160.14 43.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.785 -1.197 . . . . 0.0 110.465 161.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 147.17 28.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 157.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.1 mt -79.43 157.46 4.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -130.56 -32.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.536 1.535 . . . . 0.0 111.36 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.9 m -152.23 155.14 37.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.066 1.746 . . . . 0.0 108.878 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.2 tp -147.25 112.61 5.57 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.179 1.391 . . . . 0.0 108.671 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -133.16 94.22 3.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 51.88 -131.3 36.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.404 -0.664 . . . . 0.0 111.794 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 p -74.66 43.59 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.422 1.889 . . . . 0.0 110.839 173.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.25 107.83 3.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.849 -0.532 . . . . 0.0 111.732 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.67 165.51 11.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 165.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 14.4 m95 -126.83 148.63 49.95 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.588 1.555 . . . . 0.0 108.0 164.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 mt -135.9 172.25 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.124 1.769 . . . . 0.0 109.272 -165.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -151.03 27.22 0.7 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 49' ' ' LEU . 7.1 mt 52.25 -174.15 0.03 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.36 1.864 . . . . 0.0 113.024 -173.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 125.822 1.649 . . . . 0.0 106.952 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.56 175.23 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.753 2.302 . . . . 0.0 112.391 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -58.97 154.76 42.66 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 121.106 1.204 . . . . 0.0 110.55 160.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -65.63 174.66 5.15 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.604 2.869 . . . . 0.0 110.156 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.2 p30 52.69 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.4 m -110.09 -31.34 7.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 111.193 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -69.59 139.61 53.68 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.101 -0.999 . . . . 0.0 110.085 168.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.02 156.71 45.98 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.26 . . . . 0.0 110.049 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.71 -1.7 14.76 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -168.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.12 18.26 4.76 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.113 1.816 . . . . 0.0 111.215 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.61 141.01 58.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.67 63.79 1.25 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 123.674 1.702 . . . . 0.0 111.663 -163.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.681 HG12 HG22 ' A' ' 23' ' ' VAL . 19.6 m -68.38 162.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.014 -1.903 . . . . 0.0 112.039 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 169.17 9.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.584 1.154 . . . . 0.0 109.787 173.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.89 123.75 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 125.478 1.511 . . . . 0.0 109.565 168.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -121.64 141.87 50.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.963 0.789 . . . . 0.0 110.607 162.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.4 146.79 15.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.85 2.06 . . . . 0.0 106.337 162.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.483 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 76.6 m95 -87.77 143.05 27.36 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 163.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 t -137.5 173.68 11.4 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.01 -98.62 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.753 2.121 . . . . 0.0 112.683 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.8 22.38 2.82 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.322 1.915 . . . . 0.0 111.927 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.71 174.73 11.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.049 1.924 . . . . 0.0 114.024 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.8 tm? -115.61 122.77 46.61 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.151 1.381 . . . . 0.0 110.738 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.86 81.45 1.77 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.099 1.36 . . . . 0.0 110.074 -168.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -99.25 128.22 45.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.57 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 12.3 t -128.17 172.44 11.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.726 0.81 . . . . 0.0 110.021 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.21 160.19 16.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.125 1.77 . . . . 0.0 108.702 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -165.69 -169.32 29.15 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -144.12 160.72 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.638 1.975 . . . . 0.0 109.1 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.274 51.3 t -62.52 -31.84 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 70.23 -66.11 0.29 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.107 2.163 . . . . 0.0 114.937 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -155.71 97.16 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.796 1.638 . . . . 0.0 108.915 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tp -79.09 152.89 30.57 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.18 -58.76 1.53 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.239 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -127.15 -173.54 2.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.24 -8.35 45.07 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.966 -1.084 . . . . 0.0 111.123 166.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -131.91 -44.89 0.95 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 112.574 -169.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -91.7 133.38 35.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -167.29 164.2 15.33 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.162 0.585 . . . . 0.0 109.724 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -80.85 175.31 10.79 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.25 1.42 . . . . 0.0 110.807 172.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.46 148.17 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.391 1.076 . . . . 0.0 109.188 156.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.24 114.96 26.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.595 2.758 . . . . 0.0 107.606 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.64 147.09 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.495 1.043 . . . . 0.0 108.573 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.426 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.8 m -135.83 146.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 122.335 1.064 . . . . 0.0 109.758 176.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.74 -141.85 31.28 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -166.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.32 138.37 29.45 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.666 1.186 . . . . 0.0 110.838 -165.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.4 p -85.34 129.85 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.044 1.738 . . . . 0.0 111.662 171.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 125.914 1.686 . . . . 0.0 106.703 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.245 0.545 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -105.62 -47.71 3.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.439 1.495 . . . . 0.0 109.804 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.95 10.38 3.18 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.734 1.635 . . . . 0.0 113.363 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -90.85 -14.7 31.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.358 1.863 . . . . 0.0 112.484 165.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 100' ' ' VAL . 7.3 m-85 -121.52 -39.04 2.69 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.994 1.318 . . . . 0.0 112.329 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 61.0 m-85 -93.16 154.35 18.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -143.76 155.8 44.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -57.61 -21.7 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 126.279 1.832 . . . . 0.0 113.661 -170.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -124.39 6.47 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.019 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.462 HE21 HG21 ' A' ' 70' ' ' VAL . 2.7 mt-30 -72.16 169.0 17.01 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.508 -1.37 . . . . 0.0 110.865 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -99.79 153.31 19.23 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.04 148.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.379 1.871 . . . . 0.0 106.039 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.65 161.77 29.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.761 0.825 . . . . 0.0 111.274 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -133.37 41.68 3.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.935 0.894 . . . . 0.0 112.487 -163.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 m -66.62 100.7 0.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 25' ' ' LEU . 43.4 t -94.47 113.24 28.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -57.56 107.21 0.42 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-N 120.535 1.516 . . . . 0.0 109.334 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 126.168 1.787 . . . . 0.0 107.808 171.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.422 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.715 0 CA-C-O 121.647 0.737 . . . . 0.0 109.266 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -110.48 148.4 32.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 164.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -132.79 141.37 48.46 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.926 0.89 . . . . 0.0 110.429 166.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.15 -168.42 26.18 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.568 1.556 . . . . 0.0 110.73 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.2 m -129.26 148.85 51.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.64 162.08 32.91 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 162.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.26 144.65 25.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.04 153.53 8.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 163.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.3 p -130.89 -40.19 1.19 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.776 1.231 . . . . 0.0 110.398 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -140.88 154.51 46.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.873 2.069 . . . . 0.0 107.695 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.75 134.8 20.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -154.23 95.06 1.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.905 1.682 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 -110.8 3.29 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.861 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.5 p -100.09 36.26 1.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.597 1.198 . . . . 0.0 110.449 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.468 ' CD2' ' HB1' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -143.36 131.64 22.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.765 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.22 28.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -122.11 147.16 46.48 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.791 1.637 . . . . 0.0 108.154 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -140.2 156.73 46.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.898 1.679 . . . . 0.0 109.691 -163.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -143.53 35.89 1.31 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 mt 50.89 -170.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.9 1.28 . . . . 0.0 111.3 -171.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 126.227 1.811 . . . . 0.0 112.963 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 168.12 19.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.193 1.929 . . . . 0.0 110.152 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.94 155.76 66.17 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 120.986 1.124 . . . . 0.0 110.041 164.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.06 174.88 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.014 2.476 . . . . 0.0 108.293 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.99 23.51 12.64 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.986 -1.071 . . . . 0.0 111.34 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.4 m -137.59 -43.85 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.457 1.503 . . . . 0.0 110.182 -167.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 mt -70.96 135.65 48.02 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 120.126 1.33 . . . . 0.0 109.349 169.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.7 m -132.77 163.91 27.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.084 0.954 . . . . 0.0 111.046 168.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.96 -0.05 12.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.026 1.33 . . . . 0.0 114.178 -170.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.2 10.86 7.31 Favored Glycine 0 C--N 1.321 -0.283 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.428 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 128.19 34.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 71.22 1.41 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.076 1.417 . . . . 0.0 109.844 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.6 m -82.87 136.17 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.779 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.84 120.42 41.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.907 0.883 . . . . 0.0 109.157 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.7 m -86.93 155.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.3 p -142.76 155.66 44.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 153.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.462 HG21 HE21 ' A' ' 17' ' ' GLN . 11.1 p -150.87 150.88 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 164.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -100.06 120.5 39.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -156.74 157.04 34.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.2 42.36 62.66 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.944 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.8 -22.87 5.39 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.077 0.938 . . . . 0.0 113.733 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.8 164.17 16.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.892 1.346 . . . . 0.0 112.055 -158.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 tp -84.73 102.02 12.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.7 m -88.55 123.45 33.06 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.31 158.56 42.64 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 167.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 41.9 t -148.83 141.97 24.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.296 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.36 149.95 46.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 110.141 173.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -159.62 -167.48 20.31 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.602 -1.311 . . . . 0.0 112.747 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -139.49 178.96 6.84 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.156 1.782 . . . . 0.0 110.269 166.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.03 -46.01 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.989 1.315 . . . . 0.0 113.234 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 64.7 -58.87 0.24 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.627 2.371 . . . . 0.0 115.23 -167.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -132.44 133.63 44.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -104.8 162.58 13.18 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -139.02 -37.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 120.843 -1.161 . . . . 0.0 113.853 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.77 -175.7 4.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 164.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -68.51 1.69 2.92 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.189 -0.944 . . . . 0.0 112.457 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -134.06 -18.32 2.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -121.24 138.02 54.42 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.364 1.438 . . . . 0.0 107.221 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -172.68 164.13 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.951 0.9 . . . . 0.0 109.602 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.468 ' HB1' ' CD2' ' A' ' 44' ' ' LEU . . . -83.95 172.12 12.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.484 1.114 . . . . 0.0 109.344 168.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 pt -139.97 143.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.326 1.05 . . . . 0.0 109.156 153.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 130.55 46.06 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.685 1.194 . . . . 0.0 107.794 163.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.1 mt -87.44 135.09 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.561 HG22 ' HA2' ' A' ' 81' ' ' GLY . 6.2 m -135.85 157.23 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 122.33 1.062 . . . . 0.0 109.529 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.98 -109.67 2.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -165.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.6 166.5 31.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -96.47 148.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 1 C-N-CA 133.179 4.591 . . . . 0.0 110.79 154.579 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 . . . . . 0 C--O 1.237 0.4 0 C-N-CA 127.616 2.366 . . . . 0.0 107.346 160.936 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -62.52 -37.79 87.44 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.96 -0.462 . . . . 0.0 110.415 -170.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.41 44.07 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.26 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 mtt-85 -84.52 -16.15 43.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.66 1.23 . . . . 0.0 110.164 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -116.53 -45.85 2.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.184 1.794 . . . . 0.0 109.98 -172.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -91.4 168.39 11.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.282 1.033 . . . . 0.0 108.237 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -148.85 169.54 20.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.692 0.797 . . . . 0.0 109.183 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.453 ' HG2' HD12 ' A' ' 16' ' ' LEU . 9.4 pm0 -71.23 -20.73 62.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 ' HG2' ' A' ' 15' ' ' GLN . 5.4 mp -125.98 14.13 7.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.1 0.96 . . . . 0.0 109.138 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.443 HE22 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -74.43 -177.18 2.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.092 1.757 . . . . 0.0 110.542 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.99 33.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 120.926 -1.108 . . . . 0.0 111.042 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.67 144.86 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.529 1.131 . . . . 0.0 108.441 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.45 158.6 29.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.295 1.438 . . . . 0.0 109.934 167.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.8 mt -130.8 55.45 1.84 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.145 1.378 . . . . 0.0 109.72 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -69.06 130.26 42.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.38 130.42 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -71.17 114.6 9.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.778 1.627 . . . . 0.0 109.103 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 30' ' ' SER . 1.7 mm? . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' HD22 ' A' ' 25' ' ' LEU . 14.2 m . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 124.208 1.956 . . . . 0.0 112.961 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -132.05 147.27 52.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -139.02 130.41 27.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.55 -168.77 13.3 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.227 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 142.32 45.22 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.063 1.345 . . . . 0.0 107.808 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.68 153.93 51.77 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 164.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.79 38.81 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 156.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.5 mt -68.63 158.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 160.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.1 p -135.88 -18.52 1.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.779 1.632 . . . . 0.0 112.122 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 m -157.6 148.6 21.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -144.48 122.56 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -135.68 74.64 1.52 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.592 1.957 . . . . 0.0 107.953 -173.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.56 -123.78 29.84 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.6 p -77.1 34.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.777 1.288 . . . . 0.0 111.97 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -151.7 125.01 8.78 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.8 162.46 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 12.7 m95 -129.3 147.52 51.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.684 1.194 . . . . 0.0 110.452 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.62 173.45 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.68 1.592 . . . . 0.0 112.51 -167.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.37 19.95 1.37 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 90' ' ' ARG . 8.7 mt 55.51 -171.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.861 0.864 . . . . 0.0 112.943 -169.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 C-N-CA 126.005 1.722 . . . . 0.0 109.903 165.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.88 167.77 18.76 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.107 3.205 . . . . 0.0 112.996 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.12 154.23 71.78 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 121.204 1.269 . . . . 0.0 109.994 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.01 170.45 20.08 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.192 2.595 . . . . 0.0 110.765 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.47 -3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 128.211 2.605 . . . . 0.0 116.503 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.2 m -101.32 -24.34 14.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.025 1.33 . . . . 0.0 112.046 -161.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.5 mt -78.92 149.26 32.42 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 120.97 -1.082 . . . . 0.0 108.845 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.75 163.24 34.6 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.553 1.141 . . . . 0.0 108.447 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -70.67 -2.04 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 37.48 1.5 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 135.87 57.21 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 162.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.18 125.78 29.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 166.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.98 136.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.565 1.146 . . . . 0.0 109.616 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.63 131.83 41.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.82 154.71 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.7 p -145.29 146.98 31.87 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 157.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.443 HG21 HE22 ' A' ' 17' ' ' GLN . 10.5 p -149.87 147.75 15.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.239 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -89.38 117.98 28.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.0 t -151.17 169.86 20.86 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.62 -117.61 3.56 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -163.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.35 60.89 0.63 Allowed Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.97 -175.59 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.482 1.513 . . . . 0.0 109.053 176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.5 101.85 10.99 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.029 1.732 . . . . 0.0 108.933 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -71.71 107.9 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.74 133.56 39.7 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 165.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.21 133.2 47.44 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.51 152.25 28.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -167.91 -171.43 33.84 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.463 HH11 HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -134.16 167.14 21.22 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.9 -27.49 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 65.03 -64.16 0.17 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.129 1.772 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -149.36 110.25 4.32 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.319 2.247 . . . . 0.0 105.294 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tp -81.36 153.93 26.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 167.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -120.25 -71.36 0.74 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.03 179.48 3.94 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.116 1.766 . . . . 0.0 108.494 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.76 -2.3 0.22 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.421 2.688 . . . . 0.0 113.698 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.759 ' HB3' HD12 ' A' ' 49' ' ' LEU . 1.7 ptt85 -157.22 -38.13 0.07 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.1 -1.0 . . . . 0.0 113.151 -159.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.28 127.73 45.32 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -171.62 176.44 3.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.112 0.965 . . . . 0.0 109.308 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -104.19 179.92 4.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.338 1.055 . . . . 0.0 112.234 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -150.2 124.62 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.213 1.805 . . . . 0.0 111.654 167.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 114.18 26.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.25 1.42 . . . . 0.0 107.648 168.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -78.02 135.01 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.89 1.276 . . . . 0.0 108.129 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 HH11 ' A' ' 82' ' ' ARG . 19.5 m -136.89 167.65 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.163 0.585 . . . . 0.0 111.121 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.93 15.61 80.91 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 118.502 -1.165 . . . . 0.0 114.616 164.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.22 165.23 0.19 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.815 2.046 . . . . 0.0 111.006 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -116.59 137.45 50.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -72.91 -50.03 26.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.791 -1.193 . . . . 0.0 110.141 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.32 -24.05 77.38 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.547 0.612 . . . . 0.0 113.0 -164.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -61.79 -21.24 64.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.518 172.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -113.6 -40.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.034 1.334 . . . . 0.0 111.49 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CE1' HG12 ' A' ' 70' ' ' VAL . 99.2 m-85 -102.67 112.06 24.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.536 1.534 . . . . 0.0 108.606 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.18 157.49 19.34 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.605 0.566 . . . . 0.0 109.932 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.0 -27.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.522 2.729 . . . . 0.0 113.859 163.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.37 41.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.241 1.416 . . . . 0.0 108.561 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.0 159.9 18.66 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.462 1.105 . . . . 0.0 108.96 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 148.12 32.94 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.065 -1.022 . . . . 0.0 110.404 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.47 155.3 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.337 1.055 . . . . 0.0 108.763 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -59.23 161.09 5.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.238 0.615 . . . . 0.0 110.839 162.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.73 44.46 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.588 2.355 . . . . 0.0 108.303 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.2 m -68.2 114.59 6.82 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.47 104.73 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -50.12 114.54 1.12 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 165.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 CA--C 1.512 -0.518 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 167.539 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.315 1.2 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.64 166.69 23.31 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 105.933 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -152.59 154.95 36.42 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.04 11.52 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -133.67 151.71 51.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.9 151.0 39.25 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 167.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 145.57 26.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 166.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.0 156.32 7.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 168.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 p -132.8 -22.79 2.07 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.926 2.09 . . . . 0.0 111.819 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -157.05 132.82 9.41 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.537 1.535 . . . . 0.0 108.237 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.463 HD22 ' O ' ' A' ' 44' ' ' LEU . 1.1 tm? -126.74 146.72 50.12 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.404 1.081 . . . . 0.0 108.621 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -161.8 88.11 0.69 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.229 1.012 . . . . 0.0 111.633 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.26 -125.92 37.0 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.1 p -80.48 45.0 0.74 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.041 0.92 . . . . 0.0 110.903 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 40' ' ' LEU . 6.8 tp -153.05 129.34 10.53 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.53 149.82 51.69 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.459 ' C ' HD13 ' A' ' 47' ' ' LEU . 15.8 m95 -114.45 132.42 56.26 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.21 1.404 . . . . 0.0 108.73 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.489 HD21 HG12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -122.31 156.06 34.66 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.044 1.338 . . . . 0.0 109.9 -176.523 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -137.91 23.98 2.83 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -169.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 mt 51.37 140.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 130.671 3.589 . . . . 0.0 115.58 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.238 0.495 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.42 170.7 17.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.373 2.049 . . . . 0.0 112.317 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.54 154.19 74.84 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.15 1.9 . . . . 0.0 111.09 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.51 167.48 25.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.973 2.449 . . . . 0.0 111.424 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 49.23 26.22 1.45 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.904 2.081 . . . . 0.0 111.966 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.1 m -122.8 -55.79 1.79 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.115 1.366 . . . . 0.0 108.021 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.17 130.27 41.44 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 168.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 m -143.11 163.6 32.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 40.1 mt-10 -78.18 0.73 23.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.412 1.085 . . . . 0.0 113.713 -164.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.62 21.67 3.05 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 124.9 21.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.59 117.29 11.93 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.22 153.68 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 124.929 1.291 . . . . 0.0 107.843 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 p -125.71 130.46 51.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.105 0.866 . . . . 0.0 111.104 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.6 m -81.28 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.436 ' HB2' HD21 ' A' ' 76' ' ' LEU . 45.0 p -165.75 131.38 2.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.326 2.25 . . . . 0.0 106.428 154.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.472 HG12 ' CE1' ' A' ' 13' ' ' PHE . 11.1 p -136.16 138.3 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -81.73 112.28 18.75 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 168.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -114.2 -166.09 1.07 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 168.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.78 127.49 14.69 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.66 2.53 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.22 -0.767 . . . . 0.0 111.413 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.7 174.19 11.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.908 1.354 . . . . 0.0 111.368 -154.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 69' ' ' SER . 0.4 OUTLIER -84.59 117.74 23.92 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 173.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.462 ' SG ' HG13 ' A' ' 70' ' ' VAL . 15.0 p -99.55 122.16 42.21 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.71 162.12 32.81 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.412 ' H ' HG22 ' A' ' 68' ' ' VAL . 22.4 t -155.4 166.8 32.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.8 140.88 52.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.75 -175.57 22.11 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 123.552 0.596 . . . . 0.0 114.021 -160.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -133.35 163.84 28.43 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 166.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.3 t -65.17 -39.97 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.141 0.882 . . . . 0.0 111.961 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 64.9 -48.52 0.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.161 2.585 . . . . 0.0 113.921 -167.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 m -153.79 101.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.27 1.428 . . . . 0.0 107.685 -166.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.411 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.0 tp -81.9 161.63 23.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -133.85 -41.46 0.84 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.735 0.814 . . . . 0.0 111.792 171.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.37 173.63 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.706 2.002 . . . . 0.0 105.982 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.2 -10.2 1.85 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.975 2.11 . . . . 0.0 112.943 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -127.74 -24.4 3.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.839 1.656 . . . . 0.0 112.234 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -120.46 121.09 37.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -162.33 163.48 27.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.932 0.396 . . . . 0.0 110.038 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.11 171.55 10.17 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.029 171.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 47' ' ' LEU . 11.3 pt -146.85 131.05 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.201 1.8 . . . . 0.0 108.638 163.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.32 119.48 31.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.47 125.83 29.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.93 158.24 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.13 -154.26 49.28 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -173.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 137.46 51.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.084 -2.058 . . . . 0.0 108.214 -171.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.52 149.62 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 . . . . . 0 C--O 1.234 0.251 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 164.883 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -59.4 -47.94 83.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 111.08 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.4 -16.61 71.62 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.792 0.71 . . . . 0.0 112.671 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -74.7 -10.54 59.63 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.72 -0.871 . . . . 0.0 111.525 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 100' ' ' VAL . 3.3 m-30 -120.19 -40.93 2.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.331 1.452 . . . . 0.0 110.574 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -101.17 104.57 15.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -83.08 157.12 22.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 169.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.572 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.8 tt0 -62.42 -15.13 47.5 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 127.286 2.234 . . . . 0.0 114.805 -173.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 15' ' ' GLN . 7.1 mp -127.81 2.61 6.03 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.446 1.098 . . . . 0.0 111.203 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.45 HE21 HG21 ' A' ' 70' ' ' VAL . 2.6 mt-30 -71.43 178.83 3.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 111.712 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.81 157.61 18.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.427 1.091 . . . . 0.0 110.283 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.66 146.07 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 108.769 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -65.41 153.09 42.29 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.605 0.639 . . . . 0.0 109.387 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.83 51.39 1.53 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.328 0.651 . . . . 0.0 111.477 -165.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 112.96 4.39 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.131 -0.98 . . . . 0.0 110.294 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.64 109.6 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.029 1.332 . . . . 0.0 109.576 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -62.2 130.15 44.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.216 1.807 . . . . 0.0 109.941 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 124.493 1.117 . . . . 0.0 108.914 176.914 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -137.06 151.06 48.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 164.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.6 141.19 31.92 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.764 1.226 . . . . 0.0 108.186 166.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.23 -173.06 17.13 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.218 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.45 124.48 38.53 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.05 1.34 . . . . 0.0 107.637 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.77 149.95 45.57 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.672 1.989 . . . . 0.0 107.079 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.67 153.34 17.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.9 mt -75.19 162.62 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.625 1.57 . . . . 0.0 107.622 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.7 p -140.1 -40.85 0.43 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.986 1.715 . . . . 0.0 111.641 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 m -137.3 145.82 43.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 45' ' ' ALA . 1.6 tp -136.0 138.52 42.33 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.569 -1.332 . . . . 0.0 107.863 171.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -145.42 87.8 1.82 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.717 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.46 -119.04 16.84 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 124.37 0.986 . . . . 0.0 111.245 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 p -73.85 36.71 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.764 1.226 . . . . 0.0 111.795 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -145.16 134.95 23.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.568 -1.332 . . . . 0.0 107.725 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB2' HD12 ' A' ' 40' ' ' LEU . . . -131.24 163.25 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 161.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -122.07 140.85 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.155 1.782 . . . . 0.0 107.638 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.21 167.45 12.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.9 127.7 25.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.544 1.938 . . . . 0.0 108.29 162.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.2 mt -52.62 146.55 9.93 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 177.947 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.57 174.2 6.74 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.441 2.761 . . . . 0.0 110.775 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.84 158.11 44.49 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 120.81 1.007 . . . . 0.0 110.274 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.99 169.58 20.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.518 2.145 . . . . 0.0 111.105 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 56.12 13.7 1.26 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.402 1.881 . . . . 0.0 113.252 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.0 m -110.18 -53.25 2.7 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.834 1.253 . . . . 0.0 107.851 -166.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.88 150.25 20.77 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.403 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -144.15 163.4 33.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.685 0.794 . . . . 0.0 111.633 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 22.2 mt-10 -71.7 -7.8 50.22 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 10.43 7.58 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 124.696 1.141 . . . . 0.0 112.392 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . . . -59.58 137.35 58.05 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.21 64.0 8.32 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.532 1.158 . . . . 0.0 111.487 -168.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.88 131.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -84.95 165.94 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.83 119.33 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 124.513 1.125 . . . . 0.0 109.565 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -121.57 145.45 47.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.981 0.912 . . . . 0.0 109.432 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.45 HG21 HE21 ' A' ' 17' ' ' GLN . 9.5 p -153.78 159.16 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 165.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -94.43 106.66 18.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 t -145.57 168.77 19.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.492 0.717 . . . . 0.0 109.216 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.8 28.26 38.56 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.599 -1.112 . . . . 0.0 113.202 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.08 6.36 88.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.27 1.414 . . . . 0.0 113.904 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 176.16 9.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 112.463 -166.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.4 tp -104.71 96.29 6.48 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.933 1.693 . . . . 0.0 107.967 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.2 p -80.16 140.0 36.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -146.05 112.53 5.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.662 -0.649 . . . . 0.0 111.801 168.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 48.3 t -107.63 172.4 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.931 0.872 . . . . 0.0 111.108 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.88 154.34 24.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.774 2.43 . . . . 0.0 107.472 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.74 -166.71 33.65 Favored Glycine 0 C--O 1.239 0.458 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.517 1.527 . . . . 0.0 109.761 173.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 64' ' ' ALA . 78.2 t -70.51 -31.19 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.836 0.854 . . . . 0.0 112.658 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 68.88 -61.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.72 2.008 . . . . 0.0 112.704 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 m -146.21 115.51 7.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.142 2.177 . . . . 0.0 106.392 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.2 tp -84.78 155.97 21.59 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -128.78 -58.34 1.16 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.714 -0.616 . . . . 0.0 110.636 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -123.24 172.67 8.45 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 107.114 170.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -7.87 25.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.929 0.492 . . . . 0.0 111.08 164.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.88 -7.4 8.98 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 125.507 1.523 . . . . 0.0 114.933 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.42 130.12 25.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -162.39 162.99 28.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 118.168 0.44 . . . . 0.0 110.123 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.44 178.49 8.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.488 0.715 . . . . 0.0 109.582 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 pt -142.45 157.2 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 125.122 1.369 . . . . 0.0 108.735 156.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.77 113.91 22.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.193 2.197 . . . . 0.0 106.138 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.99 149.73 44.7 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 174.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.987 0.915 . . . . 0.0 110.624 170.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.52 -111.81 2.63 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 126.354 1.93 . . . . 0.0 109.134 -170.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.28 21.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.53 1.932 . . . . 0.0 109.999 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.487 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.5 p -121.24 156.15 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.705 2.002 . . . . 0.0 110.673 172.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 128.628 2.771 . . . . 0.0 107.279 -161.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -39.34 82.04 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.364 -0.835 . . . . 0.0 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.42 -14.32 74.5 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 118.293 -1.282 . . . . 0.0 112.587 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.93 -40.93 95.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.014 1.907 . . . . 0.0 109.989 166.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' CE2' HG13 ' A' ' 100' ' ' VAL . 2.7 m-30 -86.27 -46.38 10.39 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.265 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.18 105.47 17.63 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.496 1.118 . . . . 0.0 109.378 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -85.95 160.09 19.47 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 127.403 2.281 . . . . 0.0 110.31 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.28 -24.66 67.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -171.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -130.95 16.49 5.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.58 1.552 . . . . 0.0 109.342 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -66.05 171.95 4.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 165.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 159.48 16.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 167.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.17 164.49 29.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -76.75 159.6 30.02 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.397 167.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -120.28 45.48 2.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.579 1.081 . . . . 0.0 109.981 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 m -71.11 95.02 1.18 Allowed 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.71 130.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.307 0.958 . . . . 0.0 109.017 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -70.85 121.23 17.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 109.214 168.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 31' ' ' PHE . 3.0 mm? . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.948 0.88 . . . . 0.0 109.024 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.537 ' H ' HD23 ' A' ' 25' ' ' LEU . 77.8 t80 -84.8 158.6 20.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.7 1.2 . . . . 0.0 108.224 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.41 144.76 22.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.449 0.7 . . . . 0.0 109.993 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 -168.36 31.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.414 0.531 . . . . 0.0 112.256 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 133.32 56.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.548 1.539 . . . . 0.0 108.721 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.15 39.35 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 162.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.1 147.81 40.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.406 1.082 . . . . 0.0 109.003 164.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.6 mt -75.35 159.02 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.858 1.663 . . . . 0.0 106.83 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.7 p -141.89 -33.17 0.5 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.301 1.84 . . . . 0.0 112.325 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.43 137.05 12.17 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.789 -1.194 . . . . 0.0 110.971 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.402 HD22 ' H ' ' A' ' 41' ' ' LYS . 1.9 tm? -135.28 141.19 45.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 126.234 1.814 . . . . 0.0 107.627 -173.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' H ' HD22 ' A' ' 40' ' ' LEU . 1.5 ttmm -159.77 93.61 1.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.27 -135.92 36.97 Favored Glycine 0 C--O 1.229 -0.184 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.27 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.83 2.052 . . . . 0.0 113.176 170.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 tp -140.35 118.42 11.92 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 119.408 1.004 . . . . 0.0 109.825 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.38 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 16.0 m95 -128.5 135.83 49.97 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.938 2.095 . . . . 0.0 108.283 170.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.62 177.23 5.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.017 1.727 . . . . 0.0 111.328 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -148.15 131.27 16.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.923 2.489 . . . . 0.0 107.054 167.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.33 157.46 4.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.836 1.654 . . . . 0.0 112.716 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.34 0.162 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 161.96 43.03 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.781 1.654 . . . . 0.0 110.264 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -63.49 162.08 28.93 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 120.82 1.014 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.19 150.12 32.83 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.272 2.648 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 60.49 9.69 2.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.382 2.273 . . . . 0.0 114.074 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.9 m -88.6 -57.35 2.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.354 1.862 . . . . 0.0 111.542 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.95 131.27 50.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -122.98 159.05 29.15 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.65 0.78 . . . . 0.0 110.425 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.25 -5.1 25.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.553 0.741 . . . . 0.0 112.511 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.72 14.69 7.15 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-O 117.588 -1.673 . . . . 0.0 112.25 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.25 133.07 54.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.845 1.322 . . . . 0.0 107.624 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -83.83 110.83 18.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.48 133.86 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.241 0.616 . . . . 0.0 110.497 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.48 137.32 34.7 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.074 0.95 . . . . 0.0 108.569 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.6 126.11 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 124.29 1.036 . . . . 0.0 109.108 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 p -112.5 152.0 29.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.24 142.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 153.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -83.66 121.42 27.24 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.81 148.21 33.77 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.16 -89.47 0.33 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.866 1.222 . . . . 0.0 113.132 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.37 5.94 1.91 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.919 0.771 . . . . 0.0 112.97 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.99 177.28 9.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.212 1.506 . . . . 0.0 111.847 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.2 117.43 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 166.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.66 118.09 35.44 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -133.65 135.5 44.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.443 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 12.1 t -135.24 176.42 8.68 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.402 1.081 . . . . 0.0 108.867 177.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.04 147.38 45.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.85 -170.62 24.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.297 0.951 . . . . 0.0 111.165 -174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -134.13 172.62 12.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.856 1.662 . . . . 0.0 109.116 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -69.36 -35.57 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.913 1.233 . . . . 0.0 113.123 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.52 -62.23 0.44 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.821 2.048 . . . . 0.0 112.665 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -143.62 121.89 12.28 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.202 2.201 . . . . 0.0 106.422 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.42 160.53 18.29 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -123.15 -52.98 1.84 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.397 168.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.28 169.55 17.47 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.024 1.73 . . . . 0.0 107.648 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -4.74 1.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 112.37 170.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -128.47 -14.88 4.64 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 126.017 1.727 . . . . 0.0 113.575 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -138.99 124.98 19.9 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -170.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -165.73 165.79 18.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -83.49 173.58 11.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.467 1.107 . . . . 0.0 110.543 171.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.93 148.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.87 1.668 . . . . 0.0 107.997 154.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -113.54 125.35 54.09 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 125.011 1.324 . . . . 0.0 107.802 168.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.91 144.16 27.81 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.777 1.631 . . . . 0.0 106.781 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.79 146.98 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.777 0.717 . . . . 0.0 111.834 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.78 -99.08 0.32 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 126.069 1.795 . . . . 0.0 109.197 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 164.94 35.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 112.558 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.446 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -106.28 150.68 8.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.877 2.471 . . . . 0.0 110.199 160.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 125.431 1.492 . . . . 0.0 107.255 150.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CD1' HG12 ' A' ' 100' ' ' VAL . 3.3 m-85 -61.07 -38.45 86.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.015 1.28 . . . . 0.0 111.005 -171.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.36 1.51 65.17 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.85 0.738 . . . . 0.0 112.96 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -83.89 -4.42 58.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.577 1.689 . . . . 0.0 110.636 164.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.546 ' CE2' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -118.26 -49.48 2.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.255 1.422 . . . . 0.0 107.957 -178.188 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -98.92 105.09 17.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.896 1.278 . . . . 0.0 107.575 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -103.95 161.06 14.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.273 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -154.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.75 10.44 7.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.41 1.884 . . . . 0.0 111.008 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -65.28 172.58 3.04 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -108.28 153.87 22.61 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.455 -0.778 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.94 158.05 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.732 1.213 . . . . 0.0 110.482 166.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -74.04 161.71 29.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.39 2.276 . . . . 0.0 111.669 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.96 49.66 1.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.73 1.612 . . . . 0.0 112.769 -167.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 m -66.74 108.8 2.62 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.244 -1.535 . . . . 0.0 109.514 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.81 124.3 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.092 1.757 . . . . 0.0 108.875 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -64.85 124.07 21.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 59' ' ' THR . 55.6 mt . . . . . 0 N--CA 1.468 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 112.715 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -86.58 152.84 22.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 164.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.8 132.44 14.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.14 -170.86 21.21 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.517 1.532 . . . . 0.0 109.625 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.31 162.43 13.68 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.099 1.36 . . . . 0.0 108.289 171.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.0 172.28 13.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.959 0.904 . . . . 0.0 110.185 157.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.84 145.53 28.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.83 1.332 . . . . 0.0 108.559 163.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.3 mt -71.51 157.76 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.842 2.057 . . . . 0.0 106.97 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 p -140.91 -46.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.502 1.121 . . . . 0.0 112.362 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -135.94 136.06 40.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.248 1.419 . . . . 0.0 107.933 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 41' ' ' LYS . 2.1 tm? -145.66 137.4 25.22 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 123.161 1.457 . . . . 0.0 110.218 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' H ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -152.08 93.02 1.78 Allowed 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.641 -177.17 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.24 -110.24 0.84 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.174 1.368 . . . . 0.0 111.535 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 95' ' ' ARG . 57.8 p -68.08 -7.26 27.97 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.009 1.724 . . . . 0.0 115.62 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.34 114.02 20.74 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 120.233 1.379 . . . . 0.0 111.063 -173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.1 157.81 16.61 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 163.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -122.4 142.23 50.74 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.151 2.18 . . . . 0.0 109.239 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.4 mt -135.05 154.78 51.58 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.767 1.227 . . . . 0.0 110.089 -163.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.68 33.26 4.03 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 49.12 -174.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.437 1.895 . . . . 0.0 114.494 -169.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.512 -0.482 0 C-N-CA 124.049 0.94 . . . . 0.0 111.748 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 C--O 1.237 0.431 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.05 171.18 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.3 2.0 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -57.15 154.52 33.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.129 1.219 . . . . 0.0 109.418 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.59 164.88 29.36 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.773 1.649 . . . . 0.0 109.59 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 p30 56.18 21.48 5.27 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.93 1.692 . . . . 0.0 114.079 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 25' ' ' LEU . 47.3 m -124.49 -11.74 7.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.734 0.814 . . . . 0.0 111.124 -168.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.8 ' HB3' HD21 ' A' ' 86' ' ' LEU . 10.8 mt -88.67 140.36 29.53 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.396 1.453 . . . . 0.0 110.672 156.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -146.33 160.12 42.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.023 0.929 . . . . 0.0 111.785 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.97 -2.0 6.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.56 1.944 . . . . 0.0 115.338 -172.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.16 2.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 125.25 1.405 . . . . 0.0 110.661 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.68 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.3 122.16 31.5 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 m -140.7 154.74 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 110.26 -166.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.24 150.83 41.76 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.4 -0.812 . . . . 0.0 110.068 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.55 120.05 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.32 1.048 . . . . 0.0 110.879 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -129.16 137.68 51.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -154.5 153.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -89.27 113.26 24.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.8 t -151.24 144.46 24.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.01 44.97 41.99 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.389 0.995 . . . . 0.0 111.44 -171.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.77 -15.86 2.1 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.447 1.499 . . . . 0.0 114.502 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.9 153.82 21.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.611 1.705 . . . . 0.0 110.715 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.3 tp -80.7 94.9 6.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.44 139.59 47.83 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.67 134.99 29.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.736 -0.603 . . . . 0.0 110.269 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 8.0 t -137.93 160.97 37.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 111.652 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.97 159.68 14.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.663 1.185 . . . . 0.0 109.05 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.92 -176.1 30.59 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.557 1.551 . . . . 0.0 111.439 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -130.34 171.17 13.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 161.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.531 HG11 HD23 ' A' ' 86' ' ' LEU . 48.6 t -66.79 -35.78 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.819 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 6.1 tp10 65.36 -59.91 0.26 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.262 2.225 . . . . 0.0 112.918 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 93' ' ' ALA . 2.5 m -128.36 133.63 48.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 60' ' ' LEU . 1.4 tm? -108.64 170.98 7.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 166.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -140.49 -47.47 0.42 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 116.734 -1.987 . . . . 0.0 115.996 152.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.11 167.43 19.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.21 6.14 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.737 1.615 . . . . 0.0 111.713 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -134.49 -19.74 1.87 Allowed 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.946 -1.721 . . . . 0.0 115.563 170.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -129.16 123.82 33.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 121.183 1.81 . . . . 0.0 108.197 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CB ' HD22 ' A' ' 86' ' ' LEU . 18.3 p90 -166.79 177.72 6.31 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.61 0.364 . . . . 0.0 110.248 -172.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' A' ' 85' ' ' THR . . . -108.62 175.66 5.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.291 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -145.22 130.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 125.38 1.472 . . . . 0.0 109.116 165.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HD2' ' HB2' ' A' ' 43' ' ' SER . 18.3 tpt85 -87.48 114.16 23.84 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 125.902 1.681 . . . . 0.0 107.31 162.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.4 mt -68.89 135.07 50.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.85 148.45 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.169 0.985 . . . . 0.0 109.822 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.09 -107.44 2.06 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.23 168.39 27.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.045 1.338 . . . . 0.0 110.84 174.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.546 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -109.36 153.06 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 128.046 2.538 . . . . 0.0 111.167 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.906 0.86 . . . . 0.0 109.436 150.078 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 100' ' ' VAL . 7.1 m-30 -55.57 -37.76 68.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.947 -1.096 . . . . 0.0 110.574 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.87 -1.13 45.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.474 1.512 . . . . 0.0 112.736 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -72.67 -16.76 61.69 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.012 1.406 . . . . 0.0 111.626 165.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.53 -59.65 1.53 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.81 153.08 27.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.84 157.6 45.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.426 ' HB3' HD12 ' A' ' 16' ' ' LEU . 36.2 tt0 -54.6 -22.56 13.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.943 1.697 . . . . 0.0 114.282 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 15' ' ' GLN . 5.6 mp -127.14 8.38 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 111.954 -172.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.67 166.39 22.01 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.277 -0.89 . . . . 0.0 110.933 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -94.67 160.08 14.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.47 170.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.34 163.08 18.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.042 1.337 . . . . 0.0 109.24 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -80.23 158.5 26.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.455 0.702 . . . . 0.0 110.378 164.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 35' ' ' ALA . 72.1 mt -127.53 51.5 1.91 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.689 1.595 . . . . 0.0 111.09 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -59.34 126.7 28.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.66 121.1 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -63.84 139.56 58.78 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.457 1.48 . . . . 0.0 108.746 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.556 HD22 HG22 ' A' ' 59' ' ' THR . 35.7 mt . . . . . 0 C--O 1.235 0.293 0 C-N-CA 124.02 0.928 . . . . 0.0 112.421 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.437 -1.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -96.5 143.12 27.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 163.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.82 102.41 4.56 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.65 -171.71 15.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.364 0.983 . . . . 0.0 112.446 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -110.6 144.75 39.01 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.277 1.831 . . . . 0.0 107.938 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -138.96 161.8 36.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.548 -0.72 . . . . 0.0 111.034 157.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.57 137.95 32.52 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 113.964 -1.471 . . . . 0.0 107.594 159.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.64 155.04 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -136.02 -22.42 1.39 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.028 1.731 . . . . 0.0 112.185 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -153.55 152.62 31.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 120.923 -1.111 . . . . 0.0 108.104 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.3 tp -156.42 122.2 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -145.48 79.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.96 -139.98 27.0 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.98 2.11 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 127.921 2.488 . . . . 0.0 114.617 168.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 132.27 56.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.999 1.727 . . . . 0.0 108.592 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.35 171.68 12.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 161.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 15.6 m95 -134.15 144.18 48.38 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.426 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.23 177.37 5.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.926 1.29 . . . . 0.0 110.042 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -144.02 32.27 1.25 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 mt 47.99 -173.1 0.01 OUTLIER 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.51 1.148 . . . . 0.0 112.77 -162.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.239 1.016 . . . . 0.0 108.27 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.241 0.619 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.66 167.19 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.667 1.578 . . . . 0.0 111.111 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.28 156.67 39.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.67 2.247 . . . . 0.0 111.445 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.69 162.97 16.77 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.018 2.478 . . . . 0.0 110.413 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 50.14 21.74 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 168.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.556 HG22 HD22 ' A' ' 25' ' ' LEU . 85.4 m -114.77 -30.93 6.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.075 0.95 . . . . 0.0 111.368 -168.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mt -73.84 145.68 44.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.041 1.336 . . . . 0.0 109.704 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -148.46 162.54 39.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 46.3 mt-10 -70.43 -1.93 12.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.178 1.391 . . . . 0.0 114.11 -168.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.62 6.98 9.67 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.153 1.835 . . . . 0.0 111.836 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.93 123.23 19.26 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.07 116.82 6.87 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.89 131.63 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 138.19 50.43 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.835 1.254 . . . . 0.0 108.297 -167.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.61 143.39 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 124.325 1.05 . . . . 0.0 109.098 -166.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.17 126.73 12.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 0.0 109.053 -174.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -152.26 161.45 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.287 1.435 . . . . 0.0 110.246 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -113.14 131.71 55.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.996 1.318 . . . . 0.0 110.238 -170.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -148.19 49.04 1.04 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 111.055 -163.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.63 -97.49 0.25 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.575 1.559 . . . . 0.0 109.407 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.82 0.29 9.98 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.83 1.681 . . . . 0.0 113.569 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.62 171.1 14.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.813 1.306 . . . . 0.0 111.937 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.78 109.66 21.33 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.208 2.203 . . . . 0.0 107.559 177.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -85.02 108.0 17.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.53 162.78 25.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 35.4 t -157.7 168.35 27.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.18 0.925 . . . . 0.0 109.631 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.02 152.66 18.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.222 1.809 . . . . 0.0 107.517 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.18 -177.86 37.95 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -138.62 165.2 27.52 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.482 1.113 . . . . 0.0 109.949 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.74 -34.48 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.65 -66.85 0.15 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.342 1.857 . . . . 0.0 112.656 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.0 m -142.25 117.34 10.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.921 2.488 . . . . 0.0 106.402 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.4 tp -89.47 160.74 16.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -125.51 -56.12 1.51 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -148.39 175.61 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.71 23.31 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.198 1.399 . . . . 0.0 112.173 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -147.03 -6.59 0.49 Allowed 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 166.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -138.6 131.15 28.99 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 120.585 1.539 . . . . 0.0 107.208 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -166.13 158.91 14.8 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.138 1.375 . . . . 0.0 109.412 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -80.49 175.63 10.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.917 1.287 . . . . 0.0 109.861 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.37 139.54 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.525 1.13 . . . . 0.0 108.408 158.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -93.93 111.77 23.53 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -72.55 139.54 47.59 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.61 139.59 50.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 123.708 0.63 . . . . 0.0 110.753 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.66 -88.97 1.18 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 124.441 1.02 . . . . 0.0 112.116 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 149.1 16.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.982 1.313 . . . . 0.0 110.119 -175.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG23 ' CD1' ' A' ' 9' ' ' TYR . 39.9 t -106.8 114.71 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 158.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -58.54 -46.63 86.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.468 0.707 . . . . 0.0 109.679 -168.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.61 -0.58 80.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.713 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -73.41 -28.86 62.23 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.573 1.686 . . . . 0.0 109.903 164.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' CE2' HG13 ' A' ' 100' ' ' VAL . 7.1 m-30 -107.16 -41.68 5.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.295 1.038 . . . . 0.0 110.416 -168.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.26 116.38 30.36 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -94.94 154.39 17.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 -23.68 6.99 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 127.033 2.133 . . . . 0.0 114.102 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -129.67 8.72 5.38 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.77 1.628 . . . . 0.0 111.397 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.13 175.85 4.25 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.301 -0.874 . . . . 0.0 110.36 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE3' ' CE1' ' A' ' 50' ' ' PHE . 47.3 mtpt -114.29 145.97 41.07 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.034 0.934 . . . . 0.0 108.588 168.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 153.02 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.823 0.849 . . . . 0.0 109.768 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -68.85 154.73 41.48 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.052 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.6 mt -129.6 21.91 5.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -158.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -52.51 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.346 1.458 . . . . 0.0 112.871 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.17 135.22 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.114 1.324 . . . . 0.0 108.13 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -82.1 125.08 30.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 124.341 1.056 . . . . 0.0 112.923 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.282 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -142.13 144.49 33.52 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.986 1.715 . . . . 0.0 108.563 173.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.86 136.76 48.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.24 -174.76 21.72 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.17 0.891 . . . . 0.0 110.896 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.09 146.55 45.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.309 1.043 . . . . 0.0 108.677 170.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.37 149.71 36.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.02 31.27 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.5 mt -75.32 155.93 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 164.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -133.91 -41.14 0.84 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.057 0.943 . . . . 0.0 111.759 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -141.56 153.76 45.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.835 1.254 . . . . 0.0 108.238 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 133.97 18.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -140.51 75.13 1.49 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.88 2.072 . . . . 0.0 107.589 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.95 -116.1 6.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.279 1.418 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.6 p -64.13 11.17 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.511 1.525 . . . . 0.0 114.966 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 117.1 11.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.17 166.28 15.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -128.82 155.92 44.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.33 1.052 . . . . 0.0 109.578 174.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.46 150.66 35.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.721 2.008 . . . . 0.0 108.227 -163.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -150.04 130.39 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 164.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -57.35 157.92 6.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.107 2.563 . . . . 0.0 113.087 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE1' ' HE3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 126.249 1.82 . . . . 0.0 112.113 -166.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 120.04 -0.028 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.63 167.19 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.948 2.432 . . . . 0.0 111.849 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -62.81 161.73 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.129 1.886 . . . . 0.0 112.427 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.05 158.72 46.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.022 1.815 . . . . 0.0 111.169 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 49.22 22.64 0.68 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.658 1.983 . . . . 0.0 113.902 171.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -94.68 -46.98 6.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.075 1.75 . . . . 0.0 109.146 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.92 155.24 40.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.644 1.577 . . . . 0.0 109.496 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -145.72 171.38 14.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.275 1.03 . . . . 0.0 108.273 158.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -73.13 -7.2 50.29 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -166.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.65 2.9 27.62 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 116.936 -2.036 . . . . 0.0 111.679 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.46 138.88 58.55 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.326 1.563 . . . . 0.0 107.936 -167.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.3 64.22 3.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.973 1.368 . . . . 0.0 109.303 -155.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.52 136.68 23.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.862 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -87.13 174.38 8.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 123.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.421 1.488 . . . . 0.0 109.395 170.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -118.95 152.7 35.87 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.025 0.829 . . . . 0.0 109.477 167.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.92 142.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 108.54 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.93 113.16 15.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -156.5 170.58 22.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 14.19 25.65 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.92 -0.933 . . . . 0.0 115.178 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 5.3 82.92 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.946 1.873 . . . . 0.0 115.03 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.76 -168.01 2.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.572 1.549 . . . . 0.0 108.491 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.6 tp -99.99 125.77 46.07 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 163.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -92.32 141.02 29.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.37 1.468 . . . . 0.0 107.496 167.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -145.01 121.89 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 160.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.7 t -111.39 166.71 10.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.843 0.83 . . . . 0.0 109.09 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.14 133.07 55.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.84 -167.29 15.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 113.1 -165.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -137.37 171.0 15.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.519 1.528 . . . . 0.0 108.242 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.66 -30.18 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 72.24 -64.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.632 1.973 . . . . 0.0 111.531 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -148.35 123.64 10.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.455 2.302 . . . . 0.0 105.701 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.2 152.03 19.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 167.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.44 -47.46 2.34 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.234 0.614 . . . . 0.0 109.851 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -143.58 175.66 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -54.27 -20.95 7.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.29 11.24 4.55 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.86 115.24 13.42 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -163.3 168.42 20.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -173.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.74 178.63 6.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.099 1.76 . . . . 0.0 111.16 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 pt -144.05 145.84 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.979 1.311 . . . . 0.0 109.771 152.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.42 119.92 40.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 171.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.67 138.55 33.27 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.39 164.92 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.963 0.905 . . . . 0.0 109.857 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.55 8.61 63.38 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.408 -1.218 . . . . 0.0 115.426 165.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 62.83 143.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.436 2.295 . . . . 0.0 111.855 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 77' ' ' CYS . 1.4 p -95.85 154.77 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 125.909 1.684 . . . . 0.0 110.182 170.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.445 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -70.07 84.73 0.52 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.899 1.279 . . . . 0.0 110.961 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 m -147.9 41.42 1.01 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.376 1.87 . . . . 0.0 109.423 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 44.87 62.34 2.13 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 128.006 2.522 . . . . 0.0 111.615 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.55 172.51 2.61 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.055 1.342 . . . . 0.0 112.512 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.4 -165.02 18.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.639 1.59 . . . . 0.0 110.447 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 m -137.0 -81.78 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.96 7.99 11.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.276 1.031 . . . . 0.0 111.123 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -60.98 -45.34 95.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.948 -1.095 . . . . 0.0 110.028 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 3.38 16.72 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.181 0.42 . . . . 0.0 113.556 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.225 -1.75 . . . . 0.0 110.116 166.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.85 -46.29 2.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.363 1.065 . . . . 0.0 111.3 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.4 155.69 22.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.721 1.609 . . . . 0.0 107.575 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -144.35 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.602 ' C ' HD12 ' A' ' 16' ' ' LEU . 9.3 tt0 -60.8 -15.17 27.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.253 1.821 . . . . 0.0 115.524 -170.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 15' ' ' GLN . 7.2 mp -130.84 1.35 4.35 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 110.29 -173.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.98 165.8 23.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 155.68 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.32 144.69 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 106.374 -167.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -63.79 166.65 6.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.969 0.508 . . . . 0.0 110.058 160.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.3 mt -142.0 49.27 1.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.76 1.624 . . . . 0.0 109.563 -170.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -58.6 103.31 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 121.024 1.738 . . . . 0.0 109.003 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 HG12 ' A' ' 66' ' ' VAL . 82.4 t -95.66 119.32 43.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 121.633 2.015 . . . . 0.0 106.296 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.58 118.78 6.48 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.9 87.77 2.87 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.62 65.07 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.441 -0.787 . . . . 0.0 113.311 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -95.12 -11.12 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.224 1.009 . . . . 0.0 112.913 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.89 -48.41 1.13 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.715 0.689 . . . . 0.0 111.252 -164.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.47 -112.89 0.54 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.684 1.612 . . . . 0.0 113.893 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.27 166.3 25.11 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 160.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -141.65 109.15 5.61 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.9 -1.125 . . . . 0.0 108.209 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -125.24 95.41 4.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -154.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 -167.45 14.46 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.646 1.117 . . . . 0.0 112.163 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.82 145.38 51.97 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.961 0.904 . . . . 0.0 108.596 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.68 145.9 31.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 167.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.1 32.52 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 165.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.43 158.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.034 1.734 . . . . 0.0 107.521 166.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -131.4 -30.75 1.67 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 112.372 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.7 m -145.55 130.72 18.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.264 1.826 . . . . 0.0 106.532 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 tp -131.71 123.18 27.19 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.397 1.479 . . . . 0.0 107.715 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.72 84.74 2.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 -122.06 17.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.68 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.3 p -68.27 -12.42 60.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 117.627 0.714 . . . . 0.0 112.657 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 tp -106.29 139.06 41.39 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 110.36 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.18 168.05 16.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 164.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -133.58 138.51 46.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.775 2.03 . . . . 0.0 109.302 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.95 162.87 25.76 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.734 1.614 . . . . 0.0 110.938 -160.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.41 24.23 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.4 mt 53.14 -171.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.956 0.902 . . . . 0.0 111.936 -168.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.0 -12.24 5.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.462 1.105 . . . . 0.0 113.241 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 179.18 179.51 48.73 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 120.967 -1.083 . . . . 0.0 111.167 -164.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.84 -9.09 57.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.445 1.098 . . . . 0.0 113.026 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.49 94.86 2.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.79 1.177 . . . . 0.0 108.247 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -129.05 154.97 80.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.923 2.089 . . . . 0.0 108.054 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.85 171.08 17.26 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.407 2.738 . . . . 0.0 112.899 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.63 156.43 52.79 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.149 1.9 . . . . 0.0 111.15 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -66.51 170.97 11.34 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.265 2.644 . . . . 0.0 109.783 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 p30 53.95 1.29 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 m -101.03 -48.0 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.694 0.679 . . . . 0.0 110.404 -163.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.23 144.67 56.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -141.51 163.63 32.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.396 0.678 . . . . 0.0 110.395 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 62.9 mt-10 -73.36 -5.96 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.799 1.239 . . . . 0.0 113.691 -167.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.98 28.83 2.79 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.33 136.14 57.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 167.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.48 125.89 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 165.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG12 HG22 ' A' ' 23' ' ' VAL . 20.7 m -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 t -124.22 135.39 53.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.645 1.212 . . . . 0.0 108.977 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.43 156.62 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 112.385 -2.189 . . . . 0.0 106.709 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.59 ' HB2' HD21 ' A' ' 76' ' ' LEU . 21.2 p -151.01 133.51 15.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.551 164.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -137.87 146.13 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.501 1.12 . . . . 0.0 109.201 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -96.37 132.58 41.73 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -141.14 95.62 2.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 43.78 42.43 6.22 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 118.853 2.301 . . . . 0.0 118.853 159.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.73 -40.54 0.2 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 121.01 2.405 . . . . 0.0 112.341 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.0 -178.18 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.105 0.955 . . . . 0.0 109.327 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.01 113.17 22.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 55.5 m -89.44 108.33 19.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -121.8 158.2 29.38 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.63 136.86 22.37 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.11 158.6 32.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 -179.56 39.1 Favored Glycine 0 N--CA 1.443 -0.871 0 O-C-N 121.131 -0.98 . . . . 0.0 112.118 -171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -127.19 162.13 26.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -32.13 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.603 0.761 . . . . 0.0 110.415 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.26 -66.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.29 2.236 . . . . 0.0 113.42 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.9 m -152.13 95.89 2.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.092 1.315 . . . . 0.0 108.232 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 1.7 tp -70.06 162.13 28.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -132.87 -41.8 0.92 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.347 -0.845 . . . . 0.0 109.681 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -148.81 172.9 13.9 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -61.12 -6.0 1.77 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.809 2.043 . . . . 0.0 112.465 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -139.66 -11.53 1.17 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.559 2.344 . . . . 0.0 114.606 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -123.71 125.31 44.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -167.11 158.65 12.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.84 176.01 9.97 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.405 1.482 . . . . 0.0 110.849 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.67 150.21 13.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.97 113.8 18.29 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.842 1.257 . . . . 0.0 108.473 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.8 133.0 45.24 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.288 1.835 . . . . 0.0 108.749 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.07 158.38 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.103 1.361 . . . . 0.0 110.327 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.78 80.17 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 119.215 -0.769 . . . . 0.0 112.417 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 59.38 166.78 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.103 2.561 . . . . 0.0 114.009 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -104.39 113.76 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 161.48 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.992 0.917 . . . . 0.0 110.446 169.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.04 76.5 5.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.164 2.186 . . . . 0.0 108.933 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.512 HD13 ' HG3' ' A' ' 78' ' ' ARG . 8.0 mp -71.0 -44.1 66.6 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.775 -1.203 . . . . 0.0 112.34 -169.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -121.3 161.35 22.17 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.357 1.863 . . . . 0.0 106.845 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.0 45.26 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 111.579 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 44.29 69.72 0.39 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.718 1.607 . . . . 0.0 110.402 169.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.18 83.37 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.526 1.53 . . . . 0.0 110.096 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -128.6 108.84 10.84 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 127.776 2.43 . . . . 0.0 104.728 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 C--O 1.254 1.311 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 161.187 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.4 ttp -131.62 13.46 4.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.078 1.351 . . . . 0.0 109.9 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -52.16 110.19 0.46 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 165.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.0 121.83 30.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 153.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.34 163.18 16.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.323 1.049 . . . . 0.0 109.314 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.08 68.23 0.7 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.413 1.006 . . . . 0.0 111.187 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.3 t -155.79 -15.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -6.66 10.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.814 1.643 . . . . 0.0 112.034 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -55.41 -36.8 66.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.922 -1.111 . . . . 0.0 111.099 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.23 -14.45 76.73 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.255 -0.747 . . . . 0.0 113.108 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -75.12 -12.16 60.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.345 1.572 . . . . 0.0 110.744 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.422 ' HA ' HG21 ' A' ' 72' ' ' THR . 3.2 m-85 -118.72 -45.82 2.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.301 1.44 . . . . 0.0 110.439 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -95.7 116.39 28.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.491 1.116 . . . . 0.0 109.621 171.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 167.63 16.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 109.529 166.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.33 -18.45 55.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.558 0.743 . . . . 0.0 112.941 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.0 mt -127.28 14.09 7.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.088 1.355 . . . . 0.0 109.983 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -69.79 171.81 8.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.721 0.809 . . . . 0.0 109.827 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -108.76 149.74 28.6 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.44 157.51 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.658 1.183 . . . . 0.0 111.381 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -72.88 158.41 35.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.549 1.14 . . . . 0.0 112.048 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -131.24 60.94 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.001 1.72 . . . . 0.0 109.391 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m -78.73 110.11 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.931 -1.105 . . . . 0.0 108.424 174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.52 133.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.345 1.458 . . . . 0.0 108.375 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 147.85 46.19 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.06 1.3 . . . . 0.0 110.217 173.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.2 mt -132.15 77.9 1.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.058 1.743 . . . . 0.0 108.038 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.3 30.6 69.23 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.116 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t70 74.99 -55.21 0.65 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.433 2.293 . . . . 0.0 112.578 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.0 p -71.28 -4.08 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 113.003 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.77 164.56 29.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.4 m -144.43 165.11 28.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 107.754 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -95.36 157.18 16.01 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 163.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.27 125.15 15.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 163.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.77 -171.8 14.16 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 166.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -116.9 162.89 17.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.53 157.1 46.39 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.491 156.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.92 140.97 40.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 157.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.95 158.2 5.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.3 p -136.92 -28.74 0.94 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 m -154.57 124.02 6.49 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tt -143.98 129.76 19.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.651 1.114 . . . . 0.0 110.251 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -144.22 104.26 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.94 -131.29 44.33 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.196 0.903 . . . . 0.0 112.205 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.39 37.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.754 1.222 . . . . 0.0 112.111 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.14 117.36 9.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.784 1.234 . . . . 0.0 107.937 162.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.4 155.82 20.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 156.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -118.93 147.77 43.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.608 1.963 . . . . 0.0 108.778 164.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.67 166.5 13.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 110.478 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.3 65.41 1.25 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.537 0.735 . . . . 0.0 110.089 162.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt 45.3 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.329 3.051 . . . . 0.0 116.081 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -110.35 179.47 4.08 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.929 0.892 . . . . 0.0 111.186 159.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.21 -12.57 26.95 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -159.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.19 -32.87 11.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 110.487 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.31 171.78 13.58 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.409 0.684 . . . . 0.0 111.24 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -164.62 155.58 13.1 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.938 2.095 . . . . 0.0 108.534 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.41 169.92 16.01 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.405 2.07 . . . . 0.0 110.564 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.58 154.8 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.951 1.101 . . . . 0.0 110.586 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -63.42 168.54 11.11 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.086 1.857 . . . . 0.0 108.935 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.77 5.96 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.2 m -108.48 -47.04 3.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.958 1.303 . . . . 0.0 110.844 -163.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -64.85 138.2 58.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.958 0.903 . . . . 0.0 109.182 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -137.1 158.98 43.22 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -74.14 -8.61 56.77 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -164.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.13 22.52 4.23 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 126.235 1.874 . . . . 0.0 109.422 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 125.72 24.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.02 135.88 54.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 164.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.51 163.59 35.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.849 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.78 153.43 39.54 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 160.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.51 145.33 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 p -147.7 146.32 29.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.78 143.55 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.066 0.946 . . . . 0.0 110.272 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.499 ' CH2' ' HG3' ' A' ' 106' ' ' ARG . 98.4 m95 -81.57 74.74 8.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.561 1.945 . . . . 0.0 111.365 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 12' ' ' TYR 0.254 3.4 t -97.65 100.87 12.27 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.388 -0.82 . . . . 0.0 109.435 -170.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.52 33.98 3.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.514 2.483 . . . . 0.0 116.392 161.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.26 -65.97 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -167.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -171.18 -164.57 0.36 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.175 2.19 . . . . 0.0 107.822 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -76.95 94.32 3.93 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 134.9 54.76 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 155.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.13 161.23 36.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.8 t -157.46 175.71 13.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -114.71 156.38 24.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -164.8 178.3 40.0 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 120.455 -1.403 . . . . 0.0 111.697 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.817 HH11 HG21 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -128.78 159.04 36.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 166.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -58.7 -30.89 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.005 0.522 . . . . 0.0 111.984 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 65.69 -61.57 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.479 2.312 . . . . 0.0 111.161 -171.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -147.11 126.98 13.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.242 2.217 . . . . 0.0 105.658 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.55 157.11 16.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.4 ttm-85 -124.8 -44.43 1.95 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.869 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.37 176.38 11.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.8 -1.6 0.92 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.799 0.84 . . . . 0.0 112.325 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -130.78 -13.9 3.63 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.564 1.546 . . . . 0.0 113.579 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.64 136.74 46.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 108.6 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -175.45 166.02 3.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.366 1.066 . . . . 0.0 109.696 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.37 177.62 5.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.053 1.341 . . . . 0.0 110.671 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.07 127.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.149 1.379 . . . . 0.0 108.782 157.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -74.13 137.89 43.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 156.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -99.05 136.75 38.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.817 HG21 HH11 ' A' ' 82' ' ' ARG . 16.8 m -135.48 138.04 48.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.946 0.879 . . . . 0.0 111.93 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -107.47 3.06 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.17 142.53 7.26 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 126.155 1.782 . . . . 0.0 106.315 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.04 134.67 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -150.81 156.97 42.33 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.161 0.892 . . . . 0.0 110.592 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.32 136.65 52.11 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 166.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.67 -13.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.701 -1.142 . . . . 0.0 112.46 162.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -133.28 143.95 49.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.809 1.64 . . . . 0.0 110.095 -161.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -137.81 155.42 49.03 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.499 ' HG3' ' CH2' ' A' ' 71' ' ' TRP . 37.1 mtp180 -79.39 129.35 34.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.423 1.489 . . . . 0.0 109.065 -173.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -81.29 31.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.193 0.997 . . . . 0.0 112.141 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.03 20.58 3.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.193 1.397 . . . . 0.0 112.843 -168.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 128.092 2.557 . . . . 0.0 114.473 -173.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.9 mtp 53.67 -168.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.266 1.027 . . . . 0.0 109.822 -160.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m 66.43 -84.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.089 1.756 . . . . 0.0 112.878 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.9 -42.53 0.37 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 130.263 3.425 . . . . 0.0 114.495 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.13 -168.73 2.27 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 127.285 2.234 . . . . 0.0 108.84 173.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.46 -96.92 0.11 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 57.87 -176.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.431 1.115 . . . . 0.0 110.456 -168.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.26 0.27 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.046 2.139 . . . . 0.0 113.397 -169.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -64.77 -39.25 93.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.246 -1.534 . . . . 0.0 109.539 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.67 -0.98 74.68 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.962 -169.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -85.85 -17.06 36.68 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.203 1.001 . . . . 0.0 111.038 163.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -105.91 -53.51 2.63 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.029 0.931 . . . . 0.0 110.442 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.44 155.72 22.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.98 153.63 43.2 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -63.03 -18.03 62.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -165.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.55 8.52 5.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.73 1.612 . . . . 0.0 110.223 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -73.87 169.39 17.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.796 -1.19 . . . . 0.0 108.905 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.81 17.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.689 170.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.29 165.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.515 1.126 . . . . 0.0 109.846 164.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.55 177.75 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.883 2.473 . . . . 0.0 112.266 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 23' ' ' VAL . 61.3 mt -138.21 22.56 2.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.818 1.644 . . . . 0.0 115.113 -174.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -62.8 106.74 0.85 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.957 1.708 . . . . 0.0 110.572 -167.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 66' ' ' VAL . 67.9 t -99.12 139.77 20.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.639 1.575 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -74.51 121.17 21.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 161.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.7 84.45 1.93 Allowed 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.09 134.04 27.94 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 63.92 -5.96 0.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.61 2.764 . . . . 0.0 116.304 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 -33.41 4.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.596 -176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.96 126.84 5.86 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 125.352 1.453 . . . . 0.0 111.902 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.31 161.34 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 111.831 -160.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -130.41 139.29 50.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.09 147.75 50.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.615 0.722 . . . . 0.0 110.271 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.75 -162.81 15.27 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -131.79 162.79 29.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.21 161.67 41.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 156.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 140.19 41.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 156.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.2 mt -69.25 158.61 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 161.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.6 p -131.96 -31.28 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.444 1.898 . . . . 0.0 111.96 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.14 145.17 31.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 tp -161.81 101.62 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -121.49 78.67 1.46 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.755 1.622 . . . . 0.0 106.875 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.04 -117.85 10.37 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 14.1 p -64.82 -0.48 1.5 Allowed 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 115.817 -2.039 . . . . 0.0 113.914 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -127.04 137.47 53.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.95 1.25 . . . . 0.0 108.193 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.59 166.6 23.9 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.048 0.939 . . . . 0.0 108.527 168.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -129.49 149.44 51.26 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.784 1.634 . . . . 0.0 108.402 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.77 171.37 8.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.573 1.949 . . . . 0.0 110.94 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.66 58.5 1.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.477 1.132 . . . . 0.0 111.229 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 mt 47.72 -169.87 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.663 1.985 . . . . 0.0 114.407 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 -18.61 3.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.72 126.3 3.68 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.152 0.882 . . . . 0.0 111.565 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 69.36 -50.76 0.61 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 130.215 3.406 . . . . 0.0 114.413 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.84 98.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.042 1.337 . . . . 0.0 107.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -129.6 152.38 79.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.516 0.727 . . . . 0.0 111.548 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.61 164.84 34.38 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.402 2.735 . . . . 0.0 112.586 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.83 160.76 35.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.866 1.711 . . . . 0.0 111.587 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.98 159.58 24.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.568 2.179 . . . . 0.0 112.313 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 44.79 32.69 0.84 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.873 2.069 . . . . 0.0 112.213 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 m -111.64 -56.72 2.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.363 1.065 . . . . 0.0 108.155 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.47 127.52 30.05 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -127.65 159.68 33.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.61 -3.92 17.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.35 19.1 4.34 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.772 2.129 . . . . 0.0 110.881 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.97 131.09 49.55 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.33 123.42 25.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.642 HG12 HG22 ' A' ' 23' ' ' VAL . 34.9 m -134.42 163.8 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.274 -176.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.39 131.08 43.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.02 0.928 . . . . 0.0 108.852 -173.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.48 139.82 19.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -140.91 156.83 46.01 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.085 0.857 . . . . 0.0 110.283 159.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 p -160.86 149.13 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.197 1.799 . . . . 0.0 107.166 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.403 ' CE2' HD13 ' A' ' 76' ' ' LEU . 92.6 m95 -88.1 120.82 29.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 t -151.07 119.48 6.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.66 -162.44 47.85 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -159.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.27 2.08 22.48 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.867 1.223 . . . . 0.0 114.662 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.33 172.82 12.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.958 1.379 . . . . 0.0 110.767 -174.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.403 HD13 ' CE2' ' A' ' 71' ' ' TRP . 23.5 tp -73.9 168.74 18.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.11 153.03 49.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 154.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.27 155.63 50.31 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HB2' HG22 ' A' ' 100' ' ' VAL . 17.6 t -144.86 156.52 44.05 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 155.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -99.21 150.19 22.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.83 41.59 Favored Glycine 0 CA--C 1.523 0.593 0 O-C-N 120.958 -1.088 . . . . 0.0 110.911 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -128.02 169.15 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.648 0.779 . . . . 0.0 109.005 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.18 -35.35 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.131 0.973 . . . . 0.0 112.837 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 65.92 -54.14 0.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.764 2.426 . . . . 0.0 113.707 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -150.27 139.39 21.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.745 1.218 . . . . 0.0 108.264 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -115.77 152.29 33.55 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.52 -52.96 0.72 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.532 -169.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.54 174.93 7.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 159.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -55.5 -30.85 61.41 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.041 1.337 . . . . 0.0 111.821 166.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -104.27 -11.66 17.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -132.24 124.02 28.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 120.535 1.516 . . . . 0.0 108.596 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -162.4 166.29 25.27 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.536 1.148 . . . . 0.0 110.45 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.84 179.78 5.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.753 1.221 . . . . 0.0 110.209 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.71 133.7 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.435 1.494 . . . . 0.0 108.677 164.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -108.39 111.72 23.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.379 1.472 . . . . 0.0 107.674 174.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.5 mt -71.94 144.71 48.83 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.241 1.417 . . . . 0.0 107.563 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.59 153.65 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.557 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.32 -106.96 0.65 Allowed Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 125.721 1.629 . . . . 0.0 109.077 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.59 168.98 23.84 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.4 1.48 . . . . 0.0 110.825 -167.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 79' ' ' CYS . 78.8 t -93.47 156.27 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.018 0.927 . . . . 0.0 109.749 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.92 162.33 35.75 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.752 1.221 . . . . 0.0 110.296 150.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.46 143.37 57.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 151.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.38 -6.03 5.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.252 175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -152.93 153.67 33.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.029 2.132 . . . . 0.0 107.398 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.38 161.74 31.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.285 1.402 . . . . 0.0 110.954 171.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -108.64 0.11 20.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.172 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -77.06 48.75 0.62 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.469 1.108 . . . . 0.0 112.099 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -127.49 18.26 6.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.128 2.571 . . . . 0.0 111.445 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 C-N-CA 127.254 2.222 . . . . 0.0 111.019 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.408 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.86 32.67 17.95 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.331 1.065 . . . . 0.0 111.699 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m 66.32 118.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.093 2.157 . . . . 0.0 110.827 -169.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.58 173.39 11.99 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.94 0.876 . . . . 0.0 110.589 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 58.55 171.51 0.06 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.396 2.278 . . . . 0.0 110.784 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.16 -84.39 0.19 Allowed Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m 174.99 -71.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.657 2.783 . . . . 0.0 104.185 159.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.89 -1.42 4.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 126.484 1.914 . . . . 0.0 110.156 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -54.59 -39.99 68.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.092 1.315 . . . . 0.0 111.606 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.18 -6.06 55.92 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.478 1.037 . . . . 0.0 112.717 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.45 -16.89 55.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.16 -1.2 . . . . 0.0 111.373 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.78 -27.8 5.74 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.723 1.209 . . . . 0.0 110.422 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.83 144.25 50.73 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.445 1.117 . . . . 0.0 111.992 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.62 156.01 49.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.597 -173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.469 ' HG2' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -62.13 -17.31 57.46 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -174.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 15' ' ' GLN . 5.9 mp -124.49 13.41 8.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 118.884 0.765 . . . . 0.0 109.416 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.73 167.68 21.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.163 0.585 . . . . 0.0 109.575 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.64 147.77 32.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.859 0.864 . . . . 0.0 108.981 170.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -141.5 165.93 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.767 0.827 . . . . 0.0 111.099 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.23 165.55 24.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.043 1.737 . . . . 0.0 112.231 165.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -138.34 19.67 2.75 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.13 116.94 1.7 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.238 -161.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.5 116.05 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -64.21 133.61 53.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.657 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.2 mt -128.68 82.8 2.11 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.818 1.647 . . . . 0.0 107.031 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.14 37.66 94.87 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 122.077 -0.39 . . . . 0.0 113.887 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.91 10.46 3.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.16 2.184 . . . . 0.0 113.514 158.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -154.3 -35.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.475 1.11 . . . . 0.0 110.047 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.78 2.72 31.0 Favored Glycine 0 C--O 1.22 -0.719 0 O-C-N 121.077 -1.014 . . . . 0.0 115.434 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -54.36 135.97 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.951 -161.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.6 150.22 26.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.97 125.52 15.79 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 126.583 1.953 . . . . 0.0 106.003 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.97 -174.82 23.03 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -118.57 159.21 23.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.75 156.5 40.42 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 118.581 0.628 . . . . 0.0 110.986 161.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.12 130.78 35.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 125.177 1.548 . . . . 0.0 108.008 160.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.89 159.79 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 158.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -132.4 -36.76 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.244 1.418 . . . . 0.0 110.932 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 m -145.77 138.27 25.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.743 1.217 . . . . 0.0 107.735 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.26 124.71 15.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.525 0.73 . . . . 0.0 109.145 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -135.8 81.01 1.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.115 1.366 . . . . 0.0 108.057 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.63 -118.61 5.07 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 166.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p -64.71 -3.79 3.6 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 126.426 1.89 . . . . 0.0 113.019 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.04 134.86 53.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.739 1.215 . . . . 0.0 110.816 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.45 163.56 29.41 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.139 1.375 . . . . 0.0 110.404 167.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -128.19 118.75 23.9 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.852 1.661 . . . . 0.0 110.127 170.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -87.32 165.18 15.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.858 1.663 . . . . 0.0 112.086 167.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.69 35.82 2.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.147 1.779 . . . . 0.0 111.529 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 mt 52.04 -169.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.476 1.91 . . . . 0.0 113.383 -169.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.45 123.17 35.42 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.94 -156.81 52.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 173.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.94 -0.5 57.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.141 0.977 . . . . 0.0 112.616 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -75.74 130.22 38.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.224 0.92 . . . . 0.0 108.761 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -151.65 157.68 34.51 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 124.078 0.951 . . . . 0.0 110.415 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 173.48 9.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.846 2.364 . . . . 0.0 111.03 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.63 154.5 48.27 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.121 1.214 . . . . 0.0 110.027 162.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.31 174.45 11.48 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.151 2.567 . . . . 0.0 109.514 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.88 38.16 2.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 113.695 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -132.14 -52.31 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.323 1.449 . . . . 0.0 109.558 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.03 149.1 33.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 110.837 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 155.54 46.59 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.276 0.63 . . . . 0.0 110.879 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.8 -2.61 30.72 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.34 20.99 2.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 126.122 1.82 . . . . 0.0 109.664 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.49 25.93 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.06 130.55 41.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.65 138.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.444 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -109.5 130.63 55.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.514 0.726 . . . . 0.0 109.415 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.25 146.14 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.1 p -146.05 159.77 42.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 110.228 160.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.6 p -164.89 151.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.613 1.565 . . . . 0.0 107.841 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -79.0 108.21 12.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 166.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -144.13 152.57 41.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.62 4.58 7.12 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.644 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.87 2.08 42.57 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.821 1.81 . . . . 0.0 114.16 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.76 166.51 26.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.638 1.719 . . . . 0.0 109.836 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.54 95.01 6.99 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 155.09 39.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 170.68 18.1 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.594 172.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 t -159.93 163.35 34.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -101.98 143.6 31.63 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 108.924 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.29 24.19 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.475 1.512 . . . . 0.0 111.933 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.78 174.4 11.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.417 1.087 . . . . 0.0 111.73 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.67 -43.24 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.462 1.105 . . . . 0.0 113.659 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.45 -45.6 0.31 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.377 2.671 . . . . 0.0 114.195 -166.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.0 m -154.63 136.02 14.14 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.668 1.587 . . . . 0.0 107.772 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -116.51 161.19 19.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 108.262 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -143.39 -30.43 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.336 -0.852 . . . . 0.0 111.972 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -149.93 179.86 7.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.904 2.082 . . . . 0.0 105.824 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.7 -8.71 29.72 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.675 -0.641 . . . . 0.0 111.528 162.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -131.57 -11.92 3.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -128.55 128.2 43.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -166.47 167.33 15.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.88 172.9 7.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.994 0.918 . . . . 0.0 109.527 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 pt -141.79 138.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 108.45 160.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -107.3 111.19 23.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 128.433 2.693 . . . . 0.0 104.819 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.17 149.28 37.32 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.246 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.74 165.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.421 1.488 . . . . 0.0 108.973 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.99 -113.55 5.74 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 126.843 2.164 . . . . 0.0 109.907 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.79 137.18 2.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.589 0.756 . . . . 0.0 112.101 -160.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.97 152.97 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.673 1.189 . . . . 0.0 109.42 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -160.89 163.74 31.75 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.792 -1.192 . . . . 0.0 109.294 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.15 124.25 26.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 -12.2 3.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 169.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -140.77 162.78 34.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.084 1.353 . . . . 0.0 109.609 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 179.55 166.29 1.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.638 1.975 . . . . 0.0 110.644 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -73.73 129.47 38.0 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -158.48 92.97 1.17 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.338 0.1 OUTLIER -136.88 34.33 2.63 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.115 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.658 -171.805 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 119.028 -0.873 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.0 tpt -69.38 -33.53 73.18 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.322 1.061 . . . . 0.0 108.986 160.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -133.71 173.93 10.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.192 2.597 . . . . 0.0 108.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 75.14 -179.1 0.17 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.306 2.642 . . . . 0.0 112.358 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.24 166.78 17.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.18 1.392 . . . . 0.0 111.267 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.84 170.32 29.95 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-O 122.485 1.047 . . . . 0.0 113.484 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -154.63 3.69 0.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.099 1.759 . . . . 0.0 110.78 -168.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.73 -5.96 48.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.48 -1.387 . . . . 0.0 111.476 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.05 -33.07 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.894 -1.129 . . . . 0.0 111.097 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 2.41 53.34 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.182 0.896 . . . . 0.0 113.695 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.445 ' HG3' HH11 ' A' ' 11' ' ' ARG . 35.8 mtt85 -81.85 -16.33 51.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.178 1.489 . . . . 0.0 111.256 163.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.63 -37.23 2.92 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.056 1.342 . . . . 0.0 112.506 -172.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.04 159.56 14.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.247 1.019 . . . . 0.0 108.302 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -156.3 161.15 40.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.51 -21.88 66.17 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -163.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.2 mt -122.03 14.28 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 109.466 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.457 HE21 HG21 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -73.53 -174.0 1.58 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.528 0.517 . . . . 0.0 110.755 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -122.69 159.26 28.32 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 125.09 1.356 . . . . 0.0 109.898 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 m -146.28 155.32 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.557 1.143 . . . . 0.0 110.19 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.07 166.68 15.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.159 1.784 . . . . 0.0 110.853 157.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.2 6.23 2.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -158.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 m -49.95 105.44 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 127.327 2.251 . . . . 0.0 112.849 -155.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG22 HG12 ' A' ' 66' ' ' VAL . 25.9 t -89.99 132.01 35.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -77.99 120.61 23.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.76 68.65 0.85 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.329 1.052 . . . . 0.0 109.587 170.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 -167.35 50.51 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 122.099 0.833 . . . . 0.0 111.333 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -77.89 -13.01 60.03 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.14 1.376 . . . . 0.0 111.798 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -133.12 11.32 4.22 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.137 1.375 . . . . 0.0 113.772 -166.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.35 162.9 31.74 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.992 1.269 . . . . 0.0 112.045 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.53 170.76 20.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.0 0.905 . . . . 0.0 111.684 170.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -131.46 146.53 52.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.697 2.399 . . . . 0.0 104.773 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.64 159.37 42.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 118.832 0.742 . . . . 0.0 109.634 165.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.25 -166.73 30.5 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 155.43 32.49 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.38 159.12 42.86 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 163.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.1 145.51 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.89 153.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.002 1.721 . . . . 0.0 107.332 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.7 p -128.98 -18.21 3.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.543 1.137 . . . . 0.0 112.336 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 m -164.53 157.85 17.55 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.44 1.896 . . . . 0.0 109.123 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.16 135.31 33.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.529 1.131 . . . . 0.0 109.482 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 67.8 1.35 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 0.0 112.05 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 -81.47 1.73 Allowed Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.199 -0.938 . . . . 0.0 113.388 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -114.64 45.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.836 1.254 . . . . 0.0 109.115 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -159.21 132.53 7.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.421 1.088 . . . . 0.0 108.169 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.4 154.63 51.41 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 168.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -114.83 149.23 37.39 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.241 1.016 . . . . 0.0 109.154 169.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.7 mt -137.61 165.14 27.07 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.433 1.493 . . . . 0.0 109.771 -169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -143.42 16.33 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 54.71 161.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.324 1.85 . . . . 0.0 113.183 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -61.01 2.1 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.27 -176.31 28.07 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.92 -61.82 0.0 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 131.096 3.759 . . . . 0.0 114.63 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.73 155.71 35.25 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 165.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -165.72 161.63 13.36 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 127.23 2.212 . . . . 0.0 108.342 158.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.46 169.17 17.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.376 2.051 . . . . 0.0 110.997 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.64 159.84 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 120.817 1.011 . . . . 0.0 110.278 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.39 159.53 49.83 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.034 1.823 . . . . 0.0 109.946 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 50.47 30.67 4.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.106 1.362 . . . . 0.0 111.652 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -131.66 -2.23 3.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.335 1.054 . . . . 0.0 111.577 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.752 ' HB3' HD21 ' A' ' 86' ' ' LEU . 9.3 mt -104.16 144.86 31.02 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.564 -1.335 . . . . 0.0 108.595 159.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -154.64 161.1 41.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.979 0.8 . . . . 0.0 110.307 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -67.63 -0.39 3.9 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.14 15.78 3.96 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 126.601 2.048 . . . . 0.0 110.842 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.43 125.57 26.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.51 135.95 38.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 165.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG12 HG22 ' A' ' 23' ' ' VAL . 17.9 m -142.51 141.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 108.278 -174.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 m -95.11 166.9 11.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 0.0 109.583 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 145.3 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.244 1.018 . . . . 0.0 108.584 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -144.95 153.26 41.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 109.009 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.457 HG21 HE21 ' A' ' 17' ' ' GLN . 8.9 p -157.59 151.99 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.076 1.35 . . . . 0.0 107.645 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -91.22 115.51 28.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 t -151.24 171.82 16.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 169.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.66 19.13 54.15 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.858 -1.151 . . . . 0.0 113.417 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.08 -9.98 29.56 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 118.818 1.309 . . . . 0.0 113.494 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.85 -177.44 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.503 1.921 . . . . 0.0 110.957 -171.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.1 tp -105.9 101.37 10.87 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.871 1.268 . . . . 0.0 109.381 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 80.5 m -75.99 136.36 40.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -148.49 162.53 39.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.248 167.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.7 t -155.49 -174.47 4.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.775 0.83 . . . . 0.0 111.269 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -133.57 133.79 42.51 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 129.064 2.945 . . . . 0.0 105.505 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.32 -171.21 25.92 Favored Glycine 0 N--CA 1.463 0.454 0 O-C-N 120.441 -1.412 . . . . 0.0 112.557 -170.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.69 175.37 9.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 0.0 109.439 174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.69 -40.8 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 64.93 -47.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.375 2.27 . . . . 0.0 114.479 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.5 m -148.92 101.36 3.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.075 1.75 . . . . 0.0 107.72 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -73.34 173.61 9.29 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 120.588 -1.32 . . . . 0.0 109.573 174.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' N ' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -138.2 -51.97 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 150.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -142.16 176.65 8.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.44 -15.74 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 112.649 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -118.41 -21.05 8.22 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.937 1.695 . . . . 0.0 113.462 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -130.35 132.63 45.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 120.615 1.552 . . . . 0.0 108.949 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.573 ' HB3' HD22 ' A' ' 86' ' ' LEU . 9.8 p90 -171.2 170.2 6.14 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.575 0.547 . . . . 0.0 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.81 167.98 13.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.778 2.031 . . . . 0.0 110.431 164.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.96 141.16 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.048 1.339 . . . . 0.0 108.501 159.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 140.4 29.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.623 1.569 . . . . 0.0 107.955 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.83 142.65 28.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 164.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.07 164.33 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.028 0.531 . . . . 0.0 110.12 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.68 -109.18 2.76 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.352 1.453 . . . . 0.0 109.898 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.52 142.49 15.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.194 1.798 . . . . 0.0 108.655 -169.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.23 139.47 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 169.3 17.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.372 0.533 . . . . 0.0 110.483 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -80.53 100.25 8.48 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.598 1.959 . . . . 0.0 107.429 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.49 -26.15 57.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.984 0.811 . . . . 0.0 112.29 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -145.52 158.49 43.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.175 1.39 . . . . 0.0 108.935 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -131.99 128.74 39.03 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.166 1.786 . . . . 0.0 107.482 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -66.8 157.7 32.26 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 156.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.21 70.72 0.76 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 163.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 56.63 11.05 0.8 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 127.382 2.273 . . . . 0.0 111.953 178.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.36 2.04 2.57 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -113.24 157.7 21.41 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.429 1.468 . . . . 0.0 108.546 170.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.92 165.76 26.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 0.0 107.534 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.0 146.27 26.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.23 -129.94 43.72 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m 174.66 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 128.662 2.785 . . . . 0.0 107.307 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -131.45 -7.64 3.72 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.922 0.889 . . . . 0.0 111.059 -167.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -61.67 -36.59 81.28 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.332 -0.855 . . . . 0.0 110.657 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -10.65 67.33 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.33 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -74.36 -21.13 59.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.514 1.657 . . . . 0.0 110.428 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.563 ' HA ' HG21 ' A' ' 72' ' ' THR . 7.8 m-85 -115.43 -39.2 3.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.388 -169.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HE1' HG23 ' A' ' 70' ' ' VAL . 11.3 m-85 -105.43 131.19 53.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.405 1.882 . . . . 0.0 108.132 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.51 165.55 18.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -79.84 -8.45 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -152.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.4 mt -127.74 -0.59 6.07 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.627 2.371 . . . . 0.0 108.173 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.4 145.67 41.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.354 0.0 OUTLIER -108.19 113.76 27.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -173.241 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 HG22 ' A' ' 70' ' ' VAL . 25.7 m -102.04 172.86 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.574 2.75 . . . . 0.0 107.333 -171.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.48 163.39 15.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.405 1.882 . . . . 0.0 112.422 173.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 mt -134.98 51.4 2.1 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.492 1.517 . . . . 0.0 113.693 -167.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.1 m -67.44 120.56 14.11 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.886 -1.759 . . . . 0.0 108.109 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 t -118.73 129.71 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.868 1.267 . . . . 0.0 108.276 167.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -70.37 127.59 33.28 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.349 -0.844 . . . . 0.0 109.622 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.85 62.65 0.61 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.833 1.653 . . . . 0.0 108.606 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.36 -170.04 54.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -75.38 -25.28 57.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 p -131.11 42.05 3.27 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.463 0.649 . . . . 0.0 109.923 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.72 169.05 42.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 163.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -173.27 162.36 4.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.107 0.956 . . . . 0.0 110.535 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -97.09 142.72 28.68 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 166.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.8 150.15 51.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 165.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.2 -165.52 30.23 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.282 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.93 147.9 51.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.943 1.297 . . . . 0.0 107.687 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.53 34.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 162.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.23 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.15 161.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 162.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -142.05 -13.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.068 0.937 . . . . 0.0 112.608 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 m -156.58 151.15 25.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.16 138.74 31.79 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.364 1.078 . . . . 0.0 109.563 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.83 79.53 1.74 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.762 2.025 . . . . 0.0 106.015 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.35 -106.34 0.35 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.327 1.441 . . . . 0.0 113.49 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.79 9.85 0.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.892 1.677 . . . . 0.0 114.389 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -132.1 129.25 39.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.128 0.877 . . . . 0.0 109.781 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.83 159.2 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 155.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -117.66 147.39 42.95 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.808 1.243 . . . . 0.0 108.145 160.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.74 169.5 9.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.623 1.969 . . . . 0.0 111.284 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -142.43 21.91 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 57.93 -178.06 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 0.0 114.854 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.9 174.68 10.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.64 2.376 . . . . 0.0 108.261 164.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.42 0.61 39.16 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 154.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.86 -32.12 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.583 2.753 . . . . 0.0 115.479 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -58.66 158.71 7.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.074 1.75 . . . . 0.0 110.622 166.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -155.0 163.1 25.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.523 0.602 . . . . 0.0 110.267 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -67.54 172.11 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.006 2.471 . . . . 0.0 113.305 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.69 154.05 75.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.885 1.724 . . . . 0.0 112.128 167.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 170.1 19.29 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.278 3.319 . . . . 0.0 110.961 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 46.56 20.28 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.075 2.15 . . . . 0.0 113.891 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.5 m -116.91 -57.24 2.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.81 121.98 13.68 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 m -130.81 160.01 35.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.038 0.381 . . . . 0.0 110.65 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.76 -13.36 62.34 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -166.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.51 30.82 3.22 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.636 2.065 . . . . 0.0 108.06 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.05 141.23 56.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 169.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 134.16 35.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 171.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.21 157.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.678 -169.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.18 107.67 7.36 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.27 148.89 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 163.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -145.54 144.84 30.76 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 155.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 19' ' ' VAL . 1.7 t -140.92 163.24 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 166.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -108.75 74.56 0.92 Allowed 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 161.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 12' ' ' TYR . 5.6 t -82.54 166.35 19.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 166.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.13 24.37 6.67 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 156.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 28.81 70.52 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.169 1.484 . . . . 0.0 114.443 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.16 44.42 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 121.725 2.762 . . . . 0.0 112.579 169.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 98.69 11.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.4 p -91.38 70.07 5.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 126.421 1.888 . . . . 0.0 108.263 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.609 ' HB3' HD13 ' A' ' 103' ' ' LEU . 2.3 tmt_? -85.64 132.63 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 2.9 t -149.04 167.85 24.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.092 0.557 . . . . 0.0 109.504 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -115.6 143.59 45.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.54 -176.54 22.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.273 1.892 . . . . 0.0 111.27 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -128.45 167.48 16.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.359 1.063 . . . . 0.0 108.265 161.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.96 -31.12 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.59 -55.68 0.53 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.491 2.316 . . . . 0.0 112.797 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.5 m -150.09 117.88 6.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.128 2.171 . . . . 0.0 106.341 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.0 tp -82.94 160.49 22.05 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -130.79 -47.99 1.04 Allowed 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 167.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -143.15 176.96 8.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.09 -11.89 59.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.723 0.809 . . . . 0.0 110.537 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -117.46 -39.63 3.15 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.708 1.603 . . . . 0.0 114.091 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -105.95 128.74 54.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -169.39 172.59 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.34 0.656 . . . . 0.0 109.747 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.29 179.15 4.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.504 1.122 . . . . 0.0 111.462 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.8 pt -146.32 129.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 159.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -76.38 122.99 25.28 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 160.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.54 131.94 34.96 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 169.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.04 177.19 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.723 1.209 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.94 -10.45 52.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 116.847 1.499 . . . . 0.0 116.847 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.0 129.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 129.691 3.197 . . . . 0.0 110.086 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 112.33 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.05 144.04 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -70.69 100.81 1.93 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 78' ' ' ARG . 7.5 mp -66.51 -25.53 66.73 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.03 -0.419 . . . . 0.0 110.612 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -150.59 164.42 36.07 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.037 1.735 . . . . 0.0 109.941 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -121.71 115.53 22.88 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.872 1.669 . . . . 0.0 107.514 166.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -74.41 114.12 12.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.59 51.73 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.261 1.425 . . . . 0.0 110.267 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -130.71 28.92 4.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.316 1.046 . . . . 0.0 110.927 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 166.796 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 CA-C-O 117.176 -1.902 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 30.5 ttm 76.95 66.48 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.652 1.981 . . . . 0.0 108.979 -160.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.04 169.91 14.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.398 1.479 . . . . 0.0 108.419 -167.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.43 21.94 5.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.919 1.288 . . . . 0.0 111.995 -166.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -137.75 -69.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.943 0.792 . . . . 0.0 111.107 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.76 38.59 0.65 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.998 0.817 . . . . 0.0 114.757 -167.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 168.38 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.707 1.203 . . . . 0.0 109.679 -171.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.33 10.17 0.43 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.217 1.407 . . . . 0.0 114.54 -166.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -92.18 -51.58 5.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.099 1.318 . . . . 0.0 111.839 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 -17.22 69.83 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.098 0.832 . . . . 0.0 113.138 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -68.06 -15.53 63.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.511 ' HD2' ' HG ' ' A' ' 77' ' ' CYS . 4.5 m-85 -111.73 -56.56 2.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -84.44 119.15 24.8 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.27 156.94 16.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.503 ' C ' HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -53.42 -22.09 7.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.067 1.747 . . . . 0.0 113.551 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 15' ' ' GLN . 6.7 mp -130.68 1.45 4.44 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.561 1.544 . . . . 0.0 112.363 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 162.65 25.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 159.19 17.44 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.536 169.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.45 -173.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -92.25 159.02 15.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.872 2.069 . . . . 0.0 107.742 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.65 54.18 1.71 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.146 1.339 . . . . 0.0 110.56 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -59.33 116.82 4.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 66' ' ' VAL . 21.4 t -118.07 135.47 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -74.41 119.1 18.15 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 59' ' ' THR . 28.8 mt -112.63 84.17 1.94 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.84 90.4 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 116.907 -2.052 . . . . 0.0 113.471 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 75.55 -55.25 0.63 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.362 2.665 . . . . 0.0 110.81 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 t -51.92 -43.31 63.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 111.035 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.98 167.66 14.59 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 122.515 1.064 . . . . 0.0 110.896 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 176.55 8.85 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.549 164.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -125.77 157.4 37.57 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 162.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -140.81 144.05 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.705 0.684 . . . . 0.0 110.333 164.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.32 -163.44 12.12 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.555 1.55 . . . . 0.0 110.664 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.04 153.96 43.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.48 147.57 23.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.29 145.58 27.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 167.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.12 159.57 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.216 1.406 . . . . 0.0 107.658 162.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p -136.14 -36.75 0.73 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.586 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -144.94 140.7 28.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.786 2.034 . . . . 0.0 106.089 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.43 119.83 10.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -116.29 0.98 13.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.306 1.043 . . . . 0.0 111.805 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.38 -108.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 p -75.02 30.57 0.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.251 1.025 . . . . 0.0 112.461 170.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -153.71 109.08 3.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.556 0.742 . . . . 0.0 110.628 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.05 162.03 13.22 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 163.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -127.4 138.97 53.13 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.459 1.904 . . . . 0.0 108.619 165.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.36 169.23 10.81 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.355 1.862 . . . . 0.0 112.599 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -137.71 22.22 2.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 90' ' ' ARG . 7.9 mt 53.66 -173.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.875 1.67 . . . . 0.0 113.621 -171.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.49 113.2 10.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.579 1.552 . . . . 0.0 110.187 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.51 -125.26 9.23 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.71 7.04 3.77 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 111.807 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.54 154.14 34.81 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 163.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -158.66 159.9 29.52 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.856 1.662 . . . . 0.0 108.489 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.92 167.49 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.289 1.326 . . . . 0.0 111.463 170.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.72 155.51 62.98 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.199 2.599 . . . . 0.0 112.993 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.32 160.76 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.518 2.812 . . . . 0.0 111.142 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.93 3.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.487 2.315 . . . . 0.0 113.89 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.417 ' CG2' HD22 ' A' ' 25' ' ' LEU . 87.3 m -97.35 -43.56 7.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.611 -1.306 . . . . 0.0 109.567 -166.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 60' ' ' LEU . 15.2 mt -62.36 143.55 56.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.94 0.791 . . . . 0.0 109.36 166.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -146.06 163.68 34.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.268 1.027 . . . . 0.0 108.275 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.07 -3.07 40.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.033 0.921 . . . . 0.0 113.316 -165.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.04 30.37 2.56 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.467 1.984 . . . . 0.0 108.508 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.21 126.21 26.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 164.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.08 135.99 49.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 164.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.426 HG12 HG22 ' A' ' 23' ' ' VAL . 30.0 m -147.27 157.45 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 112.408 -2.178 . . . . 0.0 107.625 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 151.85 48.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.336 -1.478 . . . . 0.0 110.331 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.53 121.41 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 124.333 1.053 . . . . 0.0 108.681 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.32 92.63 2.2 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 124.01 0.819 . . . . 0.0 110.014 -166.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.58 143.63 37.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.818 1.247 . . . . 0.0 108.92 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -95.19 102.53 14.34 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 t -152.24 157.97 42.18 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.861 0.755 . . . . 0.0 109.63 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.17 40.91 92.37 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.243 -0.911 . . . . 0.0 112.233 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.9 3.85 37.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.282 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . . . -139.69 177.02 8.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.951 1.875 . . . . 0.0 112.55 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.31 115.27 30.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.274 1.029 . . . . 0.0 108.387 171.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.511 ' HG ' ' HD2' ' A' ' 12' ' ' TYR . 0.5 OUTLIER -93.22 112.76 24.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 127.547 2.339 . . . . 0.0 104.897 174.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 128.38 42.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 8.0 t -134.34 168.27 19.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.779 0.8 . . . . 0.0 109.831 171.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -106.88 157.69 17.57 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.467 1.507 . . . . 0.0 107.59 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.82 179.42 45.2 Favored Glycine 0 CA--C 1.524 0.625 0 O-C-N 121.656 -0.652 . . . . 0.0 113.58 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 162.72 34.1 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.414 173.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.51 -36.14 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.95 1.3 . . . . 0.0 113.928 -170.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 73.52 -66.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.394 2.278 . . . . 0.0 111.176 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -138.09 133.97 34.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.54 157.9 18.04 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -136.6 -56.06 0.74 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.038 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -123.49 168.93 11.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.95 -6.74 13.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.16 0.984 . . . . 0.0 111.104 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.469 ' HB3' HD12 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -120.04 -14.25 8.9 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -129.81 119.79 23.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -163.62 169.47 18.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.76 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.94 178.84 5.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.326 1.05 . . . . 0.0 111.01 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.6 pt -147.08 141.81 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 160.59 14.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 159.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.2 mt -117.39 128.72 55.31 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 106.193 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.83 154.51 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.1 0.864 . . . . 0.0 110.458 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.28 -111.67 3.69 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -170.45 136.11 1.28 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.205 1.402 . . . . 0.0 109.467 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.4 p -58.67 154.8 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 126.826 2.05 . . . . 0.0 111.847 164.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.97 154.99 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.99 2.516 . . . . 0.0 105.142 167.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.49 112.7 5.47 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mt -105.68 -0.47 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.543 -0.723 . . . . 0.0 111.968 -172.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -158.78 169.3 24.69 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 128.104 2.562 . . . . 0.0 107.703 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 54.0 mtm-85 -122.11 162.52 21.12 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.763 0.825 . . . . 0.0 109.971 170.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.21 95.29 4.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.147 1.379 . . . . 0.0 107.411 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.19 107.89 12.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 166.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -140.4 21.71 2.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.092 0.957 . . . . 0.0 111.804 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.817 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 63.37 9.43 4.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 m 66.56 135.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.729 1.612 . . . . 0.0 109.845 -153.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.84 7.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.06 0.944 . . . . 0.0 108.518 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -161.98 -78.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -154.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.1 53.89 0.13 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 t -151.12 -3.65 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.097 1.359 . . . . 0.0 111.0 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -65.26 -6.52 9.87 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.75 -1.218 . . . . 0.0 111.6 159.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -55.06 -39.61 69.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.922 0.889 . . . . 0.0 110.17 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -13.07 61.3 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.286 0.469 . . . . 0.0 112.967 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -69.37 -22.77 63.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.551 1.175 . . . . 0.0 110.951 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -123.08 -24.32 4.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.949 1.299 . . . . 0.0 114.346 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -111.67 106.56 15.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.23 160.7 18.37 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.433 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.88 -19.66 65.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.973 2.109 . . . . 0.0 114.484 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 mt -124.92 2.28 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.849 1.26 . . . . 0.0 111.074 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -70.43 175.83 4.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.313 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -113.46 144.71 42.36 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.63 132.99 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.185 0.994 . . . . 0.0 108.401 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -53.01 157.32 1.78 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.916 0.78 . . . . 0.0 109.434 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.63 4.15 15.96 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -166.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.27 95.95 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 113.212 -154.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.17 123.19 44.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 108.367 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.25 137.89 55.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.539 1.063 . . . . 0.0 108.757 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.82 87.53 2.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.9 0.88 . . . . 0.0 108.642 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.17 17.31 79.55 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 121.613 -0.679 . . . . 0.0 111.841 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t0 75.19 -58.79 0.56 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.073 2.549 . . . . 0.0 111.086 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -68.71 -30.26 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.259 0.936 . . . . 0.0 111.841 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.77 158.89 24.41 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 169.0 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.161 1.384 . . . . 0.0 107.551 167.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -126.14 139.42 53.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -135.21 137.41 42.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 162.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.52 -178.17 16.81 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.423 1.487 . . . . 0.0 110.195 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -101.46 150.41 23.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.22 161.71 38.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 162.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.01 155.59 17.05 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 154.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 92.7 mt -71.12 161.04 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.129 1.772 . . . . 0.0 106.265 161.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -134.39 -26.24 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.52 1.128 . . . . 0.0 112.099 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.6 m -154.73 157.06 37.46 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.46 1.504 . . . . 0.0 108.336 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.45 144.3 29.58 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -142.05 83.19 1.83 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.19 2.196 . . . . 0.0 107.894 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.73 -110.54 3.38 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.949 0.785 . . . . 0.0 112.691 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 p -72.64 -4.6 32.0 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 116.506 -1.711 . . . . 0.0 113.169 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -117.26 136.27 53.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.684 1.129 . . . . 0.0 108.469 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.18 164.13 27.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.216 1.406 . . . . 0.0 109.377 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -125.53 142.59 51.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 109.541 167.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.14 170.32 8.6 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.765 1.626 . . . . 0.0 112.002 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -141.21 22.69 2.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.58 1.552 . . . . 0.0 115.069 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 49' ' ' LEU . 7.2 mt 51.81 -169.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.045 1.338 . . . . 0.0 112.514 -169.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 -13.98 7.13 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.95 -157.77 29.31 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -165.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -16.57 61.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.999 0.9 . . . . 0.0 112.937 -172.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.7 100.21 2.77 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -124.27 165.03 26.43 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.752 1.621 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -66.11 175.16 5.03 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.69 1.594 . . . . 0.0 112.078 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.31 152.99 80.31 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 109.28 -1.085 . . . . 0.0 109.28 158.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.31 176.7 9.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.973 2.449 . . . . 0.0 111.261 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 p30 52.13 13.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.911 2.484 . . . . 0.0 115.042 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.3 m -121.35 -24.4 5.45 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.506 -0.747 . . . . 0.0 111.611 -164.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 89' ' ' ASP . 14.8 mt -80.22 141.55 35.5 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 m -127.26 165.98 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.52 1.928 . . . . 0.0 110.423 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -79.01 -2.52 40.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.532 1.133 . . . . 0.0 113.284 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.26 20.62 2.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 126.597 2.046 . . . . 0.0 109.714 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.78 132.9 52.37 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -75.48 138.01 41.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 165.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.84 167.69 21.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 126.267 1.827 . . . . 0.0 109.496 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -128.89 134.2 48.18 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.838 -1.164 . . . . 0.0 109.582 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.08 170.43 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.417 1.487 . . . . 0.0 109.753 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.57 137.87 5.96 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.96 142.94 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 109.198 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.444 ' CZ2' ' HG ' ' A' ' 76' ' ' LEU . 94.5 m95 -90.19 112.13 23.53 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -150.36 154.07 37.15 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 119.507 1.049 . . . . 0.0 110.419 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.86 -155.34 7.04 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -163.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.99 53.16 4.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.254 -1.303 . . . . 0.0 111.999 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . . . -163.26 175.78 10.59 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.531 1.665 . . . . 0.0 112.768 162.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.444 ' HG ' ' CZ2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -84.54 145.51 28.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 156.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.591 ' SG ' HG11 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -118.14 83.82 2.07 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 127.737 2.415 . . . . 0.0 104.825 170.008 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -85.13 139.19 31.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.68 176.84 10.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 123.644 0.59 . . . . 0.0 110.58 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -105.57 168.81 8.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.045 1.338 . . . . 0.0 107.512 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.29 -179.99 40.53 Favored Glycine 0 C--N 1.334 0.454 0 O-C-N 120.759 -1.213 . . . . 0.0 112.76 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -128.03 169.91 13.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.47 1.508 . . . . 0.0 108.001 160.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.0 t -68.44 -40.26 81.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 118.861 0.755 . . . . 0.0 112.871 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 65.71 -43.92 0.37 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.801 2.04 . . . . 0.0 114.337 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -153.79 133.4 12.93 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.074 -1.641 . . . . 0.0 109.524 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.89 159.72 17.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.372 0.669 . . . . 0.0 109.33 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -138.05 -50.09 0.58 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.365 -0.835 . . . . 0.0 109.957 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.79 173.4 11.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.455 ' HA ' HD12 ' A' ' 60' ' ' LEU . 1.2 m-20 -66.4 -6.46 14.52 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.753 0.821 . . . . 0.0 111.798 169.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -117.62 -18.28 9.74 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -130.98 127.85 39.2 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -168.82 166.76 11.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 109.815 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.81 174.95 7.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.631 1.173 . . . . 0.0 110.184 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -142.98 137.49 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 109.02 158.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -91.65 123.6 35.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 160.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.84 140.88 38.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 109.893 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.05 158.62 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.886 1.274 . . . . 0.0 110.954 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.54 53.64 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 125.791 1.662 . . . . 0.0 115.821 165.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.14 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.561 3.544 . . . . 0.0 111.98 -173.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.591 HG11 ' SG ' ' A' ' 77' ' ' CYS . 2.6 t -73.55 137.57 23.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 52.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.32 1.873 . . . . 0.0 114.436 172.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 45.0 53.19 7.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.172 1.389 . . . . 0.0 112.283 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.42 -11.45 42.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.268 . . . . 0.0 112.193 -170.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.93 155.45 40.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 128.414 2.686 . . . . 0.0 106.163 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -135.28 164.61 27.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.188 174.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.4 ttp85 -84.0 163.11 20.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -143.75 44.2 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.49 0.586 . . . . 0.0 110.224 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 57.22 -0.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.474 1.91 . . . . 0.0 106.125 158.427 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.522 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.47 -60.54 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.648 1.979 . . . . 0.0 110.75 -161.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -141.08 67.66 1.35 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.093 1.357 . . . . 0.0 107.949 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.07 113.95 1.69 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 109.879 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.46 -16.07 63.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.358 1.463 . . . . 0.0 111.874 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.86 -169.82 28.13 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 124.785 1.183 . . . . 0.0 110.976 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.9 m -142.22 -79.79 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -1.96 7.06 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.623 0.769 . . . . 0.0 112.9 -175.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -54.19 -41.73 68.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.619 0.767 . . . . 0.0 109.51 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -5.01 66.55 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.037 0.827 . . . . 0.0 113.834 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -88.22 -10.11 50.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.99 1.395 . . . . 0.0 111.588 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' HD2' HG21 ' A' ' 100' ' ' VAL . 4.0 m-30 -117.93 -42.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.515 1.526 . . . . 0.0 109.592 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -99.45 146.81 25.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.08 1.352 . . . . 0.0 108.132 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -143.7 158.11 43.91 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -55.61 -20.12 12.59 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 126.453 1.901 . . . . 0.0 115.392 -164.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.2 mt -126.69 5.9 6.76 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -179.66 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.991 0.814 . . . . 0.0 110.587 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 129.36 56.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.715 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 m -118.75 140.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -63.68 162.45 13.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.945 0.898 . . . . 0.0 110.291 170.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.82 45.18 2.77 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.892 0.877 . . . . 0.0 109.811 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 m -65.01 125.26 24.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 66' ' ' VAL . 23.9 t -131.95 127.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.024 1.729 . . . . 0.0 108.176 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 143.9 57.58 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.963 0.801 . . . . 0.0 109.778 172.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 59' ' ' THR . 48.9 mt -129.11 18.03 6.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.07 -103.0 0.27 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -130.08 -85.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 171.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p -79.56 63.74 4.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.36 2.664 . . . . 0.0 110.064 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.35 -95.22 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.13 167.4 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.455 2.302 . . . . 0.0 113.203 -165.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.93 149.57 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -150.35 123.16 8.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.61 -178.74 16.54 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.632 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.7 161.61 13.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 166.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.26 160.53 43.63 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.213 1.805 . . . . 0.0 109.622 161.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.98 135.6 33.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.89 153.74 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 159.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -131.52 -39.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.683 1.193 . . . . 0.0 110.279 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.4 m -152.9 123.49 7.27 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.97 1.308 . . . . 0.0 108.191 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 142.86 50.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.576 1.15 . . . . 0.0 109.645 -171.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -135.23 -169.81 2.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.754 1.622 . . . . 0.0 109.276 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.48 95.38 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -163.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -140.09 34.75 1.92 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.286 1.834 . . . . 0.0 108.376 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 146.33 36.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.28 168.59 19.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -130.83 142.86 50.41 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.514 1.926 . . . . 0.0 107.505 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -174.73 3.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.666 1.587 . . . . 0.0 109.894 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.7 mt 57.76 -177.37 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.628 1.571 . . . . 0.0 112.434 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.48 134.44 52.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 172.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.05 -134.33 29.39 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 121.645 0.58 . . . . 0.0 112.562 165.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.43 22.99 5.53 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.81 145.66 28.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -159.46 154.56 21.66 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 122.99 0.516 . . . . 0.0 110.697 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.64 169.95 14.87 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.708 2.272 . . . . 0.0 112.061 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -57.25 154.57 33.85 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.394 1.396 . . . . 0.0 111.41 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.48 169.1 16.37 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.41 2.073 . . . . 0.0 109.093 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.17 44.79 6.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.485 ' CG2' HD22 ' A' ' 25' ' ' LEU . 89.0 m -138.75 -54.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.896 0.879 . . . . 0.0 109.195 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.78 137.95 58.16 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.678 171.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -147.16 160.88 41.92 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 66.8 mt-10 -69.94 -2.25 11.94 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -163.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.49 17.1 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 126.102 1.81 . . . . 0.0 111.137 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.67 28.22 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.88 129.94 38.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 23' ' ' VAL . 35.8 m -134.86 159.36 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.128 -172.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.63 104.96 5.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.82 160.46 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.468 ' CB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -148.63 137.46 21.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.99 144.62 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.164 0.986 . . . . 0.0 109.231 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.451 ' CE2' HD13 ' A' ' 76' ' ' LEU . 81.7 m95 -86.33 111.15 20.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -156.99 150.71 24.53 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.57 -56.14 1.65 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.098 1.332 . . . . 0.0 110.936 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.92 -9.48 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.716 1.627 . . . . 0.0 112.933 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.29 174.61 7.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.186 1.493 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.468 HD11 ' CB ' ' A' ' 69' ' ' SER . 31.8 tp -81.04 99.1 8.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -70.74 110.05 5.31 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 164.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 146.12 25.51 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.672 ' SG ' HG22 ' A' ' 100' ' ' VAL . 24.7 m -134.03 144.0 48.42 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.931 168.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.85 146.26 30.97 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.66 -177.52 22.96 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.23 0.919 . . . . 0.0 111.077 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -131.02 161.06 32.8 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 162.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.02 -31.08 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.29 -60.89 0.36 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.135 1.774 . . . . 0.0 111.139 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.4 m -153.27 122.73 6.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.799 2.04 . . . . 0.0 107.121 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.483 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.4 tp -91.6 156.04 17.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -130.06 -46.68 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 111.502 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.475 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 5.7 m-20 -138.3 -178.73 5.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.231 1.812 . . . . 0.0 107.273 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -21.22 9.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.891 1.676 . . . . 0.0 111.434 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -122.07 -53.98 1.93 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 125.518 1.527 . . . . 0.0 111.214 -163.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.475 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 32.2 mt-30 -85.67 133.47 34.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.784 0.72 . . . . 0.0 109.493 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -166.94 164.04 16.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 109.012 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.78 176.21 8.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.605 0.762 . . . . 0.0 109.927 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -152.73 127.63 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.778 1.631 . . . . 0.0 110.219 164.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.13 125.39 34.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 164.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.58 137.96 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.6 164.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 120.657 1.571 . . . . 0.0 113.354 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.1 -117.6 10.87 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 127.544 2.497 . . . . 0.0 107.525 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -145.53 153.58 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.69 1.596 . . . . 0.0 108.113 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.672 HG22 ' SG ' ' A' ' 79' ' ' CYS . 85.6 t -55.93 152.69 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.347 1.859 . . . . 0.0 110.438 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -143.41 157.2 44.65 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.37 128.86 37.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -12.29 3.83 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -132.2 156.09 47.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.337 1.426 . . . . 0.0 109.778 166.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.16 -16.66 12.97 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 124.175 0.99 . . . . 0.0 111.189 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -179.84 -164.46 0.06 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.237 2.215 . . . . 0.0 106.95 -172.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 60.96 55.38 3.14 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 123.462 1.601 . . . . 0.0 111.145 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.258 0.0 OUTLIER -78.68 26.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 128.497 2.719 . . . . 0.0 107.401 177.944 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -148.65 162.54 39.51 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.919 0.888 . . . . 0.0 109.683 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -158.63 99.67 1.59 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.3 -43.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.937 2.095 . . . . 0.0 106.715 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 56.33 49.6 14.84 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.995 1.718 . . . . 0.0 109.773 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.91 134.98 1.75 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-O 118.101 -1.389 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 p 174.87 -69.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 112.735 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -59.68 9.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 1 C-N-CA 131.77 4.028 . . . . 0.0 114.365 -172.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.401 ' CD1' HG23 ' A' ' 100' ' ' VAL . 3.9 m-30 -56.55 -42.38 78.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.539 1.535 . . . . 0.0 110.779 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.78 0.13 86.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.0 0.809 . . . . 0.0 113.524 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -84.43 -15.99 44.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.283 1.042 . . . . 0.0 111.207 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -116.21 -45.76 2.83 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.851 0.751 . . . . 0.0 111.367 -169.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.97 155.56 18.05 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.92 155.76 41.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -50.05 -27.41 5.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.727 3.211 . . . . 0.0 116.628 -168.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.49 1.51 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.608 1.163 . . . . 0.0 111.459 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.57 174.54 7.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 110.107 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -112.55 152.02 29.33 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.29 -0.881 . . . . 0.0 111.124 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.02 136.33 47.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.512 1.525 . . . . 0.0 107.181 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.01 164.55 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.5 mt -129.72 6.72 5.16 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -158.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.84 90.98 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.588 2.355 . . . . 0.0 112.841 -157.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.73 128.59 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -70.83 111.84 6.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.662 0.665 . . . . 0.0 109.613 165.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HB2' ' H ' ' A' ' 30' ' ' SER . 2.5 mm? -109.99 79.39 1.21 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.53 -161.69 50.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 166.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.013 0.925 . . . . 0.0 113.231 -154.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 t -151.32 2.7 0.42 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.687 0.676 . . . . 0.0 112.295 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.49 -104.03 2.89 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 120.052 1.296 . . . . 0.0 112.137 -164.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.542 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 74.62 158.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 1 C-N-CA 132.047 4.139 . . . . 0.0 114.588 177.956 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -136.6 102.7 5.0 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.156 1.382 . . . . 0.0 107.583 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 158.55 15.4 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.053 169.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -170.05 42.79 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 140.71 50.03 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.418 1.887 . . . . 0.0 108.486 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.43 155.13 50.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.969 0.804 . . . . 0.0 110.477 160.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.86 144.92 28.1 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.5 mt -70.77 157.68 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.065 1.346 . . . . 0.0 107.576 162.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -137.18 -56.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.745 2.018 . . . . 0.0 109.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -121.16 157.22 30.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.008 1.323 . . . . 0.0 109.176 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tt -153.64 118.63 5.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.07 94.65 3.08 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.203 1.401 . . . . 0.0 108.117 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.66 -127.38 43.21 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 p -71.24 36.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.994 1.397 . . . . 0.0 112.615 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -147.51 124.24 11.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.02 165.59 12.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 157.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -126.88 146.17 50.39 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 126.325 1.85 . . . . 0.0 108.297 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -138.24 157.9 45.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.709 1.604 . . . . 0.0 109.498 -159.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.42 26.71 2.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 90' ' ' ARG . 8.3 mt 51.19 -165.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.97 1.308 . . . . 0.0 111.276 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.27 153.49 47.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.119 0.967 . . . . 0.0 111.776 168.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.31 -118.63 5.46 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.756 1.646 . . . . 0.0 111.507 167.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.01 2.82 7.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.577 1.551 . . . . 0.0 111.226 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.05 141.32 47.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.05 155.55 24.54 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.297 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.34 170.75 10.3 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.383 2.722 . . . . 0.0 112.217 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HG2' HG21 ' A' ' 59' ' ' THR . 59.3 Cg_endo -66.51 154.58 73.84 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.271 1.314 . . . . 0.0 109.286 171.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.62 161.03 47.51 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 122.72 2.28 . . . . 0.0 111.786 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 47.0 33.84 2.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.426 1.89 . . . . 0.0 112.051 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.444 HG21 ' HG2' ' A' ' 56' ' ' PRO . 95.1 m -128.56 -18.96 3.84 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.298 -0.876 . . . . 0.0 111.855 -171.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 mt -76.01 143.26 41.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.803 0.729 . . . . 0.0 109.284 155.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -141.4 168.77 18.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.364 1.466 . . . . 0.0 108.81 159.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -69.23 -3.76 15.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.443 1.497 . . . . 0.0 114.722 -170.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.44 -2.79 25.94 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 117.851 -1.527 . . . . 0.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.36 131.14 49.31 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.587 1.694 . . . . 0.0 109.188 -164.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -85.56 72.89 10.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.25 1.5 . . . . 0.0 108.48 -167.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.03 154.13 7.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.884 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -134.18 128.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.05 0.94 . . . . 0.0 108.852 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -95.15 175.66 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.694 1.597 . . . . 0.0 110.208 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' HD21 ' A' ' 76' ' ' LEU . 54.0 p -154.71 162.08 41.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.019 1.327 . . . . 0.0 107.829 152.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 p -157.33 143.06 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.747 0.703 . . . . 0.0 109.676 159.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 68.3 m95 -90.29 117.14 28.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.8 t -136.52 170.38 16.16 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.263 1.425 . . . . 0.0 107.685 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 58.44 -107.66 1.21 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.82 32.17 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.482 1.515 . . . . 0.0 111.952 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.52 -170.11 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.055 1.342 . . . . 0.0 108.789 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.6 tm? -116.88 122.03 43.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.412 1.485 . . . . 0.0 110.317 172.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.11 129.1 51.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.44 164.39 25.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.773 1.169 . . . . 0.0 108.345 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.7 t -149.67 148.17 28.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.4 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -79.84 144.3 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.302 1.441 . . . . 0.0 108.043 168.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.11 -169.61 16.46 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.229 -0.919 . . . . 0.0 112.078 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -138.07 168.9 18.76 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 106.73 163.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.88 -27.5 37.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 67.91 -62.85 0.34 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.946 1.699 . . . . 0.0 113.369 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 m -149.32 129.26 13.43 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.569 1.947 . . . . 0.0 106.601 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.97 140.03 43.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -115.2 -52.89 2.66 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.838 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -137.45 169.72 17.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -18.14 57.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.059 0.543 . . . . 0.0 111.978 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.48 ' HA ' HD12 ' A' ' 49' ' ' LEU . 7.4 ptp180 -110.41 -15.86 13.83 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.799 172.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -120.48 123.3 42.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.805 1.638 . . . . 0.0 109.127 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -165.77 165.42 18.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.474 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 176.03 8.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.705 1.202 . . . . 0.0 110.596 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.9 pt -144.75 148.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.306 1.442 . . . . 0.0 109.048 155.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 ttp85 -116.37 112.38 21.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.734 1.614 . . . . 0.0 109.286 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.3 mt -75.59 126.25 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.848 1.659 . . . . 0.0 108.571 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.77 161.87 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 111.108 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.12 8.51 87.41 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.072 -1.404 . . . . 0.0 115.039 167.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.28 135.63 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.433 2.693 . . . . 0.0 111.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.401 HG23 ' CD1' ' A' ' 9' ' ' TYR . 7.8 t -86.65 127.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -131.65 165.19 24.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.163 1.347 . . . . 0.0 109.767 171.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.78 92.33 4.18 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 170.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.73 -12.89 55.18 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.646 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -145.89 144.6 30.3 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.347 -162.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -115.34 -28.89 6.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.244 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -166.2 170.79 12.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.207 2.603 . . . . 0.0 106.849 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 49.16 0.33 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 120.033 3.346 . . . . 0.0 120.033 167.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 56.44 46.92 19.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.944 2.097 . . . . 0.0 112.797 -167.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 35.7 p90 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.075 173.889 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 CA-C-O 117.383 -1.787 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.4 ttm -63.83 -76.11 0.07 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 121.083 2.442 . . . . 0.0 108.865 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -69.42 95.92 0.85 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.57 -20.8 1.34 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.47 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 50.04 62.01 2.89 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.968 1.707 . . . . 0.0 112.129 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.0 160.93 10.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.983 2.23 . . . . 0.0 110.027 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.3 p -159.56 -172.1 3.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.993 1.317 . . . . 0.0 109.203 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.7 -14.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.53 2.332 . . . . 0.0 114.524 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.74 -47.6 77.64 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.609 -1.307 . . . . 0.0 110.895 -166.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.63 6.19 33.39 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 124.065 0.841 . . . . 0.0 113.537 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -84.95 -13.87 49.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.762 1.281 . . . . 0.0 110.65 166.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.454 ' HB3' HG21 ' A' ' 72' ' ' THR . 8.1 m-30 -123.74 -35.78 2.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.807 1.643 . . . . 0.0 112.965 -170.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 24.3 m-85 -108.49 122.17 46.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -172.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.54 159.6 16.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -60.32 -14.09 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.642 2.777 . . . . 0.0 114.203 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 mt -133.84 13.42 4.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.934 1.694 . . . . 0.0 109.911 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -97.36 163.91 12.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 127.008 2.123 . . . . 0.0 109.852 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -118.74 143.17 47.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.133 -0.98 . . . . 0.0 111.58 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.94 139.89 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.576 2.35 . . . . 0.0 104.721 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.519 ' O ' HD23 ' A' ' 21' ' ' LEU . 5.6 t-20 -62.58 156.06 24.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.264 172.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 20' ' ' ASN . 2.9 mt -132.01 93.72 3.34 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -80.32 90.02 5.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 t -85.31 102.11 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -55.02 120.96 7.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 117.21 -1.376 . . . . 0.0 109.708 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -113.5 2.38 15.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.081 0.953 . . . . 0.0 112.419 173.404 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 164.82 36.33 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.04 37.85 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.781 1.632 . . . . 0.0 113.579 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 p 59.8 16.57 5.71 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.929 -1.107 . . . . 0.0 111.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.18 -1.92 90.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 129.926 3.631 . . . . 0.0 114.309 -170.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.565 ' HA ' HD22 ' A' ' 25' ' ' LEU . 3.6 m -61.24 150.58 34.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.983 1.713 . . . . 0.0 109.351 -163.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 25' ' ' LEU . 83.3 t80 -95.55 103.68 15.56 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 -172.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.2 109.21 19.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.53 164.52 12.16 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.303 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 138.9 43.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.18 34.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.34 148.91 24.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.2 mt -72.95 160.62 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.886 1.675 . . . . 0.0 108.761 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.1 p -133.45 -32.22 1.17 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.672 2.389 . . . . 0.0 111.294 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 m -151.55 142.98 23.49 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tp -141.18 114.28 8.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 110.646 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.31 32.19 5.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.872 0.869 . . . . 0.0 112.941 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 -113.09 2.86 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -67.98 22.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.365 1.466 . . . . 0.0 111.735 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 93' ' ' ALA . 2.8 tm? -148.83 126.78 11.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.58 163.63 22.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.413 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 43.9 m95 -124.97 146.14 49.54 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 127.264 2.226 . . . . 0.0 107.866 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.5 mt -138.88 161.35 37.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.092 1.495 . . . . 0.0 110.433 -156.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -146.33 36.47 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 49' ' ' LEU . 8.8 mt 54.25 -174.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.335 -1.478 . . . . 0.0 113.847 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.36 -48.69 2.4 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.982 -0.449 . . . . 0.0 112.012 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.03 -167.44 11.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.956 1.265 . . . . 0.0 111.296 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.33 17.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.826 1.251 . . . . 0.0 112.67 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.96 104.32 0.69 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.497 1.519 . . . . 0.0 108.521 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -135.28 149.38 69.69 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 123.779 0.832 . . . . 0.0 109.948 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.23 165.33 29.01 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.841 2.36 . . . . 0.0 111.158 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.11 160.01 24.1 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.351 1.367 . . . . 0.0 110.961 171.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.92 160.49 11.85 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.515 2.143 . . . . 0.0 110.853 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 56.3 35.88 26.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.311 1.444 . . . . 0.0 111.411 -171.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -130.72 -40.25 1.22 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -172.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.1 mt -73.06 140.21 47.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -138.68 165.18 27.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.831 0.852 . . . . 0.0 109.702 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.604 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 58.9 mt-10 -70.79 -2.23 14.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.431 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.26 2.26 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 120.659 -1.275 . . . . 0.0 110.129 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.5 132.43 53.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 165.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.37 116.83 16.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 166.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.53 140.48 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.53 116.43 22.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -165.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.528 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.5 m -72.93 162.28 4.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 C-N-CA 124.045 0.938 . . . . 0.0 109.822 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -160.12 141.29 12.36 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.619 1.568 . . . . 0.0 112.031 150.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.91 158.3 10.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.165 1.386 . . . . 0.0 109.521 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -92.25 121.43 33.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.524 1.53 . . . . 0.0 107.428 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 12' ' ' TYR . 9.8 t -150.47 160.54 43.7 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.26 -117.93 3.07 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.03 20.63 5.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.343 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.51 172.34 17.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.445 2.123 . . . . 0.0 110.293 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.89 115.81 28.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.71 150.52 20.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.799 ' HB3' HD21 ' A' ' 103' ' ' LEU . 1.8 tmt_? -157.01 134.97 11.0 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 106.93 -175.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 27.9 t -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 107.173 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.13 152.68 44.84 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -150.68 -175.95 23.16 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.755 -1.215 . . . . 0.0 111.618 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -129.21 172.33 11.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.01 0.924 . . . . 0.0 109.218 163.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.0 t -68.62 -32.44 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.5 -65.53 0.2 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.885 1.674 . . . . 0.0 111.993 -172.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -145.33 126.49 14.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.142 1.377 . . . . 0.0 108.072 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.604 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 2.8 tp -86.31 165.11 16.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.797 0.839 . . . . 0.0 109.156 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -137.24 -43.71 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.783 0.72 . . . . 0.0 112.643 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -141.58 177.25 8.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.9 -6.06 7.5 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.48 -1.387 . . . . 0.0 111.884 169.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.6 ptt180 -138.9 -1.82 1.76 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -127.85 134.88 49.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 120.32 1.418 . . . . 0.0 107.282 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.54 166.43 2.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -89.8 178.9 6.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.563 0.745 . . . . 0.0 110.627 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.6 pt -147.43 134.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.654 1.181 . . . . 0.0 111.109 160.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -90.72 127.37 36.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.079 0.952 . . . . 0.0 108.665 165.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -84.85 131.02 34.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG22 ' HA2' ' A' ' 81' ' ' GLY . 27.4 m -137.26 171.19 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 119.472 1.033 . . . . 0.0 111.463 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.35 13.31 64.91 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.998 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.6 163.69 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.418 3.887 . . . . 0.0 113.577 -173.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.1 p -112.1 127.67 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.907 2.483 . . . . 0.0 110.625 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.401 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.2 ttm-85 -131.0 162.53 29.56 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 167.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.0 106.15 3.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -94.22 -16.84 23.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.787 -1.102 . . . . 0.0 112.036 175.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -142.13 150.45 41.14 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.967 0.889 . . . . 0.0 110.613 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -126.71 179.29 5.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.876 1.671 . . . . 0.0 109.746 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.74 29.47 1.12 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 127.252 2.221 . . . . 0.0 105.845 -174.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -94.77 89.44 5.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -107.85 89.53 3.02 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.334 0.654 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.25 1.121 0 C-N-CA 126.448 1.899 . . . . 0.0 109.399 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.67 164.17 14.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.053 0.927 . . . . 0.0 109.912 166.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -130.15 1.83 4.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.19 1.796 . . . . 0.0 111.836 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.24 43.67 3.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.111 1.364 . . . . 0.0 109.96 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.45 161.01 37.5 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.638 1.175 . . . . 0.0 108.209 160.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.57 65.77 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 128.731 3.063 . . . . 0.0 106.37 170.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -130.86 -29.03 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.427 1.114 . . . . 0.0 113.483 -169.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -6.6 34.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.421 1.464 . . . . 0.0 114.732 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -57.41 -48.23 79.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.421 1.464 . . . . 0.0 110.963 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -15.73 65.49 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 119.301 -0.722 . . . . 0.0 113.417 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -71.15 -21.04 62.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.591 1.195 . . . . 0.0 111.305 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 1.2 m-85 -112.03 -51.4 2.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.379 0.672 . . . . 0.0 109.539 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.14 161.75 27.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -145.42 161.08 40.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.527 -0.733 . . . . 0.0 112.07 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.86 -22.84 62.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.69 9.05 8.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.233 1.413 . . . . 0.0 111.072 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.47 174.97 1.49 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.384 0.611 . . . . 0.0 110.02 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 30.2 mtpt -116.7 146.03 43.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 109.042 166.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.56 156.76 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 109.826 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.12 141.57 28.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.936 2.094 . . . . 0.0 109.441 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.9 mt -130.98 70.99 1.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.881 1.273 . . . . 0.0 113.459 -162.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -60.98 133.58 56.24 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.043 -1.036 . . . . 0.0 108.277 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.681 HG22 HG12 ' A' ' 66' ' ' VAL . 10.2 t -126.71 121.11 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -62.56 137.23 58.22 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 120.52 1.509 . . . . 0.0 108.941 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.0 mt -138.61 101.0 4.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 171.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.24 28.53 73.73 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.111 -0.993 . . . . 0.0 111.984 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 57.47 5.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.533 2.733 . . . . 0.0 114.873 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 p -149.43 -39.09 0.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.129 1.772 . . . . 0.0 109.835 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 7.72 4.55 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 126.885 2.183 . . . . 0.0 114.631 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -58.43 138.29 56.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.371 1.868 . . . . 0.0 111.333 -160.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -80.9 154.2 27.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.18 141.76 37.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 157.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.95 174.17 24.43 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 164.24 12.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.19 160.14 43.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.785 -1.197 . . . . 0.0 110.465 161.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 147.17 28.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 157.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.1 mt -79.43 157.46 4.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -130.56 -32.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.536 1.535 . . . . 0.0 111.36 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.9 m -152.23 155.14 37.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.066 1.746 . . . . 0.0 108.878 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.2 tp -147.25 112.61 5.57 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.179 1.391 . . . . 0.0 108.671 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -133.16 94.22 3.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 51.88 -131.3 36.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.404 -0.664 . . . . 0.0 111.794 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 p -74.66 43.59 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.422 1.889 . . . . 0.0 110.839 173.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.25 107.83 3.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.849 -0.532 . . . . 0.0 111.732 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.67 165.51 11.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 165.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 14.4 m95 -126.83 148.63 49.95 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.588 1.555 . . . . 0.0 108.0 164.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 mt -135.9 172.25 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.124 1.769 . . . . 0.0 109.272 -165.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -151.03 27.22 0.7 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 49' ' ' LEU . 7.1 mt 52.25 -174.15 0.03 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.36 1.864 . . . . 0.0 113.024 -173.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -131.78 126.84 35.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.822 1.649 . . . . 0.0 106.952 174.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.34 -132.88 42.68 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.524 0.514 . . . . 0.0 112.815 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.7 4.37 17.1 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 0.0 112.586 -171.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.06 53.49 1.44 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.622 1.569 . . . . 0.0 109.616 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -87.48 156.46 53.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 121.372 -0.83 . . . . 0.0 111.197 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.56 175.23 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.753 2.302 . . . . 0.0 112.391 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -58.97 154.76 42.66 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 121.106 1.204 . . . . 0.0 110.55 160.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -65.63 174.66 5.15 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.604 2.869 . . . . 0.0 110.156 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.2 p30 52.69 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.4 m -110.09 -31.34 7.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 111.193 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -69.59 139.61 53.68 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.101 -0.999 . . . . 0.0 110.085 168.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.02 156.71 45.98 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.26 . . . . 0.0 110.049 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.71 -1.7 14.76 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -168.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.12 18.26 4.76 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.113 1.816 . . . . 0.0 111.215 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.61 141.01 58.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.67 63.79 1.25 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 123.674 1.702 . . . . 0.0 111.663 -163.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.681 HG12 HG22 ' A' ' 23' ' ' VAL . 19.6 m -68.38 162.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.014 -1.903 . . . . 0.0 112.039 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 169.17 9.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.584 1.154 . . . . 0.0 109.787 173.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.89 123.75 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 125.478 1.511 . . . . 0.0 109.565 168.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -121.64 141.87 50.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.963 0.789 . . . . 0.0 110.607 162.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.4 146.79 15.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.85 2.06 . . . . 0.0 106.337 162.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.483 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 76.6 m95 -87.77 143.05 27.36 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 163.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 t -137.5 173.68 11.4 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.01 -98.62 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.753 2.121 . . . . 0.0 112.683 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.8 22.38 2.82 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.322 1.915 . . . . 0.0 111.927 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.71 174.73 11.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.049 1.924 . . . . 0.0 114.024 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.8 tm? -115.61 122.77 46.61 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.151 1.381 . . . . 0.0 110.738 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.86 81.45 1.77 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.099 1.36 . . . . 0.0 110.074 -168.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.427 ' HB3' HD12 ' A' ' 103' ' ' LEU . 7.2 tmm_? -99.25 128.22 45.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.57 -174.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 12.3 t -128.17 172.44 11.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.726 0.81 . . . . 0.0 110.021 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.21 160.19 16.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.125 1.77 . . . . 0.0 108.702 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -165.69 -169.32 29.15 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -144.12 160.72 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.638 1.975 . . . . 0.0 109.1 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.274 51.3 t -62.52 -31.84 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 70.23 -66.11 0.29 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.107 2.163 . . . . 0.0 114.937 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -155.71 97.16 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.796 1.638 . . . . 0.0 108.915 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tp -79.09 152.89 30.57 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.18 -58.76 1.53 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.239 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -127.15 -173.54 2.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.24 -8.35 45.07 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.966 -1.084 . . . . 0.0 111.123 166.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -131.91 -44.89 0.95 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 112.574 -169.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -91.7 133.38 35.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -167.29 164.2 15.33 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.162 0.585 . . . . 0.0 109.724 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -80.85 175.31 10.79 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.25 1.42 . . . . 0.0 110.807 172.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.46 148.17 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.391 1.076 . . . . 0.0 109.188 156.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.24 114.96 26.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.595 2.758 . . . . 0.0 107.606 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.64 147.09 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.495 1.043 . . . . 0.0 108.573 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.426 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.8 m -135.83 146.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 122.335 1.064 . . . . 0.0 109.758 176.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.74 -141.85 31.28 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -166.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.32 138.37 29.45 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.666 1.186 . . . . 0.0 110.838 -165.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.4 p -85.34 129.85 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.044 1.738 . . . . 0.0 111.662 171.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.578 ' CD ' HD23 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -129.52 158.03 40.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.914 1.686 . . . . 0.0 106.703 170.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.16 97.76 0.74 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.578 HD23 ' CD ' ' A' ' 101' ' ' ARG . 42.3 mt -80.1 -9.1 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 120.951 -1.093 . . . . 0.0 111.341 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -154.94 156.01 35.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 127.207 2.203 . . . . 0.0 107.933 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -113.87 179.01 4.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.22 1.408 . . . . 0.0 107.785 166.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -129.94 129.15 43.45 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.07 90.71 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 163.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.358 0.0 OUTLIER -99.03 -4.08 33.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 169.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 127.39 2.276 . . . . 0.0 110.076 -172.941 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 72.2 mtm -144.68 65.46 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -167.37 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -155.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.13 157.32 46.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.577 1.151 . . . . 0.0 109.383 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 44.93 -158.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.216 1.806 . . . . 0.0 112.603 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.37 142.48 16.54 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 120.182 1.356 . . . . 0.0 112.365 -170.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t -144.3 175.97 9.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.945 2.098 . . . . 0.0 108.411 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 73.3 16.64 4.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.645 1.578 . . . . 0.0 110.538 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -105.62 -47.71 3.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.439 1.495 . . . . 0.0 109.804 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.95 10.38 3.18 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.734 1.635 . . . . 0.0 113.363 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -90.85 -14.7 31.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.358 1.863 . . . . 0.0 112.484 165.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 100' ' ' VAL . 7.3 m-85 -121.52 -39.04 2.69 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.994 1.318 . . . . 0.0 112.329 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 61.0 m-85 -93.16 154.35 18.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -143.76 155.8 44.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -57.61 -21.7 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 126.279 1.832 . . . . 0.0 113.661 -170.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -124.39 6.47 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.019 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.462 HE21 HG21 ' A' ' 70' ' ' VAL . 2.7 mt-30 -72.16 169.0 17.01 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.508 -1.37 . . . . 0.0 110.865 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -99.79 153.31 19.23 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.04 148.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.379 1.871 . . . . 0.0 106.039 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.65 161.77 29.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.761 0.825 . . . . 0.0 111.274 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -133.37 41.68 3.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.935 0.894 . . . . 0.0 112.487 -163.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 m -66.62 100.7 0.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 25' ' ' LEU . 43.4 t -94.47 113.24 28.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -57.56 107.21 0.42 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-N 120.535 1.516 . . . . 0.0 109.334 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -89.25 61.72 5.84 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.168 1.787 . . . . 0.0 107.808 171.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.48 7.21 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 75.09 -71.34 0.13 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.925 2.09 . . . . 0.0 112.871 161.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -63.98 -24.5 67.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.096 1.358 . . . . 0.0 111.892 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.06 174.1 22.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.422 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -168.56 172.23 8.29 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.438 1.095 . . . . 0.0 109.266 177.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -110.48 148.4 32.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 164.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -132.79 141.37 48.46 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.926 0.89 . . . . 0.0 110.429 166.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.15 -168.42 26.18 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.568 1.556 . . . . 0.0 110.73 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.2 m -129.26 148.85 51.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.64 162.08 32.91 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 162.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.26 144.65 25.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.04 153.53 8.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 163.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.3 p -130.89 -40.19 1.19 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.776 1.231 . . . . 0.0 110.398 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -140.88 154.51 46.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.873 2.069 . . . . 0.0 107.695 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.75 134.8 20.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -154.23 95.06 1.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.905 1.682 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 -110.8 3.29 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.861 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.5 p -100.09 36.26 1.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.597 1.198 . . . . 0.0 110.449 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.468 ' CD2' ' HB1' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -143.36 131.64 22.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.765 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.22 28.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -122.11 147.16 46.48 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.791 1.637 . . . . 0.0 108.154 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -140.2 156.73 46.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.898 1.679 . . . . 0.0 109.691 -163.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -143.53 35.89 1.31 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 mt 50.89 -170.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.9 1.28 . . . . 0.0 111.3 -171.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.04 -22.65 7.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.227 1.811 . . . . 0.0 112.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.76 -171.39 26.15 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -167.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.5 -67.98 0.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 128.337 2.655 . . . . 0.0 111.587 -169.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -128.73 159.88 34.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.128 2.571 . . . . 0.0 109.552 -163.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -158.37 163.17 25.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 110.34 -172.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 168.12 19.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.193 1.929 . . . . 0.0 110.152 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.94 155.76 66.17 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 120.986 1.124 . . . . 0.0 110.041 164.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.06 174.88 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.014 2.476 . . . . 0.0 108.293 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.99 23.51 12.64 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.986 -1.071 . . . . 0.0 111.34 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.4 m -137.59 -43.85 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.457 1.503 . . . . 0.0 110.182 -167.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 mt -70.96 135.65 48.02 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 120.126 1.33 . . . . 0.0 109.349 169.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.7 m -132.77 163.91 27.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.084 0.954 . . . . 0.0 111.046 168.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.96 -0.05 12.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.026 1.33 . . . . 0.0 114.178 -170.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.2 10.86 7.31 Favored Glycine 0 C--N 1.321 -0.283 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.428 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 128.19 34.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 71.22 1.41 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.076 1.417 . . . . 0.0 109.844 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.6 m -82.87 136.17 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.779 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.84 120.42 41.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.907 0.883 . . . . 0.0 109.157 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.7 m -86.93 155.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.3 p -142.76 155.66 44.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 153.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.462 HG21 HE21 ' A' ' 17' ' ' GLN . 11.1 p -150.87 150.88 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 164.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -100.06 120.5 39.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -156.74 157.04 34.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.2 42.36 62.66 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.944 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.8 -22.87 5.39 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.077 0.938 . . . . 0.0 113.733 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . . . -119.8 164.17 16.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.892 1.346 . . . . 0.0 112.055 -158.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 tp -84.73 102.02 12.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.7 m -88.55 123.45 33.06 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HG2' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -133.31 158.56 42.64 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 167.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 41.9 t -148.83 141.97 24.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.296 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.36 149.95 46.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 110.141 173.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -159.62 -167.48 20.31 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.602 -1.311 . . . . 0.0 112.747 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -139.49 178.96 6.84 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.156 1.782 . . . . 0.0 110.269 166.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.03 -46.01 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.989 1.315 . . . . 0.0 113.234 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 64.7 -58.87 0.24 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.627 2.371 . . . . 0.0 115.23 -167.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -132.44 133.63 44.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -104.8 162.58 13.18 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -139.02 -37.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 120.843 -1.161 . . . . 0.0 113.853 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.77 -175.7 4.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 164.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -68.51 1.69 2.92 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.189 -0.944 . . . . 0.0 112.457 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -134.06 -18.32 2.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -121.24 138.02 54.42 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.364 1.438 . . . . 0.0 107.221 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -172.68 164.13 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.951 0.9 . . . . 0.0 109.602 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.468 ' HB1' ' CD2' ' A' ' 44' ' ' LEU . . . -83.95 172.12 12.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.484 1.114 . . . . 0.0 109.344 168.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 pt -139.97 143.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.326 1.05 . . . . 0.0 109.156 153.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 130.55 46.06 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.685 1.194 . . . . 0.0 107.794 163.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.1 mt -87.44 135.09 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.561 HG22 ' HA2' ' A' ' 81' ' ' GLY . 6.2 m -135.85 157.23 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 122.33 1.062 . . . . 0.0 109.529 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.98 -109.67 2.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -165.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.6 166.5 31.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -96.47 148.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 1 C-N-CA 133.179 4.591 . . . . 0.0 110.79 154.579 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -137.97 171.38 14.51 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.616 2.366 . . . . 0.0 107.346 160.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -71.84 135.45 46.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 161.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.629 HD11 ' HG2' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -132.69 75.5 1.63 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.176 0.99 . . . . 0.0 109.289 173.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 77.08 173.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 131.222 3.809 . . . . 0.0 113.764 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -137.42 163.21 31.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 127.428 2.291 . . . . 0.0 110.899 -176.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -99.75 -10.96 21.25 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -88.19 98.21 11.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -105.6 91.86 3.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.653 -1.165 . . . . 0.0 110.06 -168.585 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.195 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 39.6 mtp -143.59 106.15 4.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 p -166.93 30.54 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.428 1.491 . . . . 0.0 109.984 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 68.65 -23.64 0.14 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 129.684 3.194 . . . . 0.0 115.213 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.39 171.39 7.39 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.324 1.449 . . . . 0.0 111.933 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.67 -95.62 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 O-C-N 121.278 -0.889 . . . . 0.0 112.686 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.91 27.81 14.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.544 1.138 . . . . 0.0 112.144 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -9.41 15.62 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.101 -1.624 . . . . 0.0 111.889 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -62.52 -37.79 87.44 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.96 -0.462 . . . . 0.0 110.415 -170.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.41 44.07 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.26 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 mtt-85 -84.52 -16.15 43.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.66 1.23 . . . . 0.0 110.164 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -116.53 -45.85 2.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.184 1.794 . . . . 0.0 109.98 -172.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -91.4 168.39 11.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.282 1.033 . . . . 0.0 108.237 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -148.85 169.54 20.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.692 0.797 . . . . 0.0 109.183 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.453 ' HG2' HD12 ' A' ' 16' ' ' LEU . 9.4 pm0 -71.23 -20.73 62.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 ' HG2' ' A' ' 15' ' ' GLN . 5.4 mp -125.98 14.13 7.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.1 0.96 . . . . 0.0 109.138 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.443 HE22 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -74.43 -177.18 2.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.092 1.757 . . . . 0.0 110.542 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.99 33.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 120.926 -1.108 . . . . 0.0 111.042 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.67 144.86 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.529 1.131 . . . . 0.0 108.441 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.45 158.6 29.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.295 1.438 . . . . 0.0 109.934 167.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.8 mt -130.8 55.45 1.84 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.145 1.378 . . . . 0.0 109.72 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -69.06 130.26 42.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.38 130.42 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -71.17 114.6 9.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.778 1.627 . . . . 0.0 109.103 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 30' ' ' SER . 1.7 mm? -110.79 79.15 1.17 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.36 -149.7 47.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.11 -14.26 14.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.304 1.042 . . . . 0.0 112.201 -164.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.99 7.46 3.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.155 1.382 . . . . 0.0 111.153 -169.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.34 -97.0 2.01 Favored Glycine 0 CA--C 1.501 -0.81 0 N-CA-C 106.494 -2.643 . . . . 0.0 106.494 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' HD22 ' A' ' 25' ' ' LEU . 14.2 m 50.8 170.05 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 111.61 -2.295 . . . . 0.0 112.961 -157.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -132.05 147.27 52.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -139.02 130.41 27.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.55 -168.77 13.3 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.227 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 142.32 45.22 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.063 1.345 . . . . 0.0 107.808 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.68 153.93 51.77 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 164.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.79 38.81 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 156.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.5 mt -68.63 158.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 160.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.1 p -135.88 -18.52 1.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.779 1.632 . . . . 0.0 112.122 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 m -157.6 148.6 21.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -144.48 122.56 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -135.68 74.64 1.52 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.592 1.957 . . . . 0.0 107.953 -173.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.56 -123.78 29.84 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.6 p -77.1 34.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.777 1.288 . . . . 0.0 111.97 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -151.7 125.01 8.78 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.8 162.46 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 12.7 m95 -129.3 147.52 51.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.684 1.194 . . . . 0.0 110.452 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.62 173.45 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.68 1.592 . . . . 0.0 112.51 -167.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.37 19.95 1.37 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 90' ' ' ARG . 8.7 mt 55.51 -171.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.861 0.864 . . . . 0.0 112.943 -169.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.83 148.78 52.31 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.005 1.722 . . . . 0.0 109.903 165.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.42 -111.0 2.84 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.642 1.115 . . . . 0.0 112.563 161.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.77 7.96 1.11 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.562 1.545 . . . . 0.0 111.163 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.97 146.4 46.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 163.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -173.87 149.59 1.55 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.513 1.925 . . . . 0.0 113.047 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.88 167.77 18.76 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.107 3.205 . . . . 0.0 112.996 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.12 154.23 71.78 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 121.204 1.269 . . . . 0.0 109.994 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.01 170.45 20.08 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.192 2.595 . . . . 0.0 110.765 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.47 -3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 128.211 2.605 . . . . 0.0 116.503 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.2 m -101.32 -24.34 14.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.025 1.33 . . . . 0.0 112.046 -161.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.5 mt -78.92 149.26 32.42 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 120.97 -1.082 . . . . 0.0 108.845 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.75 163.24 34.6 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.553 1.141 . . . . 0.0 108.447 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -70.67 -2.04 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 37.48 1.5 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 135.87 57.21 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 162.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.18 125.78 29.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 166.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.98 136.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.565 1.146 . . . . 0.0 109.616 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.63 131.83 41.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.82 154.71 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.7 p -145.29 146.98 31.87 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 157.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.443 HG21 HE22 ' A' ' 17' ' ' GLN . 10.5 p -149.87 147.75 15.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.239 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -89.38 117.98 28.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.0 t -151.17 169.86 20.86 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.62 -117.61 3.56 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -163.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.35 60.89 0.63 Allowed Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.97 -175.59 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.482 1.513 . . . . 0.0 109.053 176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.5 101.85 10.99 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.029 1.732 . . . . 0.0 108.933 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -71.71 107.9 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.74 133.56 39.7 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 165.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.21 133.2 47.44 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.51 152.25 28.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -167.91 -171.43 33.84 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.463 HH11 HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -134.16 167.14 21.22 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.9 -27.49 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 65.03 -64.16 0.17 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.129 1.772 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -149.36 110.25 4.32 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.319 2.247 . . . . 0.0 105.294 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tp -81.36 153.93 26.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 167.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -120.25 -71.36 0.74 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.03 179.48 3.94 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.116 1.766 . . . . 0.0 108.494 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.76 -2.3 0.22 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.421 2.688 . . . . 0.0 113.698 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.759 ' HB3' HD12 ' A' ' 49' ' ' LEU . 1.7 ptt85 -157.22 -38.13 0.07 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.1 -1.0 . . . . 0.0 113.151 -159.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.28 127.73 45.32 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -171.62 176.44 3.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.112 0.965 . . . . 0.0 109.308 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -104.19 179.92 4.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.338 1.055 . . . . 0.0 112.234 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -150.2 124.62 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.213 1.805 . . . . 0.0 111.654 167.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 114.18 26.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.25 1.42 . . . . 0.0 107.648 168.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -78.02 135.01 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.89 1.276 . . . . 0.0 108.129 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 HH11 ' A' ' 82' ' ' ARG . 19.5 m -136.89 167.65 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.163 0.585 . . . . 0.0 111.121 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.93 15.61 80.91 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 118.502 -1.165 . . . . 0.0 114.616 164.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.22 165.23 0.19 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.815 2.046 . . . . 0.0 111.006 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -116.59 137.45 50.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.19 149.77 40.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.93 106.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.773 1.629 . . . . 0.0 106.96 162.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mt -104.6 -15.12 15.4 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.567 1.076 . . . . 0.0 112.196 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -135.48 160.9 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.51 174.33 8.74 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -91.71 19.48 6.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.679 1.127 . . . . 0.0 112.839 -169.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 75.39 -15.42 0.68 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.725 2.41 . . . . 0.0 112.194 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -83.21 14.29 3.6 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 127.213 2.205 . . . . 0.0 112.664 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . 0.259 84.7 m-85 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 130.261 3.424 . . . . 0.0 112.476 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.43 96.47 1.06 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -176.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -176.68 153.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.716 1.606 . . . . 0.0 107.545 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.92 -42.64 0.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.664 0.785 . . . . 0.0 111.023 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -118.37 174.93 5.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.153 2.181 . . . . 0.0 108.073 -174.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.35 84.74 1.09 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 t -133.6 -30.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.866 1.266 . . . . 0.0 110.018 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -49.29 1.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 131.501 3.921 . . . . 0.0 115.989 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -72.91 -50.03 26.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.791 -1.193 . . . . 0.0 110.141 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.32 -24.05 77.38 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.547 0.612 . . . . 0.0 113.0 -164.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -61.79 -21.24 64.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.518 172.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -113.6 -40.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.034 1.334 . . . . 0.0 111.49 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CE1' HG12 ' A' ' 70' ' ' VAL . 99.2 m-85 -102.67 112.06 24.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.536 1.534 . . . . 0.0 108.606 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.18 157.49 19.34 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.605 0.566 . . . . 0.0 109.932 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.0 -27.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.522 2.729 . . . . 0.0 113.859 163.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.37 41.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.241 1.416 . . . . 0.0 108.561 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.0 159.9 18.66 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.462 1.105 . . . . 0.0 108.96 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 148.12 32.94 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.065 -1.022 . . . . 0.0 110.404 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.47 155.3 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.337 1.055 . . . . 0.0 108.763 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -59.23 161.09 5.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.238 0.615 . . . . 0.0 110.839 162.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.73 44.46 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.588 2.355 . . . . 0.0 108.303 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.2 m -68.2 114.59 6.82 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.47 104.73 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -50.12 114.54 1.12 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 165.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt -106.33 79.95 1.44 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.54 -5.79 27.57 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.319 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.16 -4.73 2.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 130.253 3.421 . . . . 0.0 112.175 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.0 t -85.99 -25.49 25.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.849 0.86 . . . . 0.0 110.762 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.14 -75.03 0.73 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-O 122.57 1.094 . . . . 0.0 111.419 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.315 1.2 m 56.54 166.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.319 3.048 . . . . 0.0 114.946 -166.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.64 166.69 23.31 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 105.933 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -152.59 154.95 36.42 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.04 11.52 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -133.67 151.71 51.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.9 151.0 39.25 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 167.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 145.57 26.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 166.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.0 156.32 7.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 168.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 p -132.8 -22.79 2.07 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.926 2.09 . . . . 0.0 111.819 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -157.05 132.82 9.41 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.537 1.535 . . . . 0.0 108.237 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.463 HD22 ' O ' ' A' ' 44' ' ' LEU . 1.1 tm? -126.74 146.72 50.12 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.404 1.081 . . . . 0.0 108.621 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -161.8 88.11 0.69 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.229 1.012 . . . . 0.0 111.633 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.26 -125.92 37.0 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.1 p -80.48 45.0 0.74 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.041 0.92 . . . . 0.0 110.903 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 40' ' ' LEU . 6.8 tp -153.05 129.34 10.53 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.53 149.82 51.69 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.459 ' C ' HD13 ' A' ' 47' ' ' LEU . 15.8 m95 -114.45 132.42 56.26 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.21 1.404 . . . . 0.0 108.73 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.489 HD21 HG12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -122.31 156.06 34.66 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.044 1.338 . . . . 0.0 109.9 -176.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -137.91 23.98 2.83 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -169.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 mt 51.37 140.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 130.671 3.589 . . . . 0.0 115.58 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.31 3.55 27.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.97 -160.18 52.55 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -164.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.25 -70.08 0.17 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.471 2.708 . . . . 0.0 110.161 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.12 169.71 18.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.469 1.908 . . . . 0.0 110.012 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -151.86 161.44 29.49 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.67 1.588 . . . . 0.0 109.826 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.42 170.7 17.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.373 2.049 . . . . 0.0 112.317 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.54 154.19 74.84 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.15 1.9 . . . . 0.0 111.09 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.51 167.48 25.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.973 2.449 . . . . 0.0 111.424 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 49.23 26.22 1.45 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.904 2.081 . . . . 0.0 111.966 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.1 m -122.8 -55.79 1.79 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.115 1.366 . . . . 0.0 108.021 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.17 130.27 41.44 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 168.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 m -143.11 163.6 32.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 40.1 mt-10 -78.18 0.73 23.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.412 1.085 . . . . 0.0 113.713 -164.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.62 21.67 3.05 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 124.9 21.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.59 117.29 11.93 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.22 153.68 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 124.929 1.291 . . . . 0.0 107.843 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 p -125.71 130.46 51.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.105 0.866 . . . . 0.0 111.104 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.6 m -81.28 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.436 ' HB2' HD21 ' A' ' 76' ' ' LEU . 45.0 p -165.75 131.38 2.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.326 2.25 . . . . 0.0 106.428 154.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.472 HG12 ' CE1' ' A' ' 13' ' ' PHE . 11.1 p -136.16 138.3 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -81.73 112.28 18.75 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 168.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -114.2 -166.09 1.07 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 168.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.78 127.49 14.69 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.66 2.53 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.22 -0.767 . . . . 0.0 111.413 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.7 174.19 11.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.908 1.354 . . . . 0.0 111.368 -154.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 69' ' ' SER . 0.4 OUTLIER -84.59 117.74 23.92 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 173.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.462 ' SG ' HG13 ' A' ' 70' ' ' VAL . 15.0 p -99.55 122.16 42.21 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.71 162.12 32.81 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.412 ' H ' HG22 ' A' ' 68' ' ' VAL . 22.4 t -155.4 166.8 32.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.8 140.88 52.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.75 -175.57 22.11 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 123.552 0.596 . . . . 0.0 114.021 -160.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -133.35 163.84 28.43 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 166.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.3 t -65.17 -39.97 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.141 0.882 . . . . 0.0 111.961 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 64.9 -48.52 0.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.161 2.585 . . . . 0.0 113.921 -167.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 m -153.79 101.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.27 1.428 . . . . 0.0 107.685 -166.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.411 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.0 tp -81.9 161.63 23.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -133.85 -41.46 0.84 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.735 0.814 . . . . 0.0 111.792 171.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.37 173.63 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.706 2.002 . . . . 0.0 105.982 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.2 -10.2 1.85 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.975 2.11 . . . . 0.0 112.943 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -127.74 -24.4 3.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.839 1.656 . . . . 0.0 112.234 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -120.46 121.09 37.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -162.33 163.48 27.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.932 0.396 . . . . 0.0 110.038 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.11 171.55 10.17 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.029 171.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 47' ' ' LEU . 11.3 pt -146.85 131.05 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.201 1.8 . . . . 0.0 108.638 163.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.32 119.48 31.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.47 125.83 29.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.93 158.24 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.13 -154.26 49.28 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -173.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 137.46 51.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.084 -2.058 . . . . 0.0 108.214 -171.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.52 149.62 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -145.91 158.73 43.85 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 164.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 77.81 2.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.41 -5.22 56.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.839 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.63 136.21 24.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.701 1.6 . . . . 0.0 108.994 -170.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -147.29 111.01 4.98 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.71 1.204 . . . . 0.0 109.284 -163.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 175.13 9.71 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.974 166.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 44.76 59.97 3.13 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.9 168.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.296 0.0 OUTLIER -106.78 -5.15 18.63 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.06 1.744 . . . . 0.0 114.272 -174.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.256 1.022 . . . . 0.0 109.906 171.081 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 23.8 ttt -71.51 77.55 0.79 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 165.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 t -144.31 -85.05 0.14 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.66 91.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 118.538 0.608 . . . . 0.0 111.142 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.9 t70 44.57 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.448 2.299 . . . . 0.0 114.581 168.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.12 79.64 0.27 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.479 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t 53.64 -153.23 0.28 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -106.33 11.74 30.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.844 1.258 . . . . 0.0 111.998 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -59.4 -47.94 83.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 111.08 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.4 -16.61 71.62 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.792 0.71 . . . . 0.0 112.671 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -74.7 -10.54 59.63 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.72 -0.871 . . . . 0.0 111.525 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 100' ' ' VAL . 3.3 m-30 -120.19 -40.93 2.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.331 1.452 . . . . 0.0 110.574 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -101.17 104.57 15.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -83.08 157.12 22.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 169.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.572 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.8 tt0 -62.42 -15.13 47.5 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 127.286 2.234 . . . . 0.0 114.805 -173.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 15' ' ' GLN . 7.1 mp -127.81 2.61 6.03 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.446 1.098 . . . . 0.0 111.203 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.45 HE21 HG21 ' A' ' 70' ' ' VAL . 2.6 mt-30 -71.43 178.83 3.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 111.712 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.81 157.61 18.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.427 1.091 . . . . 0.0 110.283 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.66 146.07 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 108.769 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -65.41 153.09 42.29 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.605 0.639 . . . . 0.0 109.387 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.83 51.39 1.53 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.328 0.651 . . . . 0.0 111.477 -165.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 112.96 4.39 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.131 -0.98 . . . . 0.0 110.294 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.64 109.6 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.029 1.332 . . . . 0.0 109.576 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -62.2 130.15 44.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.216 1.807 . . . . 0.0 109.941 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.1 mt -116.67 54.23 0.86 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.493 1.117 . . . . 0.0 108.914 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.24 -162.41 46.04 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -164.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -84.81 -26.97 27.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.696 -0.885 . . . . 0.0 112.489 -166.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.45 68.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.11 140.05 2.78 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.07 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.758 1.223 . . . . 0.0 108.264 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -137.06 151.06 48.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 164.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.6 141.19 31.92 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.764 1.226 . . . . 0.0 108.186 166.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.23 -173.06 17.13 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.218 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.45 124.48 38.53 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.05 1.34 . . . . 0.0 107.637 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.77 149.95 45.57 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.672 1.989 . . . . 0.0 107.079 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.67 153.34 17.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.9 mt -75.19 162.62 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.625 1.57 . . . . 0.0 107.622 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.7 p -140.1 -40.85 0.43 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.986 1.715 . . . . 0.0 111.641 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 m -137.3 145.82 43.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 45' ' ' ALA . 1.6 tp -136.0 138.52 42.33 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.569 -1.332 . . . . 0.0 107.863 171.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -145.42 87.8 1.82 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.717 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.46 -119.04 16.84 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 124.37 0.986 . . . . 0.0 111.245 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 p -73.85 36.71 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.764 1.226 . . . . 0.0 111.795 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -145.16 134.95 23.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.568 -1.332 . . . . 0.0 107.725 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB2' HD12 ' A' ' 40' ' ' LEU . . . -131.24 163.25 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 161.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -122.07 140.85 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.155 1.782 . . . . 0.0 107.638 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.21 167.45 12.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.9 127.7 25.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.544 1.938 . . . . 0.0 108.29 162.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.2 mt -52.62 146.55 9.93 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -79.83 -71.13 0.47 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.95 39.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.986 1.279 . . . . 0.0 110.622 -168.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.46 -6.82 56.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.573 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.26 77.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 128.554 2.742 . . . . 0.0 111.588 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -107.09 154.01 40.65 Favored Pre-proline 0 C--O 1.243 0.728 0 C-N-CA 124.687 1.195 . . . . 0.0 108.949 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.57 174.2 6.74 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.441 2.761 . . . . 0.0 110.775 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.84 158.11 44.49 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 120.81 1.007 . . . . 0.0 110.274 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.99 169.58 20.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.518 2.145 . . . . 0.0 111.105 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 56.12 13.7 1.26 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.402 1.881 . . . . 0.0 113.252 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.0 m -110.18 -53.25 2.7 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.834 1.253 . . . . 0.0 107.851 -166.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.88 150.25 20.77 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.403 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -144.15 163.4 33.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.685 0.794 . . . . 0.0 111.633 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 22.2 mt-10 -71.7 -7.8 50.22 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 10.43 7.58 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 124.696 1.141 . . . . 0.0 112.392 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . . . -59.58 137.35 58.05 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.21 64.0 8.32 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.532 1.158 . . . . 0.0 111.487 -168.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.88 131.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -84.95 165.94 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.83 119.33 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 124.513 1.125 . . . . 0.0 109.565 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -121.57 145.45 47.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.981 0.912 . . . . 0.0 109.432 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.45 HG21 HE21 ' A' ' 17' ' ' GLN . 9.5 p -153.78 159.16 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 165.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -94.43 106.66 18.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 t -145.57 168.77 19.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.492 0.717 . . . . 0.0 109.216 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.8 28.26 38.56 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.599 -1.112 . . . . 0.0 113.202 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.08 6.36 88.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.27 1.414 . . . . 0.0 113.904 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 176.16 9.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 112.463 -166.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.4 tp -104.71 96.29 6.48 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.933 1.693 . . . . 0.0 107.967 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.2 p -80.16 140.0 36.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -146.05 112.53 5.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.662 -0.649 . . . . 0.0 111.801 168.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 48.3 t -107.63 172.4 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.931 0.872 . . . . 0.0 111.108 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.88 154.34 24.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.774 2.43 . . . . 0.0 107.472 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.74 -166.71 33.65 Favored Glycine 0 C--O 1.239 0.458 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.517 1.527 . . . . 0.0 109.761 173.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 64' ' ' ALA . 78.2 t -70.51 -31.19 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.836 0.854 . . . . 0.0 112.658 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 68.88 -61.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.72 2.008 . . . . 0.0 112.704 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 m -146.21 115.51 7.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.142 2.177 . . . . 0.0 106.392 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.2 tp -84.78 155.97 21.59 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -128.78 -58.34 1.16 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.714 -0.616 . . . . 0.0 110.636 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -123.24 172.67 8.45 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 107.114 170.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -7.87 25.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.929 0.492 . . . . 0.0 111.08 164.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.88 -7.4 8.98 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 125.507 1.523 . . . . 0.0 114.933 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.42 130.12 25.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -162.39 162.99 28.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 118.168 0.44 . . . . 0.0 110.123 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.44 178.49 8.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.488 0.715 . . . . 0.0 109.582 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 pt -142.45 157.2 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 125.122 1.369 . . . . 0.0 108.735 156.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.77 113.91 22.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.193 2.197 . . . . 0.0 106.138 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.99 149.73 44.7 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 174.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.987 0.915 . . . . 0.0 110.624 170.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.52 -111.81 2.63 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 126.354 1.93 . . . . 0.0 109.134 -170.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.28 21.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.53 1.932 . . . . 0.0 109.999 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.487 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.5 p -121.24 156.15 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.705 2.002 . . . . 0.0 110.673 172.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 153.49 19.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.628 2.771 . . . . 0.0 107.279 -161.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -81.41 101.75 10.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.53 -31.78 72.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.45 -0.781 . . . . 0.0 111.075 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.53 162.65 34.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.734 1.613 . . . . 0.0 107.822 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -120.37 179.47 4.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.124 0.97 . . . . 0.0 109.13 166.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -129.67 177.79 6.97 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.38 6.14 24.1 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.114 1.365 . . . . 0.0 112.58 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -82.14 2.59 30.72 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.973 -1.079 . . . . 0.0 113.424 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 115.895 -2.002 . . . . 0.0 106.743 -154.318 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.617 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -171.08 -75.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.49 162.02 28.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.562 2.745 . . . . 0.0 109.6 170.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.01 96.6 4.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.949 1.7 . . . . 0.0 107.568 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -146.12 -46.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.437 0.695 . . . . 0.0 109.482 172.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.71 37.39 3.46 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.293 1.425 . . . . 0.0 112.594 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.8 t -140.37 -2.16 1.45 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.373 1.086 . . . . 0.0 113.376 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -89.47 1.9 55.25 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 126.136 1.774 . . . . 0.0 111.595 -173.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -39.34 82.04 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.364 -0.835 . . . . 0.0 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.42 -14.32 74.5 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 118.293 -1.282 . . . . 0.0 112.587 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.93 -40.93 95.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.014 1.907 . . . . 0.0 109.989 166.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' CE2' HG13 ' A' ' 100' ' ' VAL . 2.7 m-30 -86.27 -46.38 10.39 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.265 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.18 105.47 17.63 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.496 1.118 . . . . 0.0 109.378 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -85.95 160.09 19.47 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 127.403 2.281 . . . . 0.0 110.31 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.28 -24.66 67.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -171.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -130.95 16.49 5.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.58 1.552 . . . . 0.0 109.342 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -66.05 171.95 4.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 165.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 159.48 16.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 167.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.17 164.49 29.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -76.75 159.6 30.02 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.397 167.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -120.28 45.48 2.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.579 1.081 . . . . 0.0 109.981 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 m -71.11 95.02 1.18 Allowed 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.71 130.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.307 0.958 . . . . 0.0 109.017 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -70.85 121.23 17.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 109.214 168.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 31' ' ' PHE . 3.0 mm? -105.57 70.48 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.948 0.88 . . . . 0.0 109.024 171.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.35 -91.65 1.02 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 167.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.38 1.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.481 1.512 . . . . 0.0 112.615 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 t -138.98 2.64 2.15 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 111.587 -160.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.93 157.37 27.24 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.97 130.37 8.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.016 0.908 . . . . 0.0 110.07 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.537 ' H ' HD23 ' A' ' 25' ' ' LEU . 77.8 t80 -84.8 158.6 20.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.7 1.2 . . . . 0.0 108.224 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.41 144.76 22.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.449 0.7 . . . . 0.0 109.993 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 -168.36 31.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.414 0.531 . . . . 0.0 112.256 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 133.32 56.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.548 1.539 . . . . 0.0 108.721 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.15 39.35 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 162.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.1 147.81 40.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.406 1.082 . . . . 0.0 109.003 164.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.6 mt -75.35 159.02 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.858 1.663 . . . . 0.0 106.83 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.7 p -141.89 -33.17 0.5 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.301 1.84 . . . . 0.0 112.325 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.43 137.05 12.17 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.789 -1.194 . . . . 0.0 110.971 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.402 HD22 ' H ' ' A' ' 41' ' ' LYS . 1.9 tm? -135.28 141.19 45.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 126.234 1.814 . . . . 0.0 107.627 -173.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' H ' HD22 ' A' ' 40' ' ' LEU . 1.5 ttmm -159.77 93.61 1.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.27 -135.92 36.97 Favored Glycine 0 C--O 1.229 -0.184 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.27 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.83 2.052 . . . . 0.0 113.176 170.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 tp -140.35 118.42 11.92 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 119.408 1.004 . . . . 0.0 109.825 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.38 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 16.0 m95 -128.5 135.83 49.97 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.938 2.095 . . . . 0.0 108.283 170.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.62 177.23 5.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.017 1.727 . . . . 0.0 111.328 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -148.15 131.27 16.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.923 2.489 . . . . 0.0 107.054 167.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.33 157.46 4.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.836 1.654 . . . . 0.0 112.716 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.11 -37.85 7.16 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.0 -50.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.159 0 O-C-N 120.247 -1.533 . . . . 0.0 114.211 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.27 99.94 7.3 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 123.473 1.606 . . . . 0.0 109.913 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 74.85 159.75 0.22 Allowed 'General case' 0 N--CA 1.415 -2.179 1 CA-C-N 107.406 -4.452 . . . . 0.0 109.83 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.24 157.6 49.13 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.711 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 161.96 43.03 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.781 1.654 . . . . 0.0 110.264 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -63.49 162.08 28.93 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 120.82 1.014 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.19 150.12 32.83 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.272 2.648 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 60.49 9.69 2.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.382 2.273 . . . . 0.0 114.074 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.9 m -88.6 -57.35 2.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.354 1.862 . . . . 0.0 111.542 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.95 131.27 50.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -122.98 159.05 29.15 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.65 0.78 . . . . 0.0 110.425 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.25 -5.1 25.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.553 0.741 . . . . 0.0 112.511 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.72 14.69 7.15 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-O 117.588 -1.673 . . . . 0.0 112.25 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.25 133.07 54.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.845 1.322 . . . . 0.0 107.624 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -83.83 110.83 18.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.48 133.86 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.241 0.616 . . . . 0.0 110.497 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.48 137.32 34.7 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.074 0.95 . . . . 0.0 108.569 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.6 126.11 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 124.29 1.036 . . . . 0.0 109.108 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 p -112.5 152.0 29.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.24 142.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 153.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -83.66 121.42 27.24 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.81 148.21 33.77 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.16 -89.47 0.33 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.866 1.222 . . . . 0.0 113.132 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.37 5.94 1.91 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.919 0.771 . . . . 0.0 112.97 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.99 177.28 9.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.212 1.506 . . . . 0.0 111.847 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.2 117.43 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 166.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.66 118.09 35.44 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -133.65 135.5 44.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.443 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 12.1 t -135.24 176.42 8.68 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.402 1.081 . . . . 0.0 108.867 177.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.04 147.38 45.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.85 -170.62 24.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.297 0.951 . . . . 0.0 111.165 -174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -134.13 172.62 12.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.856 1.662 . . . . 0.0 109.116 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -69.36 -35.57 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.913 1.233 . . . . 0.0 113.123 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.52 -62.23 0.44 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.821 2.048 . . . . 0.0 112.665 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -143.62 121.89 12.28 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.202 2.201 . . . . 0.0 106.422 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.42 160.53 18.29 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -123.15 -52.98 1.84 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.397 168.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.28 169.55 17.47 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.024 1.73 . . . . 0.0 107.648 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -4.74 1.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 112.37 170.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -128.47 -14.88 4.64 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 126.017 1.727 . . . . 0.0 113.575 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -138.99 124.98 19.9 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -170.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -165.73 165.79 18.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -83.49 173.58 11.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.467 1.107 . . . . 0.0 110.543 171.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.93 148.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.87 1.668 . . . . 0.0 107.997 154.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -113.54 125.35 54.09 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 125.011 1.324 . . . . 0.0 107.802 168.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.91 144.16 27.81 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.777 1.631 . . . . 0.0 106.781 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.79 146.98 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.777 0.717 . . . . 0.0 111.834 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.78 -99.08 0.32 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 126.069 1.795 . . . . 0.0 109.197 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 164.94 35.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 112.558 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.446 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -106.28 150.68 8.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.877 2.471 . . . . 0.0 110.199 160.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 173.94 11.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.431 1.492 . . . . 0.0 107.255 150.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.25 120.41 10.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 157.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.5 mt -94.37 -14.45 25.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.276 0.944 . . . . 0.0 111.763 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -153.14 156.82 39.35 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.806 1.642 . . . . 0.0 108.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.0 mtm-85 -121.5 167.45 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.35 1.46 . . . . 0.0 110.122 171.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.95 68.05 1.48 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -166.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.96 52.59 2.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.136 1.775 . . . . 0.0 109.142 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -143.65 53.57 1.32 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.571 1.549 . . . . 0.0 109.073 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.251 1.177 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.433 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.07 166.68 23.52 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.478 1.511 . . . . 0.0 108.637 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.1 m -54.6 -11.19 0.52 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.568 3.147 . . . . 0.0 117.686 -162.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.36 64.35 1.88 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.992 2.117 . . . . 0.0 110.18 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -38.99 37.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 128.359 2.664 . . . . 0.0 112.801 163.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.41 21.92 15.91 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.208 0.908 . . . . 0.0 112.167 -173.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 t -140.54 -11.52 1.04 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.352 1.861 . . . . 0.0 110.354 -166.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.82 -3.63 13.2 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.386 -1.446 . . . . 0.0 113.092 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CD1' HG12 ' A' ' 100' ' ' VAL . 3.3 m-85 -61.07 -38.45 86.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.015 1.28 . . . . 0.0 111.005 -171.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.36 1.51 65.17 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.85 0.738 . . . . 0.0 112.96 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -83.89 -4.42 58.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.577 1.689 . . . . 0.0 110.636 164.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.546 ' CE2' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -118.26 -49.48 2.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.255 1.422 . . . . 0.0 107.957 -178.188 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -98.92 105.09 17.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.896 1.278 . . . . 0.0 107.575 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -103.95 161.06 14.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.273 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -154.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.75 10.44 7.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.41 1.884 . . . . 0.0 111.008 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -65.28 172.58 3.04 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -108.28 153.87 22.61 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.455 -0.778 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.94 158.05 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.732 1.213 . . . . 0.0 110.482 166.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -74.04 161.71 29.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.39 2.276 . . . . 0.0 111.669 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.96 49.66 1.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.73 1.612 . . . . 0.0 112.769 -167.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 m -66.74 108.8 2.62 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.244 -1.535 . . . . 0.0 109.514 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.81 124.3 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.092 1.757 . . . . 0.0 108.875 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -64.85 124.07 21.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 59' ' ' THR . 55.6 mt -110.18 9.73 23.88 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 112.715 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.66 -173.13 28.7 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.24 -17.48 60.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.9 0.85 . . . . 0.0 109.123 164.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -125.8 25.03 6.97 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.208 2.203 . . . . 0.0 112.047 -164.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.54 153.51 21.93 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 m -143.32 144.1 31.96 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 163.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -86.58 152.84 22.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 164.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.8 132.44 14.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.14 -170.86 21.21 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.517 1.532 . . . . 0.0 109.625 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.31 162.43 13.68 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.099 1.36 . . . . 0.0 108.289 171.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.0 172.28 13.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.959 0.904 . . . . 0.0 110.185 157.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.84 145.53 28.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.83 1.332 . . . . 0.0 108.559 163.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.3 mt -71.51 157.76 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.842 2.057 . . . . 0.0 106.97 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 p -140.91 -46.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.502 1.121 . . . . 0.0 112.362 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -135.94 136.06 40.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.248 1.419 . . . . 0.0 107.933 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 41' ' ' LYS . 2.1 tm? -145.66 137.4 25.22 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 123.161 1.457 . . . . 0.0 110.218 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' H ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -152.08 93.02 1.78 Allowed 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.641 -177.17 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.24 -110.24 0.84 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.174 1.368 . . . . 0.0 111.535 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 95' ' ' ARG . 57.8 p -68.08 -7.26 27.97 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.009 1.724 . . . . 0.0 115.62 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.34 114.02 20.74 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 120.233 1.379 . . . . 0.0 111.063 -173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.1 157.81 16.61 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 163.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -122.4 142.23 50.74 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.151 2.18 . . . . 0.0 109.239 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.4 mt -135.05 154.78 51.58 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.767 1.227 . . . . 0.0 110.089 -163.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.68 33.26 4.03 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 49.12 -174.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.437 1.895 . . . . 0.0 114.494 -169.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 139.12 29.32 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.049 0.94 . . . . 0.0 111.748 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.8 -152.65 22.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -168.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.41 -7.98 17.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.18 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -54.75 143.4 25.48 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.253 0.621 . . . . 0.0 109.563 167.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -155.67 157.63 31.56 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 125.338 1.455 . . . . 0.0 108.839 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.05 171.18 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.3 2.0 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -57.15 154.52 33.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.129 1.219 . . . . 0.0 109.418 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.59 164.88 29.36 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.773 1.649 . . . . 0.0 109.59 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 p30 56.18 21.48 5.27 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.93 1.692 . . . . 0.0 114.079 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 25' ' ' LEU . 47.3 m -124.49 -11.74 7.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.734 0.814 . . . . 0.0 111.124 -168.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.8 ' HB3' HD21 ' A' ' 86' ' ' LEU . 10.8 mt -88.67 140.36 29.53 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.396 1.453 . . . . 0.0 110.672 156.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -146.33 160.12 42.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.023 0.929 . . . . 0.0 111.785 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.97 -2.0 6.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.56 1.944 . . . . 0.0 115.338 -172.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.16 2.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 125.25 1.405 . . . . 0.0 110.661 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.68 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.3 122.16 31.5 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 m -140.7 154.74 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 110.26 -166.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.24 150.83 41.76 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.4 -0.812 . . . . 0.0 110.068 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.55 120.05 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.32 1.048 . . . . 0.0 110.879 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -129.16 137.68 51.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -154.5 153.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -89.27 113.26 24.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.8 t -151.24 144.46 24.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.01 44.97 41.99 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.389 0.995 . . . . 0.0 111.44 -171.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.77 -15.86 2.1 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.447 1.499 . . . . 0.0 114.502 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.9 153.82 21.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.611 1.705 . . . . 0.0 110.715 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.3 tp -80.7 94.9 6.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.44 139.59 47.83 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.67 134.99 29.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.736 -0.603 . . . . 0.0 110.269 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 8.0 t -137.93 160.97 37.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 111.652 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.97 159.68 14.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.663 1.185 . . . . 0.0 109.05 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.92 -176.1 30.59 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.557 1.551 . . . . 0.0 111.439 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -130.34 171.17 13.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 161.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.531 HG11 HD23 ' A' ' 86' ' ' LEU . 48.6 t -66.79 -35.78 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.819 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 6.1 tp10 65.36 -59.91 0.26 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.262 2.225 . . . . 0.0 112.918 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 93' ' ' ALA . 2.5 m -128.36 133.63 48.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 60' ' ' LEU . 1.4 tm? -108.64 170.98 7.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 166.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -140.49 -47.47 0.42 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 116.734 -1.987 . . . . 0.0 115.996 152.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.11 167.43 19.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.21 6.14 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.737 1.615 . . . . 0.0 111.713 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -134.49 -19.74 1.87 Allowed 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.946 -1.721 . . . . 0.0 115.563 170.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -129.16 123.82 33.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 121.183 1.81 . . . . 0.0 108.197 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CB ' HD22 ' A' ' 86' ' ' LEU . 18.3 p90 -166.79 177.72 6.31 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.61 0.364 . . . . 0.0 110.248 -172.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' A' ' 85' ' ' THR . . . -108.62 175.66 5.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.291 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -145.22 130.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 125.38 1.472 . . . . 0.0 109.116 165.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HD2' ' HB2' ' A' ' 43' ' ' SER . 18.3 tpt85 -87.48 114.16 23.84 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 125.902 1.681 . . . . 0.0 107.31 162.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.4 mt -68.89 135.07 50.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.85 148.45 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.169 0.985 . . . . 0.0 109.822 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.09 -107.44 2.06 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.23 168.39 27.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.045 1.338 . . . . 0.0 110.84 174.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.546 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -109.36 153.06 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 128.046 2.538 . . . . 0.0 111.167 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' HD2' HD23 ' A' ' 103' ' ' LEU . 2.1 ppt_? -149.09 172.21 15.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.906 0.86 . . . . 0.0 109.436 150.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -45.62 81.12 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.749 1 C-N-CA 132.363 4.265 . . . . 0.0 111.365 158.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.571 HD23 ' HD2' ' A' ' 101' ' ' ARG . 19.7 mt -74.7 -27.53 60.43 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 119.952 -1.717 . . . . 0.0 111.696 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.24 162.5 33.33 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.923 2.089 . . . . 0.0 108.16 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -135.06 168.99 18.12 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.737 1.615 . . . . 0.0 108.667 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -145.18 154.17 42.14 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 120.514 1.506 . . . . 0.0 109.61 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 52.36 24.41 2.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.198 0.999 . . . . 0.0 112.352 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 74.47 -5.5 2.09 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 131.492 3.917 . . . . 0.0 117.054 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.851 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 164.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.441 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -149.48 160.93 43.05 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.649 1.98 . . . . 0.0 107.442 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -139.79 121.17 15.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -173.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 47.46 34.89 3.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.961 1.304 . . . . 0.0 111.723 -172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.1 t70 69.5 -3.76 1.54 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.8 2.44 . . . . 0.0 114.856 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.91 92.08 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 O-C-N 121.016 -1.053 . . . . 0.0 111.541 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 t -157.27 -8.73 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.435 0.694 . . . . 0.0 111.936 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -60.73 -9.91 4.64 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.607 1.163 . . . . 0.0 111.225 160.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 100' ' ' VAL . 7.1 m-30 -55.57 -37.76 68.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.947 -1.096 . . . . 0.0 110.574 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.87 -1.13 45.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.474 1.512 . . . . 0.0 112.736 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -72.67 -16.76 61.69 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.012 1.406 . . . . 0.0 111.626 165.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.53 -59.65 1.53 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.81 153.08 27.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.84 157.6 45.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.426 ' HB3' HD12 ' A' ' 16' ' ' LEU . 36.2 tt0 -54.6 -22.56 13.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.943 1.697 . . . . 0.0 114.282 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 15' ' ' GLN . 5.6 mp -127.14 8.38 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 111.954 -172.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.67 166.39 22.01 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.277 -0.89 . . . . 0.0 110.933 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -94.67 160.08 14.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.47 170.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.34 163.08 18.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.042 1.337 . . . . 0.0 109.24 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -80.23 158.5 26.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.455 0.702 . . . . 0.0 110.378 164.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 35' ' ' ALA . 72.1 mt -127.53 51.5 1.91 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.689 1.595 . . . . 0.0 111.09 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -59.34 126.7 28.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.66 121.1 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -63.84 139.56 58.78 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.457 1.48 . . . . 0.0 108.746 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.556 HD22 HG22 ' A' ' 59' ' ' THR . 35.7 mt -118.1 11.52 13.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.02 0.928 . . . . 0.0 112.421 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.88 -105.81 0.72 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.23 -71.99 0.74 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -159.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -116.72 87.76 2.76 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.31 -102.23 0.18 Allowed Glycine 0 CA--C 1.498 -0.969 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 163.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 m 68.26 142.67 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 126.913 2.085 . . . . 0.0 110.824 -153.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -96.5 143.12 27.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 163.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.82 102.41 4.56 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.65 -171.71 15.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.364 0.983 . . . . 0.0 112.446 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -110.6 144.75 39.01 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.277 1.831 . . . . 0.0 107.938 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -138.96 161.8 36.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.548 -0.72 . . . . 0.0 111.034 157.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.57 137.95 32.52 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 113.964 -1.471 . . . . 0.0 107.594 159.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.64 155.04 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -136.02 -22.42 1.39 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.028 1.731 . . . . 0.0 112.185 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -153.55 152.62 31.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 120.923 -1.111 . . . . 0.0 108.104 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.3 tp -156.42 122.2 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -145.48 79.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.96 -139.98 27.0 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.98 2.11 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 127.921 2.488 . . . . 0.0 114.617 168.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 132.27 56.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.999 1.727 . . . . 0.0 108.592 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.35 171.68 12.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 161.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 15.6 m95 -134.15 144.18 48.38 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.426 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.23 177.37 5.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.926 1.29 . . . . 0.0 110.042 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -144.02 32.27 1.25 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 mt 47.99 -173.1 0.01 OUTLIER 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.51 1.148 . . . . 0.0 112.77 -162.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.82 -60.66 1.5 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.239 1.016 . . . . 0.0 108.27 161.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.03 170.57 12.49 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -164.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 63.4 -70.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.893 2.077 . . . . 0.0 110.565 -169.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -71.65 142.09 49.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.76 1.224 . . . . 0.0 109.414 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -151.95 155.74 33.77 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.864 1.266 . . . . 0.0 107.817 152.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.66 167.19 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.667 1.578 . . . . 0.0 111.111 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.28 156.67 39.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.67 2.247 . . . . 0.0 111.445 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.69 162.97 16.77 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.018 2.478 . . . . 0.0 110.413 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 50.14 21.74 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 168.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.556 HG22 HD22 ' A' ' 25' ' ' LEU . 85.4 m -114.77 -30.93 6.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.075 0.95 . . . . 0.0 111.368 -168.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mt -73.84 145.68 44.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.041 1.336 . . . . 0.0 109.704 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -148.46 162.54 39.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 46.3 mt-10 -70.43 -1.93 12.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.178 1.391 . . . . 0.0 114.11 -168.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.62 6.98 9.67 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.153 1.835 . . . . 0.0 111.836 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.93 123.23 19.26 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.07 116.82 6.87 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.89 131.63 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 138.19 50.43 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.835 1.254 . . . . 0.0 108.297 -167.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.61 143.39 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 124.325 1.05 . . . . 0.0 109.098 -166.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.17 126.73 12.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 0.0 109.053 -174.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -152.26 161.45 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.287 1.435 . . . . 0.0 110.246 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -113.14 131.71 55.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.996 1.318 . . . . 0.0 110.238 -170.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -148.19 49.04 1.04 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 111.055 -163.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.63 -97.49 0.25 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.575 1.559 . . . . 0.0 109.407 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.82 0.29 9.98 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.83 1.681 . . . . 0.0 113.569 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.62 171.1 14.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.813 1.306 . . . . 0.0 111.937 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.78 109.66 21.33 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.208 2.203 . . . . 0.0 107.559 177.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -85.02 108.0 17.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.53 162.78 25.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 35.4 t -157.7 168.35 27.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.18 0.925 . . . . 0.0 109.631 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.02 152.66 18.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.222 1.809 . . . . 0.0 107.517 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.18 -177.86 37.95 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -138.62 165.2 27.52 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.482 1.113 . . . . 0.0 109.949 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.74 -34.48 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.65 -66.85 0.15 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.342 1.857 . . . . 0.0 112.656 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.0 m -142.25 117.34 10.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.921 2.488 . . . . 0.0 106.402 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.4 tp -89.47 160.74 16.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -125.51 -56.12 1.51 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -148.39 175.61 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.71 23.31 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.198 1.399 . . . . 0.0 112.173 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -147.03 -6.59 0.49 Allowed 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 166.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -138.6 131.15 28.99 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 120.585 1.539 . . . . 0.0 107.208 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -166.13 158.91 14.8 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.138 1.375 . . . . 0.0 109.412 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -80.49 175.63 10.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.917 1.287 . . . . 0.0 109.861 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.37 139.54 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.525 1.13 . . . . 0.0 108.408 158.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -93.93 111.77 23.53 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -72.55 139.54 47.59 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.61 139.59 50.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 123.708 0.63 . . . . 0.0 110.753 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.66 -88.97 1.18 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 124.441 1.02 . . . . 0.0 112.116 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 149.1 16.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.982 1.313 . . . . 0.0 110.119 -175.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG23 ' CD1' ' A' ' 9' ' ' TYR . 39.9 t -106.8 114.71 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 158.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.35 35.17 2.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 47.25 92.35 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.52 2.328 . . . . 0.0 114.247 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.86 -3.7 17.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -161.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -135.8 162.8 31.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -120.81 161.04 22.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.875 0.87 . . . . 0.0 110.274 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -101.04 137.08 39.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -134.59 62.65 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 119.566 1.075 . . . . 0.0 110.374 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 55.43 7.7 0.24 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 160.227 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -136.19 69.37 1.43 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.97 43.86 30.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.676 1.59 . . . . 0.0 112.3 168.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.48 91.51 2.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.211 1.005 . . . . 0.0 110.422 -172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.94 102.94 0.66 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.899 0.88 . . . . 0.0 109.972 171.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 82.78 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.162 -0.961 . . . . 0.0 112.557 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.7 m -136.7 6.83 2.97 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.83 -0.806 . . . . 0.0 111.309 159.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -82.93 -7.4 59.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.56 2.344 . . . . 0.0 113.525 -172.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -58.54 -46.63 86.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.468 0.707 . . . . 0.0 109.679 -168.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.61 -0.58 80.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.713 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -73.41 -28.86 62.23 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.573 1.686 . . . . 0.0 109.903 164.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' CE2' HG13 ' A' ' 100' ' ' VAL . 7.1 m-30 -107.16 -41.68 5.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.295 1.038 . . . . 0.0 110.416 -168.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.26 116.38 30.36 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -94.94 154.39 17.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 -23.68 6.99 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 127.033 2.133 . . . . 0.0 114.102 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -129.67 8.72 5.38 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.77 1.628 . . . . 0.0 111.397 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.13 175.85 4.25 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.301 -0.874 . . . . 0.0 110.36 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE3' ' CE1' ' A' ' 50' ' ' PHE . 47.3 mtpt -114.29 145.97 41.07 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.034 0.934 . . . . 0.0 108.588 168.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 153.02 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.823 0.849 . . . . 0.0 109.768 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -68.85 154.73 41.48 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.052 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.6 mt -129.6 21.91 5.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -158.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -52.51 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.346 1.458 . . . . 0.0 112.871 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.17 135.22 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.114 1.324 . . . . 0.0 108.13 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -82.1 125.08 30.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.18 13.81 24.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.341 1.056 . . . . 0.0 112.923 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.74 -144.55 15.43 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -83.73 -85.36 0.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.0 p -87.53 43.44 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.815 2.446 . . . . 0.0 111.566 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.09 -91.49 0.76 Allowed Glycine 0 C--N 1.334 0.426 0 O-C-N 121.211 -0.93 . . . . 0.0 110.864 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.282 0.0 OUTLIER 58.99 170.02 0.06 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.913 2.485 . . . . 0.0 114.462 -178.06 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -142.13 144.49 33.52 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.986 1.715 . . . . 0.0 108.563 173.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.86 136.76 48.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.24 -174.76 21.72 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.17 0.891 . . . . 0.0 110.896 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.09 146.55 45.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.309 1.043 . . . . 0.0 108.677 170.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.37 149.71 36.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.02 31.27 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.5 mt -75.32 155.93 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 164.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -133.91 -41.14 0.84 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.057 0.943 . . . . 0.0 111.759 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -141.56 153.76 45.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.835 1.254 . . . . 0.0 108.238 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 133.97 18.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -140.51 75.13 1.49 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.88 2.072 . . . . 0.0 107.589 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.95 -116.1 6.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.279 1.418 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.6 p -64.13 11.17 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.511 1.525 . . . . 0.0 114.966 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 117.1 11.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.17 166.28 15.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -128.82 155.92 44.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.33 1.052 . . . . 0.0 109.578 174.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.46 150.66 35.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.721 2.008 . . . . 0.0 108.227 -163.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -150.04 130.39 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 164.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -57.35 157.92 6.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.107 2.563 . . . . 0.0 113.087 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE1' ' HE3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -78.75 -70.19 0.51 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.249 1.82 . . . . 0.0 112.113 -166.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.76 131.68 1.25 Allowed Glycine 0 CA--C 1.524 0.639 0 O-C-N 120.502 -1.374 . . . . 0.0 109.68 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.38 -3.84 2.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.037 2.935 . . . . 0.0 113.871 -171.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.89 34.87 1.57 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.764 1.226 . . . . 0.0 112.144 -167.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.2 161.17 78.19 Favored Pre-proline 0 N--CA 1.473 0.708 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 159.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.63 167.19 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.948 2.432 . . . . 0.0 111.849 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -62.81 161.73 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.129 1.886 . . . . 0.0 112.427 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.05 158.72 46.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.022 1.815 . . . . 0.0 111.169 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 49.22 22.64 0.68 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.658 1.983 . . . . 0.0 113.902 171.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -94.68 -46.98 6.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.075 1.75 . . . . 0.0 109.146 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.92 155.24 40.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.644 1.577 . . . . 0.0 109.496 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -145.72 171.38 14.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.275 1.03 . . . . 0.0 108.273 158.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -73.13 -7.2 50.29 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -166.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.65 2.9 27.62 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 116.936 -2.036 . . . . 0.0 111.679 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.46 138.88 58.55 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.326 1.563 . . . . 0.0 107.936 -167.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.3 64.22 3.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.973 1.368 . . . . 0.0 109.303 -155.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.52 136.68 23.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.862 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -87.13 174.38 8.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 123.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.421 1.488 . . . . 0.0 109.395 170.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -118.95 152.7 35.87 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.025 0.829 . . . . 0.0 109.477 167.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.92 142.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 108.54 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.93 113.16 15.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -156.5 170.58 22.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 14.19 25.65 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.92 -0.933 . . . . 0.0 115.178 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 5.3 82.92 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.946 1.873 . . . . 0.0 115.03 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.76 -168.01 2.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.572 1.549 . . . . 0.0 108.491 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.6 tp -99.99 125.77 46.07 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 163.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -92.32 141.02 29.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.37 1.468 . . . . 0.0 107.496 167.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.461 ' H ' HD11 ' A' ' 103' ' ' LEU . 7.6 tmm_? -145.01 121.89 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 160.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.7 t -111.39 166.71 10.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.843 0.83 . . . . 0.0 109.09 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.14 133.07 55.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.84 -167.29 15.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 113.1 -165.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -137.37 171.0 15.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.519 1.528 . . . . 0.0 108.242 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.66 -30.18 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 72.24 -64.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.632 1.973 . . . . 0.0 111.531 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -148.35 123.64 10.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.455 2.302 . . . . 0.0 105.701 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.2 152.03 19.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 167.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.44 -47.46 2.34 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.234 0.614 . . . . 0.0 109.851 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -143.58 175.66 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -54.27 -20.95 7.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.29 11.24 4.55 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.86 115.24 13.42 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -163.3 168.42 20.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -173.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.74 178.63 6.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.099 1.76 . . . . 0.0 111.16 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 pt -144.05 145.84 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.979 1.311 . . . . 0.0 109.771 152.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.42 119.92 40.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 171.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.67 138.55 33.27 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.39 164.92 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.963 0.905 . . . . 0.0 109.857 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.55 8.61 63.38 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.408 -1.218 . . . . 0.0 115.426 165.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 62.83 143.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.436 2.295 . . . . 0.0 111.855 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 77' ' ' CYS . 1.4 p -95.85 154.77 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 125.909 1.684 . . . . 0.0 110.182 170.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -150.4 -170.89 3.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -96.96 121.22 38.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.698 2.399 . . . . 0.0 105.884 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.461 HD11 ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.96 -10.13 7.17 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -171.26 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -139.0 163.59 31.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.077 1.351 . . . . 0.0 107.928 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -135.01 172.49 12.94 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -64.08 169.09 4.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.334 0.588 . . . . 0.0 110.053 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -108.75 60.9 0.6 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 55.17 30.45 14.51 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.985 0.914 . . . . 0.0 112.117 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.907 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -60.98 -45.34 95.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.948 -1.095 . . . . 0.0 110.028 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 3.38 16.72 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.181 0.42 . . . . 0.0 113.556 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.225 -1.75 . . . . 0.0 110.116 166.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.85 -46.29 2.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.363 1.065 . . . . 0.0 111.3 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.4 155.69 22.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.721 1.609 . . . . 0.0 107.575 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -144.35 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.602 ' C ' HD12 ' A' ' 16' ' ' LEU . 9.3 tt0 -60.8 -15.17 27.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.253 1.821 . . . . 0.0 115.524 -170.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 15' ' ' GLN . 7.2 mp -130.84 1.35 4.35 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 110.29 -173.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.98 165.8 23.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 155.68 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.32 144.69 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 106.374 -167.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -63.79 166.65 6.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.969 0.508 . . . . 0.0 110.058 160.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.3 mt -142.0 49.27 1.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.76 1.624 . . . . 0.0 109.563 -170.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -58.6 103.31 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 121.024 1.738 . . . . 0.0 109.003 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 HG12 ' A' ' 66' ' ' VAL . 82.4 t -95.66 119.32 43.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 121.633 2.015 . . . . 0.0 106.296 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.58 118.78 6.48 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.505 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -141.65 109.15 5.61 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.9 -1.125 . . . . 0.0 108.209 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -125.24 95.41 4.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -154.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 -167.45 14.46 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.646 1.117 . . . . 0.0 112.163 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.82 145.38 51.97 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.961 0.904 . . . . 0.0 108.596 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.68 145.9 31.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 167.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.1 32.52 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 165.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.43 158.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.034 1.734 . . . . 0.0 107.521 166.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -131.4 -30.75 1.67 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 112.372 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.7 m -145.55 130.72 18.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.264 1.826 . . . . 0.0 106.532 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 tp -131.71 123.18 27.19 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.397 1.479 . . . . 0.0 107.715 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.72 84.74 2.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 -122.06 17.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.68 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.3 p -68.27 -12.42 60.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 117.627 0.714 . . . . 0.0 112.657 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 tp -106.29 139.06 41.39 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 110.36 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.18 168.05 16.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 164.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -133.58 138.51 46.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.775 2.03 . . . . 0.0 109.302 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.95 162.87 25.76 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.734 1.614 . . . . 0.0 110.938 -160.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.41 24.23 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.4 mt 53.14 -171.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.956 0.902 . . . . 0.0 111.936 -168.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 124.462 1.105 . . . . 0.0 113.241 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.85 171.08 17.26 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.407 2.738 . . . . 0.0 112.899 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.63 156.43 52.79 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.149 1.9 . . . . 0.0 111.15 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -66.51 170.97 11.34 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.265 2.644 . . . . 0.0 109.783 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 p30 53.95 1.29 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 m -101.03 -48.0 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.694 0.679 . . . . 0.0 110.404 -163.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.23 144.67 56.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -141.51 163.63 32.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.396 0.678 . . . . 0.0 110.395 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 62.9 mt-10 -73.36 -5.96 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.799 1.239 . . . . 0.0 113.691 -167.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.98 28.83 2.79 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.33 136.14 57.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 167.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.48 125.89 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 165.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG12 HG22 ' A' ' 23' ' ' VAL . 20.7 m -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 t -124.22 135.39 53.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.645 1.212 . . . . 0.0 108.977 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.43 156.62 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 112.385 -2.189 . . . . 0.0 106.709 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.59 ' HB2' HD21 ' A' ' 76' ' ' LEU . 21.2 p -151.01 133.51 15.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.551 164.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -137.87 146.13 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.501 1.12 . . . . 0.0 109.201 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -96.37 132.58 41.73 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -141.14 95.62 2.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 43.78 42.43 6.22 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 118.853 2.301 . . . . 0.0 118.853 159.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.73 -40.54 0.2 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 121.01 2.405 . . . . 0.0 112.341 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.0 -178.18 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.105 0.955 . . . . 0.0 109.327 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.01 113.17 22.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 55.5 m -89.44 108.33 19.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.8 158.2 29.38 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.63 136.86 22.37 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.11 158.6 32.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 -179.56 39.1 Favored Glycine 0 N--CA 1.443 -0.871 0 O-C-N 121.131 -0.98 . . . . 0.0 112.118 -171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -127.19 162.13 26.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -32.13 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.603 0.761 . . . . 0.0 110.415 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.26 -66.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.29 2.236 . . . . 0.0 113.42 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.9 m -152.13 95.89 2.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.092 1.315 . . . . 0.0 108.232 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 1.7 tp -70.06 162.13 28.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -132.87 -41.8 0.92 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.347 -0.845 . . . . 0.0 109.681 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -148.81 172.9 13.9 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -61.12 -6.0 1.77 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.809 2.043 . . . . 0.0 112.465 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -139.66 -11.53 1.17 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.559 2.344 . . . . 0.0 114.606 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -123.71 125.31 44.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -167.11 158.65 12.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.84 176.01 9.97 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.405 1.482 . . . . 0.0 110.849 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.67 150.21 13.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.97 113.8 18.29 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.842 1.257 . . . . 0.0 108.473 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.8 133.0 45.24 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.288 1.835 . . . . 0.0 108.749 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.07 158.38 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.103 1.361 . . . . 0.0 110.327 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.78 80.17 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 119.215 -0.769 . . . . 0.0 112.417 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 59.38 166.78 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.103 2.561 . . . . 0.0 114.009 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -104.39 113.76 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.992 0.917 . . . . 0.0 110.446 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -55.41 -36.8 66.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.922 -1.111 . . . . 0.0 111.099 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.23 -14.45 76.73 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.255 -0.747 . . . . 0.0 113.108 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -75.12 -12.16 60.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.345 1.572 . . . . 0.0 110.744 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.422 ' HA ' HG21 ' A' ' 72' ' ' THR . 3.2 m-85 -118.72 -45.82 2.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.301 1.44 . . . . 0.0 110.439 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -95.7 116.39 28.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.491 1.116 . . . . 0.0 109.621 171.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 167.63 16.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 109.529 166.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.33 -18.45 55.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.558 0.743 . . . . 0.0 112.941 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.0 mt -127.28 14.09 7.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.088 1.355 . . . . 0.0 109.983 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.79 171.81 8.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.721 0.809 . . . . 0.0 109.827 173.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -108.76 149.74 28.6 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.44 157.51 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.658 1.183 . . . . 0.0 111.381 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -72.88 158.41 35.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.549 1.14 . . . . 0.0 112.048 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -131.24 60.94 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.001 1.72 . . . . 0.0 109.391 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m -78.73 110.11 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.931 -1.105 . . . . 0.0 108.424 174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.52 133.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.345 1.458 . . . . 0.0 108.375 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 147.85 46.19 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.06 1.3 . . . . 0.0 110.217 173.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.327 -0.386 0 C-N-CA 126.058 1.743 . . . . 0.0 108.038 169.837 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -95.36 157.18 16.01 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 163.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.27 125.15 15.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 163.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.77 -171.8 14.16 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 166.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -116.9 162.89 17.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.53 157.1 46.39 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.491 156.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.92 140.97 40.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 157.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.95 158.2 5.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.3 p -136.92 -28.74 0.94 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 m -154.57 124.02 6.49 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tt -143.98 129.76 19.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.651 1.114 . . . . 0.0 110.251 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -144.22 104.26 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.94 -131.29 44.33 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.196 0.903 . . . . 0.0 112.205 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.39 37.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.754 1.222 . . . . 0.0 112.111 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.14 117.36 9.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.784 1.234 . . . . 0.0 107.937 162.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.4 155.82 20.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 156.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -118.93 147.77 43.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.608 1.963 . . . . 0.0 108.778 164.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.67 166.5 13.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 110.478 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.3 65.41 1.25 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.537 0.735 . . . . 0.0 110.089 162.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt 45.3 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.329 3.051 . . . . 0.0 116.081 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 C-N-CA 123.929 0.892 . . . . 0.0 111.186 159.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.41 169.92 16.01 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.405 2.07 . . . . 0.0 110.564 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.58 154.8 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.951 1.101 . . . . 0.0 110.586 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -63.42 168.54 11.11 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.086 1.857 . . . . 0.0 108.935 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.77 5.96 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.2 m -108.48 -47.04 3.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.958 1.303 . . . . 0.0 110.844 -163.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -64.85 138.2 58.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.958 0.903 . . . . 0.0 109.182 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -137.1 158.98 43.22 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -74.14 -8.61 56.77 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -164.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.13 22.52 4.23 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 126.235 1.874 . . . . 0.0 109.422 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 125.72 24.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.02 135.88 54.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 164.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.51 163.59 35.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.849 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.78 153.43 39.54 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 160.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.51 145.33 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 p -147.7 146.32 29.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.78 143.55 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.066 0.946 . . . . 0.0 110.272 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.57 74.74 8.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.561 1.945 . . . . 0.0 111.365 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 12' ' ' TYR 0.254 3.4 t -97.65 100.87 12.27 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.388 -0.82 . . . . 0.0 109.435 -170.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.52 33.98 3.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.514 2.483 . . . . 0.0 116.392 161.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.26 -65.97 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -167.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -171.18 -164.57 0.36 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.175 2.19 . . . . 0.0 107.822 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -76.95 94.32 3.93 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 134.9 54.76 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 155.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.13 161.23 36.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.8 t -157.46 175.71 13.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -114.71 156.38 24.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -164.8 178.3 40.0 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 120.455 -1.403 . . . . 0.0 111.697 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.817 HH11 HG21 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -128.78 159.04 36.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 166.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -58.7 -30.89 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.005 0.522 . . . . 0.0 111.984 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 65.69 -61.57 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.479 2.312 . . . . 0.0 111.161 -171.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -147.11 126.98 13.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.242 2.217 . . . . 0.0 105.658 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.55 157.11 16.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.4 ttm-85 -124.8 -44.43 1.95 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.869 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.37 176.38 11.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.8 -1.6 0.92 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.799 0.84 . . . . 0.0 112.325 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -130.78 -13.9 3.63 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.564 1.546 . . . . 0.0 113.579 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.64 136.74 46.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 108.6 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -175.45 166.02 3.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.366 1.066 . . . . 0.0 109.696 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.37 177.62 5.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.053 1.341 . . . . 0.0 110.671 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.07 127.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.149 1.379 . . . . 0.0 108.782 157.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -74.13 137.89 43.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 156.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -99.05 136.75 38.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.817 HG21 HH11 ' A' ' 82' ' ' ARG . 16.8 m -135.48 138.04 48.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.946 0.879 . . . . 0.0 111.93 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -107.47 3.06 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.17 142.53 7.26 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 126.155 1.782 . . . . 0.0 106.315 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.04 134.67 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 C--O 1.236 0.346 0 CA-C-N 119.161 0.892 . . . . 0.0 110.592 179.762 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -64.77 -39.25 93.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.246 -1.534 . . . . 0.0 109.539 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.67 -0.98 74.68 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.962 -169.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -85.85 -17.06 36.68 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.203 1.001 . . . . 0.0 111.038 163.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -105.91 -53.51 2.63 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.029 0.931 . . . . 0.0 110.442 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.44 155.72 22.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.98 153.63 43.2 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -63.03 -18.03 62.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -165.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.55 8.52 5.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.73 1.612 . . . . 0.0 110.223 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -73.87 169.39 17.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.796 -1.19 . . . . 0.0 108.905 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.81 17.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.689 170.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.29 165.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.515 1.126 . . . . 0.0 109.846 164.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.55 177.75 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.883 2.473 . . . . 0.0 112.266 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 23' ' ' VAL . 61.3 mt -138.21 22.56 2.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.818 1.644 . . . . 0.0 115.113 -174.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -62.8 106.74 0.85 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.957 1.708 . . . . 0.0 110.572 -167.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 66' ' ' VAL . 67.9 t -99.12 139.77 20.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.639 1.575 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -74.51 121.17 21.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 161.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 N--CA 1.433 -1.321 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 160.513 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.386 0.613 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -130.41 139.29 50.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.09 147.75 50.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.615 0.722 . . . . 0.0 110.271 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.75 -162.81 15.27 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -131.79 162.79 29.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.21 161.67 41.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 156.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 140.19 41.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 156.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.2 mt -69.25 158.61 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 161.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.6 p -131.96 -31.28 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.444 1.898 . . . . 0.0 111.96 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.14 145.17 31.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 tp -161.81 101.62 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -121.49 78.67 1.46 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.755 1.622 . . . . 0.0 106.875 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.04 -117.85 10.37 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 14.1 p -64.82 -0.48 1.5 Allowed 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 115.817 -2.039 . . . . 0.0 113.914 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -127.04 137.47 53.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.95 1.25 . . . . 0.0 108.193 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.59 166.6 23.9 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.048 0.939 . . . . 0.0 108.527 168.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -129.49 149.44 51.26 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.784 1.634 . . . . 0.0 108.402 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.77 171.37 8.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.573 1.949 . . . . 0.0 110.94 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.66 58.5 1.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.477 1.132 . . . . 0.0 111.229 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 mt 47.72 -169.87 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.663 1.985 . . . . 0.0 114.407 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.617 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.61 164.84 34.38 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.402 2.735 . . . . 0.0 112.586 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.83 160.76 35.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.866 1.711 . . . . 0.0 111.587 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.98 159.58 24.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.568 2.179 . . . . 0.0 112.313 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 44.79 32.69 0.84 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.873 2.069 . . . . 0.0 112.213 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 m -111.64 -56.72 2.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.363 1.065 . . . . 0.0 108.155 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.47 127.52 30.05 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -127.65 159.68 33.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.61 -3.92 17.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.35 19.1 4.34 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.772 2.129 . . . . 0.0 110.881 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.97 131.09 49.55 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.33 123.42 25.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.642 HG12 HG22 ' A' ' 23' ' ' VAL . 34.9 m -134.42 163.8 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.274 -176.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.39 131.08 43.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.02 0.928 . . . . 0.0 108.852 -173.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.48 139.82 19.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -140.91 156.83 46.01 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.085 0.857 . . . . 0.0 110.283 159.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 p -160.86 149.13 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.197 1.799 . . . . 0.0 107.166 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.403 ' CE2' HD13 ' A' ' 76' ' ' LEU . 92.6 m95 -88.1 120.82 29.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 t -151.07 119.48 6.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.66 -162.44 47.85 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -159.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.27 2.08 22.48 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.867 1.223 . . . . 0.0 114.662 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.33 172.82 12.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.958 1.379 . . . . 0.0 110.767 -174.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.403 HD13 ' CE2' ' A' ' 71' ' ' TRP . 23.5 tp -73.9 168.74 18.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.11 153.03 49.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 154.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.27 155.63 50.31 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HB2' HG22 ' A' ' 100' ' ' VAL . 17.6 t -144.86 156.52 44.05 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 155.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -99.21 150.19 22.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.83 41.59 Favored Glycine 0 CA--C 1.523 0.593 0 O-C-N 120.958 -1.088 . . . . 0.0 110.911 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -128.02 169.15 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.648 0.779 . . . . 0.0 109.005 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.18 -35.35 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.131 0.973 . . . . 0.0 112.837 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 65.92 -54.14 0.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.764 2.426 . . . . 0.0 113.707 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -150.27 139.39 21.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.745 1.218 . . . . 0.0 108.264 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -115.77 152.29 33.55 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.52 -52.96 0.72 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.532 -169.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.54 174.93 7.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 159.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -55.5 -30.85 61.41 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.041 1.337 . . . . 0.0 111.821 166.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -104.27 -11.66 17.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -132.24 124.02 28.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 120.535 1.516 . . . . 0.0 108.596 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -162.4 166.29 25.27 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.536 1.148 . . . . 0.0 110.45 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.84 179.78 5.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.753 1.221 . . . . 0.0 110.209 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.71 133.7 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.435 1.494 . . . . 0.0 108.677 164.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -108.39 111.72 23.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.379 1.472 . . . . 0.0 107.674 174.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.5 mt -71.94 144.71 48.83 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.241 1.417 . . . . 0.0 107.563 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.59 153.65 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.557 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.32 -106.96 0.65 Allowed Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 125.721 1.629 . . . . 0.0 109.077 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.59 168.98 23.84 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.4 1.48 . . . . 0.0 110.825 -167.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 79' ' ' CYS . 78.8 t -93.47 156.27 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.018 0.927 . . . . 0.0 109.749 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.55 0 C-N-CA 124.752 1.221 . . . . 0.0 110.296 150.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 C--O 1.222 -0.385 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -54.59 -39.99 68.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.092 1.315 . . . . 0.0 111.606 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.18 -6.06 55.92 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.478 1.037 . . . . 0.0 112.717 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.45 -16.89 55.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.16 -1.2 . . . . 0.0 111.373 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.78 -27.8 5.74 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.723 1.209 . . . . 0.0 110.422 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.83 144.25 50.73 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.445 1.117 . . . . 0.0 111.992 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.62 156.01 49.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.597 -173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.469 ' HG2' HD12 ' A' ' 16' ' ' LEU . 1.5 pm0 -62.13 -17.31 57.46 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 15' ' ' GLN . 5.9 mp -124.49 13.41 8.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 118.884 0.765 . . . . 0.0 109.416 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.73 167.68 21.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.163 0.585 . . . . 0.0 109.575 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.64 147.77 32.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.859 0.864 . . . . 0.0 108.981 170.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -141.5 165.93 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.767 0.827 . . . . 0.0 111.099 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.23 165.55 24.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.043 1.737 . . . . 0.0 112.231 165.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -138.34 19.67 2.75 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.13 116.94 1.7 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.238 -161.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.5 116.05 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -64.21 133.61 53.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.657 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.2 mt . . . . . 0 C--O 1.238 0.477 0 C-N-CA 125.818 1.647 . . . . 0.0 107.031 173.393 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.6 150.22 26.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.97 125.52 15.79 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 126.583 1.953 . . . . 0.0 106.003 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.97 -174.82 23.03 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -118.57 159.21 23.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.75 156.5 40.42 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 118.581 0.628 . . . . 0.0 110.986 161.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.12 130.78 35.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 125.177 1.548 . . . . 0.0 108.008 160.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.89 159.79 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 158.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -132.4 -36.76 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.244 1.418 . . . . 0.0 110.932 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 m -145.77 138.27 25.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.743 1.217 . . . . 0.0 107.735 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.26 124.71 15.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.525 0.73 . . . . 0.0 109.145 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -135.8 81.01 1.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.115 1.366 . . . . 0.0 108.057 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.63 -118.61 5.07 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 166.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p -64.71 -3.79 3.6 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 126.426 1.89 . . . . 0.0 113.019 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.04 134.86 53.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.739 1.215 . . . . 0.0 110.816 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.45 163.56 29.41 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.139 1.375 . . . . 0.0 110.404 167.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -128.19 118.75 23.9 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.852 1.661 . . . . 0.0 110.127 170.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -87.32 165.18 15.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.858 1.663 . . . . 0.0 112.086 167.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.69 35.82 2.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.147 1.779 . . . . 0.0 111.529 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 mt 52.04 -169.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.476 1.91 . . . . 0.0 113.383 -169.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 . . . . . 0 C--O 1.235 0.34 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 173.48 9.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.846 2.364 . . . . 0.0 111.03 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.63 154.5 48.27 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.121 1.214 . . . . 0.0 110.027 162.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.31 174.45 11.48 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.151 2.567 . . . . 0.0 109.514 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.88 38.16 2.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 113.695 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -132.14 -52.31 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.323 1.449 . . . . 0.0 109.558 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.03 149.1 33.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 110.837 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 155.54 46.59 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.276 0.63 . . . . 0.0 110.879 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.8 -2.61 30.72 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.34 20.99 2.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 126.122 1.82 . . . . 0.0 109.664 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.49 25.93 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.06 130.55 41.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.65 138.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.444 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -109.5 130.63 55.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.514 0.726 . . . . 0.0 109.415 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.25 146.14 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.1 p -146.05 159.77 42.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 110.228 160.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.6 p -164.89 151.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.613 1.565 . . . . 0.0 107.841 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -79.0 108.21 12.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 166.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -144.13 152.57 41.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.62 4.58 7.12 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.644 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.87 2.08 42.57 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.821 1.81 . . . . 0.0 114.16 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.76 166.51 26.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.638 1.719 . . . . 0.0 109.836 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.54 95.01 6.99 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 155.09 39.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 170.68 18.1 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.594 172.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 t -159.93 163.35 34.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -101.98 143.6 31.63 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 108.924 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.29 24.19 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.475 1.512 . . . . 0.0 111.933 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.78 174.4 11.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.417 1.087 . . . . 0.0 111.73 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.67 -43.24 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.462 1.105 . . . . 0.0 113.659 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.45 -45.6 0.31 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.377 2.671 . . . . 0.0 114.195 -166.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.0 m -154.63 136.02 14.14 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.668 1.587 . . . . 0.0 107.772 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -116.51 161.19 19.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 108.262 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -143.39 -30.43 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.336 -0.852 . . . . 0.0 111.972 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -149.93 179.86 7.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.904 2.082 . . . . 0.0 105.824 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.7 -8.71 29.72 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.675 -0.641 . . . . 0.0 111.528 162.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -131.57 -11.92 3.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -128.55 128.2 43.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -166.47 167.33 15.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.88 172.9 7.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.994 0.918 . . . . 0.0 109.527 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 pt -141.79 138.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 108.45 160.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -107.3 111.19 23.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 128.433 2.693 . . . . 0.0 104.819 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.17 149.28 37.32 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.246 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.74 165.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.421 1.488 . . . . 0.0 108.973 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.99 -113.55 5.74 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 126.843 2.164 . . . . 0.0 109.907 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.79 137.18 2.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.589 0.756 . . . . 0.0 112.101 -160.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.97 152.97 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.673 1.189 . . . . 0.0 109.42 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 . . . . . 0 C--O 1.236 0.382 0 O-C-N 120.792 -1.192 . . . . 0.0 109.294 174.668 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.05 -33.07 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.894 -1.129 . . . . 0.0 111.097 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 2.41 53.34 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.182 0.896 . . . . 0.0 113.695 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.445 ' HG3' HH11 ' A' ' 11' ' ' ARG . 35.8 mtt85 -81.85 -16.33 51.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.178 1.489 . . . . 0.0 111.256 163.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.63 -37.23 2.92 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.056 1.342 . . . . 0.0 112.506 -172.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.04 159.56 14.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.247 1.019 . . . . 0.0 108.302 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -156.3 161.15 40.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.51 -21.88 66.17 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -163.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.2 mt -122.03 14.28 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 109.466 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.457 HE21 HG21 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -73.53 -174.0 1.58 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.528 0.517 . . . . 0.0 110.755 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -122.69 159.26 28.32 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 125.09 1.356 . . . . 0.0 109.898 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 m -146.28 155.32 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.557 1.143 . . . . 0.0 110.19 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.07 166.68 15.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.159 1.784 . . . . 0.0 110.853 157.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.2 6.23 2.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -158.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 m -49.95 105.44 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 127.327 2.251 . . . . 0.0 112.849 -155.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG22 HG12 ' A' ' 66' ' ' VAL . 25.9 t -89.99 132.01 35.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -77.99 120.61 23.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.238 0.481 0 C-N-CA 124.329 1.052 . . . . 0.0 109.587 170.498 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.0 0.905 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -131.46 146.53 52.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.697 2.399 . . . . 0.0 104.773 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.64 159.37 42.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 118.832 0.742 . . . . 0.0 109.634 165.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.25 -166.73 30.5 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 155.43 32.49 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.38 159.12 42.86 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 163.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.1 145.51 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.89 153.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.002 1.721 . . . . 0.0 107.332 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.7 p -128.98 -18.21 3.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.543 1.137 . . . . 0.0 112.336 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 m -164.53 157.85 17.55 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.44 1.896 . . . . 0.0 109.123 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.16 135.31 33.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.529 1.131 . . . . 0.0 109.482 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 67.8 1.35 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 0.0 112.05 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 -81.47 1.73 Allowed Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.199 -0.938 . . . . 0.0 113.388 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -114.64 45.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.836 1.254 . . . . 0.0 109.115 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -159.21 132.53 7.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.421 1.088 . . . . 0.0 108.169 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.4 154.63 51.41 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 168.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -114.83 149.23 37.39 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.241 1.016 . . . . 0.0 109.154 169.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.7 mt -137.61 165.14 27.07 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.433 1.493 . . . . 0.0 109.771 -169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -143.42 16.33 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 54.71 161.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.324 1.85 . . . . 0.0 113.183 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.196 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.242 0.708 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.46 169.17 17.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.376 2.051 . . . . 0.0 110.997 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.64 159.84 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 120.817 1.011 . . . . 0.0 110.278 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.39 159.53 49.83 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.034 1.823 . . . . 0.0 109.946 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 50.47 30.67 4.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.106 1.362 . . . . 0.0 111.652 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -131.66 -2.23 3.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.335 1.054 . . . . 0.0 111.577 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.752 ' HB3' HD21 ' A' ' 86' ' ' LEU . 9.3 mt -104.16 144.86 31.02 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.564 -1.335 . . . . 0.0 108.595 159.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -154.64 161.1 41.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.979 0.8 . . . . 0.0 110.307 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -67.63 -0.39 3.9 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.14 15.78 3.96 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 126.601 2.048 . . . . 0.0 110.842 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.43 125.57 26.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.51 135.95 38.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 165.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG12 HG22 ' A' ' 23' ' ' VAL . 17.9 m -142.51 141.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 108.278 -174.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 m -95.11 166.9 11.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 0.0 109.583 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 145.3 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.244 1.018 . . . . 0.0 108.584 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -144.95 153.26 41.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 109.009 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.457 HG21 HE21 ' A' ' 17' ' ' GLN . 8.9 p -157.59 151.99 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.076 1.35 . . . . 0.0 107.645 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -91.22 115.51 28.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 t -151.24 171.82 16.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 169.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.66 19.13 54.15 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.858 -1.151 . . . . 0.0 113.417 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.08 -9.98 29.56 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 118.818 1.309 . . . . 0.0 113.494 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.85 -177.44 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.503 1.921 . . . . 0.0 110.957 -171.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.1 tp -105.9 101.37 10.87 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.871 1.268 . . . . 0.0 109.381 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 80.5 m -75.99 136.36 40.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -148.49 162.53 39.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.248 167.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.7 t -155.49 -174.47 4.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.775 0.83 . . . . 0.0 111.269 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -133.57 133.79 42.51 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 129.064 2.945 . . . . 0.0 105.505 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.32 -171.21 25.92 Favored Glycine 0 N--CA 1.463 0.454 0 O-C-N 120.441 -1.412 . . . . 0.0 112.557 -170.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.69 175.37 9.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 0.0 109.439 174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.69 -40.8 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 64.93 -47.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.375 2.27 . . . . 0.0 114.479 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.5 m -148.92 101.36 3.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.075 1.75 . . . . 0.0 107.72 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -73.34 173.61 9.29 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 120.588 -1.32 . . . . 0.0 109.573 174.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.429 ' N ' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -138.2 -51.97 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 150.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -142.16 176.65 8.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.44 -15.74 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 112.649 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -118.41 -21.05 8.22 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.937 1.695 . . . . 0.0 113.462 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -130.35 132.63 45.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 120.615 1.552 . . . . 0.0 108.949 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.573 ' HB3' HD22 ' A' ' 86' ' ' LEU . 9.8 p90 -171.2 170.2 6.14 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.575 0.547 . . . . 0.0 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.81 167.98 13.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.778 2.031 . . . . 0.0 110.431 164.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.96 141.16 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.048 1.339 . . . . 0.0 108.501 159.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 140.4 29.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.623 1.569 . . . . 0.0 107.955 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.83 142.65 28.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 164.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.07 164.33 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.028 0.531 . . . . 0.0 110.12 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.68 -109.18 2.76 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.352 1.453 . . . . 0.0 109.898 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.52 142.49 15.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.194 1.798 . . . . 0.0 108.655 -169.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.23 139.47 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-N 118.372 0.533 . . . . 0.0 110.483 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 C--O 1.224 -0.266 0 N-CA-C 111.059 0.022 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -61.67 -36.59 81.28 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.332 -0.855 . . . . 0.0 110.657 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -10.65 67.33 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.33 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -74.36 -21.13 59.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.514 1.657 . . . . 0.0 110.428 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.563 ' HA ' HG21 ' A' ' 72' ' ' THR . 7.8 m-85 -115.43 -39.2 3.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.388 -169.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HE1' HG23 ' A' ' 70' ' ' VAL . 11.3 m-85 -105.43 131.19 53.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.405 1.882 . . . . 0.0 108.132 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.51 165.55 18.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -79.84 -8.45 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -152.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.4 mt -127.74 -0.59 6.07 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.627 2.371 . . . . 0.0 108.173 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.4 145.67 41.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.354 0.0 OUTLIER -108.19 113.76 27.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -173.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 HG22 ' A' ' 70' ' ' VAL . 25.7 m -102.04 172.86 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.574 2.75 . . . . 0.0 107.333 -171.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.48 163.39 15.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.405 1.882 . . . . 0.0 112.422 173.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 mt -134.98 51.4 2.1 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.492 1.517 . . . . 0.0 113.693 -167.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.1 m -67.44 120.56 14.11 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.886 -1.759 . . . . 0.0 108.109 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 t -118.73 129.71 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.868 1.267 . . . . 0.0 108.276 167.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -70.37 127.59 33.28 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.349 -0.844 . . . . 0.0 109.622 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.335 0 C-N-CA 125.833 1.653 . . . . 0.0 108.606 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.236 0.388 0 CA-C-O 122.107 0.956 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -97.09 142.72 28.68 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 166.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.8 150.15 51.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 165.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.2 -165.52 30.23 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.282 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.93 147.9 51.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.943 1.297 . . . . 0.0 107.687 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.53 34.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 162.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.23 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.15 161.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 162.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -142.05 -13.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.068 0.937 . . . . 0.0 112.608 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 m -156.58 151.15 25.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.16 138.74 31.79 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.364 1.078 . . . . 0.0 109.563 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.83 79.53 1.74 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.762 2.025 . . . . 0.0 106.015 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.35 -106.34 0.35 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.327 1.441 . . . . 0.0 113.49 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.79 9.85 0.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.892 1.677 . . . . 0.0 114.389 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -132.1 129.25 39.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.128 0.877 . . . . 0.0 109.781 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.83 159.2 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 155.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -117.66 147.39 42.95 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.808 1.243 . . . . 0.0 108.145 160.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.74 169.5 9.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.623 1.969 . . . . 0.0 111.284 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -142.43 21.91 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 57.93 -178.06 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 0.0 114.854 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 127.64 2.376 . . . . 0.0 108.261 164.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.939 -0.553 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -67.54 172.11 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.006 2.471 . . . . 0.0 113.305 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.69 154.05 75.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.885 1.724 . . . . 0.0 112.128 167.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 170.1 19.29 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.278 3.319 . . . . 0.0 110.961 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 46.56 20.28 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.075 2.15 . . . . 0.0 113.891 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.5 m -116.91 -57.24 2.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.81 121.98 13.68 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 m -130.81 160.01 35.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.038 0.381 . . . . 0.0 110.65 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.76 -13.36 62.34 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -166.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.51 30.82 3.22 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.636 2.065 . . . . 0.0 108.06 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.05 141.23 56.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 169.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 134.16 35.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 171.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.21 157.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.678 -169.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.18 107.67 7.36 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.27 148.89 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 163.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -145.54 144.84 30.76 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 155.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 19' ' ' VAL . 1.7 t -140.92 163.24 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 166.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -108.75 74.56 0.92 Allowed 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 161.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 12' ' ' TYR . 5.6 t -82.54 166.35 19.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 166.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.13 24.37 6.67 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 156.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 28.81 70.52 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.169 1.484 . . . . 0.0 114.443 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.16 44.42 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 121.725 2.762 . . . . 0.0 112.579 169.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 98.69 11.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.4 p -91.38 70.07 5.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 126.421 1.888 . . . . 0.0 108.263 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -85.64 132.63 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 2.9 t -149.04 167.85 24.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.092 0.557 . . . . 0.0 109.504 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -115.6 143.59 45.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.54 -176.54 22.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.273 1.892 . . . . 0.0 111.27 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -128.45 167.48 16.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.359 1.063 . . . . 0.0 108.265 161.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.96 -31.12 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.59 -55.68 0.53 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.491 2.316 . . . . 0.0 112.797 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.5 m -150.09 117.88 6.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.128 2.171 . . . . 0.0 106.341 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.0 tp -82.94 160.49 22.05 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -130.79 -47.99 1.04 Allowed 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 167.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -143.15 176.96 8.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.09 -11.89 59.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.723 0.809 . . . . 0.0 110.537 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -117.46 -39.63 3.15 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.708 1.603 . . . . 0.0 114.091 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -105.95 128.74 54.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -169.39 172.59 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.34 0.656 . . . . 0.0 109.747 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.29 179.15 4.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.504 1.122 . . . . 0.0 111.462 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.8 pt -146.32 129.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 159.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -76.38 122.99 25.28 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 160.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.54 131.94 34.96 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 169.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.04 177.19 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.723 1.209 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.94 -10.45 52.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 116.847 1.499 . . . . 0.0 116.847 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.0 129.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 129.691 3.197 . . . . 0.0 110.086 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 112.33 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -92.18 -51.58 5.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.099 1.318 . . . . 0.0 111.839 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 -17.22 69.83 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.098 0.832 . . . . 0.0 113.138 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -68.06 -15.53 63.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.511 ' HD2' ' HG ' ' A' ' 77' ' ' CYS . 4.5 m-85 -111.73 -56.56 2.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -84.44 119.15 24.8 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.27 156.94 16.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.503 ' C ' HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -53.42 -22.09 7.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.067 1.747 . . . . 0.0 113.551 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 15' ' ' GLN . 6.7 mp -130.68 1.45 4.44 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.561 1.544 . . . . 0.0 112.363 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 162.65 25.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 159.19 17.44 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.536 169.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.45 -173.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 20' ' ' ASN . 1.3 t-20 -92.25 159.02 15.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.872 2.069 . . . . 0.0 107.742 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.65 54.18 1.71 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.146 1.339 . . . . 0.0 110.56 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -59.33 116.82 4.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 66' ' ' VAL . 21.4 t -118.07 135.47 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -74.41 119.1 18.15 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 59' ' ' THR . 28.8 mt . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.239 0.526 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -125.77 157.4 37.57 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 162.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -140.81 144.05 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.705 0.684 . . . . 0.0 110.333 164.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.32 -163.44 12.12 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.555 1.55 . . . . 0.0 110.664 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.04 153.96 43.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.48 147.57 23.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.29 145.58 27.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 167.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.12 159.57 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.216 1.406 . . . . 0.0 107.658 162.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p -136.14 -36.75 0.73 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.586 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -144.94 140.7 28.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.786 2.034 . . . . 0.0 106.089 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.43 119.83 10.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -116.29 0.98 13.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.306 1.043 . . . . 0.0 111.805 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.38 -108.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 p -75.02 30.57 0.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.251 1.025 . . . . 0.0 112.461 170.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -153.71 109.08 3.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.556 0.742 . . . . 0.0 110.628 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.05 162.03 13.22 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 163.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -127.4 138.97 53.13 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.459 1.904 . . . . 0.0 108.619 165.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.36 169.23 10.81 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.355 1.862 . . . . 0.0 112.599 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -137.71 22.22 2.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 90' ' ' ARG . 7.9 mt 53.66 -173.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.875 1.67 . . . . 0.0 113.621 -171.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 125.579 1.552 . . . . 0.0 110.187 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.92 167.49 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.289 1.326 . . . . 0.0 111.463 170.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.72 155.51 62.98 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.199 2.599 . . . . 0.0 112.993 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.32 160.76 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.518 2.812 . . . . 0.0 111.142 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.93 3.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.487 2.315 . . . . 0.0 113.89 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.417 ' CG2' HD22 ' A' ' 25' ' ' LEU . 87.3 m -97.35 -43.56 7.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.611 -1.306 . . . . 0.0 109.567 -166.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 60' ' ' LEU . 15.2 mt -62.36 143.55 56.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.94 0.791 . . . . 0.0 109.36 166.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -146.06 163.68 34.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.268 1.027 . . . . 0.0 108.275 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.07 -3.07 40.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.033 0.921 . . . . 0.0 113.316 -165.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.04 30.37 2.56 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.467 1.984 . . . . 0.0 108.508 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.21 126.21 26.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 164.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.08 135.99 49.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 164.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.426 HG12 HG22 ' A' ' 23' ' ' VAL . 30.0 m -147.27 157.45 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 112.408 -2.178 . . . . 0.0 107.625 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 151.85 48.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.336 -1.478 . . . . 0.0 110.331 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.53 121.41 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 124.333 1.053 . . . . 0.0 108.681 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.32 92.63 2.2 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 124.01 0.819 . . . . 0.0 110.014 -166.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.58 143.63 37.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.818 1.247 . . . . 0.0 108.92 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -95.19 102.53 14.34 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 t -152.24 157.97 42.18 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.861 0.755 . . . . 0.0 109.63 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.17 40.91 92.37 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.243 -0.911 . . . . 0.0 112.233 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.9 3.85 37.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.282 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.69 177.02 8.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.951 1.875 . . . . 0.0 112.55 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.31 115.27 30.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.274 1.029 . . . . 0.0 108.387 171.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.511 ' HG ' ' HD2' ' A' ' 12' ' ' TYR . 0.5 OUTLIER -93.22 112.76 24.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 127.547 2.339 . . . . 0.0 104.897 174.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 128.38 42.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 8.0 t -134.34 168.27 19.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.779 0.8 . . . . 0.0 109.831 171.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -106.88 157.69 17.57 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.467 1.507 . . . . 0.0 107.59 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.82 179.42 45.2 Favored Glycine 0 CA--C 1.524 0.625 0 O-C-N 121.656 -0.652 . . . . 0.0 113.58 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 162.72 34.1 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.414 173.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.51 -36.14 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.95 1.3 . . . . 0.0 113.928 -170.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 73.52 -66.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.394 2.278 . . . . 0.0 111.176 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -138.09 133.97 34.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.54 157.9 18.04 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -136.6 -56.06 0.74 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.038 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -123.49 168.93 11.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.95 -6.74 13.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.16 0.984 . . . . 0.0 111.104 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.469 ' HB3' HD12 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -120.04 -14.25 8.9 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -129.81 119.79 23.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -163.62 169.47 18.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.76 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.94 178.84 5.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.326 1.05 . . . . 0.0 111.01 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.6 pt -147.08 141.81 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 160.59 14.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 159.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.2 mt -117.39 128.72 55.31 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 106.193 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.83 154.51 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.1 0.864 . . . . 0.0 110.458 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.28 -111.67 3.69 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -170.45 136.11 1.28 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.205 1.402 . . . . 0.0 109.467 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.4 p -58.67 154.8 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 126.826 2.05 . . . . 0.0 111.847 164.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 127.99 2.516 . . . . 0.0 105.142 167.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -55.06 -39.61 69.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.922 0.889 . . . . 0.0 110.17 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -13.07 61.3 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.286 0.469 . . . . 0.0 112.967 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -69.37 -22.77 63.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.551 1.175 . . . . 0.0 110.951 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -123.08 -24.32 4.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.949 1.299 . . . . 0.0 114.346 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -111.67 106.56 15.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.23 160.7 18.37 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.433 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.88 -19.66 65.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.973 2.109 . . . . 0.0 114.484 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 mt -124.92 2.28 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.849 1.26 . . . . 0.0 111.074 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -70.43 175.83 4.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.313 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -113.46 144.71 42.36 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.63 132.99 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.185 0.994 . . . . 0.0 108.401 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -53.01 157.32 1.78 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.916 0.78 . . . . 0.0 109.434 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.63 4.15 15.96 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -166.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.27 95.95 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 113.212 -154.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.17 123.19 44.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 108.367 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.25 137.89 55.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.539 1.063 . . . . 0.0 108.757 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.9 0.88 . . . . 0.0 108.642 179.117 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.238 0.456 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -126.14 139.42 53.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -135.21 137.41 42.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 162.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.52 -178.17 16.81 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.423 1.487 . . . . 0.0 110.195 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -101.46 150.41 23.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.22 161.71 38.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 162.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.01 155.59 17.05 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 154.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 92.7 mt -71.12 161.04 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.129 1.772 . . . . 0.0 106.265 161.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -134.39 -26.24 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.52 1.128 . . . . 0.0 112.099 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.6 m -154.73 157.06 37.46 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.46 1.504 . . . . 0.0 108.336 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.45 144.3 29.58 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -142.05 83.19 1.83 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.19 2.196 . . . . 0.0 107.894 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.73 -110.54 3.38 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.949 0.785 . . . . 0.0 112.691 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 p -72.64 -4.6 32.0 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 116.506 -1.711 . . . . 0.0 113.169 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -117.26 136.27 53.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.684 1.129 . . . . 0.0 108.469 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.18 164.13 27.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.216 1.406 . . . . 0.0 109.377 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -125.53 142.59 51.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 109.541 167.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.14 170.32 8.6 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.765 1.626 . . . . 0.0 112.002 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -141.21 22.69 2.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.58 1.552 . . . . 0.0 115.069 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 49' ' ' LEU . 7.2 mt 51.81 -169.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.045 1.338 . . . . 0.0 112.514 -169.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.341 0.223 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -66.11 175.16 5.03 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.69 1.594 . . . . 0.0 112.078 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.31 152.99 80.31 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 109.28 -1.085 . . . . 0.0 109.28 158.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.31 176.7 9.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.973 2.449 . . . . 0.0 111.261 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 p30 52.13 13.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.911 2.484 . . . . 0.0 115.042 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.3 m -121.35 -24.4 5.45 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.506 -0.747 . . . . 0.0 111.611 -164.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 89' ' ' ASP . 14.8 mt -80.22 141.55 35.5 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 m -127.26 165.98 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.52 1.928 . . . . 0.0 110.423 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -79.01 -2.52 40.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.532 1.133 . . . . 0.0 113.284 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.26 20.62 2.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 126.597 2.046 . . . . 0.0 109.714 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.78 132.9 52.37 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -75.48 138.01 41.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 165.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.84 167.69 21.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 126.267 1.827 . . . . 0.0 109.496 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -128.89 134.2 48.18 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.838 -1.164 . . . . 0.0 109.582 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.08 170.43 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.417 1.487 . . . . 0.0 109.753 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.57 137.87 5.96 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.96 142.94 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 109.198 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.444 ' CZ2' ' HG ' ' A' ' 76' ' ' LEU . 94.5 m95 -90.19 112.13 23.53 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -150.36 154.07 37.15 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 119.507 1.049 . . . . 0.0 110.419 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.86 -155.34 7.04 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -163.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.99 53.16 4.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.254 -1.303 . . . . 0.0 111.999 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -163.26 175.78 10.59 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.531 1.665 . . . . 0.0 112.768 162.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.444 ' HG ' ' CZ2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -84.54 145.51 28.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 156.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.591 ' SG ' HG11 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -118.14 83.82 2.07 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 127.737 2.415 . . . . 0.0 104.825 170.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -85.13 139.19 31.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.68 176.84 10.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 123.644 0.59 . . . . 0.0 110.58 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -105.57 168.81 8.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.045 1.338 . . . . 0.0 107.512 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.29 -179.99 40.53 Favored Glycine 0 C--N 1.334 0.454 0 O-C-N 120.759 -1.213 . . . . 0.0 112.76 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -128.03 169.91 13.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.47 1.508 . . . . 0.0 108.001 160.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.0 t -68.44 -40.26 81.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 118.861 0.755 . . . . 0.0 112.871 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 65.71 -43.92 0.37 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.801 2.04 . . . . 0.0 114.337 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -153.79 133.4 12.93 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.074 -1.641 . . . . 0.0 109.524 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.89 159.72 17.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.372 0.669 . . . . 0.0 109.33 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -138.05 -50.09 0.58 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.365 -0.835 . . . . 0.0 109.957 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.79 173.4 11.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.455 ' HA ' HD12 ' A' ' 60' ' ' LEU . 1.2 m-20 -66.4 -6.46 14.52 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.753 0.821 . . . . 0.0 111.798 169.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -117.62 -18.28 9.74 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -130.98 127.85 39.2 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -168.82 166.76 11.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 109.815 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.81 174.95 7.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.631 1.173 . . . . 0.0 110.184 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -142.98 137.49 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 109.02 158.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -91.65 123.6 35.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 160.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.84 140.88 38.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 109.893 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.05 158.62 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.886 1.274 . . . . 0.0 110.954 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.54 53.64 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 125.791 1.662 . . . . 0.0 115.821 165.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.14 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.561 3.544 . . . . 0.0 111.98 -173.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.591 HG11 ' SG ' ' A' ' 77' ' ' CYS . 2.6 t -73.55 137.57 23.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 CA-C-N 121.32 1.873 . . . . 0.0 114.436 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.275 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -54.19 -41.73 68.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.619 0.767 . . . . 0.0 109.51 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -5.01 66.55 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.037 0.827 . . . . 0.0 113.834 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -88.22 -10.11 50.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.99 1.395 . . . . 0.0 111.588 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' HD2' HG21 ' A' ' 100' ' ' VAL . 4.0 m-30 -117.93 -42.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.515 1.526 . . . . 0.0 109.592 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -99.45 146.81 25.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.08 1.352 . . . . 0.0 108.132 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -143.7 158.11 43.91 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -55.61 -20.12 12.59 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 126.453 1.901 . . . . 0.0 115.392 -164.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.2 mt -126.69 5.9 6.76 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -179.66 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.991 0.814 . . . . 0.0 110.587 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 129.36 56.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.715 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 m -118.75 140.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.402 HD21 ' CG ' ' A' ' 32' ' ' ASP . 0.8 OUTLIER -63.68 162.45 13.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.945 0.898 . . . . 0.0 110.291 170.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.82 45.18 2.77 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.892 0.877 . . . . 0.0 109.811 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 m -65.01 125.26 24.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 66' ' ' VAL . 23.9 t -131.95 127.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.024 1.729 . . . . 0.0 108.176 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 143.9 57.58 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.963 0.801 . . . . 0.0 109.778 172.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 59' ' ' THR . 48.9 mt . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 121.837 0.827 . . . . 0.0 113.203 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.93 149.57 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.402 ' CG ' HD21 ' A' ' 20' ' ' ASN . 6.2 t70 -150.35 123.16 8.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.61 -178.74 16.54 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.632 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.7 161.61 13.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 166.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.26 160.53 43.63 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.213 1.805 . . . . 0.0 109.622 161.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.98 135.6 33.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.89 153.74 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 159.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -131.52 -39.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.683 1.193 . . . . 0.0 110.279 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.4 m -152.9 123.49 7.27 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.97 1.308 . . . . 0.0 108.191 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 142.86 50.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.576 1.15 . . . . 0.0 109.645 -171.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -135.23 -169.81 2.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.754 1.622 . . . . 0.0 109.276 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.48 95.38 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -163.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -140.09 34.75 1.92 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.286 1.834 . . . . 0.0 108.376 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 146.33 36.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.28 168.59 19.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -130.83 142.86 50.41 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.514 1.926 . . . . 0.0 107.505 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -174.73 3.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.666 1.587 . . . . 0.0 109.894 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.7 mt 57.76 -177.37 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.628 1.571 . . . . 0.0 112.434 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.64 169.95 14.87 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.708 2.272 . . . . 0.0 112.061 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -57.25 154.57 33.85 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.394 1.396 . . . . 0.0 111.41 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.48 169.1 16.37 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.41 2.073 . . . . 0.0 109.093 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.17 44.79 6.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.485 ' CG2' HD22 ' A' ' 25' ' ' LEU . 89.0 m -138.75 -54.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.896 0.879 . . . . 0.0 109.195 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.78 137.95 58.16 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.678 171.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -147.16 160.88 41.92 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 66.8 mt-10 -69.94 -2.25 11.94 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -163.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.49 17.1 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 126.102 1.81 . . . . 0.0 111.137 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.67 28.22 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.88 129.94 38.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 23' ' ' VAL . 35.8 m -134.86 159.36 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.128 -172.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.63 104.96 5.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.82 160.46 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.468 ' CB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -148.63 137.46 21.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.99 144.62 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.164 0.986 . . . . 0.0 109.231 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.451 ' CE2' HD13 ' A' ' 76' ' ' LEU . 81.7 m95 -86.33 111.15 20.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -156.99 150.71 24.53 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.57 -56.14 1.65 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.098 1.332 . . . . 0.0 110.936 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.92 -9.48 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.716 1.627 . . . . 0.0 112.933 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.29 174.61 7.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.186 1.493 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.468 HD11 ' CB ' ' A' ' 69' ' ' SER . 31.8 tp -81.04 99.1 8.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -70.74 110.05 5.31 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 164.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 146.12 25.51 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.672 ' SG ' HG22 ' A' ' 100' ' ' VAL . 24.7 m -134.03 144.0 48.42 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.931 168.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.85 146.26 30.97 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.66 -177.52 22.96 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.23 0.919 . . . . 0.0 111.077 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -131.02 161.06 32.8 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 162.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.02 -31.08 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.29 -60.89 0.36 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.135 1.774 . . . . 0.0 111.139 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.4 m -153.27 122.73 6.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.799 2.04 . . . . 0.0 107.121 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.483 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.4 tp -91.6 156.04 17.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -130.06 -46.68 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 111.502 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.475 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 5.7 m-20 -138.3 -178.73 5.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.231 1.812 . . . . 0.0 107.273 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -21.22 9.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.891 1.676 . . . . 0.0 111.434 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -122.07 -53.98 1.93 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 125.518 1.527 . . . . 0.0 111.214 -163.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.475 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 32.2 mt-30 -85.67 133.47 34.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.784 0.72 . . . . 0.0 109.493 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -166.94 164.04 16.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 109.012 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.78 176.21 8.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.605 0.762 . . . . 0.0 109.927 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -152.73 127.63 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.778 1.631 . . . . 0.0 110.219 164.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.13 125.39 34.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 164.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.58 137.96 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.6 164.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 120.657 1.571 . . . . 0.0 113.354 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.1 -117.6 10.87 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 127.544 2.497 . . . . 0.0 107.525 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -145.53 153.58 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.69 1.596 . . . . 0.0 108.113 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.672 HG22 ' SG ' ' A' ' 79' ' ' CYS . 85.6 t -55.93 152.69 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.347 1.859 . . . . 0.0 110.438 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.675 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.401 ' CD1' HG23 ' A' ' 100' ' ' VAL . 3.9 m-30 -56.55 -42.38 78.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.539 1.535 . . . . 0.0 110.779 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.78 0.13 86.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.0 0.809 . . . . 0.0 113.524 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -84.43 -15.99 44.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.283 1.042 . . . . 0.0 111.207 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -116.21 -45.76 2.83 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.851 0.751 . . . . 0.0 111.367 -169.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.97 155.56 18.05 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.92 155.76 41.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -50.05 -27.41 5.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.727 3.211 . . . . 0.0 116.628 -168.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.49 1.51 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.608 1.163 . . . . 0.0 111.459 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.57 174.54 7.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 110.107 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -112.55 152.02 29.33 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.29 -0.881 . . . . 0.0 111.124 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.02 136.33 47.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.512 1.525 . . . . 0.0 107.181 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.01 164.55 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.5 mt -129.72 6.72 5.16 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -158.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.84 90.98 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.588 2.355 . . . . 0.0 112.841 -157.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.73 128.59 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -70.83 111.84 6.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.662 0.665 . . . . 0.0 109.613 165.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.766 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.319 0 CA-C-O 123.333 1.54 . . . . 0.0 114.588 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -136.6 102.7 5.0 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.156 1.382 . . . . 0.0 107.583 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 158.55 15.4 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.053 169.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -170.05 42.79 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 140.71 50.03 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.418 1.887 . . . . 0.0 108.486 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.43 155.13 50.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.969 0.804 . . . . 0.0 110.477 160.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.86 144.92 28.1 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.5 mt -70.77 157.68 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.065 1.346 . . . . 0.0 107.576 162.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -137.18 -56.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.745 2.018 . . . . 0.0 109.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -121.16 157.22 30.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.008 1.323 . . . . 0.0 109.176 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tt -153.64 118.63 5.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.07 94.65 3.08 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.203 1.401 . . . . 0.0 108.117 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.66 -127.38 43.21 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 p -71.24 36.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.994 1.397 . . . . 0.0 112.615 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -147.51 124.24 11.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.02 165.59 12.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 157.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -126.88 146.17 50.39 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 126.325 1.85 . . . . 0.0 108.297 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -138.24 157.9 45.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.709 1.604 . . . . 0.0 109.498 -159.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.42 26.71 2.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 90' ' ' ARG . 8.3 mt 51.19 -165.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.97 1.308 . . . . 0.0 111.276 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 C-N-CA 124.119 0.967 . . . . 0.0 111.776 168.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.34 170.75 10.3 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.383 2.722 . . . . 0.0 112.217 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HG2' HG21 ' A' ' 59' ' ' THR . 59.3 Cg_endo -66.51 154.58 73.84 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.271 1.314 . . . . 0.0 109.286 171.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.62 161.03 47.51 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 122.72 2.28 . . . . 0.0 111.786 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 47.0 33.84 2.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.426 1.89 . . . . 0.0 112.051 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.444 HG21 ' HG2' ' A' ' 56' ' ' PRO . 95.1 m -128.56 -18.96 3.84 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.298 -0.876 . . . . 0.0 111.855 -171.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 mt -76.01 143.26 41.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.803 0.729 . . . . 0.0 109.284 155.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -141.4 168.77 18.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.364 1.466 . . . . 0.0 108.81 159.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -69.23 -3.76 15.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.443 1.497 . . . . 0.0 114.722 -170.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.44 -2.79 25.94 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 117.851 -1.527 . . . . 0.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.36 131.14 49.31 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.587 1.694 . . . . 0.0 109.188 -164.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -85.56 72.89 10.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.25 1.5 . . . . 0.0 108.48 -167.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.03 154.13 7.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.884 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -134.18 128.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.05 0.94 . . . . 0.0 108.852 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -95.15 175.66 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.694 1.597 . . . . 0.0 110.208 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' HD21 ' A' ' 76' ' ' LEU . 54.0 p -154.71 162.08 41.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.019 1.327 . . . . 0.0 107.829 152.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 p -157.33 143.06 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.747 0.703 . . . . 0.0 109.676 159.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 68.3 m95 -90.29 117.14 28.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.8 t -136.52 170.38 16.16 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.263 1.425 . . . . 0.0 107.685 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 58.44 -107.66 1.21 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.82 32.17 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.482 1.515 . . . . 0.0 111.952 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.52 -170.11 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.055 1.342 . . . . 0.0 108.789 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.6 tm? -116.88 122.03 43.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.412 1.485 . . . . 0.0 110.317 172.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.11 129.1 51.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.44 164.39 25.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.773 1.169 . . . . 0.0 108.345 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.7 t -149.67 148.17 28.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.4 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -79.84 144.3 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.302 1.441 . . . . 0.0 108.043 168.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.11 -169.61 16.46 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.229 -0.919 . . . . 0.0 112.078 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -138.07 168.9 18.76 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 106.73 163.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.88 -27.5 37.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 67.91 -62.85 0.34 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.946 1.699 . . . . 0.0 113.369 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 m -149.32 129.26 13.43 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.569 1.947 . . . . 0.0 106.601 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.97 140.03 43.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -115.2 -52.89 2.66 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.838 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -137.45 169.72 17.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -18.14 57.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.059 0.543 . . . . 0.0 111.978 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.48 ' HA ' HD12 ' A' ' 49' ' ' LEU . 7.4 ptp180 -110.41 -15.86 13.83 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.799 172.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -120.48 123.3 42.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.805 1.638 . . . . 0.0 109.127 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -165.77 165.42 18.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.474 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 176.03 8.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.705 1.202 . . . . 0.0 110.596 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.9 pt -144.75 148.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.306 1.442 . . . . 0.0 109.048 155.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 ttp85 -116.37 112.38 21.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.734 1.614 . . . . 0.0 109.286 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.3 mt -75.59 126.25 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.848 1.659 . . . . 0.0 108.571 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.77 161.87 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 111.108 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.12 8.51 87.41 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.072 -1.404 . . . . 0.0 115.039 167.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.28 135.63 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.433 2.693 . . . . 0.0 111.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.401 HG23 ' CD1' ' A' ' 9' ' ' TYR . 7.8 t -86.65 127.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 120.163 1.347 . . . . 0.0 109.767 171.133 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.74 -47.6 77.64 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.609 -1.307 . . . . 0.0 110.895 -166.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.63 6.19 33.39 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 124.065 0.841 . . . . 0.0 113.537 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -84.95 -13.87 49.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.762 1.281 . . . . 0.0 110.65 166.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.454 ' HB3' HG21 ' A' ' 72' ' ' THR . 8.1 m-30 -123.74 -35.78 2.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.807 1.643 . . . . 0.0 112.965 -170.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 24.3 m-85 -108.49 122.17 46.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -172.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.54 159.6 16.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -60.32 -14.09 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.642 2.777 . . . . 0.0 114.203 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 mt -133.84 13.42 4.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.934 1.694 . . . . 0.0 109.911 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -97.36 163.91 12.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 127.008 2.123 . . . . 0.0 109.852 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -118.74 143.17 47.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.133 -0.98 . . . . 0.0 111.58 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.94 139.89 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.576 2.35 . . . . 0.0 104.721 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.519 ' O ' HD23 ' A' ' 21' ' ' LEU . 5.6 t-20 -62.58 156.06 24.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.264 172.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 20' ' ' ASN . 2.9 mt -132.01 93.72 3.34 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -80.32 90.02 5.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 t -85.31 102.11 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -55.02 120.96 7.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 117.21 -1.376 . . . . 0.0 109.708 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.921 0 C-N-CA 124.081 0.953 . . . . 0.0 112.419 173.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.565 ' HA ' HD22 ' A' ' 25' ' ' LEU . 3.6 m . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 122.049 0.928 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 25' ' ' LEU . 83.3 t80 -95.55 103.68 15.56 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 -172.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.2 109.21 19.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.53 164.52 12.16 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.303 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 138.9 43.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.18 34.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.34 148.91 24.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.2 mt -72.95 160.62 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.886 1.675 . . . . 0.0 108.761 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.1 p -133.45 -32.22 1.17 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.672 2.389 . . . . 0.0 111.294 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 m -151.55 142.98 23.49 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tp -141.18 114.28 8.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 110.646 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.31 32.19 5.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.872 0.869 . . . . 0.0 112.941 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 -113.09 2.86 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -67.98 22.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.365 1.466 . . . . 0.0 111.735 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 93' ' ' ALA . 2.8 tm? -148.83 126.78 11.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.58 163.63 22.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.413 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 43.9 m95 -124.97 146.14 49.54 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 127.264 2.226 . . . . 0.0 107.866 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.5 mt -138.88 161.35 37.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.092 1.495 . . . . 0.0 110.433 -156.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -146.33 36.47 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 49' ' ' LEU . 8.8 mt 54.25 -174.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.335 -1.478 . . . . 0.0 113.847 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.185 0 O-C-N 121.982 -0.449 . . . . 0.0 112.012 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 119.085 -0.484 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.23 165.33 29.01 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.841 2.36 . . . . 0.0 111.158 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.11 160.01 24.1 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.351 1.367 . . . . 0.0 110.961 171.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.92 160.49 11.85 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.515 2.143 . . . . 0.0 110.853 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 56.3 35.88 26.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.311 1.444 . . . . 0.0 111.411 -171.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -130.72 -40.25 1.22 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -172.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.1 mt -73.06 140.21 47.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -138.68 165.18 27.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.831 0.852 . . . . 0.0 109.702 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.604 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 58.9 mt-10 -70.79 -2.23 14.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.431 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.26 2.26 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 120.659 -1.275 . . . . 0.0 110.129 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.5 132.43 53.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 165.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.37 116.83 16.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 166.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.53 140.48 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.53 116.43 22.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -165.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.528 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.5 m -72.93 162.28 4.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 C-N-CA 124.045 0.938 . . . . 0.0 109.822 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -160.12 141.29 12.36 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.619 1.568 . . . . 0.0 112.031 150.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.91 158.3 10.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.165 1.386 . . . . 0.0 109.521 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -92.25 121.43 33.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.524 1.53 . . . . 0.0 107.428 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 12' ' ' TYR . 9.8 t -150.47 160.54 43.7 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.26 -117.93 3.07 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.03 20.63 5.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.343 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.51 172.34 17.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.445 2.123 . . . . 0.0 110.293 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.89 115.81 28.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.71 150.52 20.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -157.01 134.97 11.0 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 106.93 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 27.9 t -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 107.173 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.13 152.68 44.84 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -150.68 -175.95 23.16 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.755 -1.215 . . . . 0.0 111.618 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -129.21 172.33 11.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.01 0.924 . . . . 0.0 109.218 163.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.0 t -68.62 -32.44 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.5 -65.53 0.2 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.885 1.674 . . . . 0.0 111.993 -172.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -145.33 126.49 14.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.142 1.377 . . . . 0.0 108.072 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.604 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 2.8 tp -86.31 165.11 16.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.797 0.839 . . . . 0.0 109.156 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -137.24 -43.71 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.783 0.72 . . . . 0.0 112.643 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -141.58 177.25 8.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.9 -6.06 7.5 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.48 -1.387 . . . . 0.0 111.884 169.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.6 ptt180 -138.9 -1.82 1.76 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -127.85 134.88 49.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 120.32 1.418 . . . . 0.0 107.282 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.54 166.43 2.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -89.8 178.9 6.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.563 0.745 . . . . 0.0 110.627 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.6 pt -147.43 134.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.654 1.181 . . . . 0.0 111.109 160.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -90.72 127.37 36.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.079 0.952 . . . . 0.0 108.665 165.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -84.85 131.02 34.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG22 ' HA2' ' A' ' 81' ' ' GLY . 27.4 m -137.26 171.19 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 119.472 1.033 . . . . 0.0 111.463 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.35 13.31 64.91 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.998 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.6 163.69 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.418 3.887 . . . . 0.0 113.577 -173.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.1 p -112.1 127.67 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.907 2.483 . . . . 0.0 110.625 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 167.904 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -57.41 -48.23 79.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.421 1.464 . . . . 0.0 110.963 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -15.73 65.49 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 119.301 -0.722 . . . . 0.0 113.417 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -71.15 -21.04 62.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.591 1.195 . . . . 0.0 111.305 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 1.2 m-85 -112.03 -51.4 2.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.379 0.672 . . . . 0.0 109.539 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.14 161.75 27.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -145.42 161.08 40.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.527 -0.733 . . . . 0.0 112.07 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.86 -22.84 62.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.69 9.05 8.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.233 1.413 . . . . 0.0 111.072 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.47 174.97 1.49 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.384 0.611 . . . . 0.0 110.02 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 30.2 mtpt -116.7 146.03 43.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 109.042 166.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.56 156.76 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 109.826 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.12 141.57 28.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.936 2.094 . . . . 0.0 109.441 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.9 mt -130.98 70.99 1.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.881 1.273 . . . . 0.0 113.459 -162.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -60.98 133.58 56.24 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.043 -1.036 . . . . 0.0 108.277 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.681 HG22 HG12 ' A' ' 66' ' ' VAL . 10.2 t -126.71 121.11 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -62.56 137.23 58.22 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 120.52 1.509 . . . . 0.0 108.941 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 171.454 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 121.838 0.828 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -80.9 154.2 27.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.18 141.76 37.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 157.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.95 174.17 24.43 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 164.24 12.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.19 160.14 43.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.785 -1.197 . . . . 0.0 110.465 161.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 147.17 28.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 157.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.1 mt -79.43 157.46 4.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -130.56 -32.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.536 1.535 . . . . 0.0 111.36 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.9 m -152.23 155.14 37.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.066 1.746 . . . . 0.0 108.878 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.2 tp -147.25 112.61 5.57 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.179 1.391 . . . . 0.0 108.671 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -133.16 94.22 3.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 51.88 -131.3 36.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.404 -0.664 . . . . 0.0 111.794 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 p -74.66 43.59 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.422 1.889 . . . . 0.0 110.839 173.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.25 107.83 3.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.849 -0.532 . . . . 0.0 111.732 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.67 165.51 11.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 165.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 14.4 m95 -126.83 148.63 49.95 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.588 1.555 . . . . 0.0 108.0 164.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 mt -135.9 172.25 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.124 1.769 . . . . 0.0 109.272 -165.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -151.03 27.22 0.7 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 49' ' ' LEU . 7.1 mt 52.25 -174.15 0.03 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.36 1.864 . . . . 0.0 113.024 -173.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 125.822 1.649 . . . . 0.0 106.952 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.56 175.23 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.753 2.302 . . . . 0.0 112.391 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -58.97 154.76 42.66 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 121.106 1.204 . . . . 0.0 110.55 160.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -65.63 174.66 5.15 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.604 2.869 . . . . 0.0 110.156 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.2 p30 52.69 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.4 m -110.09 -31.34 7.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 111.193 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -69.59 139.61 53.68 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.101 -0.999 . . . . 0.0 110.085 168.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.02 156.71 45.98 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.26 . . . . 0.0 110.049 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.71 -1.7 14.76 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -168.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.12 18.26 4.76 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.113 1.816 . . . . 0.0 111.215 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.61 141.01 58.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.67 63.79 1.25 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 123.674 1.702 . . . . 0.0 111.663 -163.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.681 HG12 HG22 ' A' ' 23' ' ' VAL . 19.6 m -68.38 162.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.014 -1.903 . . . . 0.0 112.039 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 169.17 9.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.584 1.154 . . . . 0.0 109.787 173.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.89 123.75 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 125.478 1.511 . . . . 0.0 109.565 168.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -121.64 141.87 50.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.963 0.789 . . . . 0.0 110.607 162.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.4 146.79 15.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.85 2.06 . . . . 0.0 106.337 162.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.483 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 76.6 m95 -87.77 143.05 27.36 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 163.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 t -137.5 173.68 11.4 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.01 -98.62 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.753 2.121 . . . . 0.0 112.683 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.8 22.38 2.82 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.322 1.915 . . . . 0.0 111.927 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.71 174.73 11.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.049 1.924 . . . . 0.0 114.024 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.8 tm? -115.61 122.77 46.61 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.151 1.381 . . . . 0.0 110.738 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.86 81.45 1.77 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.099 1.36 . . . . 0.0 110.074 -168.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -99.25 128.22 45.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.57 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 12.3 t -128.17 172.44 11.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.726 0.81 . . . . 0.0 110.021 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.21 160.19 16.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.125 1.77 . . . . 0.0 108.702 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -165.69 -169.32 29.15 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -144.12 160.72 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.638 1.975 . . . . 0.0 109.1 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.274 51.3 t -62.52 -31.84 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 70.23 -66.11 0.29 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.107 2.163 . . . . 0.0 114.937 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -155.71 97.16 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.796 1.638 . . . . 0.0 108.915 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tp -79.09 152.89 30.57 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.18 -58.76 1.53 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.239 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -127.15 -173.54 2.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.24 -8.35 45.07 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.966 -1.084 . . . . 0.0 111.123 166.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -131.91 -44.89 0.95 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 112.574 -169.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -91.7 133.38 35.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -167.29 164.2 15.33 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.162 0.585 . . . . 0.0 109.724 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -80.85 175.31 10.79 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.25 1.42 . . . . 0.0 110.807 172.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.46 148.17 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.391 1.076 . . . . 0.0 109.188 156.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.24 114.96 26.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.595 2.758 . . . . 0.0 107.606 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.64 147.09 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.495 1.043 . . . . 0.0 108.573 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.426 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.8 m -135.83 146.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 122.335 1.064 . . . . 0.0 109.758 176.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.74 -141.85 31.28 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -166.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.32 138.37 29.45 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.666 1.186 . . . . 0.0 110.838 -165.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.4 p -85.34 129.85 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.044 1.738 . . . . 0.0 111.662 171.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 C-N-CA 125.914 1.686 . . . . 0.0 106.703 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.245 0.545 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -105.62 -47.71 3.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.439 1.495 . . . . 0.0 109.804 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.95 10.38 3.18 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.734 1.635 . . . . 0.0 113.363 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -90.85 -14.7 31.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.358 1.863 . . . . 0.0 112.484 165.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 100' ' ' VAL . 7.3 m-85 -121.52 -39.04 2.69 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.994 1.318 . . . . 0.0 112.329 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 61.0 m-85 -93.16 154.35 18.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -143.76 155.8 44.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -57.61 -21.7 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 126.279 1.832 . . . . 0.0 113.661 -170.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -124.39 6.47 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.019 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.462 HE21 HG21 ' A' ' 70' ' ' VAL . 2.7 mt-30 -72.16 169.0 17.01 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.508 -1.37 . . . . 0.0 110.865 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -99.79 153.31 19.23 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.04 148.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.379 1.871 . . . . 0.0 106.039 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.65 161.77 29.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.761 0.825 . . . . 0.0 111.274 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -133.37 41.68 3.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.935 0.894 . . . . 0.0 112.487 -163.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 m -66.62 100.7 0.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 25' ' ' LEU . 43.4 t -94.47 113.24 28.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -57.56 107.21 0.42 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-N 120.535 1.516 . . . . 0.0 109.334 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 126.168 1.787 . . . . 0.0 107.808 171.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.422 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.715 0 CA-C-O 121.647 0.737 . . . . 0.0 109.266 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -110.48 148.4 32.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 164.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -132.79 141.37 48.46 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.926 0.89 . . . . 0.0 110.429 166.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.15 -168.42 26.18 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.568 1.556 . . . . 0.0 110.73 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.2 m -129.26 148.85 51.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.64 162.08 32.91 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 162.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.26 144.65 25.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.04 153.53 8.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 163.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.3 p -130.89 -40.19 1.19 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.776 1.231 . . . . 0.0 110.398 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -140.88 154.51 46.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.873 2.069 . . . . 0.0 107.695 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.75 134.8 20.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -154.23 95.06 1.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.905 1.682 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 -110.8 3.29 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.861 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.5 p -100.09 36.26 1.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.597 1.198 . . . . 0.0 110.449 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.468 ' CD2' ' HB1' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -143.36 131.64 22.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.22 28.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -122.11 147.16 46.48 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.791 1.637 . . . . 0.0 108.154 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -140.2 156.73 46.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.898 1.679 . . . . 0.0 109.691 -163.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -143.53 35.89 1.31 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 mt 50.89 -170.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.9 1.28 . . . . 0.0 111.3 -171.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 126.227 1.811 . . . . 0.0 112.963 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 168.12 19.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.193 1.929 . . . . 0.0 110.152 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.94 155.76 66.17 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 120.986 1.124 . . . . 0.0 110.041 164.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.06 174.88 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.014 2.476 . . . . 0.0 108.293 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.99 23.51 12.64 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.986 -1.071 . . . . 0.0 111.34 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.4 m -137.59 -43.85 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.457 1.503 . . . . 0.0 110.182 -167.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 mt -70.96 135.65 48.02 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 120.126 1.33 . . . . 0.0 109.349 169.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.7 m -132.77 163.91 27.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.084 0.954 . . . . 0.0 111.046 168.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.96 -0.05 12.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.026 1.33 . . . . 0.0 114.178 -170.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.2 10.86 7.31 Favored Glycine 0 C--N 1.321 -0.283 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.428 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 128.19 34.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 71.22 1.41 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.076 1.417 . . . . 0.0 109.844 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.6 m -82.87 136.17 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.779 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.84 120.42 41.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.907 0.883 . . . . 0.0 109.157 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.7 m -86.93 155.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.3 p -142.76 155.66 44.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 153.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.462 HG21 HE21 ' A' ' 17' ' ' GLN . 11.1 p -150.87 150.88 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 164.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -100.06 120.5 39.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -156.74 157.04 34.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.2 42.36 62.66 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.944 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.8 -22.87 5.39 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.077 0.938 . . . . 0.0 113.733 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.8 164.17 16.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.892 1.346 . . . . 0.0 112.055 -158.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 tp -84.73 102.02 12.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.7 m -88.55 123.45 33.06 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.31 158.56 42.64 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 167.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 41.9 t -148.83 141.97 24.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.296 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.36 149.95 46.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 110.141 173.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -159.62 -167.48 20.31 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.602 -1.311 . . . . 0.0 112.747 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -139.49 178.96 6.84 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.156 1.782 . . . . 0.0 110.269 166.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.03 -46.01 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.989 1.315 . . . . 0.0 113.234 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 64.7 -58.87 0.24 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.627 2.371 . . . . 0.0 115.23 -167.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -132.44 133.63 44.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -104.8 162.58 13.18 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -139.02 -37.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 120.843 -1.161 . . . . 0.0 113.853 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.77 -175.7 4.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 164.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -68.51 1.69 2.92 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.189 -0.944 . . . . 0.0 112.457 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -134.06 -18.32 2.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -121.24 138.02 54.42 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.364 1.438 . . . . 0.0 107.221 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -172.68 164.13 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.951 0.9 . . . . 0.0 109.602 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.468 ' HB1' ' CD2' ' A' ' 44' ' ' LEU . . . -83.95 172.12 12.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.484 1.114 . . . . 0.0 109.344 168.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 pt -139.97 143.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.326 1.05 . . . . 0.0 109.156 153.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 130.55 46.06 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.685 1.194 . . . . 0.0 107.794 163.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.1 mt -87.44 135.09 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.561 HG22 ' HA2' ' A' ' 81' ' ' GLY . 6.2 m -135.85 157.23 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 122.33 1.062 . . . . 0.0 109.529 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.98 -109.67 2.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -165.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.6 166.5 31.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -96.47 148.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 1 C-N-CA 133.179 4.591 . . . . 0.0 110.79 154.579 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 . . . . . 0 C--O 1.237 0.4 0 C-N-CA 127.616 2.366 . . . . 0.0 107.346 160.936 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -62.52 -37.79 87.44 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.96 -0.462 . . . . 0.0 110.415 -170.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.41 44.07 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.26 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 mtt-85 -84.52 -16.15 43.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.66 1.23 . . . . 0.0 110.164 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -116.53 -45.85 2.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.184 1.794 . . . . 0.0 109.98 -172.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -91.4 168.39 11.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.282 1.033 . . . . 0.0 108.237 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -148.85 169.54 20.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.692 0.797 . . . . 0.0 109.183 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.453 ' HG2' HD12 ' A' ' 16' ' ' LEU . 9.4 pm0 -71.23 -20.73 62.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 ' HG2' ' A' ' 15' ' ' GLN . 5.4 mp -125.98 14.13 7.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.1 0.96 . . . . 0.0 109.138 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.443 HE22 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -74.43 -177.18 2.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.092 1.757 . . . . 0.0 110.542 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.99 33.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 120.926 -1.108 . . . . 0.0 111.042 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.67 144.86 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.529 1.131 . . . . 0.0 108.441 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.45 158.6 29.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.295 1.438 . . . . 0.0 109.934 167.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.8 mt -130.8 55.45 1.84 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.145 1.378 . . . . 0.0 109.72 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -69.06 130.26 42.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.38 130.42 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -71.17 114.6 9.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.778 1.627 . . . . 0.0 109.103 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 30' ' ' SER . 1.7 mm? . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' HD22 ' A' ' 25' ' ' LEU . 14.2 m . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 124.208 1.956 . . . . 0.0 112.961 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -132.05 147.27 52.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -139.02 130.41 27.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.55 -168.77 13.3 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.227 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 142.32 45.22 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.063 1.345 . . . . 0.0 107.808 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.68 153.93 51.77 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 164.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.79 38.81 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 156.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.5 mt -68.63 158.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 160.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.1 p -135.88 -18.52 1.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.779 1.632 . . . . 0.0 112.122 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 m -157.6 148.6 21.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -144.48 122.56 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -135.68 74.64 1.52 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.592 1.957 . . . . 0.0 107.953 -173.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.56 -123.78 29.84 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.6 p -77.1 34.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.777 1.288 . . . . 0.0 111.97 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -151.7 125.01 8.78 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.8 162.46 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 12.7 m95 -129.3 147.52 51.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.684 1.194 . . . . 0.0 110.452 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.62 173.45 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.68 1.592 . . . . 0.0 112.51 -167.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.37 19.95 1.37 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 90' ' ' ARG . 8.7 mt 55.51 -171.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.861 0.864 . . . . 0.0 112.943 -169.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 C-N-CA 126.005 1.722 . . . . 0.0 109.903 165.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.88 167.77 18.76 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.107 3.205 . . . . 0.0 112.996 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.12 154.23 71.78 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 121.204 1.269 . . . . 0.0 109.994 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.01 170.45 20.08 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.192 2.595 . . . . 0.0 110.765 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.47 -3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 128.211 2.605 . . . . 0.0 116.503 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.2 m -101.32 -24.34 14.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.025 1.33 . . . . 0.0 112.046 -161.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.5 mt -78.92 149.26 32.42 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 120.97 -1.082 . . . . 0.0 108.845 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.75 163.24 34.6 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.553 1.141 . . . . 0.0 108.447 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -70.67 -2.04 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 37.48 1.5 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 135.87 57.21 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 162.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.18 125.78 29.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 166.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.98 136.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.565 1.146 . . . . 0.0 109.616 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.63 131.83 41.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.82 154.71 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.7 p -145.29 146.98 31.87 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 157.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.443 HG21 HE22 ' A' ' 17' ' ' GLN . 10.5 p -149.87 147.75 15.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.239 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -89.38 117.98 28.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.0 t -151.17 169.86 20.86 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.62 -117.61 3.56 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -163.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.35 60.89 0.63 Allowed Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.97 -175.59 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.482 1.513 . . . . 0.0 109.053 176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.5 101.85 10.99 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.029 1.732 . . . . 0.0 108.933 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -71.71 107.9 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.74 133.56 39.7 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 165.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.21 133.2 47.44 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.51 152.25 28.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -167.91 -171.43 33.84 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.463 HH11 HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -134.16 167.14 21.22 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.9 -27.49 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 65.03 -64.16 0.17 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.129 1.772 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -149.36 110.25 4.32 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.319 2.247 . . . . 0.0 105.294 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tp -81.36 153.93 26.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 167.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -120.25 -71.36 0.74 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.03 179.48 3.94 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.116 1.766 . . . . 0.0 108.494 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.76 -2.3 0.22 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.421 2.688 . . . . 0.0 113.698 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.759 ' HB3' HD12 ' A' ' 49' ' ' LEU . 1.7 ptt85 -157.22 -38.13 0.07 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.1 -1.0 . . . . 0.0 113.151 -159.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.28 127.73 45.32 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -171.62 176.44 3.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.112 0.965 . . . . 0.0 109.308 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -104.19 179.92 4.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.338 1.055 . . . . 0.0 112.234 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -150.2 124.62 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.213 1.805 . . . . 0.0 111.654 167.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 114.18 26.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.25 1.42 . . . . 0.0 107.648 168.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -78.02 135.01 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.89 1.276 . . . . 0.0 108.129 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 HH11 ' A' ' 82' ' ' ARG . 19.5 m -136.89 167.65 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.163 0.585 . . . . 0.0 111.121 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.93 15.61 80.91 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 118.502 -1.165 . . . . 0.0 114.616 164.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.22 165.23 0.19 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.815 2.046 . . . . 0.0 111.006 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -116.59 137.45 50.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -72.91 -50.03 26.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.791 -1.193 . . . . 0.0 110.141 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.32 -24.05 77.38 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.547 0.612 . . . . 0.0 113.0 -164.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -61.79 -21.24 64.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.518 172.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -113.6 -40.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.034 1.334 . . . . 0.0 111.49 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CE1' HG12 ' A' ' 70' ' ' VAL . 99.2 m-85 -102.67 112.06 24.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.536 1.534 . . . . 0.0 108.606 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.18 157.49 19.34 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.605 0.566 . . . . 0.0 109.932 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.0 -27.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.522 2.729 . . . . 0.0 113.859 163.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.37 41.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.241 1.416 . . . . 0.0 108.561 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.481 HE21 HG21 ' A' ' 70' ' ' VAL . 3.1 mt-30 -113.0 159.9 18.66 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.462 1.105 . . . . 0.0 108.96 164.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 148.12 32.94 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.065 -1.022 . . . . 0.0 110.404 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.47 155.3 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.337 1.055 . . . . 0.0 108.763 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 161.09 5.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.238 0.615 . . . . 0.0 110.839 162.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.73 44.46 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.588 2.355 . . . . 0.0 108.303 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.2 m -68.2 114.59 6.82 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.47 104.73 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -50.12 114.54 1.12 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 165.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 CA--C 1.512 -0.518 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 167.539 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.315 1.2 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.64 166.69 23.31 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 105.933 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -152.59 154.95 36.42 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.04 11.52 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -133.67 151.71 51.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.9 151.0 39.25 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 167.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 145.57 26.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 166.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.0 156.32 7.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 168.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 p -132.8 -22.79 2.07 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.926 2.09 . . . . 0.0 111.819 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -157.05 132.82 9.41 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.537 1.535 . . . . 0.0 108.237 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.463 HD22 ' O ' ' A' ' 44' ' ' LEU . 1.1 tm? -126.74 146.72 50.12 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.404 1.081 . . . . 0.0 108.621 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -161.8 88.11 0.69 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.229 1.012 . . . . 0.0 111.633 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.26 -125.92 37.0 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.1 p -80.48 45.0 0.74 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.041 0.92 . . . . 0.0 110.903 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 40' ' ' LEU . 6.8 tp -153.05 129.34 10.53 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.53 149.82 51.69 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.459 ' C ' HD13 ' A' ' 47' ' ' LEU . 15.8 m95 -114.45 132.42 56.26 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.21 1.404 . . . . 0.0 108.73 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.489 HD21 HG12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -122.31 156.06 34.66 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.044 1.338 . . . . 0.0 109.9 -176.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -137.91 23.98 2.83 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -169.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 mt 51.37 140.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 130.671 3.589 . . . . 0.0 115.58 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.238 0.495 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.42 170.7 17.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.373 2.049 . . . . 0.0 112.317 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.54 154.19 74.84 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.15 1.9 . . . . 0.0 111.09 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.51 167.48 25.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.973 2.449 . . . . 0.0 111.424 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 49.23 26.22 1.45 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.904 2.081 . . . . 0.0 111.966 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.1 m -122.8 -55.79 1.79 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.115 1.366 . . . . 0.0 108.021 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.17 130.27 41.44 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 168.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 m -143.11 163.6 32.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 40.1 mt-10 -78.18 0.73 23.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.412 1.085 . . . . 0.0 113.713 -164.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.62 21.67 3.05 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 124.9 21.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.59 117.29 11.93 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.22 153.68 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 124.929 1.291 . . . . 0.0 107.843 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 p -125.71 130.46 51.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.105 0.866 . . . . 0.0 111.104 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.6 m -81.28 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.436 ' HB2' HD21 ' A' ' 76' ' ' LEU . 45.0 p -165.75 131.38 2.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.326 2.25 . . . . 0.0 106.428 154.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG21 HE21 ' A' ' 17' ' ' GLN . 11.1 p -136.16 138.3 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -81.73 112.28 18.75 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 168.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -114.2 -166.09 1.07 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 168.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.78 127.49 14.69 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.66 2.53 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.22 -0.767 . . . . 0.0 111.413 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.7 174.19 11.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.908 1.354 . . . . 0.0 111.368 -154.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 69' ' ' SER . 0.4 OUTLIER -84.59 117.74 23.92 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 173.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.462 ' SG ' HG13 ' A' ' 70' ' ' VAL . 15.0 p -99.55 122.16 42.21 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.71 162.12 32.81 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.412 ' H ' HG22 ' A' ' 68' ' ' VAL . 22.4 t -155.4 166.8 32.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.8 140.88 52.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.75 -175.57 22.11 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 123.552 0.596 . . . . 0.0 114.021 -160.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -133.35 163.84 28.43 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 166.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.3 t -65.17 -39.97 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.141 0.882 . . . . 0.0 111.961 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 64.9 -48.52 0.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.161 2.585 . . . . 0.0 113.921 -167.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 m -153.79 101.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.27 1.428 . . . . 0.0 107.685 -166.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.411 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.0 tp -81.9 161.63 23.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -133.85 -41.46 0.84 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.735 0.814 . . . . 0.0 111.792 171.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.37 173.63 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.706 2.002 . . . . 0.0 105.982 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.2 -10.2 1.85 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.975 2.11 . . . . 0.0 112.943 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -127.74 -24.4 3.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.839 1.656 . . . . 0.0 112.234 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -120.46 121.09 37.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -162.33 163.48 27.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.932 0.396 . . . . 0.0 110.038 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.11 171.55 10.17 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.029 171.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 47' ' ' LEU . 11.3 pt -146.85 131.05 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.201 1.8 . . . . 0.0 108.638 163.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.32 119.48 31.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.47 125.83 29.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.93 158.24 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.13 -154.26 49.28 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -173.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 137.46 51.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.084 -2.058 . . . . 0.0 108.214 -171.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.52 149.62 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 . . . . . 0 C--O 1.234 0.251 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 164.883 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -59.4 -47.94 83.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 111.08 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.4 -16.61 71.62 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.792 0.71 . . . . 0.0 112.671 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -74.7 -10.54 59.63 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.72 -0.871 . . . . 0.0 111.525 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 100' ' ' VAL . 3.3 m-30 -120.19 -40.93 2.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.331 1.452 . . . . 0.0 110.574 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -101.17 104.57 15.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -83.08 157.12 22.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 169.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.572 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.8 tt0 -62.42 -15.13 47.5 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 127.286 2.234 . . . . 0.0 114.805 -173.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 15' ' ' GLN . 7.1 mp -127.81 2.61 6.03 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.446 1.098 . . . . 0.0 111.203 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.45 HE21 HG21 ' A' ' 70' ' ' VAL . 2.6 mt-30 -71.43 178.83 3.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 111.712 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.81 157.61 18.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.427 1.091 . . . . 0.0 110.283 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.66 146.07 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 108.769 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -65.41 153.09 42.29 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.605 0.639 . . . . 0.0 109.387 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.83 51.39 1.53 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.328 0.651 . . . . 0.0 111.477 -165.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 112.96 4.39 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.131 -0.98 . . . . 0.0 110.294 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.64 109.6 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.029 1.332 . . . . 0.0 109.576 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -62.2 130.15 44.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.216 1.807 . . . . 0.0 109.941 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 124.493 1.117 . . . . 0.0 108.914 176.914 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -137.06 151.06 48.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 164.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.6 141.19 31.92 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.764 1.226 . . . . 0.0 108.186 166.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.23 -173.06 17.13 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.218 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.45 124.48 38.53 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.05 1.34 . . . . 0.0 107.637 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.77 149.95 45.57 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.672 1.989 . . . . 0.0 107.079 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.67 153.34 17.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.9 mt -75.19 162.62 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.625 1.57 . . . . 0.0 107.622 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.7 p -140.1 -40.85 0.43 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.986 1.715 . . . . 0.0 111.641 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 m -137.3 145.82 43.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 45' ' ' ALA . 1.6 tp -136.0 138.52 42.33 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.569 -1.332 . . . . 0.0 107.863 171.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -145.42 87.8 1.82 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.717 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.46 -119.04 16.84 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 124.37 0.986 . . . . 0.0 111.245 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 p -73.85 36.71 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.764 1.226 . . . . 0.0 111.795 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -145.16 134.95 23.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.568 -1.332 . . . . 0.0 107.725 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB2' HD12 ' A' ' 40' ' ' LEU . . . -131.24 163.25 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 161.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -122.07 140.85 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.155 1.782 . . . . 0.0 107.638 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.21 167.45 12.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.9 127.7 25.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.544 1.938 . . . . 0.0 108.29 162.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.2 mt -52.62 146.55 9.93 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 177.947 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.57 174.2 6.74 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.441 2.761 . . . . 0.0 110.775 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.84 158.11 44.49 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 120.81 1.007 . . . . 0.0 110.274 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.99 169.58 20.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.518 2.145 . . . . 0.0 111.105 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 56.12 13.7 1.26 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.402 1.881 . . . . 0.0 113.252 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.0 m -110.18 -53.25 2.7 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.834 1.253 . . . . 0.0 107.851 -166.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.88 150.25 20.77 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.403 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -144.15 163.4 33.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.685 0.794 . . . . 0.0 111.633 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 22.2 mt-10 -71.7 -7.8 50.22 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 10.43 7.58 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 124.696 1.141 . . . . 0.0 112.392 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . . . -59.58 137.35 58.05 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.21 64.0 8.32 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.532 1.158 . . . . 0.0 111.487 -168.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.88 131.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -84.95 165.94 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.83 119.33 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 124.513 1.125 . . . . 0.0 109.565 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -121.57 145.45 47.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.981 0.912 . . . . 0.0 109.432 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.45 HG21 HE21 ' A' ' 17' ' ' GLN . 9.5 p -153.78 159.16 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 165.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -94.43 106.66 18.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 t -145.57 168.77 19.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.492 0.717 . . . . 0.0 109.216 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.8 28.26 38.56 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.599 -1.112 . . . . 0.0 113.202 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.08 6.36 88.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.27 1.414 . . . . 0.0 113.904 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 176.16 9.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 112.463 -166.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.4 tp -104.71 96.29 6.48 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.933 1.693 . . . . 0.0 107.967 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.2 p -80.16 140.0 36.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -146.05 112.53 5.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.662 -0.649 . . . . 0.0 111.801 168.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 48.3 t -107.63 172.4 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.931 0.872 . . . . 0.0 111.108 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.88 154.34 24.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.774 2.43 . . . . 0.0 107.472 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.74 -166.71 33.65 Favored Glycine 0 C--O 1.239 0.458 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.517 1.527 . . . . 0.0 109.761 173.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 64' ' ' ALA . 78.2 t -70.51 -31.19 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.836 0.854 . . . . 0.0 112.658 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 68.88 -61.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.72 2.008 . . . . 0.0 112.704 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 m -146.21 115.51 7.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.142 2.177 . . . . 0.0 106.392 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.2 tp -84.78 155.97 21.59 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -128.78 -58.34 1.16 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.714 -0.616 . . . . 0.0 110.636 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -123.24 172.67 8.45 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 107.114 170.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -7.87 25.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.929 0.492 . . . . 0.0 111.08 164.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.88 -7.4 8.98 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 125.507 1.523 . . . . 0.0 114.933 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.42 130.12 25.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -162.39 162.99 28.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 118.168 0.44 . . . . 0.0 110.123 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.44 178.49 8.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.488 0.715 . . . . 0.0 109.582 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 pt -142.45 157.2 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 125.122 1.369 . . . . 0.0 108.735 156.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.77 113.91 22.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.193 2.197 . . . . 0.0 106.138 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.99 149.73 44.7 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 174.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.987 0.915 . . . . 0.0 110.624 170.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.52 -111.81 2.63 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 126.354 1.93 . . . . 0.0 109.134 -170.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.28 21.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.53 1.932 . . . . 0.0 109.999 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.487 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.5 p -121.24 156.15 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.705 2.002 . . . . 0.0 110.673 172.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 128.628 2.771 . . . . 0.0 107.279 -161.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -39.34 82.04 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.364 -0.835 . . . . 0.0 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.42 -14.32 74.5 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 118.293 -1.282 . . . . 0.0 112.587 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.93 -40.93 95.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.014 1.907 . . . . 0.0 109.989 166.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' CE2' HG13 ' A' ' 100' ' ' VAL . 2.7 m-30 -86.27 -46.38 10.39 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.265 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.18 105.47 17.63 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.496 1.118 . . . . 0.0 109.378 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -85.95 160.09 19.47 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 127.403 2.281 . . . . 0.0 110.31 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.28 -24.66 67.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -171.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -130.95 16.49 5.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.58 1.552 . . . . 0.0 109.342 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.628 HE21 HG21 ' A' ' 70' ' ' VAL . 3.8 mt-30 -66.05 171.95 4.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 165.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 159.48 16.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 167.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.17 164.49 29.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.461 HD22 ' HA ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -76.75 159.6 30.02 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.397 167.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -120.28 45.48 2.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.579 1.081 . . . . 0.0 109.981 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 m -71.11 95.02 1.18 Allowed 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.71 130.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.307 0.958 . . . . 0.0 109.017 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -70.85 121.23 17.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 109.214 168.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 31' ' ' PHE . 3.0 mm? . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.948 0.88 . . . . 0.0 109.024 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.537 ' H ' HD23 ' A' ' 25' ' ' LEU . 77.8 t80 -84.8 158.6 20.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.7 1.2 . . . . 0.0 108.224 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.41 144.76 22.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.449 0.7 . . . . 0.0 109.993 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 -168.36 31.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.414 0.531 . . . . 0.0 112.256 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 133.32 56.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.548 1.539 . . . . 0.0 108.721 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.15 39.35 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 162.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.1 147.81 40.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.406 1.082 . . . . 0.0 109.003 164.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.6 mt -75.35 159.02 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.858 1.663 . . . . 0.0 106.83 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.7 p -141.89 -33.17 0.5 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.301 1.84 . . . . 0.0 112.325 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.43 137.05 12.17 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.789 -1.194 . . . . 0.0 110.971 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.402 HD22 ' H ' ' A' ' 41' ' ' LYS . 1.9 tm? -135.28 141.19 45.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 126.234 1.814 . . . . 0.0 107.627 -173.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' H ' HD22 ' A' ' 40' ' ' LEU . 1.5 ttmm -159.77 93.61 1.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.27 -135.92 36.97 Favored Glycine 0 C--O 1.229 -0.184 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.27 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.83 2.052 . . . . 0.0 113.176 170.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 tp -140.35 118.42 11.92 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 119.408 1.004 . . . . 0.0 109.825 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.38 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 16.0 m95 -128.5 135.83 49.97 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.938 2.095 . . . . 0.0 108.283 170.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.62 177.23 5.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.017 1.727 . . . . 0.0 111.328 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -148.15 131.27 16.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.923 2.489 . . . . 0.0 107.054 167.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.33 157.46 4.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.836 1.654 . . . . 0.0 112.716 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.34 0.162 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 161.96 43.03 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.781 1.654 . . . . 0.0 110.264 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -63.49 162.08 28.93 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 120.82 1.014 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.19 150.12 32.83 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.272 2.648 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 60.49 9.69 2.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.382 2.273 . . . . 0.0 114.074 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.9 m -88.6 -57.35 2.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.354 1.862 . . . . 0.0 111.542 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.95 131.27 50.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -122.98 159.05 29.15 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.65 0.78 . . . . 0.0 110.425 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.25 -5.1 25.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.553 0.741 . . . . 0.0 112.511 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.72 14.69 7.15 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-O 117.588 -1.673 . . . . 0.0 112.25 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.25 133.07 54.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.845 1.322 . . . . 0.0 107.624 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -83.83 110.83 18.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.48 133.86 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.241 0.616 . . . . 0.0 110.497 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.48 137.32 34.7 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.074 0.95 . . . . 0.0 108.569 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.6 126.11 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 124.29 1.036 . . . . 0.0 109.108 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 p -112.5 152.0 29.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.628 HG21 HE21 ' A' ' 17' ' ' GLN . 7.7 p -151.24 142.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 153.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -83.66 121.42 27.24 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.81 148.21 33.77 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.16 -89.47 0.33 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.866 1.222 . . . . 0.0 113.132 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.37 5.94 1.91 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.919 0.771 . . . . 0.0 112.97 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.99 177.28 9.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.212 1.506 . . . . 0.0 111.847 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.2 117.43 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 166.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.66 118.09 35.44 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -133.65 135.5 44.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.443 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 12.1 t -135.24 176.42 8.68 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.402 1.081 . . . . 0.0 108.867 177.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.04 147.38 45.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.85 -170.62 24.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.297 0.951 . . . . 0.0 111.165 -174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -134.13 172.62 12.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.856 1.662 . . . . 0.0 109.116 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -69.36 -35.57 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.913 1.233 . . . . 0.0 113.123 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.52 -62.23 0.44 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.821 2.048 . . . . 0.0 112.665 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -143.62 121.89 12.28 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.202 2.201 . . . . 0.0 106.422 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.42 160.53 18.29 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -123.15 -52.98 1.84 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.397 168.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.28 169.55 17.47 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.024 1.73 . . . . 0.0 107.648 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -4.74 1.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 112.37 170.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -128.47 -14.88 4.64 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 126.017 1.727 . . . . 0.0 113.575 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -138.99 124.98 19.9 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -170.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -165.73 165.79 18.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -83.49 173.58 11.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.467 1.107 . . . . 0.0 110.543 171.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.93 148.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.87 1.668 . . . . 0.0 107.997 154.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -113.54 125.35 54.09 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 125.011 1.324 . . . . 0.0 107.802 168.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.91 144.16 27.81 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.777 1.631 . . . . 0.0 106.781 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.79 146.98 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.777 0.717 . . . . 0.0 111.834 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.78 -99.08 0.32 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 126.069 1.795 . . . . 0.0 109.197 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 164.94 35.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 112.558 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.446 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -106.28 150.68 8.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.877 2.471 . . . . 0.0 110.199 160.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 125.431 1.492 . . . . 0.0 107.255 150.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CD1' HG12 ' A' ' 100' ' ' VAL . 3.3 m-85 -61.07 -38.45 86.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.015 1.28 . . . . 0.0 111.005 -171.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.36 1.51 65.17 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.85 0.738 . . . . 0.0 112.96 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -83.89 -4.42 58.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.577 1.689 . . . . 0.0 110.636 164.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.546 ' CE2' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -118.26 -49.48 2.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.255 1.422 . . . . 0.0 107.957 -178.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -98.92 105.09 17.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.896 1.278 . . . . 0.0 107.575 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -103.95 161.06 14.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.273 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -154.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.75 10.44 7.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.41 1.884 . . . . 0.0 111.008 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -65.28 172.58 3.04 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -108.28 153.87 22.61 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.455 -0.778 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.94 158.05 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.732 1.213 . . . . 0.0 110.482 166.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -74.04 161.71 29.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.39 2.276 . . . . 0.0 111.669 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.96 49.66 1.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.73 1.612 . . . . 0.0 112.769 -167.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 m -66.74 108.8 2.62 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.244 -1.535 . . . . 0.0 109.514 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.81 124.3 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.092 1.757 . . . . 0.0 108.875 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -64.85 124.07 21.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 59' ' ' THR . 55.6 mt . . . . . 0 N--CA 1.468 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 112.715 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -86.58 152.84 22.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 164.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.8 132.44 14.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.14 -170.86 21.21 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.517 1.532 . . . . 0.0 109.625 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.31 162.43 13.68 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.099 1.36 . . . . 0.0 108.289 171.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.0 172.28 13.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.959 0.904 . . . . 0.0 110.185 157.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.84 145.53 28.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.83 1.332 . . . . 0.0 108.559 163.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.3 mt -71.51 157.76 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.842 2.057 . . . . 0.0 106.97 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 p -140.91 -46.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.502 1.121 . . . . 0.0 112.362 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -135.94 136.06 40.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.248 1.419 . . . . 0.0 107.933 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 41' ' ' LYS . 2.1 tm? -145.66 137.4 25.22 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 123.161 1.457 . . . . 0.0 110.218 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' H ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -152.08 93.02 1.78 Allowed 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.641 -177.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.24 -110.24 0.84 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.174 1.368 . . . . 0.0 111.535 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 95' ' ' ARG . 57.8 p -68.08 -7.26 27.97 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.009 1.724 . . . . 0.0 115.62 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.34 114.02 20.74 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 120.233 1.379 . . . . 0.0 111.063 -173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.1 157.81 16.61 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 163.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -122.4 142.23 50.74 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.151 2.18 . . . . 0.0 109.239 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.4 mt -135.05 154.78 51.58 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.767 1.227 . . . . 0.0 110.089 -163.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.68 33.26 4.03 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 49.12 -174.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.437 1.895 . . . . 0.0 114.494 -169.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.512 -0.482 0 C-N-CA 124.049 0.94 . . . . 0.0 111.748 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 C--O 1.237 0.431 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.05 171.18 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.3 2.0 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -57.15 154.52 33.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.129 1.219 . . . . 0.0 109.418 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.59 164.88 29.36 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.773 1.649 . . . . 0.0 109.59 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 p30 56.18 21.48 5.27 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.93 1.692 . . . . 0.0 114.079 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 25' ' ' LEU . 47.3 m -124.49 -11.74 7.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.734 0.814 . . . . 0.0 111.124 -168.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.8 ' HB3' HD21 ' A' ' 86' ' ' LEU . 10.8 mt -88.67 140.36 29.53 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.396 1.453 . . . . 0.0 110.672 156.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -146.33 160.12 42.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.023 0.929 . . . . 0.0 111.785 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.97 -2.0 6.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.56 1.944 . . . . 0.0 115.338 -172.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.16 2.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 125.25 1.405 . . . . 0.0 110.661 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.68 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.3 122.16 31.5 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 m -140.7 154.74 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 110.26 -166.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.24 150.83 41.76 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.4 -0.812 . . . . 0.0 110.068 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.55 120.05 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.32 1.048 . . . . 0.0 110.879 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -129.16 137.68 51.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -154.5 153.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -89.27 113.26 24.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.8 t -151.24 144.46 24.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.01 44.97 41.99 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.389 0.995 . . . . 0.0 111.44 -171.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.77 -15.86 2.1 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.447 1.499 . . . . 0.0 114.502 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.9 153.82 21.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.611 1.705 . . . . 0.0 110.715 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.3 tp -80.7 94.9 6.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.44 139.59 47.83 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.67 134.99 29.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.736 -0.603 . . . . 0.0 110.269 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 8.0 t -137.93 160.97 37.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 111.652 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.97 159.68 14.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.663 1.185 . . . . 0.0 109.05 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.92 -176.1 30.59 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.557 1.551 . . . . 0.0 111.439 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -130.34 171.17 13.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 161.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.531 HG11 HD23 ' A' ' 86' ' ' LEU . 48.6 t -66.79 -35.78 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.819 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 6.1 tp10 65.36 -59.91 0.26 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.262 2.225 . . . . 0.0 112.918 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 93' ' ' ALA . 2.5 m -128.36 133.63 48.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 60' ' ' LEU . 1.4 tm? -108.64 170.98 7.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 166.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -140.49 -47.47 0.42 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 116.734 -1.987 . . . . 0.0 115.996 152.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.11 167.43 19.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.21 6.14 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.737 1.615 . . . . 0.0 111.713 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -134.49 -19.74 1.87 Allowed 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.946 -1.721 . . . . 0.0 115.563 170.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -129.16 123.82 33.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 121.183 1.81 . . . . 0.0 108.197 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CB ' HD22 ' A' ' 86' ' ' LEU . 18.3 p90 -166.79 177.72 6.31 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.61 0.364 . . . . 0.0 110.248 -172.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' A' ' 85' ' ' THR . . . -108.62 175.66 5.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.291 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -145.22 130.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 125.38 1.472 . . . . 0.0 109.116 165.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HD2' ' HB2' ' A' ' 43' ' ' SER . 18.3 tpt85 -87.48 114.16 23.84 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 125.902 1.681 . . . . 0.0 107.31 162.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.4 mt -68.89 135.07 50.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.85 148.45 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.169 0.985 . . . . 0.0 109.822 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.09 -107.44 2.06 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.23 168.39 27.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.045 1.338 . . . . 0.0 110.84 174.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.546 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -109.36 153.06 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 128.046 2.538 . . . . 0.0 111.167 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.906 0.86 . . . . 0.0 109.436 150.078 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 100' ' ' VAL . 7.1 m-30 -55.57 -37.76 68.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.947 -1.096 . . . . 0.0 110.574 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.87 -1.13 45.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.474 1.512 . . . . 0.0 112.736 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -72.67 -16.76 61.69 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.012 1.406 . . . . 0.0 111.626 165.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.53 -59.65 1.53 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.81 153.08 27.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.84 157.6 45.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.426 ' HB3' HD12 ' A' ' 16' ' ' LEU . 36.2 tt0 -54.6 -22.56 13.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.943 1.697 . . . . 0.0 114.282 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 15' ' ' GLN . 5.6 mp -127.14 8.38 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 111.954 -172.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.67 166.39 22.01 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.277 -0.89 . . . . 0.0 110.933 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -94.67 160.08 14.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.47 170.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.34 163.08 18.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.042 1.337 . . . . 0.0 109.24 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -80.23 158.5 26.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.455 0.702 . . . . 0.0 110.378 164.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 35' ' ' ALA . 72.1 mt -127.53 51.5 1.91 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.689 1.595 . . . . 0.0 111.09 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -59.34 126.7 28.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.66 121.1 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -63.84 139.56 58.78 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.457 1.48 . . . . 0.0 108.746 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.556 HD22 HG22 ' A' ' 59' ' ' THR . 35.7 mt . . . . . 0 C--O 1.235 0.293 0 C-N-CA 124.02 0.928 . . . . 0.0 112.421 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.437 -1.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -96.5 143.12 27.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 163.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.82 102.41 4.56 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.65 -171.71 15.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.364 0.983 . . . . 0.0 112.446 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -110.6 144.75 39.01 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.277 1.831 . . . . 0.0 107.938 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -138.96 161.8 36.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.548 -0.72 . . . . 0.0 111.034 157.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.57 137.95 32.52 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 113.964 -1.471 . . . . 0.0 107.594 159.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.64 155.04 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -136.02 -22.42 1.39 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.028 1.731 . . . . 0.0 112.185 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -153.55 152.62 31.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 120.923 -1.111 . . . . 0.0 108.104 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.3 tp -156.42 122.2 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -145.48 79.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.96 -139.98 27.0 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.98 2.11 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 127.921 2.488 . . . . 0.0 114.617 168.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 132.27 56.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.999 1.727 . . . . 0.0 108.592 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.35 171.68 12.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 161.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 15.6 m95 -134.15 144.18 48.38 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.426 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.23 177.37 5.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.926 1.29 . . . . 0.0 110.042 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -144.02 32.27 1.25 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 mt 47.99 -173.1 0.01 OUTLIER 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.51 1.148 . . . . 0.0 112.77 -162.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.239 1.016 . . . . 0.0 108.27 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.241 0.619 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.66 167.19 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.667 1.578 . . . . 0.0 111.111 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.28 156.67 39.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.67 2.247 . . . . 0.0 111.445 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.69 162.97 16.77 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.018 2.478 . . . . 0.0 110.413 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 50.14 21.74 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 168.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.556 HG22 HD22 ' A' ' 25' ' ' LEU . 85.4 m -114.77 -30.93 6.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.075 0.95 . . . . 0.0 111.368 -168.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mt -73.84 145.68 44.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.041 1.336 . . . . 0.0 109.704 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -148.46 162.54 39.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 46.3 mt-10 -70.43 -1.93 12.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.178 1.391 . . . . 0.0 114.11 -168.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.62 6.98 9.67 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.153 1.835 . . . . 0.0 111.836 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.93 123.23 19.26 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.07 116.82 6.87 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.89 131.63 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 138.19 50.43 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.835 1.254 . . . . 0.0 108.297 -167.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.61 143.39 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 124.325 1.05 . . . . 0.0 109.098 -166.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.17 126.73 12.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 0.0 109.053 -174.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -152.26 161.45 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.287 1.435 . . . . 0.0 110.246 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -113.14 131.71 55.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.996 1.318 . . . . 0.0 110.238 -170.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -148.19 49.04 1.04 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 111.055 -163.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.63 -97.49 0.25 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.575 1.559 . . . . 0.0 109.407 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.82 0.29 9.98 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.83 1.681 . . . . 0.0 113.569 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.62 171.1 14.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.813 1.306 . . . . 0.0 111.937 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.78 109.66 21.33 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.208 2.203 . . . . 0.0 107.559 177.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -85.02 108.0 17.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.53 162.78 25.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 35.4 t -157.7 168.35 27.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.18 0.925 . . . . 0.0 109.631 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.02 152.66 18.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.222 1.809 . . . . 0.0 107.517 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.18 -177.86 37.95 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -138.62 165.2 27.52 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.482 1.113 . . . . 0.0 109.949 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.74 -34.48 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.65 -66.85 0.15 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.342 1.857 . . . . 0.0 112.656 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.0 m -142.25 117.34 10.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.921 2.488 . . . . 0.0 106.402 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.4 tp -89.47 160.74 16.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -125.51 -56.12 1.51 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -148.39 175.61 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.71 23.31 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.198 1.399 . . . . 0.0 112.173 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -147.03 -6.59 0.49 Allowed 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 166.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -138.6 131.15 28.99 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 120.585 1.539 . . . . 0.0 107.208 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -166.13 158.91 14.8 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.138 1.375 . . . . 0.0 109.412 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -80.49 175.63 10.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.917 1.287 . . . . 0.0 109.861 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.37 139.54 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.525 1.13 . . . . 0.0 108.408 158.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -93.93 111.77 23.53 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -72.55 139.54 47.59 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.61 139.59 50.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 123.708 0.63 . . . . 0.0 110.753 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.66 -88.97 1.18 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 124.441 1.02 . . . . 0.0 112.116 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 149.1 16.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.982 1.313 . . . . 0.0 110.119 -175.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG23 ' CD1' ' A' ' 9' ' ' TYR . 39.9 t -106.8 114.71 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 158.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -58.54 -46.63 86.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.468 0.707 . . . . 0.0 109.679 -168.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.61 -0.58 80.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.713 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -73.41 -28.86 62.23 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.573 1.686 . . . . 0.0 109.903 164.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' CE2' HG13 ' A' ' 100' ' ' VAL . 7.1 m-30 -107.16 -41.68 5.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.295 1.038 . . . . 0.0 110.416 -168.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.26 116.38 30.36 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -94.94 154.39 17.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 -23.68 6.99 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 127.033 2.133 . . . . 0.0 114.102 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -129.67 8.72 5.38 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.77 1.628 . . . . 0.0 111.397 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.13 175.85 4.25 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.301 -0.874 . . . . 0.0 110.36 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE3' ' CE1' ' A' ' 50' ' ' PHE . 47.3 mtpt -114.29 145.97 41.07 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.034 0.934 . . . . 0.0 108.588 168.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 153.02 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.823 0.849 . . . . 0.0 109.768 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -68.85 154.73 41.48 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.052 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.6 mt -129.6 21.91 5.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -158.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -52.51 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.346 1.458 . . . . 0.0 112.871 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.17 135.22 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.114 1.324 . . . . 0.0 108.13 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -82.1 125.08 30.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 124.341 1.056 . . . . 0.0 112.923 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.282 0.0 OUTLIER . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -142.13 144.49 33.52 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.986 1.715 . . . . 0.0 108.563 173.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.86 136.76 48.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.24 -174.76 21.72 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.17 0.891 . . . . 0.0 110.896 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.09 146.55 45.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.309 1.043 . . . . 0.0 108.677 170.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.37 149.71 36.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.02 31.27 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.5 mt -75.32 155.93 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 164.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -133.91 -41.14 0.84 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.057 0.943 . . . . 0.0 111.759 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -141.56 153.76 45.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.835 1.254 . . . . 0.0 108.238 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 133.97 18.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -140.51 75.13 1.49 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.88 2.072 . . . . 0.0 107.589 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.95 -116.1 6.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.279 1.418 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.6 p -64.13 11.17 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.511 1.525 . . . . 0.0 114.966 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 117.1 11.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.17 166.28 15.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -128.82 155.92 44.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.33 1.052 . . . . 0.0 109.578 174.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.46 150.66 35.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.721 2.008 . . . . 0.0 108.227 -163.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -150.04 130.39 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 164.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -57.35 157.92 6.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.107 2.563 . . . . 0.0 113.087 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE1' ' HE3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 126.249 1.82 . . . . 0.0 112.113 -166.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 120.04 -0.028 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.63 167.19 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.948 2.432 . . . . 0.0 111.849 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -62.81 161.73 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.129 1.886 . . . . 0.0 112.427 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.05 158.72 46.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.022 1.815 . . . . 0.0 111.169 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 49.22 22.64 0.68 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.658 1.983 . . . . 0.0 113.902 171.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -94.68 -46.98 6.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.075 1.75 . . . . 0.0 109.146 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.92 155.24 40.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.644 1.577 . . . . 0.0 109.496 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -145.72 171.38 14.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.275 1.03 . . . . 0.0 108.273 158.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -73.13 -7.2 50.29 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -166.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.65 2.9 27.62 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 116.936 -2.036 . . . . 0.0 111.679 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.46 138.88 58.55 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.326 1.563 . . . . 0.0 107.936 -167.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.3 64.22 3.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.973 1.368 . . . . 0.0 109.303 -155.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.52 136.68 23.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.862 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -87.13 174.38 8.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 123.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.421 1.488 . . . . 0.0 109.395 170.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -118.95 152.7 35.87 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.025 0.829 . . . . 0.0 109.477 167.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.92 142.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 108.54 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.93 113.16 15.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -156.5 170.58 22.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 14.19 25.65 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.92 -0.933 . . . . 0.0 115.178 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 5.3 82.92 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.946 1.873 . . . . 0.0 115.03 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.76 -168.01 2.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.572 1.549 . . . . 0.0 108.491 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.6 tp -99.99 125.77 46.07 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 163.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -92.32 141.02 29.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.37 1.468 . . . . 0.0 107.496 167.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -145.01 121.89 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 160.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.7 t -111.39 166.71 10.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.843 0.83 . . . . 0.0 109.09 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.14 133.07 55.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.84 -167.29 15.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 113.1 -165.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -137.37 171.0 15.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.519 1.528 . . . . 0.0 108.242 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.66 -30.18 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 72.24 -64.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.632 1.973 . . . . 0.0 111.531 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -148.35 123.64 10.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.455 2.302 . . . . 0.0 105.701 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.2 152.03 19.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 167.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.44 -47.46 2.34 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.234 0.614 . . . . 0.0 109.851 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -143.58 175.66 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -54.27 -20.95 7.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.29 11.24 4.55 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.86 115.24 13.42 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -163.3 168.42 20.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -173.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.74 178.63 6.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.099 1.76 . . . . 0.0 111.16 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 pt -144.05 145.84 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.979 1.311 . . . . 0.0 109.771 152.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.42 119.92 40.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 171.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.67 138.55 33.27 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.39 164.92 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.963 0.905 . . . . 0.0 109.857 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.55 8.61 63.38 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.408 -1.218 . . . . 0.0 115.426 165.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 62.83 143.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.436 2.295 . . . . 0.0 111.855 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 77' ' ' CYS . 1.4 p -95.85 154.77 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 125.909 1.684 . . . . 0.0 110.182 170.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.445 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -70.07 84.73 0.52 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.899 1.279 . . . . 0.0 110.961 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 m -147.9 41.42 1.01 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.376 1.87 . . . . 0.0 109.423 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 44.87 62.34 2.13 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 128.006 2.522 . . . . 0.0 111.615 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.55 172.51 2.61 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.055 1.342 . . . . 0.0 112.512 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.4 -165.02 18.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.639 1.59 . . . . 0.0 110.447 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 m -137.0 -81.78 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.96 7.99 11.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.276 1.031 . . . . 0.0 111.123 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -60.98 -45.34 95.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.948 -1.095 . . . . 0.0 110.028 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.41 3.38 16.72 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.181 0.42 . . . . 0.0 113.556 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.225 -1.75 . . . . 0.0 110.116 166.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.85 -46.29 2.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.363 1.065 . . . . 0.0 111.3 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.4 155.69 22.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.721 1.609 . . . . 0.0 107.575 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -144.35 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.602 ' C ' HD12 ' A' ' 16' ' ' LEU . 9.3 tt0 -60.8 -15.17 27.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.253 1.821 . . . . 0.0 115.524 -170.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 15' ' ' GLN . 7.2 mp -130.84 1.35 4.35 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.632 1.573 . . . . 0.0 110.29 -173.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.98 165.8 23.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 155.68 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.32 144.69 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 106.374 -167.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -63.79 166.65 6.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.969 0.508 . . . . 0.0 110.058 160.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.3 mt -142.0 49.27 1.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.76 1.624 . . . . 0.0 109.563 -170.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -58.6 103.31 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 121.024 1.738 . . . . 0.0 109.003 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG22 HG12 ' A' ' 66' ' ' VAL . 82.4 t -95.66 119.32 43.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 121.633 2.015 . . . . 0.0 106.296 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -59.58 118.78 6.48 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.9 87.77 2.87 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.62 65.07 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.441 -0.787 . . . . 0.0 113.311 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -95.12 -11.12 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.224 1.009 . . . . 0.0 112.913 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.89 -48.41 1.13 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.715 0.689 . . . . 0.0 111.252 -164.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.47 -112.89 0.54 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 125.684 1.612 . . . . 0.0 113.893 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.27 166.3 25.11 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 160.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -141.65 109.15 5.61 Favored 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 120.9 -1.125 . . . . 0.0 108.209 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -125.24 95.41 4.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -154.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 -167.45 14.46 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.646 1.117 . . . . 0.0 112.163 -168.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.82 145.38 51.97 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.961 0.904 . . . . 0.0 108.596 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.68 145.9 31.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 167.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.1 32.52 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 165.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.43 158.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.034 1.734 . . . . 0.0 107.521 166.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 p -131.4 -30.75 1.67 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 112.372 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.7 m -145.55 130.72 18.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.264 1.826 . . . . 0.0 106.532 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 tp -131.71 123.18 27.19 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.397 1.479 . . . . 0.0 107.715 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.72 84.74 2.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -172.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 -122.06 17.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.68 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.3 p -68.27 -12.42 60.99 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 117.627 0.714 . . . . 0.0 112.657 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 tp -106.29 139.06 41.39 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 110.36 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.18 168.05 16.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 164.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -133.58 138.51 46.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.775 2.03 . . . . 0.0 109.302 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -127.95 162.87 25.76 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.734 1.614 . . . . 0.0 110.938 -160.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.41 24.23 2.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.4 mt 53.14 -171.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.956 0.902 . . . . 0.0 111.936 -168.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.0 -12.24 5.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.462 1.105 . . . . 0.0 113.241 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 179.18 179.51 48.73 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 120.967 -1.083 . . . . 0.0 111.167 -164.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.84 -9.09 57.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.445 1.098 . . . . 0.0 113.026 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -74.49 94.86 2.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.79 1.177 . . . . 0.0 108.247 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -129.05 154.97 80.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.923 2.089 . . . . 0.0 108.054 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.85 171.08 17.26 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.407 2.738 . . . . 0.0 112.899 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.63 156.43 52.79 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.149 1.9 . . . . 0.0 111.15 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -66.51 170.97 11.34 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.265 2.644 . . . . 0.0 109.783 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 p30 53.95 1.29 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 m -101.03 -48.0 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.694 0.679 . . . . 0.0 110.404 -163.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.23 144.67 56.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -141.51 163.63 32.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.396 0.678 . . . . 0.0 110.395 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 62.9 mt-10 -73.36 -5.96 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.799 1.239 . . . . 0.0 113.691 -167.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.98 28.83 2.79 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.33 136.14 57.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 167.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.48 125.89 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 165.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG12 HG22 ' A' ' 23' ' ' VAL . 20.7 m -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 t -124.22 135.39 53.41 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.645 1.212 . . . . 0.0 108.977 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.43 156.62 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 112.385 -2.189 . . . . 0.0 106.709 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.59 ' HB2' HD21 ' A' ' 76' ' ' LEU . 21.2 p -151.01 133.51 15.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.551 164.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -137.87 146.13 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.501 1.12 . . . . 0.0 109.201 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -96.37 132.58 41.73 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -141.14 95.62 2.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 43.78 42.43 6.22 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 118.853 2.301 . . . . 0.0 118.853 159.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.73 -40.54 0.2 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 121.01 2.405 . . . . 0.0 112.341 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.0 -178.18 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.105 0.955 . . . . 0.0 109.327 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -87.01 113.17 22.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 55.5 m -89.44 108.33 19.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -121.8 158.2 29.38 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.63 136.86 22.37 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.11 158.6 32.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.11 -179.56 39.1 Favored Glycine 0 N--CA 1.443 -0.871 0 O-C-N 121.131 -0.98 . . . . 0.0 112.118 -171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -127.19 162.13 26.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -32.13 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.603 0.761 . . . . 0.0 110.415 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.26 -66.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.29 2.236 . . . . 0.0 113.42 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.9 m -152.13 95.89 2.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.092 1.315 . . . . 0.0 108.232 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 1.7 tp -70.06 162.13 28.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -132.87 -41.8 0.92 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.347 -0.845 . . . . 0.0 109.681 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -148.81 172.9 13.9 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -61.12 -6.0 1.77 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.809 2.043 . . . . 0.0 112.465 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -139.66 -11.53 1.17 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.559 2.344 . . . . 0.0 114.606 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -123.71 125.31 44.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -167.11 158.65 12.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.899 0.857 . . . . 0.0 109.173 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.84 176.01 9.97 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.405 1.482 . . . . 0.0 110.849 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.67 150.21 13.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.97 113.8 18.29 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.842 1.257 . . . . 0.0 108.473 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.8 133.0 45.24 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.288 1.835 . . . . 0.0 108.749 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.07 158.38 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.103 1.361 . . . . 0.0 110.327 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.78 80.17 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 119.215 -0.769 . . . . 0.0 112.417 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 59.38 166.78 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.103 2.561 . . . . 0.0 114.009 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -104.39 113.76 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 161.48 14.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.992 0.917 . . . . 0.0 110.446 169.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.04 76.5 5.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.164 2.186 . . . . 0.0 108.933 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.512 HD13 ' HG3' ' A' ' 78' ' ' ARG . 8.0 mp -71.0 -44.1 66.6 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.775 -1.203 . . . . 0.0 112.34 -169.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -121.3 161.35 22.17 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.357 1.863 . . . . 0.0 106.845 -171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.0 45.26 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 111.579 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 44.29 69.72 0.39 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.718 1.607 . . . . 0.0 110.402 169.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -66.18 83.37 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.526 1.53 . . . . 0.0 110.096 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -128.6 108.84 10.84 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 127.776 2.43 . . . . 0.0 104.728 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 C--O 1.254 1.311 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 161.187 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.4 ttp -131.62 13.46 4.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.078 1.351 . . . . 0.0 109.9 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -52.16 110.19 0.46 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 165.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.0 121.83 30.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 153.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.34 163.18 16.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.323 1.049 . . . . 0.0 109.314 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.08 68.23 0.7 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.413 1.006 . . . . 0.0 111.187 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.3 t -155.79 -15.2 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -6.66 10.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.814 1.643 . . . . 0.0 112.034 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -55.41 -36.8 66.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.922 -1.111 . . . . 0.0 111.099 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.23 -14.45 76.73 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.255 -0.747 . . . . 0.0 113.108 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -75.12 -12.16 60.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.345 1.572 . . . . 0.0 110.744 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.422 ' HA ' HG21 ' A' ' 72' ' ' THR . 3.2 m-85 -118.72 -45.82 2.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.301 1.44 . . . . 0.0 110.439 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -95.7 116.39 28.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.491 1.116 . . . . 0.0 109.621 171.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 167.63 16.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 109.529 166.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.33 -18.45 55.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.558 0.743 . . . . 0.0 112.941 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.0 mt -127.28 14.09 7.18 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.088 1.355 . . . . 0.0 109.983 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.79 171.81 8.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.721 0.809 . . . . 0.0 109.827 173.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -108.76 149.74 28.6 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 m -142.44 157.51 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.658 1.183 . . . . 0.0 111.381 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -72.88 158.41 35.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.549 1.14 . . . . 0.0 112.048 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -131.24 60.94 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.001 1.72 . . . . 0.0 109.391 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m -78.73 110.11 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.931 -1.105 . . . . 0.0 108.424 174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.52 133.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.345 1.458 . . . . 0.0 108.375 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.12 147.85 46.19 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.06 1.3 . . . . 0.0 110.217 173.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.2 mt -132.15 77.9 1.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.058 1.743 . . . . 0.0 108.038 169.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.3 30.6 69.23 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.116 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t70 74.99 -55.21 0.65 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.433 2.293 . . . . 0.0 112.578 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.0 p -71.28 -4.08 23.93 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 113.003 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.77 164.56 29.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.4 m -144.43 165.11 28.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.409 1.484 . . . . 0.0 107.754 166.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -95.36 157.18 16.01 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 163.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -143.27 125.15 15.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 163.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.77 -171.8 14.16 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 166.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.4 m -116.9 162.89 17.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.53 157.1 46.39 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.491 156.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.92 140.97 40.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 157.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.95 158.2 5.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.3 p -136.92 -28.74 0.94 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 m -154.57 124.02 6.49 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tt -143.98 129.76 19.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.651 1.114 . . . . 0.0 110.251 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -144.22 104.26 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.94 -131.29 44.33 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 124.196 0.903 . . . . 0.0 112.205 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.39 37.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.754 1.222 . . . . 0.0 112.111 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.14 117.36 9.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.784 1.234 . . . . 0.0 107.937 162.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.4 155.82 20.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 156.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -118.93 147.77 43.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.608 1.963 . . . . 0.0 108.778 164.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.67 166.5 13.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.345 1.858 . . . . 0.0 110.478 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.3 65.41 1.25 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.537 0.735 . . . . 0.0 110.089 162.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt 45.3 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.329 3.051 . . . . 0.0 116.081 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -110.35 179.47 4.08 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.929 0.892 . . . . 0.0 111.186 159.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.21 -12.57 26.95 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -159.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.19 -32.87 11.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 110.487 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -141.31 171.78 13.58 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.409 0.684 . . . . 0.0 111.24 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -164.62 155.58 13.1 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.938 2.095 . . . . 0.0 108.534 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.41 169.92 16.01 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.405 2.07 . . . . 0.0 110.564 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.58 154.8 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.951 1.101 . . . . 0.0 110.586 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -63.42 168.54 11.11 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.086 1.857 . . . . 0.0 108.935 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.77 5.96 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.2 m -108.48 -47.04 3.57 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.958 1.303 . . . . 0.0 110.844 -163.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -64.85 138.2 58.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.958 0.903 . . . . 0.0 109.182 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -137.1 158.98 43.22 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -74.14 -8.61 56.77 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -164.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.13 22.52 4.23 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 126.235 1.874 . . . . 0.0 109.422 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 125.72 24.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.02 135.88 54.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 164.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.51 163.59 35.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.849 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -122.78 153.43 39.54 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 160.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.51 145.33 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 p -147.7 146.32 29.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.78 143.55 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.066 0.946 . . . . 0.0 110.272 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.499 ' CH2' ' HG3' ' A' ' 106' ' ' ARG . 98.4 m95 -81.57 74.74 8.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.561 1.945 . . . . 0.0 111.365 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 12' ' ' TYR 0.254 3.4 t -97.65 100.87 12.27 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.388 -0.82 . . . . 0.0 109.435 -170.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.52 33.98 3.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.514 2.483 . . . . 0.0 116.392 161.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.26 -65.97 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -167.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -171.18 -164.57 0.36 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.175 2.19 . . . . 0.0 107.822 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -76.95 94.32 3.93 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 134.9 54.76 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 155.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.13 161.23 36.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.8 t -157.46 175.71 13.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -114.71 156.38 24.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -164.8 178.3 40.0 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 120.455 -1.403 . . . . 0.0 111.697 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.817 HH11 HG21 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -128.78 159.04 36.95 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 166.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -58.7 -30.89 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.005 0.522 . . . . 0.0 111.984 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 65.69 -61.57 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.479 2.312 . . . . 0.0 111.161 -171.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -147.11 126.98 13.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.242 2.217 . . . . 0.0 105.658 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.55 157.11 16.19 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.4 ttm-85 -124.8 -44.43 1.95 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.869 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.37 176.38 11.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.8 -1.6 0.92 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.799 0.84 . . . . 0.0 112.325 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -130.78 -13.9 3.63 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.564 1.546 . . . . 0.0 113.579 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.64 136.74 46.68 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.877 1.271 . . . . 0.0 108.6 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -175.45 166.02 3.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.366 1.066 . . . . 0.0 109.696 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.37 177.62 5.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.053 1.341 . . . . 0.0 110.671 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.07 127.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.149 1.379 . . . . 0.0 108.782 157.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -74.13 137.89 43.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 156.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -99.05 136.75 38.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.817 HG21 HH11 ' A' ' 82' ' ' ARG . 16.8 m -135.48 138.04 48.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.946 0.879 . . . . 0.0 111.93 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.24 -107.47 3.06 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.17 142.53 7.26 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 126.155 1.782 . . . . 0.0 106.315 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.04 134.67 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -150.81 156.97 42.33 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.161 0.892 . . . . 0.0 110.592 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.32 136.65 52.11 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 166.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.67 -13.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 117.701 -1.142 . . . . 0.0 112.46 162.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -133.28 143.95 49.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.809 1.64 . . . . 0.0 110.095 -161.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -137.81 155.42 49.03 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.499 ' HG3' ' CH2' ' A' ' 71' ' ' TRP . 37.1 mtp180 -79.39 129.35 34.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.423 1.489 . . . . 0.0 109.065 -173.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -81.29 31.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.193 0.997 . . . . 0.0 112.141 -176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -136.03 20.58 3.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.193 1.397 . . . . 0.0 112.843 -168.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 128.092 2.557 . . . . 0.0 114.473 -173.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.9 mtp 53.67 -168.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.266 1.027 . . . . 0.0 109.822 -160.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m 66.43 -84.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.089 1.756 . . . . 0.0 112.878 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.9 -42.53 0.37 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 130.263 3.425 . . . . 0.0 114.495 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.13 -168.73 2.27 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 127.285 2.234 . . . . 0.0 108.84 173.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.46 -96.92 0.11 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t 57.87 -176.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.431 1.115 . . . . 0.0 110.456 -168.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.26 0.27 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.046 2.139 . . . . 0.0 113.397 -169.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -64.77 -39.25 93.3 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.246 -1.534 . . . . 0.0 109.539 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.67 -0.98 74.68 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.962 -169.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -85.85 -17.06 36.68 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.203 1.001 . . . . 0.0 111.038 163.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -105.91 -53.51 2.63 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.029 0.931 . . . . 0.0 110.442 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.44 155.72 22.1 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -142.98 153.63 43.2 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -63.03 -18.03 62.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -165.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.55 8.52 5.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.73 1.612 . . . . 0.0 110.223 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -73.87 169.39 17.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.796 -1.19 . . . . 0.0 108.905 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.81 17.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.689 170.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.29 165.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.515 1.126 . . . . 0.0 109.846 164.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.55 177.75 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.883 2.473 . . . . 0.0 112.266 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 23' ' ' VAL . 61.3 mt -138.21 22.56 2.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.818 1.644 . . . . 0.0 115.113 -174.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -62.8 106.74 0.85 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.957 1.708 . . . . 0.0 110.572 -167.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 66' ' ' VAL . 67.9 t -99.12 139.77 20.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.639 1.575 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -74.51 121.17 21.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 161.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.7 84.45 1.93 Allowed 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 160.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.09 134.04 27.94 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 63.92 -5.96 0.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.61 2.764 . . . . 0.0 116.304 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 -33.41 4.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.596 -176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.96 126.84 5.86 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 125.352 1.453 . . . . 0.0 111.902 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.31 161.34 4.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 111.831 -160.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -130.41 139.29 50.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.09 147.75 50.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.615 0.722 . . . . 0.0 110.271 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.75 -162.81 15.27 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -131.79 162.79 29.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.21 161.67 41.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 156.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 140.19 41.07 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 156.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.2 mt -69.25 158.61 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 161.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.6 p -131.96 -31.28 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.444 1.898 . . . . 0.0 111.96 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.14 145.17 31.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 tp -161.81 101.62 1.15 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -172.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -121.49 78.67 1.46 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.755 1.622 . . . . 0.0 106.875 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.04 -117.85 10.37 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 14.1 p -64.82 -0.48 1.5 Allowed 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 115.817 -2.039 . . . . 0.0 113.914 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -127.04 137.47 53.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.95 1.25 . . . . 0.0 108.193 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.59 166.6 23.9 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.048 0.939 . . . . 0.0 108.527 168.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -129.49 149.44 51.26 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.784 1.634 . . . . 0.0 108.402 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.77 171.37 8.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.573 1.949 . . . . 0.0 110.94 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.66 58.5 1.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.477 1.132 . . . . 0.0 111.229 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 mt 47.72 -169.87 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.663 1.985 . . . . 0.0 114.407 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 -18.61 3.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.72 126.3 3.68 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.152 0.882 . . . . 0.0 111.565 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 69.36 -50.76 0.61 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 130.215 3.406 . . . . 0.0 114.413 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -70.84 98.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.042 1.337 . . . . 0.0 107.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -129.6 152.38 79.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.516 0.727 . . . . 0.0 111.548 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.61 164.84 34.38 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.402 2.735 . . . . 0.0 112.586 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.83 160.76 35.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.866 1.711 . . . . 0.0 111.587 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.98 159.58 24.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.568 2.179 . . . . 0.0 112.313 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 44.79 32.69 0.84 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.873 2.069 . . . . 0.0 112.213 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 m -111.64 -56.72 2.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.363 1.065 . . . . 0.0 108.155 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.47 127.52 30.05 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -127.65 159.68 33.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.61 -3.92 17.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.35 19.1 4.34 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.772 2.129 . . . . 0.0 110.881 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.97 131.09 49.55 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.33 123.42 25.32 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.642 HG12 HG22 ' A' ' 23' ' ' VAL . 34.9 m -134.42 163.8 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.274 -176.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.39 131.08 43.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.02 0.928 . . . . 0.0 108.852 -173.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.48 139.82 19.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -140.91 156.83 46.01 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.085 0.857 . . . . 0.0 110.283 159.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 p -160.86 149.13 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.197 1.799 . . . . 0.0 107.166 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.403 ' CE2' HD13 ' A' ' 76' ' ' LEU . 92.6 m95 -88.1 120.82 29.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 166.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 t -151.07 119.48 6.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.66 -162.44 47.85 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -159.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.27 2.08 22.48 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.867 1.223 . . . . 0.0 114.662 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.33 172.82 12.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 118.958 1.379 . . . . 0.0 110.767 -174.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.403 HD13 ' CE2' ' A' ' 71' ' ' TRP . 23.5 tp -73.9 168.74 18.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.11 153.03 49.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 154.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.27 155.63 50.31 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 171.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HB2' HG22 ' A' ' 100' ' ' VAL . 17.6 t -144.86 156.52 44.05 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 155.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -99.21 150.19 22.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.83 41.59 Favored Glycine 0 CA--C 1.523 0.593 0 O-C-N 120.958 -1.088 . . . . 0.0 110.911 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -128.02 169.15 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.648 0.779 . . . . 0.0 109.005 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.18 -35.35 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.131 0.973 . . . . 0.0 112.837 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 65.92 -54.14 0.38 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.764 2.426 . . . . 0.0 113.707 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -150.27 139.39 21.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.745 1.218 . . . . 0.0 108.264 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -115.77 152.29 33.55 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.52 -52.96 0.72 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.532 -169.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.54 174.93 7.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 159.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -55.5 -30.85 61.41 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.041 1.337 . . . . 0.0 111.821 166.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -104.27 -11.66 17.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -132.24 124.02 28.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 120.535 1.516 . . . . 0.0 108.596 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -162.4 166.29 25.27 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 124.536 1.148 . . . . 0.0 110.45 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.84 179.78 5.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.753 1.221 . . . . 0.0 110.209 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.71 133.7 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.435 1.494 . . . . 0.0 108.677 164.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -108.39 111.72 23.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.379 1.472 . . . . 0.0 107.674 174.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.5 mt -71.94 144.71 48.83 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.241 1.417 . . . . 0.0 107.563 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.59 153.65 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.557 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.32 -106.96 0.65 Allowed Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 125.721 1.629 . . . . 0.0 109.077 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.59 168.98 23.84 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.4 1.48 . . . . 0.0 110.825 -167.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 79' ' ' CYS . 78.8 t -93.47 156.27 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.018 0.927 . . . . 0.0 109.749 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.92 162.33 35.75 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.752 1.221 . . . . 0.0 110.296 150.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.46 143.37 57.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 151.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.38 -6.03 5.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.252 175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -152.93 153.67 33.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.029 2.132 . . . . 0.0 107.398 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.38 161.74 31.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.285 1.402 . . . . 0.0 110.954 171.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -108.64 0.11 20.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.172 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -77.06 48.75 0.62 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.469 1.108 . . . . 0.0 112.099 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -127.49 18.26 6.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.128 2.571 . . . . 0.0 111.445 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 C-N-CA 127.254 2.222 . . . . 0.0 111.019 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.408 0 CA-C-O 118.457 -1.191 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.86 32.67 17.95 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.331 1.065 . . . . 0.0 111.699 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m 66.32 118.95 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.093 2.157 . . . . 0.0 110.827 -169.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.58 173.39 11.99 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.94 0.876 . . . . 0.0 110.589 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 58.55 171.51 0.06 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.396 2.278 . . . . 0.0 110.784 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.16 -84.39 0.19 Allowed Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m 174.99 -71.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.657 2.783 . . . . 0.0 104.185 159.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.89 -1.42 4.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 126.484 1.914 . . . . 0.0 110.156 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -54.59 -39.99 68.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 120.092 1.315 . . . . 0.0 111.606 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.18 -6.06 55.92 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.478 1.037 . . . . 0.0 112.717 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.45 -16.89 55.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.16 -1.2 . . . . 0.0 111.373 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -118.78 -27.8 5.74 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.723 1.209 . . . . 0.0 110.422 -173.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -125.83 144.25 50.73 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.445 1.117 . . . . 0.0 111.992 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.62 156.01 49.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.597 -173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.469 ' HG2' HD12 ' A' ' 16' ' ' LEU . 1.5 pm0 -62.13 -17.31 57.46 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -174.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 15' ' ' GLN . 5.9 mp -124.49 13.41 8.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 118.884 0.765 . . . . 0.0 109.416 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.73 167.68 21.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.163 0.585 . . . . 0.0 109.575 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.64 147.77 32.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.859 0.864 . . . . 0.0 108.981 170.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -141.5 165.93 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.767 0.827 . . . . 0.0 111.099 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.23 165.55 24.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.043 1.737 . . . . 0.0 112.231 165.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -138.34 19.67 2.75 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.13 116.94 1.7 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.683 -1.151 . . . . 0.0 111.238 -161.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.5 116.05 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -64.21 133.61 53.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.657 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.2 mt -128.68 82.8 2.11 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.818 1.647 . . . . 0.0 107.031 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.14 37.66 94.87 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 122.077 -0.39 . . . . 0.0 113.887 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.91 10.46 3.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.16 2.184 . . . . 0.0 113.514 158.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -154.3 -35.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.475 1.11 . . . . 0.0 110.047 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.78 2.72 31.0 Favored Glycine 0 C--O 1.22 -0.719 0 O-C-N 121.077 -1.014 . . . . 0.0 115.434 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -54.36 135.97 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.902 1.281 . . . . 0.0 111.951 -161.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.6 150.22 26.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.97 125.52 15.79 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 126.583 1.953 . . . . 0.0 106.003 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.97 -174.82 23.03 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -118.57 159.21 23.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.75 156.5 40.42 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 118.581 0.628 . . . . 0.0 110.986 161.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.12 130.78 35.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 125.177 1.548 . . . . 0.0 108.008 160.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.89 159.79 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 158.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -132.4 -36.76 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.244 1.418 . . . . 0.0 110.932 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.7 m -145.77 138.27 25.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.743 1.217 . . . . 0.0 107.735 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.26 124.71 15.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.525 0.73 . . . . 0.0 109.145 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -135.8 81.01 1.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.115 1.366 . . . . 0.0 108.057 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.63 -118.61 5.07 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 166.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p -64.71 -3.79 3.6 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 126.426 1.89 . . . . 0.0 113.019 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.04 134.86 53.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.739 1.215 . . . . 0.0 110.816 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.45 163.56 29.41 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.139 1.375 . . . . 0.0 110.404 167.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -128.19 118.75 23.9 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.852 1.661 . . . . 0.0 110.127 170.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -87.32 165.18 15.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.858 1.663 . . . . 0.0 112.086 167.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.69 35.82 2.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.147 1.779 . . . . 0.0 111.529 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 mt 52.04 -169.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.476 1.91 . . . . 0.0 113.383 -169.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.45 123.17 35.42 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.94 -156.81 52.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 173.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.94 -0.5 57.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.141 0.977 . . . . 0.0 112.616 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -75.74 130.22 38.32 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.224 0.92 . . . . 0.0 108.761 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -151.65 157.68 34.51 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 124.078 0.951 . . . . 0.0 110.415 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 173.48 9.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.846 2.364 . . . . 0.0 111.03 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.63 154.5 48.27 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.121 1.214 . . . . 0.0 110.027 162.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.31 174.45 11.48 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.151 2.567 . . . . 0.0 109.514 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.88 38.16 2.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 113.695 177.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -132.14 -52.31 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.323 1.449 . . . . 0.0 109.558 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.03 149.1 33.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 110.837 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 155.54 46.59 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.276 0.63 . . . . 0.0 110.879 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.8 -2.61 30.72 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.34 20.99 2.6 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 126.122 1.82 . . . . 0.0 109.664 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.49 25.93 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.06 130.55 41.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.65 138.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.444 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -109.5 130.63 55.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.514 0.726 . . . . 0.0 109.415 -172.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.25 146.14 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.1 p -146.05 159.77 42.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.072 0.949 . . . . 0.0 110.228 160.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.6 p -164.89 151.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.613 1.565 . . . . 0.0 107.841 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -79.0 108.21 12.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 166.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -144.13 152.57 41.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.62 4.58 7.12 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.135 -1.37 . . . . 0.0 114.644 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.87 2.08 42.57 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.821 1.81 . . . . 0.0 114.16 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.76 166.51 26.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.638 1.719 . . . . 0.0 109.836 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.54 95.01 6.99 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 155.09 39.35 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 170.68 18.1 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.594 172.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 t -159.93 163.35 34.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -101.98 143.6 31.63 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 108.924 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.44 -166.29 24.19 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.475 1.512 . . . . 0.0 111.933 -172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.78 174.4 11.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.417 1.087 . . . . 0.0 111.73 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.67 -43.24 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.462 1.105 . . . . 0.0 113.659 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.45 -45.6 0.31 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.377 2.671 . . . . 0.0 114.195 -166.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.0 m -154.63 136.02 14.14 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.668 1.587 . . . . 0.0 107.772 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -116.51 161.19 19.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.06 1.344 . . . . 0.0 108.262 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -143.39 -30.43 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.336 -0.852 . . . . 0.0 111.972 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -149.93 179.86 7.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.904 2.082 . . . . 0.0 105.824 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.7 -8.71 29.72 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.675 -0.641 . . . . 0.0 111.528 162.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -131.57 -11.92 3.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.582 1.326 . . . . 0.0 114.582 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -128.55 128.2 43.83 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -166.47 167.33 15.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.88 172.9 7.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.994 0.918 . . . . 0.0 109.527 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 pt -141.79 138.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 108.45 160.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -107.3 111.19 23.44 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 128.433 2.693 . . . . 0.0 104.819 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.17 149.28 37.32 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.246 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.74 165.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.421 1.488 . . . . 0.0 108.973 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.99 -113.55 5.74 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 126.843 2.164 . . . . 0.0 109.907 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.79 137.18 2.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.589 0.756 . . . . 0.0 112.101 -160.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.97 152.97 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.673 1.189 . . . . 0.0 109.42 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -160.89 163.74 31.75 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.792 -1.192 . . . . 0.0 109.294 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.15 124.25 26.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 -12.2 3.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 169.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -140.77 162.78 34.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.084 1.353 . . . . 0.0 109.609 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 179.55 166.29 1.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.638 1.975 . . . . 0.0 110.644 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -73.73 129.47 38.0 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -158.48 92.97 1.17 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.338 0.1 OUTLIER -136.88 34.33 2.63 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.658 -171.805 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 119.028 -0.873 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.0 tpt -69.38 -33.53 73.18 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.322 1.061 . . . . 0.0 108.986 160.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -133.71 173.93 10.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.192 2.597 . . . . 0.0 108.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 75.14 -179.1 0.17 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.306 2.642 . . . . 0.0 112.358 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.24 166.78 17.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.18 1.392 . . . . 0.0 111.267 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.84 170.32 29.95 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-O 122.485 1.047 . . . . 0.0 113.484 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -154.63 3.69 0.23 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.099 1.759 . . . . 0.0 110.78 -168.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.73 -5.96 48.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.48 -1.387 . . . . 0.0 111.476 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.05 -33.07 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.894 -1.129 . . . . 0.0 111.097 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 2.41 53.34 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.182 0.896 . . . . 0.0 113.695 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.445 ' HG3' HH11 ' A' ' 11' ' ' ARG . 35.8 mtt85 -81.85 -16.33 51.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.178 1.489 . . . . 0.0 111.256 163.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -121.63 -37.23 2.92 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.056 1.342 . . . . 0.0 112.506 -172.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.04 159.56 14.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.247 1.019 . . . . 0.0 108.302 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -156.3 161.15 40.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.51 -21.88 66.17 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -163.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.2 mt -122.03 14.28 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.72 1.208 . . . . 0.0 109.466 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.457 HE21 HG21 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -73.53 -174.0 1.58 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.528 0.517 . . . . 0.0 110.755 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -122.69 159.26 28.32 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 125.09 1.356 . . . . 0.0 109.898 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.7 m -146.28 155.32 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.557 1.143 . . . . 0.0 110.19 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.07 166.68 15.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.159 1.784 . . . . 0.0 110.853 157.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.1 mt -137.2 6.23 2.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -158.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 m -49.95 105.44 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 127.327 2.251 . . . . 0.0 112.849 -155.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG22 HG12 ' A' ' 66' ' ' VAL . 25.9 t -89.99 132.01 35.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -77.99 120.61 23.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.76 68.65 0.85 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.329 1.052 . . . . 0.0 109.587 170.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 -167.35 50.51 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 122.099 0.833 . . . . 0.0 111.333 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -77.89 -13.01 60.03 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.14 1.376 . . . . 0.0 111.798 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -133.12 11.32 4.22 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.137 1.375 . . . . 0.0 113.772 -166.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.35 162.9 31.74 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.992 1.269 . . . . 0.0 112.045 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.53 170.76 20.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.0 0.905 . . . . 0.0 111.684 170.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -131.46 146.53 52.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.697 2.399 . . . . 0.0 104.773 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.64 159.37 42.58 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 118.832 0.742 . . . . 0.0 109.634 165.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.25 -166.73 30.5 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 155.43 32.49 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.38 159.12 42.86 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 163.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.1 145.51 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.89 153.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.002 1.721 . . . . 0.0 107.332 166.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.7 p -128.98 -18.21 3.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.543 1.137 . . . . 0.0 112.336 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 m -164.53 157.85 17.55 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.44 1.896 . . . . 0.0 109.123 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.16 135.31 33.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.529 1.131 . . . . 0.0 109.482 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 67.8 1.35 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 0.0 112.05 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 -81.47 1.73 Allowed Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.199 -0.938 . . . . 0.0 113.388 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -114.64 45.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.836 1.254 . . . . 0.0 109.115 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -159.21 132.53 7.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.421 1.088 . . . . 0.0 108.169 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.4 154.63 51.41 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 168.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -114.83 149.23 37.39 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.241 1.016 . . . . 0.0 109.154 169.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.7 mt -137.61 165.14 27.07 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.433 1.493 . . . . 0.0 109.771 -169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -143.42 16.33 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 54.71 161.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.324 1.85 . . . . 0.0 113.183 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -61.01 2.1 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 167.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.27 -176.31 28.07 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.92 -61.82 0.0 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 131.096 3.759 . . . . 0.0 114.63 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.73 155.71 35.25 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 165.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -165.72 161.63 13.36 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 127.23 2.212 . . . . 0.0 108.342 158.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.46 169.17 17.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.376 2.051 . . . . 0.0 110.997 171.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.64 159.84 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 120.817 1.011 . . . . 0.0 110.278 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.39 159.53 49.83 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.034 1.823 . . . . 0.0 109.946 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 50.47 30.67 4.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.106 1.362 . . . . 0.0 111.652 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -131.66 -2.23 3.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.335 1.054 . . . . 0.0 111.577 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.752 ' HB3' HD21 ' A' ' 86' ' ' LEU . 9.3 mt -104.16 144.86 31.02 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.564 -1.335 . . . . 0.0 108.595 159.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -154.64 161.1 41.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.979 0.8 . . . . 0.0 110.307 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -67.63 -0.39 3.9 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.14 15.78 3.96 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 126.601 2.048 . . . . 0.0 110.842 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.43 125.57 26.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.51 135.95 38.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 165.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG12 HG22 ' A' ' 23' ' ' VAL . 17.9 m -142.51 141.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 108.278 -174.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 m -95.11 166.9 11.69 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 0.0 109.583 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 145.3 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.244 1.018 . . . . 0.0 108.584 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -144.95 153.26 41.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 109.009 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.457 HG21 HE21 ' A' ' 17' ' ' GLN . 8.9 p -157.59 151.99 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.076 1.35 . . . . 0.0 107.645 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -91.22 115.51 28.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 t -151.24 171.82 16.81 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 169.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.66 19.13 54.15 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.858 -1.151 . . . . 0.0 113.417 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.08 -9.98 29.56 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 118.818 1.309 . . . . 0.0 113.494 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.85 -177.44 3.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.503 1.921 . . . . 0.0 110.957 -171.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.1 tp -105.9 101.37 10.87 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.871 1.268 . . . . 0.0 109.381 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 80.5 m -75.99 136.36 40.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -148.49 162.53 39.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.248 167.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.7 t -155.49 -174.47 4.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.775 0.83 . . . . 0.0 111.269 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -133.57 133.79 42.51 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 129.064 2.945 . . . . 0.0 105.505 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.32 -171.21 25.92 Favored Glycine 0 N--CA 1.463 0.454 0 O-C-N 120.441 -1.412 . . . . 0.0 112.557 -170.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.69 175.37 9.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 0.0 109.439 174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.69 -40.8 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 64.93 -47.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.375 2.27 . . . . 0.0 114.479 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.5 m -148.92 101.36 3.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.075 1.75 . . . . 0.0 107.72 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -73.34 173.61 9.29 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 120.588 -1.32 . . . . 0.0 109.573 174.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' N ' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -138.2 -51.97 0.6 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 150.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -142.16 176.65 8.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -54.44 -15.74 1.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 112.649 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -118.41 -21.05 8.22 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.937 1.695 . . . . 0.0 113.462 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -130.35 132.63 45.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 120.615 1.552 . . . . 0.0 108.949 -168.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.573 ' HB3' HD22 ' A' ' 86' ' ' LEU . 9.8 p90 -171.2 170.2 6.14 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.575 0.547 . . . . 0.0 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.81 167.98 13.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.778 2.031 . . . . 0.0 110.431 164.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.96 141.16 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.048 1.339 . . . . 0.0 108.501 159.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 140.4 29.78 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.623 1.569 . . . . 0.0 107.955 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.83 142.65 28.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 164.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.07 164.33 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.028 0.531 . . . . 0.0 110.12 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.68 -109.18 2.76 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.352 1.453 . . . . 0.0 109.898 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.52 142.49 15.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.194 1.798 . . . . 0.0 108.655 -169.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.23 139.47 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 169.3 17.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.372 0.533 . . . . 0.0 110.483 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -80.53 100.25 8.48 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.598 1.959 . . . . 0.0 107.429 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.49 -26.15 57.92 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.984 0.811 . . . . 0.0 112.29 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -145.52 158.49 43.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.175 1.39 . . . . 0.0 108.935 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -131.99 128.74 39.03 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.166 1.786 . . . . 0.0 107.482 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -66.8 157.7 32.26 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 156.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.21 70.72 0.76 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 163.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 56.63 11.05 0.8 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 127.382 2.273 . . . . 0.0 111.953 178.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.36 2.04 2.57 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -113.24 157.7 21.41 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 120.429 1.468 . . . . 0.0 108.546 170.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.92 165.76 26.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.004 1.322 . . . . 0.0 107.534 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.0 146.27 26.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.23 -129.94 43.72 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m 174.66 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 128.662 2.785 . . . . 0.0 107.307 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -131.45 -7.64 3.72 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.922 0.889 . . . . 0.0 111.059 -167.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -61.67 -36.59 81.28 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.332 -0.855 . . . . 0.0 110.657 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -10.65 67.33 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.33 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -74.36 -21.13 59.82 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.514 1.657 . . . . 0.0 110.428 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.563 ' HA ' HG21 ' A' ' 72' ' ' THR . 7.8 m-85 -115.43 -39.2 3.61 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.388 -169.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HE1' HG23 ' A' ' 70' ' ' VAL . 11.3 m-85 -105.43 131.19 53.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.405 1.882 . . . . 0.0 108.132 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.51 165.55 18.91 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -79.84 -8.45 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -152.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.4 mt -127.74 -0.59 6.07 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.627 2.371 . . . . 0.0 108.173 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.4 145.67 41.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.354 0.0 OUTLIER -108.19 113.76 27.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -173.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 HG22 ' A' ' 70' ' ' VAL . 25.7 m -102.04 172.86 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.574 2.75 . . . . 0.0 107.333 -171.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.48 163.39 15.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.405 1.882 . . . . 0.0 112.422 173.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 mt -134.98 51.4 2.1 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.492 1.517 . . . . 0.0 113.693 -167.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.1 m -67.44 120.56 14.11 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.886 -1.759 . . . . 0.0 108.109 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 t -118.73 129.71 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.868 1.267 . . . . 0.0 108.276 167.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -70.37 127.59 33.28 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.349 -0.844 . . . . 0.0 109.622 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.85 62.65 0.61 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.833 1.653 . . . . 0.0 108.606 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.36 -170.04 54.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -75.38 -25.28 57.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 p -131.11 42.05 3.27 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.463 0.649 . . . . 0.0 109.923 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.72 169.05 42.09 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 163.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -173.27 162.36 4.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.107 0.956 . . . . 0.0 110.535 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -97.09 142.72 28.68 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 166.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.8 150.15 51.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 165.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.2 -165.52 30.23 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.282 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.93 147.9 51.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.943 1.297 . . . . 0.0 107.687 175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.53 34.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 162.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.23 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.15 161.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 162.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -142.05 -13.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.068 0.937 . . . . 0.0 112.608 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 m -156.58 151.15 25.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.16 138.74 31.79 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.364 1.078 . . . . 0.0 109.563 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.83 79.53 1.74 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.762 2.025 . . . . 0.0 106.015 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.35 -106.34 0.35 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.327 1.441 . . . . 0.0 113.49 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.79 9.85 0.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.892 1.677 . . . . 0.0 114.389 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -132.1 129.25 39.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.128 0.877 . . . . 0.0 109.781 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.83 159.2 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 155.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -117.66 147.39 42.95 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.808 1.243 . . . . 0.0 108.145 160.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.74 169.5 9.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.623 1.969 . . . . 0.0 111.284 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -142.43 21.91 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 57.93 -178.06 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 0.0 114.854 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.9 174.68 10.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.64 2.376 . . . . 0.0 108.261 164.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.42 0.61 39.16 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 154.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.86 -32.12 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.583 2.753 . . . . 0.0 115.479 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -58.66 158.71 7.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.074 1.75 . . . . 0.0 110.622 166.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -155.0 163.1 25.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.523 0.602 . . . . 0.0 110.267 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -67.54 172.11 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.006 2.471 . . . . 0.0 113.305 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.69 154.05 75.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.885 1.724 . . . . 0.0 112.128 167.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.48 170.1 19.29 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.278 3.319 . . . . 0.0 110.961 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 46.56 20.28 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.075 2.15 . . . . 0.0 113.891 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.5 m -116.91 -57.24 2.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.81 121.98 13.68 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 m -130.81 160.01 35.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.038 0.381 . . . . 0.0 110.65 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.76 -13.36 62.34 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -166.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.51 30.82 3.22 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.636 2.065 . . . . 0.0 108.06 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.05 141.23 56.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 169.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 134.16 35.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 171.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.21 157.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.678 -169.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.18 107.67 7.36 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.27 148.89 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 163.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -145.54 144.84 30.76 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 155.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 19' ' ' VAL . 1.7 t -140.92 163.24 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 166.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -108.75 74.56 0.92 Allowed 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 161.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 12' ' ' TYR . 5.6 t -82.54 166.35 19.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 166.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.13 24.37 6.67 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 156.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.68 28.81 70.52 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.169 1.484 . . . . 0.0 114.443 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.16 44.42 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 121.725 2.762 . . . . 0.0 112.579 169.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 98.69 11.65 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.4 p -91.38 70.07 5.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 126.421 1.888 . . . . 0.0 108.263 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.609 ' HB3' HD13 ' A' ' 103' ' ' LEU . 2.3 tmt_? -85.64 132.63 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 2.9 t -149.04 167.85 24.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.092 0.557 . . . . 0.0 109.504 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -115.6 143.59 45.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.54 -176.54 22.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.273 1.892 . . . . 0.0 111.27 -169.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -128.45 167.48 16.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.359 1.063 . . . . 0.0 108.265 161.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.96 -31.12 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.59 -55.68 0.53 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.491 2.316 . . . . 0.0 112.797 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.5 m -150.09 117.88 6.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.128 2.171 . . . . 0.0 106.341 176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.0 tp -82.94 160.49 22.05 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -130.79 -47.99 1.04 Allowed 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 167.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -143.15 176.96 8.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.09 -11.89 59.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.723 0.809 . . . . 0.0 110.537 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -117.46 -39.63 3.15 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.708 1.603 . . . . 0.0 114.091 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -105.95 128.74 54.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -169.39 172.59 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.34 0.656 . . . . 0.0 109.747 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.29 179.15 4.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.504 1.122 . . . . 0.0 111.462 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.8 pt -146.32 129.02 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 159.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -76.38 122.99 25.28 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 160.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.54 131.94 34.96 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 169.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.04 177.19 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.723 1.209 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.94 -10.45 52.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 116.847 1.499 . . . . 0.0 116.847 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.0 129.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 129.691 3.197 . . . . 0.0 110.086 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 112.33 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.05 144.04 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -70.69 100.81 1.93 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 78' ' ' ARG . 7.5 mp -66.51 -25.53 66.73 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.03 -0.419 . . . . 0.0 110.612 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -150.59 164.42 36.07 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.037 1.735 . . . . 0.0 109.941 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -121.71 115.53 22.88 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.872 1.669 . . . . 0.0 107.514 166.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -74.41 114.12 12.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.59 51.73 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.261 1.425 . . . . 0.0 110.267 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -130.71 28.92 4.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.316 1.046 . . . . 0.0 110.927 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 166.796 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 CA-C-O 117.176 -1.902 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 30.5 ttm 76.95 66.48 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.652 1.981 . . . . 0.0 108.979 -160.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.04 169.91 14.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.398 1.479 . . . . 0.0 108.419 -167.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.43 21.94 5.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.919 1.288 . . . . 0.0 111.995 -166.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -137.75 -69.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.943 0.792 . . . . 0.0 111.107 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.76 38.59 0.65 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.998 0.817 . . . . 0.0 114.757 -167.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 168.38 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.707 1.203 . . . . 0.0 109.679 -171.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.33 10.17 0.43 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.217 1.407 . . . . 0.0 114.54 -166.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -92.18 -51.58 5.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.099 1.318 . . . . 0.0 111.839 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 -17.22 69.83 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 122.098 0.832 . . . . 0.0 113.138 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -68.06 -15.53 63.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.511 ' HD2' ' HG ' ' A' ' 77' ' ' CYS . 4.5 m-85 -111.73 -56.56 2.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -84.44 119.15 24.8 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.27 156.94 16.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.503 ' C ' HD12 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -53.42 -22.09 7.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.067 1.747 . . . . 0.0 113.551 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 15' ' ' GLN . 6.7 mp -130.68 1.45 4.44 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.561 1.544 . . . . 0.0 112.363 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.5 162.65 25.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 159.19 17.44 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.536 169.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.45 -173.74 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 20' ' ' ASN . 1.3 t-20 -92.25 159.02 15.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.872 2.069 . . . . 0.0 107.742 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.65 54.18 1.71 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.146 1.339 . . . . 0.0 110.56 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -59.33 116.82 4.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 66' ' ' VAL . 21.4 t -118.07 135.47 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -74.41 119.1 18.15 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 59' ' ' THR . 28.8 mt -112.63 84.17 1.94 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.84 90.4 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 116.907 -2.052 . . . . 0.0 113.471 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 75.55 -55.25 0.63 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.362 2.665 . . . . 0.0 110.81 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 t -51.92 -43.31 63.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 111.035 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.98 167.66 14.59 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 122.515 1.064 . . . . 0.0 110.896 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 176.55 8.85 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.02 1.328 . . . . 0.0 108.549 164.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -125.77 157.4 37.57 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 162.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -140.81 144.05 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.705 0.684 . . . . 0.0 110.333 164.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.32 -163.44 12.12 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.555 1.55 . . . . 0.0 110.664 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.04 153.96 43.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.48 147.57 23.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.29 145.58 27.46 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 167.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.12 159.57 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.216 1.406 . . . . 0.0 107.658 162.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.5 p -136.14 -36.75 0.73 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.586 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -144.94 140.7 28.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.786 2.034 . . . . 0.0 106.089 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.43 119.83 10.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -116.29 0.98 13.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.306 1.043 . . . . 0.0 111.805 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.38 -108.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 p -75.02 30.57 0.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.251 1.025 . . . . 0.0 112.461 170.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -153.71 109.08 3.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.556 0.742 . . . . 0.0 110.628 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.05 162.03 13.22 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 163.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -127.4 138.97 53.13 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.459 1.904 . . . . 0.0 108.619 165.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.36 169.23 10.81 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.355 1.862 . . . . 0.0 112.599 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -137.71 22.22 2.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 90' ' ' ARG . 7.9 mt 53.66 -173.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.875 1.67 . . . . 0.0 113.621 -171.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.49 113.2 10.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.579 1.552 . . . . 0.0 110.187 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.51 -125.26 9.23 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.71 7.04 3.77 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 111.807 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.54 154.14 34.81 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 163.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -158.66 159.9 29.52 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.856 1.662 . . . . 0.0 108.489 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.92 167.49 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.289 1.326 . . . . 0.0 111.463 170.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.72 155.51 62.98 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.199 2.599 . . . . 0.0 112.993 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.32 160.76 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.518 2.812 . . . . 0.0 111.142 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.93 3.25 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.487 2.315 . . . . 0.0 113.89 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.417 ' CG2' HD22 ' A' ' 25' ' ' LEU . 87.3 m -97.35 -43.56 7.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.611 -1.306 . . . . 0.0 109.567 -166.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 60' ' ' LEU . 15.2 mt -62.36 143.55 56.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.94 0.791 . . . . 0.0 109.36 166.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -146.06 163.68 34.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.268 1.027 . . . . 0.0 108.275 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.07 -3.07 40.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.033 0.921 . . . . 0.0 113.316 -165.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.04 30.37 2.56 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.467 1.984 . . . . 0.0 108.508 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.21 126.21 26.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 164.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.08 135.99 49.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 164.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.426 HG12 HG22 ' A' ' 23' ' ' VAL . 30.0 m -147.27 157.45 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 112.408 -2.178 . . . . 0.0 107.625 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.05 151.85 48.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.336 -1.478 . . . . 0.0 110.331 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.53 121.41 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 124.333 1.053 . . . . 0.0 108.681 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.32 92.63 2.2 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 124.01 0.819 . . . . 0.0 110.014 -166.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.58 143.63 37.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.818 1.247 . . . . 0.0 108.92 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -95.19 102.53 14.34 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 t -152.24 157.97 42.18 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.861 0.755 . . . . 0.0 109.63 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.17 40.91 92.37 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.243 -0.911 . . . . 0.0 112.233 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.9 3.85 37.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.282 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . . . -139.69 177.02 8.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.951 1.875 . . . . 0.0 112.55 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.31 115.27 30.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.274 1.029 . . . . 0.0 108.387 171.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.511 ' HG ' ' HD2' ' A' ' 12' ' ' TYR . 0.5 OUTLIER -93.22 112.76 24.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 127.547 2.339 . . . . 0.0 104.897 174.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 128.38 42.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 8.0 t -134.34 168.27 19.2 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.779 0.8 . . . . 0.0 109.831 171.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -106.88 157.69 17.57 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.467 1.507 . . . . 0.0 107.59 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.82 179.42 45.2 Favored Glycine 0 CA--C 1.524 0.625 0 O-C-N 121.656 -0.652 . . . . 0.0 113.58 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 162.72 34.1 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.414 173.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.51 -36.14 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.95 1.3 . . . . 0.0 113.928 -170.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 73.52 -66.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.394 2.278 . . . . 0.0 111.176 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -138.09 133.97 34.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.54 157.9 18.04 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -136.6 -56.06 0.74 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.038 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -123.49 168.93 11.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.95 -6.74 13.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.16 0.984 . . . . 0.0 111.104 171.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.469 ' HB3' HD12 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -120.04 -14.25 8.9 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -129.81 119.79 23.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -163.62 169.47 18.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.76 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.94 178.84 5.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.326 1.05 . . . . 0.0 111.01 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.6 pt -147.08 141.81 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 160.59 14.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 159.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.2 mt -117.39 128.72 55.31 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.204 1.802 . . . . 0.0 106.193 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.83 154.51 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.1 0.864 . . . . 0.0 110.458 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.28 -111.67 3.69 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -170.45 136.11 1.28 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.205 1.402 . . . . 0.0 109.467 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.4 p -58.67 154.8 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 126.826 2.05 . . . . 0.0 111.847 164.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.97 154.99 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.99 2.516 . . . . 0.0 105.142 167.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.49 112.7 5.47 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mt -105.68 -0.47 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.543 -0.723 . . . . 0.0 111.968 -172.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -158.78 169.3 24.69 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 128.104 2.562 . . . . 0.0 107.703 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 54.0 mtm-85 -122.11 162.52 21.12 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.763 0.825 . . . . 0.0 109.971 170.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -118.21 95.29 4.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.147 1.379 . . . . 0.0 107.411 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.19 107.89 12.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 166.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -140.4 21.71 2.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.092 0.957 . . . . 0.0 111.804 170.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.817 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 63.37 9.43 4.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 m 66.56 135.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.729 1.612 . . . . 0.0 109.845 -153.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.84 7.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.06 0.944 . . . . 0.0 108.518 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -161.98 -78.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -154.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.1 53.89 0.13 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 t -151.12 -3.65 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.097 1.359 . . . . 0.0 111.0 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -65.26 -6.52 9.87 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 120.75 -1.218 . . . . 0.0 111.6 159.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -55.06 -39.61 69.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.922 0.889 . . . . 0.0 110.17 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -13.07 61.3 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.286 0.469 . . . . 0.0 112.967 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -69.37 -22.77 63.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.551 1.175 . . . . 0.0 110.951 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -123.08 -24.32 4.75 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.949 1.299 . . . . 0.0 114.346 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -111.67 106.56 15.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.23 160.7 18.37 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.989 -1.914 . . . . 0.0 109.433 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.88 -19.66 65.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.973 2.109 . . . . 0.0 114.484 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 mt -124.92 2.28 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.849 1.26 . . . . 0.0 111.074 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -70.43 175.83 4.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.596 0.713 . . . . 0.0 110.313 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -113.46 144.71 42.36 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.63 132.99 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.185 0.994 . . . . 0.0 108.401 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -53.01 157.32 1.78 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.916 0.78 . . . . 0.0 109.434 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.63 4.15 15.96 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -166.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.27 95.95 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 113.212 -154.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.17 123.19 44.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 108.367 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.25 137.89 55.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.539 1.063 . . . . 0.0 108.757 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.82 87.53 2.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.9 0.88 . . . . 0.0 108.642 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.17 17.31 79.55 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 121.613 -0.679 . . . . 0.0 111.841 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t0 75.19 -58.79 0.56 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.073 2.549 . . . . 0.0 111.086 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -68.71 -30.26 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.259 0.936 . . . . 0.0 111.841 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.77 158.89 24.41 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 169.0 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.161 1.384 . . . . 0.0 107.551 167.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -126.14 139.42 53.38 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -135.21 137.41 42.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 162.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.52 -178.17 16.81 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.423 1.487 . . . . 0.0 110.195 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -101.46 150.41 23.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.22 161.71 38.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 162.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.01 155.59 17.05 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 154.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 92.7 mt -71.12 161.04 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.129 1.772 . . . . 0.0 106.265 161.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -134.39 -26.24 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.52 1.128 . . . . 0.0 112.099 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.6 m -154.73 157.06 37.46 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.46 1.504 . . . . 0.0 108.336 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.45 144.3 29.58 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -142.05 83.19 1.83 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.19 2.196 . . . . 0.0 107.894 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.73 -110.54 3.38 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.949 0.785 . . . . 0.0 112.691 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 p -72.64 -4.6 32.0 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 116.506 -1.711 . . . . 0.0 113.169 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -117.26 136.27 53.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.684 1.129 . . . . 0.0 108.469 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.18 164.13 27.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.216 1.406 . . . . 0.0 109.377 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -125.53 142.59 51.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 109.541 167.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.14 170.32 8.6 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.765 1.626 . . . . 0.0 112.002 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -141.21 22.69 2.22 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.58 1.552 . . . . 0.0 115.069 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 49' ' ' LEU . 7.2 mt 51.81 -169.45 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.045 1.338 . . . . 0.0 112.514 -169.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 -13.98 7.13 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.95 -157.77 29.31 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -165.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -16.57 61.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.999 0.9 . . . . 0.0 112.937 -172.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.7 100.21 2.77 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -124.27 165.03 26.43 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.752 1.621 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -66.11 175.16 5.03 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 121.69 1.594 . . . . 0.0 112.078 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.31 152.99 80.31 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 109.28 -1.085 . . . . 0.0 109.28 158.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.31 176.7 9.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.973 2.449 . . . . 0.0 111.261 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 p30 52.13 13.73 0.29 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.911 2.484 . . . . 0.0 115.042 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.3 m -121.35 -24.4 5.45 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.506 -0.747 . . . . 0.0 111.611 -164.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 89' ' ' ASP . 14.8 mt -80.22 141.55 35.5 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 m -127.26 165.98 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.52 1.928 . . . . 0.0 110.423 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -79.01 -2.52 40.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.532 1.133 . . . . 0.0 113.284 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.26 20.62 2.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 126.597 2.046 . . . . 0.0 109.714 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.78 132.9 52.37 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -75.48 138.01 41.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 165.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.84 167.69 21.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 126.267 1.827 . . . . 0.0 109.496 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -128.89 134.2 48.18 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.838 -1.164 . . . . 0.0 109.582 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -91.08 170.43 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.417 1.487 . . . . 0.0 109.753 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.57 137.87 5.96 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.96 142.94 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 109.198 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.444 ' CZ2' ' HG ' ' A' ' 76' ' ' LEU . 94.5 m95 -90.19 112.13 23.53 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -150.36 154.07 37.15 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 119.507 1.049 . . . . 0.0 110.419 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.86 -155.34 7.04 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -163.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.99 53.16 4.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.254 -1.303 . . . . 0.0 111.999 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . . . -163.26 175.78 10.59 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.531 1.665 . . . . 0.0 112.768 162.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.444 ' HG ' ' CZ2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -84.54 145.51 28.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 156.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.591 ' SG ' HG11 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -118.14 83.82 2.07 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 127.737 2.415 . . . . 0.0 104.825 170.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 -85.13 139.19 31.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.68 176.84 10.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 123.644 0.59 . . . . 0.0 110.58 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -105.57 168.81 8.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.045 1.338 . . . . 0.0 107.512 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.29 -179.99 40.53 Favored Glycine 0 C--N 1.334 0.454 0 O-C-N 120.759 -1.213 . . . . 0.0 112.76 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -128.03 169.91 13.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.47 1.508 . . . . 0.0 108.001 160.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.0 t -68.44 -40.26 81.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 118.861 0.755 . . . . 0.0 112.871 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 65.71 -43.92 0.37 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.801 2.04 . . . . 0.0 114.337 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.1 m -153.79 133.4 12.93 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 120.074 -1.641 . . . . 0.0 109.524 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.89 159.72 17.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.372 0.669 . . . . 0.0 109.33 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -138.05 -50.09 0.58 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.365 -0.835 . . . . 0.0 109.957 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.79 173.4 11.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.455 ' HA ' HD12 ' A' ' 60' ' ' LEU . 1.2 m-20 -66.4 -6.46 14.52 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.753 0.821 . . . . 0.0 111.798 169.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -117.62 -18.28 9.74 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -130.98 127.85 39.2 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -168.82 166.76 11.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 109.815 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.81 174.95 7.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 124.631 1.173 . . . . 0.0 110.184 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -142.98 137.49 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 109.02 158.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -91.65 123.6 35.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 160.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.84 140.88 38.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 109.893 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.05 158.62 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.886 1.274 . . . . 0.0 110.954 171.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.7 -4.54 53.64 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 125.791 1.662 . . . . 0.0 115.821 165.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.14 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.561 3.544 . . . . 0.0 111.98 -173.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.591 HG11 ' SG ' ' A' ' 77' ' ' CYS . 2.6 t -73.55 137.57 23.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 52.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.32 1.873 . . . . 0.0 114.436 172.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 45.0 53.19 7.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.172 1.389 . . . . 0.0 112.283 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.42 -11.45 42.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.268 . . . . 0.0 112.193 -170.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.93 155.45 40.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 128.414 2.686 . . . . 0.0 106.163 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -135.28 164.61 27.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.188 174.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.4 ttp85 -84.0 163.11 20.14 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -143.75 44.2 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.49 0.586 . . . . 0.0 110.224 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 57.22 -0.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.474 1.91 . . . . 0.0 106.125 158.427 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.522 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.47 -60.54 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.648 1.979 . . . . 0.0 110.75 -161.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -141.08 67.66 1.35 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.093 1.357 . . . . 0.0 107.949 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.07 113.95 1.69 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 109.879 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.46 -16.07 63.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.358 1.463 . . . . 0.0 111.874 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.86 -169.82 28.13 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 124.785 1.183 . . . . 0.0 110.976 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.9 m -142.22 -79.79 0.23 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -1.96 7.06 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.623 0.769 . . . . 0.0 112.9 -175.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -54.19 -41.73 68.92 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.619 0.767 . . . . 0.0 109.51 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -5.01 66.55 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.037 0.827 . . . . 0.0 113.834 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -88.22 -10.11 50.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.99 1.395 . . . . 0.0 111.588 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' HD2' HG21 ' A' ' 100' ' ' VAL . 4.0 m-30 -117.93 -42.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.515 1.526 . . . . 0.0 109.592 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -99.45 146.81 25.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.08 1.352 . . . . 0.0 108.132 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -143.7 158.11 43.91 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -55.61 -20.12 12.59 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 126.453 1.901 . . . . 0.0 115.392 -164.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.2 mt -126.69 5.9 6.76 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -179.66 3.16 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.991 0.814 . . . . 0.0 110.587 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 129.36 56.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.715 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 m -118.75 140.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.402 HD21 ' CG ' ' A' ' 32' ' ' ASP . 0.8 OUTLIER -63.68 162.45 13.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.945 0.898 . . . . 0.0 110.291 170.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.82 45.18 2.77 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.892 0.877 . . . . 0.0 109.811 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 m -65.01 125.26 24.37 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 66' ' ' VAL . 23.9 t -131.95 127.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.024 1.729 . . . . 0.0 108.176 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 143.9 57.58 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 118.963 0.801 . . . . 0.0 109.778 172.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 59' ' ' THR . 48.9 mt -129.11 18.03 6.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.07 -103.0 0.27 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -130.08 -85.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 171.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p -79.56 63.74 4.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.36 2.664 . . . . 0.0 110.064 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.35 -95.22 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.13 167.4 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.455 2.302 . . . . 0.0 113.203 -165.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.93 149.57 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.402 ' CG ' HD21 ' A' ' 20' ' ' ASN . 6.2 t70 -150.35 123.16 8.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.61 -178.74 16.54 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.632 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.7 161.61 13.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 166.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.26 160.53 43.63 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.213 1.805 . . . . 0.0 109.622 161.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.98 135.6 33.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.89 153.74 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 159.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -131.52 -39.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.683 1.193 . . . . 0.0 110.279 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.4 m -152.9 123.49 7.27 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.97 1.308 . . . . 0.0 108.191 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.63 142.86 50.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.576 1.15 . . . . 0.0 109.645 -171.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -135.23 -169.81 2.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.754 1.622 . . . . 0.0 109.276 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.33 -45.48 95.38 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -163.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -140.09 34.75 1.92 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.286 1.834 . . . . 0.0 108.376 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 146.33 36.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.28 168.59 19.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 166.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -130.83 142.86 50.41 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.514 1.926 . . . . 0.0 107.505 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -174.73 3.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.666 1.587 . . . . 0.0 109.894 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.7 mt 57.76 -177.37 0.07 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.628 1.571 . . . . 0.0 112.434 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.48 134.44 52.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 172.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.05 -134.33 29.39 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 121.645 0.58 . . . . 0.0 112.562 165.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.43 22.99 5.53 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.81 145.66 28.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -159.46 154.56 21.66 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 122.99 0.516 . . . . 0.0 110.697 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.64 169.95 14.87 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.708 2.272 . . . . 0.0 112.061 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -57.25 154.57 33.85 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.394 1.396 . . . . 0.0 111.41 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -67.48 169.1 16.37 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.41 2.073 . . . . 0.0 109.093 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.17 44.79 6.66 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 172.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.485 ' CG2' HD22 ' A' ' 25' ' ' LEU . 89.0 m -138.75 -54.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.896 0.879 . . . . 0.0 109.195 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.78 137.95 58.16 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 118.742 -0.647 . . . . 0.0 109.678 171.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -147.16 160.88 41.92 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 66.8 mt-10 -69.94 -2.25 11.94 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -163.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.49 17.1 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 126.102 1.81 . . . . 0.0 111.137 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.67 28.22 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.88 129.94 38.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 23' ' ' VAL . 35.8 m -134.86 159.36 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 113.442 -1.708 . . . . 0.0 108.128 -172.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.63 104.96 5.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -80.82 160.46 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.468 ' CB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -148.63 137.46 21.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.99 144.62 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.164 0.986 . . . . 0.0 109.231 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.451 ' CE2' HD13 ' A' ' 76' ' ' LEU . 81.7 m95 -86.33 111.15 20.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -156.99 150.71 24.53 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.57 -56.14 1.65 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.098 1.332 . . . . 0.0 110.936 -168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.92 -9.48 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.716 1.627 . . . . 0.0 112.933 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.29 174.61 7.6 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.186 1.493 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.468 HD11 ' CB ' ' A' ' 69' ' ' SER . 31.8 tp -81.04 99.1 8.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -70.74 110.05 5.31 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 164.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 146.12 25.51 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.672 ' SG ' HG22 ' A' ' 100' ' ' VAL . 24.7 m -134.03 144.0 48.42 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.931 168.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.85 146.26 30.97 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.66 -177.52 22.96 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.23 0.919 . . . . 0.0 111.077 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -131.02 161.06 32.8 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 162.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.02 -31.08 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.29 -60.89 0.36 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.135 1.774 . . . . 0.0 111.139 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.4 m -153.27 122.73 6.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.799 2.04 . . . . 0.0 107.121 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.483 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.4 tp -91.6 156.04 17.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -130.06 -46.68 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 111.502 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.475 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 5.7 m-20 -138.3 -178.73 5.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.231 1.812 . . . . 0.0 107.273 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -21.22 9.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.891 1.676 . . . . 0.0 111.434 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -122.07 -53.98 1.93 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 125.518 1.527 . . . . 0.0 111.214 -163.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.475 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 32.2 mt-30 -85.67 133.47 34.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.784 0.72 . . . . 0.0 109.493 175.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -166.94 164.04 16.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 109.012 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.78 176.21 8.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.605 0.762 . . . . 0.0 109.927 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -152.73 127.63 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.778 1.631 . . . . 0.0 110.219 164.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.13 125.39 34.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 164.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -85.58 137.96 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.6 164.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 120.657 1.571 . . . . 0.0 113.354 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.1 -117.6 10.87 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 127.544 2.497 . . . . 0.0 107.525 -170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -145.53 153.58 41.26 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.69 1.596 . . . . 0.0 108.113 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.672 HG22 ' SG ' ' A' ' 79' ' ' CYS . 85.6 t -55.93 152.69 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.347 1.859 . . . . 0.0 110.438 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -143.41 157.2 44.65 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.37 128.86 37.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -12.29 3.83 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -132.2 156.09 47.07 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.337 1.426 . . . . 0.0 109.778 166.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.16 -16.66 12.97 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 124.175 0.99 . . . . 0.0 111.189 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -179.84 -164.46 0.06 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.237 2.215 . . . . 0.0 106.95 -172.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 60.96 55.38 3.14 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 123.462 1.601 . . . . 0.0 111.145 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.258 0.0 OUTLIER -78.68 26.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 C--O 1.251 1.153 0 C-N-CA 128.497 2.719 . . . . 0.0 107.401 177.944 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -148.65 162.54 39.51 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.919 0.888 . . . . 0.0 109.683 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -158.63 99.67 1.59 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 163.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.3 -43.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.937 2.095 . . . . 0.0 106.715 170.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 56.33 49.6 14.84 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.995 1.718 . . . . 0.0 109.773 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.91 134.98 1.75 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-O 118.101 -1.389 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 p 174.87 -69.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 112.735 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -59.68 9.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 1 C-N-CA 131.77 4.028 . . . . 0.0 114.365 -172.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.401 ' CD1' HG23 ' A' ' 100' ' ' VAL . 3.9 m-30 -56.55 -42.38 78.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.539 1.535 . . . . 0.0 110.779 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.78 0.13 86.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.0 0.809 . . . . 0.0 113.524 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -84.43 -15.99 44.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.283 1.042 . . . . 0.0 111.207 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -116.21 -45.76 2.83 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.851 0.751 . . . . 0.0 111.367 -169.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.97 155.56 18.05 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.92 155.76 41.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -50.05 -27.41 5.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.727 3.211 . . . . 0.0 116.628 -168.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.49 1.51 10.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.608 1.163 . . . . 0.0 111.459 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.57 174.54 7.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.334 1.054 . . . . 0.0 110.107 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -112.55 152.02 29.33 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.29 -0.881 . . . . 0.0 111.124 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.02 136.33 47.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.512 1.525 . . . . 0.0 107.181 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.01 164.55 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.5 mt -129.72 6.72 5.16 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 -158.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.84 90.98 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 127.588 2.355 . . . . 0.0 112.841 -157.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.73 128.59 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -70.83 111.84 6.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.662 0.665 . . . . 0.0 109.613 165.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HB2' ' H ' ' A' ' 30' ' ' SER . 2.5 mm? -109.99 79.39 1.21 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.53 -161.69 50.71 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 166.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -88.5 -2.99 58.9 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.013 0.925 . . . . 0.0 113.231 -154.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 t -151.32 2.7 0.42 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.687 0.676 . . . . 0.0 112.295 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.49 -104.03 2.89 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 120.052 1.296 . . . . 0.0 112.137 -164.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.542 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 74.62 158.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 1 C-N-CA 132.047 4.139 . . . . 0.0 114.588 177.956 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -136.6 102.7 5.0 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 125.156 1.382 . . . . 0.0 107.583 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 158.55 15.4 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.053 169.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -170.05 42.79 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 140.71 50.03 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.418 1.887 . . . . 0.0 108.486 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.43 155.13 50.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.969 0.804 . . . . 0.0 110.477 160.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.86 144.92 28.1 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.5 mt -70.77 157.68 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.065 1.346 . . . . 0.0 107.576 162.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -137.18 -56.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.745 2.018 . . . . 0.0 109.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -121.16 157.22 30.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.008 1.323 . . . . 0.0 109.176 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tt -153.64 118.63 5.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.07 94.65 3.08 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.203 1.401 . . . . 0.0 108.117 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.66 -127.38 43.21 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 p -71.24 36.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.994 1.397 . . . . 0.0 112.615 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -147.51 124.24 11.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.02 165.59 12.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 157.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -126.88 146.17 50.39 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 126.325 1.85 . . . . 0.0 108.297 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -138.24 157.9 45.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.709 1.604 . . . . 0.0 109.498 -159.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.42 26.71 2.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 90' ' ' ARG . 8.3 mt 51.19 -165.99 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.97 1.308 . . . . 0.0 111.276 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.27 153.49 47.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.119 0.967 . . . . 0.0 111.776 168.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.31 -118.63 5.46 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.756 1.646 . . . . 0.0 111.507 167.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.01 2.82 7.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.577 1.551 . . . . 0.0 111.226 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.05 141.32 47.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.05 155.55 24.54 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.297 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.34 170.75 10.3 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.383 2.722 . . . . 0.0 112.217 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HG2' HG21 ' A' ' 59' ' ' THR . 59.3 Cg_endo -66.51 154.58 73.84 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.271 1.314 . . . . 0.0 109.286 171.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.62 161.03 47.51 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 122.72 2.28 . . . . 0.0 111.786 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 47.0 33.84 2.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.426 1.89 . . . . 0.0 112.051 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.444 HG21 ' HG2' ' A' ' 56' ' ' PRO . 95.1 m -128.56 -18.96 3.84 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.298 -0.876 . . . . 0.0 111.855 -171.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 mt -76.01 143.26 41.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.803 0.729 . . . . 0.0 109.284 155.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -141.4 168.77 18.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.364 1.466 . . . . 0.0 108.81 159.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -69.23 -3.76 15.03 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.443 1.497 . . . . 0.0 114.722 -170.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.44 -2.79 25.94 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 117.851 -1.527 . . . . 0.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.36 131.14 49.31 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.587 1.694 . . . . 0.0 109.188 -164.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -85.56 72.89 10.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.25 1.5 . . . . 0.0 108.48 -167.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.2 m -73.03 154.13 7.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.884 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -134.18 128.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.05 0.94 . . . . 0.0 108.852 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -95.15 175.66 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.694 1.597 . . . . 0.0 110.208 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' HD21 ' A' ' 76' ' ' LEU . 54.0 p -154.71 162.08 41.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.019 1.327 . . . . 0.0 107.829 152.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.3 p -157.33 143.06 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.747 0.703 . . . . 0.0 109.676 159.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 68.3 m95 -90.29 117.14 28.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.8 t -136.52 170.38 16.16 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.263 1.425 . . . . 0.0 107.685 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 58.44 -107.66 1.21 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.82 32.17 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.482 1.515 . . . . 0.0 111.952 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.52 -170.11 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.055 1.342 . . . . 0.0 108.789 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.6 tm? -116.88 122.03 43.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.412 1.485 . . . . 0.0 110.317 172.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.11 129.1 51.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.44 164.39 25.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.773 1.169 . . . . 0.0 108.345 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.7 t -149.67 148.17 28.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.4 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -79.84 144.3 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.302 1.441 . . . . 0.0 108.043 168.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.11 -169.61 16.46 Favored Glycine 0 CA--C 1.522 0.489 0 O-C-N 121.229 -0.919 . . . . 0.0 112.078 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -138.07 168.9 18.76 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.676 1.59 . . . . 0.0 106.73 163.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.88 -27.5 37.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 67.91 -62.85 0.34 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.946 1.699 . . . . 0.0 113.369 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 m -149.32 129.26 13.43 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.569 1.947 . . . . 0.0 106.601 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.97 140.03 43.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -115.2 -52.89 2.66 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.838 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -137.45 169.72 17.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -18.14 57.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.059 0.543 . . . . 0.0 111.978 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.48 ' HA ' HD12 ' A' ' 49' ' ' LEU . 7.4 ptp180 -110.41 -15.86 13.83 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 116.924 -1.512 . . . . 0.0 114.799 172.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -120.48 123.3 42.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.805 1.638 . . . . 0.0 109.127 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -165.77 165.42 18.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.474 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 176.03 8.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.705 1.202 . . . . 0.0 110.596 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.9 pt -144.75 148.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.306 1.442 . . . . 0.0 109.048 155.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 ttp85 -116.37 112.38 21.41 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.734 1.614 . . . . 0.0 109.286 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.3 mt -75.59 126.25 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.848 1.659 . . . . 0.0 108.571 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.77 161.87 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 111.108 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.12 8.51 87.41 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.072 -1.404 . . . . 0.0 115.039 167.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.28 135.63 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.433 2.693 . . . . 0.0 111.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.401 HG23 ' CD1' ' A' ' 9' ' ' TYR . 7.8 t -86.65 127.57 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -131.65 165.19 24.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.163 1.347 . . . . 0.0 109.767 171.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.78 92.33 4.18 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 170.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.73 -12.89 55.18 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.646 172.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -145.89 144.6 30.3 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.347 -162.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -115.34 -28.89 6.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.244 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -166.2 170.79 12.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.207 2.603 . . . . 0.0 106.849 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 49.16 0.33 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 120.033 3.346 . . . . 0.0 120.033 167.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 56.44 46.92 19.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.944 2.097 . . . . 0.0 112.797 -167.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 35.7 p90 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.075 173.889 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 CA-C-O 117.383 -1.787 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 53.4 ttm -63.83 -76.11 0.07 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 121.083 2.442 . . . . 0.0 108.865 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -69.42 95.92 0.85 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.57 -20.8 1.34 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.6 0.76 . . . . 0.0 111.47 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 50.04 62.01 2.89 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.968 1.707 . . . . 0.0 112.129 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.0 160.93 10.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.983 2.23 . . . . 0.0 110.027 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.3 p -159.56 -172.1 3.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.993 1.317 . . . . 0.0 109.203 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.7 -14.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.53 2.332 . . . . 0.0 114.524 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.74 -47.6 77.64 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.609 -1.307 . . . . 0.0 110.895 -166.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.63 6.19 33.39 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 124.065 0.841 . . . . 0.0 113.537 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -84.95 -13.87 49.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.762 1.281 . . . . 0.0 110.65 166.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.454 ' HB3' HG21 ' A' ' 72' ' ' THR . 8.1 m-30 -123.74 -35.78 2.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.807 1.643 . . . . 0.0 112.965 -170.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 24.3 m-85 -108.49 122.17 46.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -172.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -107.54 159.6 16.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -60.32 -14.09 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.642 2.777 . . . . 0.0 114.203 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 mt -133.84 13.42 4.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.934 1.694 . . . . 0.0 109.911 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -97.36 163.91 12.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 127.008 2.123 . . . . 0.0 109.852 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -118.74 143.17 47.06 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.133 -0.98 . . . . 0.0 111.58 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.94 139.89 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.576 2.35 . . . . 0.0 104.721 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.519 ' O ' HD23 ' A' ' 21' ' ' LEU . 5.6 t-20 -62.58 156.06 24.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.607 0.763 . . . . 0.0 110.264 172.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 20' ' ' ASN . 2.9 mt -132.01 93.72 3.34 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -80.32 90.02 5.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 t -85.31 102.11 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -55.02 120.96 7.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 117.21 -1.376 . . . . 0.0 109.708 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -113.5 2.38 15.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.081 0.953 . . . . 0.0 112.419 173.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 164.82 36.33 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.04 37.85 2.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.781 1.632 . . . . 0.0 113.579 -175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 p 59.8 16.57 5.71 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.929 -1.107 . . . . 0.0 111.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.18 -1.92 90.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 129.926 3.631 . . . . 0.0 114.309 -170.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.565 ' HA ' HD22 ' A' ' 25' ' ' LEU . 3.6 m -61.24 150.58 34.2 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.983 1.713 . . . . 0.0 109.351 -163.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 25' ' ' LEU . 83.3 t80 -95.55 103.68 15.56 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 -172.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.2 109.21 19.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.53 164.52 12.16 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.303 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.27 138.9 43.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.2 152.18 34.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.34 148.91 24.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.2 mt -72.95 160.62 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.886 1.675 . . . . 0.0 108.761 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.1 p -133.45 -32.22 1.17 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.672 2.389 . . . . 0.0 111.294 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 m -151.55 142.98 23.49 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tp -141.18 114.28 8.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.991 1.316 . . . . 0.0 110.646 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.31 32.19 5.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.872 0.869 . . . . 0.0 112.941 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 -113.09 2.86 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.5 p -67.98 22.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.365 1.466 . . . . 0.0 111.735 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 93' ' ' ALA . 2.8 tm? -148.83 126.78 11.93 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.58 163.63 22.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.413 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 43.9 m95 -124.97 146.14 49.54 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 127.264 2.226 . . . . 0.0 107.866 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.5 mt -138.88 161.35 37.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.092 1.495 . . . . 0.0 110.433 -156.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -146.33 36.47 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 49' ' ' LEU . 8.8 mt 54.25 -174.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.335 -1.478 . . . . 0.0 113.847 -175.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.36 -48.69 2.4 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.982 -0.449 . . . . 0.0 112.012 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.03 -167.44 11.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.956 1.265 . . . . 0.0 111.296 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.33 17.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.826 1.251 . . . . 0.0 112.67 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.96 104.32 0.69 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.497 1.519 . . . . 0.0 108.521 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -135.28 149.38 69.69 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 123.779 0.832 . . . . 0.0 109.948 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.23 165.33 29.01 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.841 2.36 . . . . 0.0 111.158 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.11 160.01 24.1 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.351 1.367 . . . . 0.0 110.961 171.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.92 160.49 11.85 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.515 2.143 . . . . 0.0 110.853 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 56.3 35.88 26.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.311 1.444 . . . . 0.0 111.411 -171.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -130.72 -40.25 1.22 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -172.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.1 mt -73.06 140.21 47.06 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -138.68 165.18 27.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.831 0.852 . . . . 0.0 109.702 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.604 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 58.9 mt-10 -70.79 -2.23 14.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.431 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.26 2.26 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 120.659 -1.275 . . . . 0.0 110.129 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.5 132.43 53.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 165.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.37 116.83 16.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 166.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.53 140.48 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.53 116.43 22.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -165.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.528 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.5 m -72.93 162.28 4.5 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 C-N-CA 124.045 0.938 . . . . 0.0 109.822 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -160.12 141.29 12.36 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.619 1.568 . . . . 0.0 112.031 150.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.91 158.3 10.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.165 1.386 . . . . 0.0 109.521 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -92.25 121.43 33.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.524 1.53 . . . . 0.0 107.428 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 12' ' ' TYR . 9.8 t -150.47 160.54 43.7 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.26 -117.93 3.07 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.03 20.63 5.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.343 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.51 172.34 17.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.445 2.123 . . . . 0.0 110.293 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.89 115.81 28.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.71 150.52 20.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.799 ' HB3' HD21 ' A' ' 103' ' ' LEU . 1.8 tmt_? -157.01 134.97 11.0 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 106.93 -175.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 27.9 t -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 107.173 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.13 152.68 44.84 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -150.68 -175.95 23.16 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.755 -1.215 . . . . 0.0 111.618 -172.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -129.21 172.33 11.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.01 0.924 . . . . 0.0 109.218 163.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.0 t -68.62 -32.44 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.5 -65.53 0.2 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.885 1.674 . . . . 0.0 111.993 -172.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.3 m -145.33 126.49 14.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.142 1.377 . . . . 0.0 108.072 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.604 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 2.8 tp -86.31 165.11 16.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.797 0.839 . . . . 0.0 109.156 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -137.24 -43.71 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.783 0.72 . . . . 0.0 112.643 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -141.58 177.25 8.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.9 -6.06 7.5 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.48 -1.387 . . . . 0.0 111.884 169.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.6 ptt180 -138.9 -1.82 1.76 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -127.85 134.88 49.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 120.32 1.418 . . . . 0.0 107.282 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -176.54 166.43 2.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -89.8 178.9 6.12 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.563 0.745 . . . . 0.0 110.627 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.6 pt -147.43 134.1 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.654 1.181 . . . . 0.0 111.109 160.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -90.72 127.37 36.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.079 0.952 . . . . 0.0 108.665 165.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -84.85 131.02 34.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG22 ' HA2' ' A' ' 81' ' ' GLY . 27.4 m -137.26 171.19 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 119.472 1.033 . . . . 0.0 111.463 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.35 13.31 64.91 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.998 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.6 163.69 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.418 3.887 . . . . 0.0 113.577 -173.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.1 p -112.1 127.67 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.907 2.483 . . . . 0.0 110.625 173.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.401 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.2 ttm-85 -131.0 162.53 29.56 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 167.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.0 106.15 3.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -94.22 -16.84 23.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.787 -1.102 . . . . 0.0 112.036 175.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -142.13 150.45 41.14 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.967 0.889 . . . . 0.0 110.613 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -126.71 179.29 5.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.876 1.671 . . . . 0.0 109.746 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.74 29.47 1.12 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 127.252 2.221 . . . . 0.0 105.845 -174.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -94.77 89.44 5.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -107.85 89.53 3.02 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.334 0.654 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.25 1.121 0 C-N-CA 126.448 1.899 . . . . 0.0 109.399 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.67 164.17 14.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.053 0.927 . . . . 0.0 109.912 166.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -130.15 1.83 4.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.19 1.796 . . . . 0.0 111.836 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.24 43.67 3.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.111 1.364 . . . . 0.0 109.96 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.45 161.01 37.5 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.638 1.175 . . . . 0.0 108.209 160.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.57 65.77 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 128.731 3.063 . . . . 0.0 106.37 170.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 t -130.86 -29.03 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.427 1.114 . . . . 0.0 113.483 -169.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -6.6 34.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.421 1.464 . . . . 0.0 114.732 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -57.41 -48.23 79.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.421 1.464 . . . . 0.0 110.963 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.04 -15.73 65.49 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 119.301 -0.722 . . . . 0.0 113.417 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -71.15 -21.04 62.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.591 1.195 . . . . 0.0 111.305 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 1.2 m-85 -112.03 -51.4 2.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.379 0.672 . . . . 0.0 109.539 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.14 161.75 27.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -145.42 161.08 40.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.527 -0.733 . . . . 0.0 112.07 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.86 -22.84 62.85 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.69 9.05 8.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.233 1.413 . . . . 0.0 111.072 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -64.47 174.97 1.49 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.384 0.611 . . . . 0.0 110.02 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 30.2 mtpt -116.7 146.03 43.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 109.042 166.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.56 156.76 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 109.826 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.12 141.57 28.4 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.936 2.094 . . . . 0.0 109.441 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.9 mt -130.98 70.99 1.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.881 1.273 . . . . 0.0 113.459 -162.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -60.98 133.58 56.24 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.043 -1.036 . . . . 0.0 108.277 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.681 HG22 HG12 ' A' ' 66' ' ' VAL . 10.2 t -126.71 121.11 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -62.56 137.23 58.22 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 120.52 1.509 . . . . 0.0 108.941 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.0 mt -138.61 101.0 4.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 171.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.24 28.53 73.73 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.111 -0.993 . . . . 0.0 111.984 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 57.47 5.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.533 2.733 . . . . 0.0 114.873 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 p -149.43 -39.09 0.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.129 1.772 . . . . 0.0 109.835 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 7.72 4.55 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 126.885 2.183 . . . . 0.0 114.631 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -58.43 138.29 56.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.371 1.868 . . . . 0.0 111.333 -160.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -80.9 154.2 27.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -139.18 141.76 37.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 157.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.95 174.17 24.43 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 164.24 12.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.19 160.14 43.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 120.785 -1.197 . . . . 0.0 110.465 161.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.61 147.17 28.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 157.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.1 mt -79.43 157.46 4.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -130.56 -32.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.536 1.535 . . . . 0.0 111.36 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.9 m -152.23 155.14 37.16 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.066 1.746 . . . . 0.0 108.878 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.2 tp -147.25 112.61 5.57 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.179 1.391 . . . . 0.0 108.671 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -133.16 94.22 3.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 51.88 -131.3 36.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.404 -0.664 . . . . 0.0 111.794 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 p -74.66 43.59 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.422 1.889 . . . . 0.0 110.839 173.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.25 107.83 3.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.849 -0.532 . . . . 0.0 111.732 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.67 165.51 11.57 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 165.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 14.4 m95 -126.83 148.63 49.95 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.588 1.555 . . . . 0.0 108.0 164.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 mt -135.9 172.25 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.124 1.769 . . . . 0.0 109.272 -165.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -151.03 27.22 0.7 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 49' ' ' LEU . 7.1 mt 52.25 -174.15 0.03 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.36 1.864 . . . . 0.0 113.024 -173.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -131.78 126.84 35.41 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.822 1.649 . . . . 0.0 106.952 174.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.34 -132.88 42.68 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.524 0.514 . . . . 0.0 112.815 169.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.7 4.37 17.1 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.844 1.257 . . . . 0.0 112.586 -171.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.06 53.49 1.44 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.622 1.569 . . . . 0.0 109.616 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -87.48 156.46 53.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 121.372 -0.83 . . . . 0.0 111.197 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.56 175.23 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.753 2.302 . . . . 0.0 112.391 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -58.97 154.76 42.66 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 121.106 1.204 . . . . 0.0 110.55 160.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -65.63 174.66 5.15 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.604 2.869 . . . . 0.0 110.156 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.2 p30 52.69 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.4 m -110.09 -31.34 7.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 111.193 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -69.59 139.61 53.68 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.101 -0.999 . . . . 0.0 110.085 168.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.02 156.71 45.98 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.26 . . . . 0.0 110.049 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.71 -1.7 14.76 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.084 1.512 . . . . 0.0 115.084 -168.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.12 18.26 4.76 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.113 1.816 . . . . 0.0 111.215 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.61 141.01 58.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.67 63.79 1.25 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 123.674 1.702 . . . . 0.0 111.663 -163.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.681 HG12 HG22 ' A' ' 23' ' ' VAL . 19.6 m -68.38 162.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.014 -1.903 . . . . 0.0 112.039 -171.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 169.17 9.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.584 1.154 . . . . 0.0 109.787 173.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.89 123.75 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 125.478 1.511 . . . . 0.0 109.565 168.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -121.64 141.87 50.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.963 0.789 . . . . 0.0 110.607 162.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.4 146.79 15.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.85 2.06 . . . . 0.0 106.337 162.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.483 ' CZ3' ' HB2' ' A' ' 76' ' ' LEU . 76.6 m95 -87.77 143.05 27.36 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 163.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.5 t -137.5 173.68 11.4 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 44.01 -98.62 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.753 2.121 . . . . 0.0 112.683 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.8 22.38 2.82 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.322 1.915 . . . . 0.0 111.927 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.71 174.73 11.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.049 1.924 . . . . 0.0 114.024 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 1.8 tm? -115.61 122.77 46.61 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.151 1.381 . . . . 0.0 110.738 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.86 81.45 1.77 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.099 1.36 . . . . 0.0 110.074 -168.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.427 ' HB3' HD12 ' A' ' 103' ' ' LEU . 7.2 tmm_? -99.25 128.22 45.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.57 -174.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 12.3 t -128.17 172.44 11.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.726 0.81 . . . . 0.0 110.021 175.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.21 160.19 16.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.125 1.77 . . . . 0.0 108.702 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -165.69 -169.32 29.15 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -144.12 160.72 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.638 1.975 . . . . 0.0 109.1 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.274 51.3 t -62.52 -31.84 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 70.23 -66.11 0.29 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.107 2.163 . . . . 0.0 114.937 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -155.71 97.16 1.82 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.796 1.638 . . . . 0.0 108.915 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tp -79.09 152.89 30.57 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.18 -58.76 1.53 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.46 0.704 . . . . 0.0 109.239 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -127.15 -173.54 2.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.24 -8.35 45.07 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.966 -1.084 . . . . 0.0 111.123 166.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -131.91 -44.89 0.95 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 112.574 -169.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -91.7 133.38 35.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -167.29 164.2 15.33 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.162 0.585 . . . . 0.0 109.724 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -80.85 175.31 10.79 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.25 1.42 . . . . 0.0 110.807 172.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.46 148.17 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.391 1.076 . . . . 0.0 109.188 156.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.24 114.96 26.68 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.595 2.758 . . . . 0.0 107.606 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.64 147.09 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.495 1.043 . . . . 0.0 108.573 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.426 HG22 ' HA2' ' A' ' 81' ' ' GLY . 15.8 m -135.83 146.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 122.335 1.064 . . . . 0.0 109.758 176.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.74 -141.85 31.28 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -166.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.32 138.37 29.45 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.666 1.186 . . . . 0.0 110.838 -165.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 1.4 p -85.34 129.85 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.044 1.738 . . . . 0.0 111.662 171.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.578 ' CD ' HD23 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -129.52 158.03 40.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.914 1.686 . . . . 0.0 106.703 170.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.16 97.76 0.74 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.578 HD23 ' CD ' ' A' ' 101' ' ' ARG . 42.3 mt -80.1 -9.1 59.68 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 120.951 -1.093 . . . . 0.0 111.341 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -154.94 156.01 35.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 127.207 2.203 . . . . 0.0 107.933 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -113.87 179.01 4.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.22 1.408 . . . . 0.0 107.785 166.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -129.94 129.15 43.45 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -70.07 90.71 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 163.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.358 0.0 OUTLIER -99.03 -4.08 33.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 169.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 127.39 2.276 . . . . 0.0 110.076 -172.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 72.2 mtm -144.68 65.46 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -167.37 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -155.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.13 157.32 46.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.577 1.151 . . . . 0.0 109.383 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 44.93 -158.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.216 1.806 . . . . 0.0 112.603 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.37 142.48 16.54 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 120.182 1.356 . . . . 0.0 112.365 -170.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t -144.3 175.97 9.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.945 2.098 . . . . 0.0 108.411 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 73.3 16.64 4.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.645 1.578 . . . . 0.0 110.538 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -105.62 -47.71 3.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.439 1.495 . . . . 0.0 109.804 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.95 10.38 3.18 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.734 1.635 . . . . 0.0 113.363 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -90.85 -14.7 31.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.358 1.863 . . . . 0.0 112.484 165.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 100' ' ' VAL . 7.3 m-85 -121.52 -39.04 2.69 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.994 1.318 . . . . 0.0 112.329 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CZ ' HG21 ' A' ' 68' ' ' VAL . 61.0 m-85 -93.16 154.35 18.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -143.76 155.8 44.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -57.61 -21.7 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 126.279 1.832 . . . . 0.0 113.661 -170.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -124.39 6.47 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.019 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.462 HE21 HG21 ' A' ' 70' ' ' VAL . 2.7 mt-30 -72.16 169.0 17.01 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 120.508 -1.37 . . . . 0.0 110.865 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -99.79 153.31 19.23 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.04 148.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.379 1.871 . . . . 0.0 106.039 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.65 161.77 29.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.761 0.825 . . . . 0.0 111.274 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -133.37 41.68 3.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.935 0.894 . . . . 0.0 112.487 -163.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 m -66.62 100.7 0.7 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 25' ' ' LEU . 43.4 t -94.47 113.24 28.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -57.56 107.21 0.42 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-N 120.535 1.516 . . . . 0.0 109.334 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -89.25 61.72 5.84 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.168 1.787 . . . . 0.0 107.808 171.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.48 7.21 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 75.09 -71.34 0.13 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.925 2.09 . . . . 0.0 112.871 161.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -63.98 -24.5 67.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.096 1.358 . . . . 0.0 111.892 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.06 174.1 22.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.422 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -168.56 172.23 8.29 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.438 1.095 . . . . 0.0 109.266 177.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -110.48 148.4 32.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 164.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -132.79 141.37 48.46 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.926 0.89 . . . . 0.0 110.429 166.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.15 -168.42 26.18 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.568 1.556 . . . . 0.0 110.73 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.2 m -129.26 148.85 51.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.64 162.08 32.91 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 162.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.26 144.65 25.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.04 153.53 8.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 163.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.3 p -130.89 -40.19 1.19 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.776 1.231 . . . . 0.0 110.398 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.8 m -140.88 154.51 46.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.873 2.069 . . . . 0.0 107.695 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.75 134.8 20.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -154.23 95.06 1.79 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.905 1.682 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 -110.8 3.29 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.861 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.5 p -100.09 36.26 1.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.597 1.198 . . . . 0.0 110.449 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.468 ' CD2' ' HB1' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -143.36 131.64 22.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.22 28.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -122.11 147.16 46.48 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.791 1.637 . . . . 0.0 108.154 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -140.2 156.73 46.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.898 1.679 . . . . 0.0 109.691 -163.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -143.53 35.89 1.31 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 mt 50.89 -170.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.9 1.28 . . . . 0.0 111.3 -171.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.04 -22.65 7.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.227 1.811 . . . . 0.0 112.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.76 -171.39 26.15 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -167.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.5 -67.98 0.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 128.337 2.655 . . . . 0.0 111.587 -169.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -128.73 159.88 34.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.128 2.571 . . . . 0.0 109.552 -163.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -158.37 163.17 25.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 110.34 -172.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 168.12 19.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.193 1.929 . . . . 0.0 110.152 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.94 155.76 66.17 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 120.986 1.124 . . . . 0.0 110.041 164.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.06 174.88 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.014 2.476 . . . . 0.0 108.293 165.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.99 23.51 12.64 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.986 -1.071 . . . . 0.0 111.34 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.4 m -137.59 -43.85 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.457 1.503 . . . . 0.0 110.182 -167.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.3 mt -70.96 135.65 48.02 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 120.126 1.33 . . . . 0.0 109.349 169.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.7 m -132.77 163.91 27.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.084 0.954 . . . . 0.0 111.046 168.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.96 -0.05 12.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.026 1.33 . . . . 0.0 114.178 -170.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.2 10.86 7.31 Favored Glycine 0 C--N 1.321 -0.283 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.428 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 128.19 34.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -170.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 71.22 1.41 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.076 1.417 . . . . 0.0 109.844 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.6 m -82.87 136.17 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.779 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.84 120.42 41.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.907 0.883 . . . . 0.0 109.157 -168.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.7 m -86.93 155.54 3.29 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.3 p -142.76 155.66 44.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 153.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.462 HG21 HE21 ' A' ' 17' ' ' GLN . 11.1 p -150.87 150.88 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 164.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -100.06 120.5 39.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -156.74 157.04 34.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.2 42.36 62.66 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.944 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.8 -22.87 5.39 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.077 0.938 . . . . 0.0 113.733 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . . . -119.8 164.17 16.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.892 1.346 . . . . 0.0 112.055 -158.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 tp -84.73 102.02 12.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.7 m -88.55 123.45 33.06 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HG2' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -133.31 158.56 42.64 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 167.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 41.9 t -148.83 141.97 24.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.296 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.36 149.95 46.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 110.141 173.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -159.62 -167.48 20.31 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.602 -1.311 . . . . 0.0 112.747 176.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 mtt85 -139.49 178.96 6.84 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.156 1.782 . . . . 0.0 110.269 166.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.03 -46.01 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.989 1.315 . . . . 0.0 113.234 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 64.7 -58.87 0.24 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.627 2.371 . . . . 0.0 115.23 -167.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.9 m -132.44 133.63 44.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tp -104.8 162.58 13.18 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -139.02 -37.65 0.51 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 120.843 -1.161 . . . . 0.0 113.853 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.77 -175.7 4.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 164.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -68.51 1.69 2.92 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.189 -0.944 . . . . 0.0 112.457 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -134.06 -18.32 2.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -121.24 138.02 54.42 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 120.364 1.438 . . . . 0.0 107.221 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -172.68 164.13 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.951 0.9 . . . . 0.0 109.602 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.468 ' HB1' ' CD2' ' A' ' 44' ' ' LEU . . . -83.95 172.12 12.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.484 1.114 . . . . 0.0 109.344 168.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 pt -139.97 143.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 124.326 1.05 . . . . 0.0 109.156 153.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 130.55 46.06 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.685 1.194 . . . . 0.0 107.794 163.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.1 mt -87.44 135.09 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.561 HG22 ' HA2' ' A' ' 81' ' ' GLY . 6.2 m -135.85 157.23 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 122.33 1.062 . . . . 0.0 109.529 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.98 -109.67 2.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -165.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.6 166.5 31.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.285 1.834 . . . . 0.0 112.964 -170.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -96.47 148.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 1 C-N-CA 133.179 4.591 . . . . 0.0 110.79 154.579 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -137.97 171.38 14.51 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.616 2.366 . . . . 0.0 107.346 160.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -71.84 135.45 46.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 161.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.629 HD11 ' HG2' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -132.69 75.5 1.63 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.176 0.99 . . . . 0.0 109.289 173.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 77.08 173.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 131.222 3.809 . . . . 0.0 113.764 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -137.42 163.21 31.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 127.428 2.291 . . . . 0.0 110.899 -176.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -99.75 -10.96 21.25 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -88.19 98.21 11.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -105.6 91.86 3.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.653 -1.165 . . . . 0.0 110.06 -168.585 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.195 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 39.6 mtp -143.59 106.15 4.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 p -166.93 30.54 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.428 1.491 . . . . 0.0 109.984 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 68.65 -23.64 0.14 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 129.684 3.194 . . . . 0.0 115.213 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.39 171.39 7.39 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.324 1.449 . . . . 0.0 111.933 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.67 -95.62 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 O-C-N 121.278 -0.889 . . . . 0.0 112.686 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.91 27.81 14.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.544 1.138 . . . . 0.0 112.144 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -9.41 15.62 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.101 -1.624 . . . . 0.0 111.889 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -62.52 -37.79 87.44 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.96 -0.462 . . . . 0.0 110.415 -170.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.41 44.07 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.26 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 mtt-85 -84.52 -16.15 43.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.66 1.23 . . . . 0.0 110.164 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -116.53 -45.85 2.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.184 1.794 . . . . 0.0 109.98 -172.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -91.4 168.39 11.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.282 1.033 . . . . 0.0 108.237 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -148.85 169.54 20.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.692 0.797 . . . . 0.0 109.183 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.453 ' HG2' HD12 ' A' ' 16' ' ' LEU . 9.4 pm0 -71.23 -20.73 62.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 ' HG2' ' A' ' 15' ' ' GLN . 5.4 mp -125.98 14.13 7.91 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.1 0.96 . . . . 0.0 109.138 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.443 HE22 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -74.43 -177.18 2.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.092 1.757 . . . . 0.0 110.542 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.99 33.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 120.926 -1.108 . . . . 0.0 111.042 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.67 144.86 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 124.529 1.131 . . . . 0.0 108.441 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.45 158.6 29.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.295 1.438 . . . . 0.0 109.934 167.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.8 mt -130.8 55.45 1.84 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.145 1.378 . . . . 0.0 109.72 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -69.06 130.26 42.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.38 130.42 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -71.17 114.6 9.4 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.778 1.627 . . . . 0.0 109.103 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 30' ' ' SER . 1.7 mm? -110.79 79.15 1.17 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.36 -149.7 47.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.11 -14.26 14.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.304 1.042 . . . . 0.0 112.201 -164.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.99 7.46 3.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.155 1.382 . . . . 0.0 111.153 -169.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.34 -97.0 2.01 Favored Glycine 0 CA--C 1.501 -0.81 0 N-CA-C 106.494 -2.643 . . . . 0.0 106.494 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' HD22 ' A' ' 25' ' ' LEU . 14.2 m 50.8 170.05 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 111.61 -2.295 . . . . 0.0 112.961 -157.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -132.05 147.27 52.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -139.02 130.41 27.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.55 -168.77 13.3 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.227 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 142.32 45.22 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.063 1.345 . . . . 0.0 107.808 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.68 153.93 51.77 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 164.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.79 38.81 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 156.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.5 mt -68.63 158.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 160.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.1 p -135.88 -18.52 1.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.779 1.632 . . . . 0.0 112.122 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 m -157.6 148.6 21.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -144.48 122.56 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -135.68 74.64 1.52 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.592 1.957 . . . . 0.0 107.953 -173.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.56 -123.78 29.84 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.6 p -77.1 34.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.777 1.288 . . . . 0.0 111.97 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -151.7 125.01 8.78 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.8 162.46 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 12.7 m95 -129.3 147.52 51.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.684 1.194 . . . . 0.0 110.452 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.62 173.45 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.68 1.592 . . . . 0.0 112.51 -167.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.37 19.95 1.37 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 90' ' ' ARG . 8.7 mt 55.51 -171.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.861 0.864 . . . . 0.0 112.943 -169.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.83 148.78 52.31 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 126.005 1.722 . . . . 0.0 109.903 165.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.42 -111.0 2.84 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.642 1.115 . . . . 0.0 112.563 161.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.77 7.96 1.11 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.562 1.545 . . . . 0.0 111.163 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.97 146.4 46.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 163.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -173.87 149.59 1.55 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.513 1.925 . . . . 0.0 113.047 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.88 167.77 18.76 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.107 3.205 . . . . 0.0 112.996 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.12 154.23 71.78 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 121.204 1.269 . . . . 0.0 109.994 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.01 170.45 20.08 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.192 2.595 . . . . 0.0 110.765 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.47 -3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 128.211 2.605 . . . . 0.0 116.503 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.2 m -101.32 -24.34 14.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.025 1.33 . . . . 0.0 112.046 -161.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.5 mt -78.92 149.26 32.42 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 120.97 -1.082 . . . . 0.0 108.845 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.75 163.24 34.6 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.553 1.141 . . . . 0.0 108.447 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -70.67 -2.04 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 37.48 1.5 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 135.87 57.21 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 162.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.18 125.78 29.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 166.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.98 136.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 124.565 1.146 . . . . 0.0 109.616 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.63 131.83 41.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.82 154.71 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.7 p -145.29 146.98 31.87 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 157.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.443 HG21 HE22 ' A' ' 17' ' ' GLN . 10.5 p -149.87 147.75 15.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.239 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -89.38 117.98 28.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.0 t -151.17 169.86 20.86 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.62 -117.61 3.56 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -163.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.35 60.89 0.63 Allowed Glycine 0 C--N 1.331 0.253 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.97 -175.59 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.482 1.513 . . . . 0.0 109.053 176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.5 101.85 10.99 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.029 1.732 . . . . 0.0 108.933 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -71.71 107.9 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.74 133.56 39.7 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 165.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.2 t -129.21 133.2 47.44 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -80.51 152.25 28.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 97' ' ' VAL . . . -167.91 -171.43 33.84 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.463 HH11 HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -134.16 167.14 21.22 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.9 -27.49 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 65.03 -64.16 0.17 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.129 1.772 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -149.36 110.25 4.32 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.319 2.247 . . . . 0.0 105.294 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tp -81.36 153.93 26.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 167.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -120.25 -71.36 0.74 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.03 179.48 3.94 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.116 1.766 . . . . 0.0 108.494 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.76 -2.3 0.22 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.421 2.688 . . . . 0.0 113.698 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.759 ' HB3' HD12 ' A' ' 49' ' ' LEU . 1.7 ptt85 -157.22 -38.13 0.07 Allowed 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.1 -1.0 . . . . 0.0 113.151 -159.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.28 127.73 45.32 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -171.62 176.44 3.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.112 0.965 . . . . 0.0 109.308 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -104.19 179.92 4.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.338 1.055 . . . . 0.0 112.234 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -150.2 124.62 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.213 1.805 . . . . 0.0 111.654 167.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.54 114.18 26.34 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.25 1.42 . . . . 0.0 107.648 168.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -78.02 135.01 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.89 1.276 . . . . 0.0 108.129 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 HH11 ' A' ' 82' ' ' ARG . 19.5 m -136.89 167.65 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.163 0.585 . . . . 0.0 111.121 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.93 15.61 80.91 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 118.502 -1.165 . . . . 0.0 114.616 164.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 66.22 165.23 0.19 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.815 2.046 . . . . 0.0 111.006 -171.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -116.59 137.45 50.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.19 149.77 40.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.93 106.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.773 1.629 . . . . 0.0 106.96 162.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mt -104.6 -15.12 15.4 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.567 1.076 . . . . 0.0 112.196 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -135.48 160.9 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.51 174.33 8.74 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -91.71 19.48 6.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.679 1.127 . . . . 0.0 112.839 -169.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 75.39 -15.42 0.68 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.725 2.41 . . . . 0.0 112.194 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -83.21 14.29 3.6 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 127.213 2.205 . . . . 0.0 112.664 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . 0.259 84.7 m-85 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 130.261 3.424 . . . . 0.0 112.476 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.43 96.47 1.06 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -176.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -176.68 153.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.716 1.606 . . . . 0.0 107.545 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.92 -42.64 0.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.664 0.785 . . . . 0.0 111.023 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -118.37 174.93 5.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.153 2.181 . . . . 0.0 108.073 -174.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.35 84.74 1.09 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 t -133.6 -30.93 1.23 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.866 1.266 . . . . 0.0 110.018 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -49.29 1.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 131.501 3.921 . . . . 0.0 115.989 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -72.91 -50.03 26.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.791 -1.193 . . . . 0.0 110.141 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.32 -24.05 77.38 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.547 0.612 . . . . 0.0 113.0 -164.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -61.79 -21.24 64.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.518 172.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -113.6 -40.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.034 1.334 . . . . 0.0 111.49 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CE1' HG12 ' A' ' 70' ' ' VAL . 99.2 m-85 -102.67 112.06 24.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.536 1.534 . . . . 0.0 108.606 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.18 157.49 19.34 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.605 0.566 . . . . 0.0 109.932 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -45.0 -27.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.522 2.729 . . . . 0.0 113.859 163.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.37 41.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.241 1.416 . . . . 0.0 108.561 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.481 HE21 HG21 ' A' ' 70' ' ' VAL . 3.1 mt-30 -113.0 159.9 18.66 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.462 1.105 . . . . 0.0 108.96 164.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 148.12 32.94 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.065 -1.022 . . . . 0.0 110.404 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.47 155.3 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.337 1.055 . . . . 0.0 108.763 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.23 161.09 5.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.238 0.615 . . . . 0.0 110.839 162.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.73 44.46 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.588 2.355 . . . . 0.0 108.303 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.2 m -68.2 114.59 6.82 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.47 104.73 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -50.12 114.54 1.12 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 165.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt -106.33 79.95 1.44 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.54 -5.79 27.57 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.319 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.16 -4.73 2.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 130.253 3.421 . . . . 0.0 112.175 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.0 t -85.99 -25.49 25.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.849 0.86 . . . . 0.0 110.762 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -112.14 -75.03 0.73 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-O 122.57 1.094 . . . . 0.0 111.419 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.315 1.2 m 56.54 166.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.319 3.048 . . . . 0.0 114.946 -166.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.64 166.69 23.31 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 105.933 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -152.59 154.95 36.42 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.04 11.52 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 m -133.67 151.71 51.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.9 151.0 39.25 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 167.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 145.57 26.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 166.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.0 156.32 7.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 168.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 p -132.8 -22.79 2.07 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.926 2.09 . . . . 0.0 111.819 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -157.05 132.82 9.41 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.537 1.535 . . . . 0.0 108.237 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.463 HD22 ' O ' ' A' ' 44' ' ' LEU . 1.1 tm? -126.74 146.72 50.12 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.404 1.081 . . . . 0.0 108.621 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -161.8 88.11 0.69 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.229 1.012 . . . . 0.0 111.633 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.26 -125.92 37.0 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.1 p -80.48 45.0 0.74 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.041 0.92 . . . . 0.0 110.903 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 40' ' ' LEU . 6.8 tp -153.05 129.34 10.53 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.53 149.82 51.69 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.459 ' C ' HD13 ' A' ' 47' ' ' LEU . 15.8 m95 -114.45 132.42 56.26 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.21 1.404 . . . . 0.0 108.73 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.489 HD21 HG12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -122.31 156.06 34.66 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.044 1.338 . . . . 0.0 109.9 -176.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -137.91 23.98 2.83 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -169.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 mt 51.37 140.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 130.671 3.589 . . . . 0.0 115.58 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.31 3.55 27.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.97 -160.18 52.55 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -164.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 73.25 -70.08 0.17 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.471 2.708 . . . . 0.0 110.161 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.12 169.71 18.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.469 1.908 . . . . 0.0 110.012 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -151.86 161.44 29.49 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.67 1.588 . . . . 0.0 109.826 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.42 170.7 17.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.373 2.049 . . . . 0.0 112.317 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.54 154.19 74.84 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.15 1.9 . . . . 0.0 111.09 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.51 167.48 25.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.973 2.449 . . . . 0.0 111.424 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 49.23 26.22 1.45 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.904 2.081 . . . . 0.0 111.966 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.1 m -122.8 -55.79 1.79 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.115 1.366 . . . . 0.0 108.021 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.17 130.27 41.44 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 168.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 m -143.11 163.6 32.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -172.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 40.1 mt-10 -78.18 0.73 23.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.412 1.085 . . . . 0.0 113.713 -164.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.62 21.67 3.05 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 124.9 21.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.59 117.29 11.93 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.22 153.68 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 124.929 1.291 . . . . 0.0 107.843 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 p -125.71 130.46 51.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.105 0.866 . . . . 0.0 111.104 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.6 m -81.28 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.436 ' HB2' HD21 ' A' ' 76' ' ' LEU . 45.0 p -165.75 131.38 2.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.326 2.25 . . . . 0.0 106.428 154.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG21 HE21 ' A' ' 17' ' ' GLN . 11.1 p -136.16 138.3 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -81.73 112.28 18.75 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 168.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -114.2 -166.09 1.07 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 168.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.78 127.49 14.69 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.99 -71.66 2.53 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.22 -0.767 . . . . 0.0 111.413 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.7 174.19 11.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.908 1.354 . . . . 0.0 111.368 -154.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 69' ' ' SER . 0.4 OUTLIER -84.59 117.74 23.92 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 173.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.462 ' SG ' HG13 ' A' ' 70' ' ' VAL . 15.0 p -99.55 122.16 42.21 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.71 162.12 32.81 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.412 ' H ' HG22 ' A' ' 68' ' ' VAL . 22.4 t -155.4 166.8 32.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.8 140.88 52.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.75 -175.57 22.11 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 123.552 0.596 . . . . 0.0 114.021 -160.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -133.35 163.84 28.43 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 166.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.3 t -65.17 -39.97 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.141 0.882 . . . . 0.0 111.961 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 64.9 -48.52 0.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.161 2.585 . . . . 0.0 113.921 -167.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 m -153.79 101.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.27 1.428 . . . . 0.0 107.685 -166.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.411 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.0 tp -81.9 161.63 23.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -133.85 -41.46 0.84 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.735 0.814 . . . . 0.0 111.792 171.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.37 173.63 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.706 2.002 . . . . 0.0 105.982 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.2 -10.2 1.85 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.975 2.11 . . . . 0.0 112.943 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -127.74 -24.4 3.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.839 1.656 . . . . 0.0 112.234 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -120.46 121.09 37.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -162.33 163.48 27.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.932 0.396 . . . . 0.0 110.038 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.11 171.55 10.17 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.029 171.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 47' ' ' LEU . 11.3 pt -146.85 131.05 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.201 1.8 . . . . 0.0 108.638 163.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.32 119.48 31.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.47 125.83 29.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.93 158.24 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.13 -154.26 49.28 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -173.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 137.46 51.51 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.084 -2.058 . . . . 0.0 108.214 -171.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.52 149.62 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -145.91 158.73 43.85 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 164.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.89 77.81 2.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.41 -5.22 56.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.839 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.63 136.21 24.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.701 1.6 . . . . 0.0 108.994 -170.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -147.29 111.01 4.98 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.71 1.204 . . . . 0.0 109.284 -163.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 175.13 9.71 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.974 166.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 44.76 59.97 3.13 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.9 168.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . 0.296 0.0 OUTLIER -106.78 -5.15 18.63 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.06 1.744 . . . . 0.0 114.272 -174.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 124.256 1.022 . . . . 0.0 109.906 171.081 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.315 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 23.8 ttt -71.51 77.55 0.79 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 165.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 t -144.31 -85.05 0.14 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.66 91.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 118.538 0.608 . . . . 0.0 111.142 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.9 t70 44.57 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.448 2.299 . . . . 0.0 114.581 168.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.12 79.64 0.27 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.479 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 t 53.64 -153.23 0.28 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -106.33 11.74 30.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.844 1.258 . . . . 0.0 111.998 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -59.4 -47.94 83.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.387 0.675 . . . . 0.0 111.08 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.4 -16.61 71.62 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.792 0.71 . . . . 0.0 112.671 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -74.7 -10.54 59.63 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.72 -0.871 . . . . 0.0 111.525 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 100' ' ' VAL . 3.3 m-30 -120.19 -40.93 2.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.331 1.452 . . . . 0.0 110.574 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -101.17 104.57 15.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -83.08 157.12 22.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 169.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.572 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.8 tt0 -62.42 -15.13 47.5 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 127.286 2.234 . . . . 0.0 114.805 -173.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 15' ' ' GLN . 7.1 mp -127.81 2.61 6.03 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.446 1.098 . . . . 0.0 111.203 -174.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.45 HE21 HG21 ' A' ' 70' ' ' VAL . 2.6 mt-30 -71.43 178.83 3.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 111.712 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.81 157.61 18.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.427 1.091 . . . . 0.0 110.283 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.66 146.07 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 108.769 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -65.41 153.09 42.29 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.605 0.639 . . . . 0.0 109.387 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.83 51.39 1.53 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.328 0.651 . . . . 0.0 111.477 -165.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 112.96 4.39 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.131 -0.98 . . . . 0.0 110.294 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.64 109.6 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.029 1.332 . . . . 0.0 109.576 174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -62.2 130.15 44.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.216 1.807 . . . . 0.0 109.941 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.1 mt -116.67 54.23 0.86 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.493 1.117 . . . . 0.0 108.914 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.24 -162.41 46.04 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -164.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -84.81 -26.97 27.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.696 -0.885 . . . . 0.0 112.489 -166.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.45 68.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.11 140.05 2.78 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.07 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.758 1.223 . . . . 0.0 108.264 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -137.06 151.06 48.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 164.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.6 141.19 31.92 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.764 1.226 . . . . 0.0 108.186 166.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.23 -173.06 17.13 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.218 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.45 124.48 38.53 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.05 1.34 . . . . 0.0 107.637 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.77 149.95 45.57 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.672 1.989 . . . . 0.0 107.079 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.67 153.34 17.77 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.9 mt -75.19 162.62 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.625 1.57 . . . . 0.0 107.622 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.7 p -140.1 -40.85 0.43 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.986 1.715 . . . . 0.0 111.641 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 m -137.3 145.82 43.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 45' ' ' ALA . 1.6 tp -136.0 138.52 42.33 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.569 -1.332 . . . . 0.0 107.863 171.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -145.42 87.8 1.82 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.717 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.46 -119.04 16.84 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 124.37 0.986 . . . . 0.0 111.245 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 p -73.85 36.71 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.764 1.226 . . . . 0.0 111.795 172.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -145.16 134.95 23.56 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.568 -1.332 . . . . 0.0 107.725 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB2' HD12 ' A' ' 40' ' ' LEU . . . -131.24 163.25 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 161.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -122.07 140.85 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.155 1.782 . . . . 0.0 107.638 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.21 167.45 12.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.329 1.052 . . . . 0.0 111.265 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.9 127.7 25.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.544 1.938 . . . . 0.0 108.29 162.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.2 mt -52.62 146.55 9.93 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -79.83 -71.13 0.47 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.88 -163.95 39.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.986 1.279 . . . . 0.0 110.622 -168.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.46 -6.82 56.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.573 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.26 77.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 128.554 2.742 . . . . 0.0 111.588 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -107.09 154.01 40.65 Favored Pre-proline 0 C--O 1.243 0.728 0 C-N-CA 124.687 1.195 . . . . 0.0 108.949 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.57 174.2 6.74 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.441 2.761 . . . . 0.0 110.775 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.84 158.11 44.49 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 120.81 1.007 . . . . 0.0 110.274 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.99 169.58 20.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.518 2.145 . . . . 0.0 111.105 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 56.12 13.7 1.26 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.402 1.881 . . . . 0.0 113.252 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.0 m -110.18 -53.25 2.7 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.834 1.253 . . . . 0.0 107.851 -166.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.88 150.25 20.77 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.403 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -144.15 163.4 33.72 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.685 0.794 . . . . 0.0 111.633 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 22.2 mt-10 -71.7 -7.8 50.22 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.66 10.43 7.58 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 124.696 1.141 . . . . 0.0 112.392 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . . . -59.58 137.35 58.05 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.21 64.0 8.32 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.532 1.158 . . . . 0.0 111.487 -168.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.88 131.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 p -84.95 165.94 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 169.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.83 119.33 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 124.513 1.125 . . . . 0.0 109.565 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -121.57 145.45 47.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.981 0.912 . . . . 0.0 109.432 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.45 HG21 HE21 ' A' ' 17' ' ' GLN . 9.5 p -153.78 159.16 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 165.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -94.43 106.66 18.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 t -145.57 168.77 19.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.492 0.717 . . . . 0.0 109.216 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.8 28.26 38.56 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.599 -1.112 . . . . 0.0 113.202 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.08 6.36 88.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.27 1.414 . . . . 0.0 113.904 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 176.16 9.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 112.463 -166.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.4 tp -104.71 96.29 6.48 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.933 1.693 . . . . 0.0 107.967 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.2 p -80.16 140.0 36.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -146.05 112.53 5.89 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.662 -0.649 . . . . 0.0 111.801 168.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 48.3 t -107.63 172.4 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.931 0.872 . . . . 0.0 111.108 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.88 154.34 24.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.774 2.43 . . . . 0.0 107.472 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.74 -166.71 33.65 Favored Glycine 0 C--O 1.239 0.458 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.517 1.527 . . . . 0.0 109.761 173.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 64' ' ' ALA . 78.2 t -70.51 -31.19 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.836 0.854 . . . . 0.0 112.658 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 68.88 -61.92 0.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.72 2.008 . . . . 0.0 112.704 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 m -146.21 115.51 7.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.142 2.177 . . . . 0.0 106.392 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.2 tp -84.78 155.97 21.59 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -128.78 -58.34 1.16 Allowed 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.714 -0.616 . . . . 0.0 110.636 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -123.24 172.67 8.45 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 107.114 170.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -7.87 25.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.929 0.492 . . . . 0.0 111.08 164.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.88 -7.4 8.98 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 125.507 1.523 . . . . 0.0 114.933 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.42 130.12 25.97 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -162.39 162.99 28.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 118.168 0.44 . . . . 0.0 110.123 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.44 178.49 8.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.488 0.715 . . . . 0.0 109.582 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 pt -142.45 157.2 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 125.122 1.369 . . . . 0.0 108.735 156.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.77 113.91 22.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.193 2.197 . . . . 0.0 106.138 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.99 149.73 44.7 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 174.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.987 0.915 . . . . 0.0 110.624 170.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.52 -111.81 2.63 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 126.354 1.93 . . . . 0.0 109.134 -170.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.28 21.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.53 1.932 . . . . 0.0 109.999 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.487 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.5 p -121.24 156.15 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.705 2.002 . . . . 0.0 110.673 172.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 153.49 19.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.628 2.771 . . . . 0.0 107.279 -161.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -81.41 101.75 10.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.53 -31.78 72.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.45 -0.781 . . . . 0.0 111.075 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.53 162.65 34.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.734 1.613 . . . . 0.0 107.822 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -120.37 179.47 4.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.124 0.97 . . . . 0.0 109.13 166.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -129.67 177.79 6.97 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.38 6.14 24.1 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.114 1.365 . . . . 0.0 112.58 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -82.14 2.59 30.72 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.973 -1.079 . . . . 0.0 113.424 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 115.895 -2.002 . . . . 0.0 106.743 -154.318 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.617 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -171.08 -75.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.49 162.02 28.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.562 2.745 . . . . 0.0 109.6 170.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.01 96.6 4.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.949 1.7 . . . . 0.0 107.568 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -146.12 -46.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.437 0.695 . . . . 0.0 109.482 172.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.71 37.39 3.46 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.293 1.425 . . . . 0.0 112.594 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.8 t -140.37 -2.16 1.45 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.373 1.086 . . . . 0.0 113.376 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -89.47 1.9 55.25 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 126.136 1.774 . . . . 0.0 111.595 -173.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -39.34 82.04 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.364 -0.835 . . . . 0.0 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.42 -14.32 74.5 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 118.293 -1.282 . . . . 0.0 112.587 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.93 -40.93 95.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.014 1.907 . . . . 0.0 109.989 166.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' CE2' HG13 ' A' ' 100' ' ' VAL . 2.7 m-30 -86.27 -46.38 10.39 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.265 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -97.18 105.47 17.63 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.496 1.118 . . . . 0.0 109.378 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -85.95 160.09 19.47 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 127.403 2.281 . . . . 0.0 110.31 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.28 -24.66 67.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -171.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -130.95 16.49 5.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.58 1.552 . . . . 0.0 109.342 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.628 HE21 HG21 ' A' ' 70' ' ' VAL . 3.8 mt-30 -66.05 171.95 4.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 165.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 159.48 16.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 167.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.17 164.49 29.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.461 HD22 ' HA ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -76.75 159.6 30.02 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.397 167.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 mt -120.28 45.48 2.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.579 1.081 . . . . 0.0 109.981 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 m -71.11 95.02 1.18 Allowed 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 t -95.71 130.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.307 0.958 . . . . 0.0 109.017 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -70.85 121.23 17.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 109.214 168.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 31' ' ' PHE . 3.0 mm? -105.57 70.48 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.948 0.88 . . . . 0.0 109.024 171.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.35 -91.65 1.02 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 167.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -152.38 1.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.481 1.512 . . . . 0.0 112.615 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 t -138.98 2.64 2.15 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 111.587 -160.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.93 157.37 27.24 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.97 130.37 8.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.016 0.908 . . . . 0.0 110.07 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.537 ' H ' HD23 ' A' ' 25' ' ' LEU . 77.8 t80 -84.8 158.6 20.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.7 1.2 . . . . 0.0 108.224 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.41 144.76 22.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.449 0.7 . . . . 0.0 109.993 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 -168.36 31.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.414 0.531 . . . . 0.0 112.256 -174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 133.32 56.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.548 1.539 . . . . 0.0 108.721 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.34 140.15 39.35 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 162.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.1 147.81 40.26 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.406 1.082 . . . . 0.0 109.003 164.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.6 mt -75.35 159.02 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.858 1.663 . . . . 0.0 106.83 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.7 p -141.89 -33.17 0.5 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.301 1.84 . . . . 0.0 112.325 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.43 137.05 12.17 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 120.789 -1.194 . . . . 0.0 110.971 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.402 HD22 ' H ' ' A' ' 41' ' ' LYS . 1.9 tm? -135.28 141.19 45.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 126.234 1.814 . . . . 0.0 107.627 -173.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' H ' HD22 ' A' ' 40' ' ' LEU . 1.5 ttmm -159.77 93.61 1.09 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.27 -135.92 36.97 Favored Glycine 0 C--O 1.229 -0.184 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.27 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.83 2.052 . . . . 0.0 113.176 170.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 tp -140.35 118.42 11.92 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 119.408 1.004 . . . . 0.0 109.825 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.38 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 16.0 m95 -128.5 135.83 49.97 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.938 2.095 . . . . 0.0 108.283 170.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.62 177.23 5.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.017 1.727 . . . . 0.0 111.328 -174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -148.15 131.27 16.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.923 2.489 . . . . 0.0 107.054 167.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.33 157.46 4.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.836 1.654 . . . . 0.0 112.716 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.11 -37.85 7.16 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.0 -50.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.159 0 O-C-N 120.247 -1.533 . . . . 0.0 114.211 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.27 99.94 7.3 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 123.473 1.606 . . . . 0.0 109.913 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 74.85 159.75 0.22 Allowed 'General case' 0 N--CA 1.415 -2.179 1 CA-C-N 107.406 -4.452 . . . . 0.0 109.83 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.24 157.6 49.13 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.711 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 161.96 43.03 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.781 1.654 . . . . 0.0 110.264 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -63.49 162.08 28.93 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 120.82 1.014 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.19 150.12 32.83 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.272 2.648 . . . . 0.0 111.032 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 60.49 9.69 2.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.382 2.273 . . . . 0.0 114.074 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.9 m -88.6 -57.35 2.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.354 1.862 . . . . 0.0 111.542 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.95 131.27 50.53 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -122.98 159.05 29.15 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.65 0.78 . . . . 0.0 110.425 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.25 -5.1 25.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.553 0.741 . . . . 0.0 112.511 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.72 14.69 7.15 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-O 117.588 -1.673 . . . . 0.0 112.25 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.25 133.07 54.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.845 1.322 . . . . 0.0 107.624 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -83.83 110.83 18.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.48 133.86 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.241 0.616 . . . . 0.0 110.497 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.48 137.32 34.7 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.074 0.95 . . . . 0.0 108.569 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.6 126.11 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 124.29 1.036 . . . . 0.0 109.108 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 p -112.5 152.0 29.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.628 HG21 HE21 ' A' ' 17' ' ' GLN . 7.7 p -151.24 142.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 153.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -83.66 121.42 27.24 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.81 148.21 33.77 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.16 -89.47 0.33 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.866 1.222 . . . . 0.0 113.132 165.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.37 5.94 1.91 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.919 0.771 . . . . 0.0 112.97 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.99 177.28 9.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.212 1.506 . . . . 0.0 111.847 -171.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.2 117.43 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 166.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.5 m -99.66 118.09 35.44 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -133.65 135.5 44.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.443 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 12.1 t -135.24 176.42 8.68 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.402 1.081 . . . . 0.0 108.867 177.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.04 147.38 45.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.85 -170.62 24.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.297 0.951 . . . . 0.0 111.165 -174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -134.13 172.62 12.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.856 1.662 . . . . 0.0 109.116 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -69.36 -35.57 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.913 1.233 . . . . 0.0 113.123 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.52 -62.23 0.44 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.821 2.048 . . . . 0.0 112.665 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.3 m -143.62 121.89 12.28 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.202 2.201 . . . . 0.0 106.422 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.42 160.53 18.29 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -123.15 -52.98 1.84 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.397 168.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.28 169.55 17.47 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.024 1.73 . . . . 0.0 107.648 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.06 -4.74 1.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 112.37 170.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -128.47 -14.88 4.64 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 126.017 1.727 . . . . 0.0 113.575 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -138.99 124.98 19.9 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -170.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -165.73 165.79 18.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -83.49 173.58 11.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.467 1.107 . . . . 0.0 110.543 171.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.93 148.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 125.87 1.668 . . . . 0.0 107.997 154.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -113.54 125.35 54.09 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 125.011 1.324 . . . . 0.0 107.802 168.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.91 144.16 27.81 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.777 1.631 . . . . 0.0 106.781 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.79 146.98 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.777 0.717 . . . . 0.0 111.834 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.78 -99.08 0.32 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 126.069 1.795 . . . . 0.0 109.197 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 164.94 35.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 112.558 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.446 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -106.28 150.68 8.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 127.877 2.471 . . . . 0.0 110.199 160.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 173.94 11.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.431 1.492 . . . . 0.0 107.255 150.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.25 120.41 10.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 157.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.5 mt -94.37 -14.45 25.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.276 0.944 . . . . 0.0 111.763 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -153.14 156.82 39.35 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.806 1.642 . . . . 0.0 108.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.0 mtm-85 -121.5 167.45 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.35 1.46 . . . . 0.0 110.122 171.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.95 68.05 1.48 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 -166.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.96 52.59 2.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.136 1.775 . . . . 0.0 109.142 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -143.65 53.57 1.32 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.571 1.549 . . . . 0.0 109.073 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.251 1.177 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.433 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.07 166.68 23.52 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.478 1.511 . . . . 0.0 108.637 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.1 m -54.6 -11.19 0.52 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.568 3.147 . . . . 0.0 117.686 -162.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.36 64.35 1.88 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.992 2.117 . . . . 0.0 110.18 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -38.99 37.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 128.359 2.664 . . . . 0.0 112.801 163.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.41 21.92 15.91 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.208 0.908 . . . . 0.0 112.167 -173.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 t -140.54 -11.52 1.04 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.352 1.861 . . . . 0.0 110.354 -166.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.82 -3.63 13.2 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.386 -1.446 . . . . 0.0 113.092 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CD1' HG12 ' A' ' 100' ' ' VAL . 3.3 m-85 -61.07 -38.45 86.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.015 1.28 . . . . 0.0 111.005 -171.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.36 1.51 65.17 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.85 0.738 . . . . 0.0 112.96 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -83.89 -4.42 58.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.577 1.689 . . . . 0.0 110.636 164.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.546 ' CE2' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -118.26 -49.48 2.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.255 1.422 . . . . 0.0 107.957 -178.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -98.92 105.09 17.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.896 1.278 . . . . 0.0 107.575 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -103.95 161.06 14.3 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.273 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -154.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.75 10.44 7.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.41 1.884 . . . . 0.0 111.008 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -65.28 172.58 3.04 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -108.28 153.87 22.61 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.455 -0.778 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.94 158.05 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.732 1.213 . . . . 0.0 110.482 166.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -74.04 161.71 29.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.39 2.276 . . . . 0.0 111.669 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.96 49.66 1.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.73 1.612 . . . . 0.0 112.769 -167.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 m -66.74 108.8 2.62 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.244 -1.535 . . . . 0.0 109.514 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.81 124.3 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.092 1.757 . . . . 0.0 108.875 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -64.85 124.07 21.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 59' ' ' THR . 55.6 mt -110.18 9.73 23.88 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 112.715 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.66 -173.13 28.7 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.24 -17.48 60.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.9 0.85 . . . . 0.0 109.123 164.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 p -125.8 25.03 6.97 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.208 2.203 . . . . 0.0 112.047 -164.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.54 153.51 21.93 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 m -143.32 144.1 31.96 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 163.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -86.58 152.84 22.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 164.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.8 132.44 14.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.14 -170.86 21.21 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.517 1.532 . . . . 0.0 109.625 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.31 162.43 13.68 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.099 1.36 . . . . 0.0 108.289 171.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.0 172.28 13.62 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.959 0.904 . . . . 0.0 110.185 157.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.84 145.53 28.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.83 1.332 . . . . 0.0 108.559 163.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.3 mt -71.51 157.76 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.842 2.057 . . . . 0.0 106.97 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 p -140.91 -46.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.502 1.121 . . . . 0.0 112.362 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -135.94 136.06 40.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.248 1.419 . . . . 0.0 107.933 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 41' ' ' LYS . 2.1 tm? -145.66 137.4 25.22 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 123.161 1.457 . . . . 0.0 110.218 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' H ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -152.08 93.02 1.78 Allowed 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.641 -177.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.24 -110.24 0.84 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.174 1.368 . . . . 0.0 111.535 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 95' ' ' ARG . 57.8 p -68.08 -7.26 27.97 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.009 1.724 . . . . 0.0 115.62 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.34 114.02 20.74 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 120.233 1.379 . . . . 0.0 111.063 -173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.1 157.81 16.61 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 163.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -122.4 142.23 50.74 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.151 2.18 . . . . 0.0 109.239 168.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.4 mt -135.05 154.78 51.58 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.767 1.227 . . . . 0.0 110.089 -163.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.68 33.26 4.03 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt 49.12 -174.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.437 1.895 . . . . 0.0 114.494 -169.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 139.12 29.32 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.049 0.94 . . . . 0.0 111.748 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.8 -152.65 22.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -168.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.41 -7.98 17.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.18 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -54.75 143.4 25.48 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.253 0.621 . . . . 0.0 109.563 167.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -155.67 157.63 31.56 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 125.338 1.455 . . . . 0.0 108.839 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.05 171.18 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.3 2.0 . . . . 0.0 111.871 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -57.15 154.52 33.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.129 1.219 . . . . 0.0 109.418 167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.59 164.88 29.36 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.773 1.649 . . . . 0.0 109.59 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 p30 56.18 21.48 5.27 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.93 1.692 . . . . 0.0 114.079 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 25' ' ' LEU . 47.3 m -124.49 -11.74 7.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.734 0.814 . . . . 0.0 111.124 -168.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.8 ' HB3' HD21 ' A' ' 86' ' ' LEU . 10.8 mt -88.67 140.36 29.53 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.396 1.453 . . . . 0.0 110.672 156.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -146.33 160.12 42.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.023 0.929 . . . . 0.0 111.785 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.97 -2.0 6.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.56 1.944 . . . . 0.0 115.338 -172.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.16 2.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 125.25 1.405 . . . . 0.0 110.661 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.68 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.3 122.16 31.5 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.5 m -140.7 154.74 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 110.26 -166.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.24 150.83 41.76 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.4 -0.812 . . . . 0.0 110.068 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.55 120.05 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.32 1.048 . . . . 0.0 110.879 175.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -129.16 137.68 51.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -154.5 153.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -89.27 113.26 24.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.8 t -151.24 144.46 24.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 50.01 44.97 41.99 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.389 0.995 . . . . 0.0 111.44 -171.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.77 -15.86 2.1 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.447 1.499 . . . . 0.0 114.502 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.9 153.82 21.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.611 1.705 . . . . 0.0 110.715 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.3 tp -80.7 94.9 6.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.44 139.59 47.83 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.67 134.99 29.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.736 -0.603 . . . . 0.0 110.269 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 8.0 t -137.93 160.97 37.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 111.652 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.97 159.68 14.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.663 1.185 . . . . 0.0 109.05 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.92 -176.1 30.59 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.557 1.551 . . . . 0.0 111.439 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -130.34 171.17 13.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 161.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.531 HG11 HD23 ' A' ' 86' ' ' LEU . 48.6 t -66.79 -35.78 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.819 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 6.1 tp10 65.36 -59.91 0.26 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.262 2.225 . . . . 0.0 112.918 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 93' ' ' ALA . 2.5 m -128.36 133.63 48.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 60' ' ' LEU . 1.4 tm? -108.64 170.98 7.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 166.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -140.49 -47.47 0.42 Allowed 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 116.734 -1.987 . . . . 0.0 115.996 152.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.11 167.43 19.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.21 6.14 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.737 1.615 . . . . 0.0 111.713 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -134.49 -19.74 1.87 Allowed 'General case' 0 C--N 1.35 0.614 0 O-C-N 119.946 -1.721 . . . . 0.0 115.563 170.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -129.16 123.82 33.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 121.183 1.81 . . . . 0.0 108.197 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CB ' HD22 ' A' ' 86' ' ' LEU . 18.3 p90 -166.79 177.72 6.31 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.61 0.364 . . . . 0.0 110.248 -172.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' A' ' 85' ' ' THR . . . -108.62 175.66 5.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.291 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -145.22 130.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 125.38 1.472 . . . . 0.0 109.116 165.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HD2' ' HB2' ' A' ' 43' ' ' SER . 18.3 tpt85 -87.48 114.16 23.84 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 125.902 1.681 . . . . 0.0 107.31 162.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.4 mt -68.89 135.07 50.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.85 148.45 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.169 0.985 . . . . 0.0 109.822 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.09 -107.44 2.06 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.23 168.39 27.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.045 1.338 . . . . 0.0 110.84 174.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.546 HG13 ' CE2' ' A' ' 12' ' ' TYR . 1.2 p -109.36 153.06 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 128.046 2.538 . . . . 0.0 111.167 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' HD2' HD23 ' A' ' 103' ' ' LEU . 2.1 ppt_? -149.09 172.21 15.15 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.906 0.86 . . . . 0.0 109.436 150.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -45.62 81.12 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.749 1 C-N-CA 132.363 4.265 . . . . 0.0 111.365 158.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.571 HD23 ' HD2' ' A' ' 101' ' ' ARG . 19.7 mt -74.7 -27.53 60.43 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 119.952 -1.717 . . . . 0.0 111.696 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.24 162.5 33.33 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.923 2.089 . . . . 0.0 108.16 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -135.06 168.99 18.12 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.737 1.615 . . . . 0.0 108.667 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -145.18 154.17 42.14 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 120.514 1.506 . . . . 0.0 109.61 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 52.36 24.41 2.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.198 0.999 . . . . 0.0 112.352 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 74.47 -5.5 2.09 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 131.492 3.917 . . . . 0.0 117.054 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.851 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 164.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.441 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.4 ptt? -149.48 160.93 43.05 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.649 1.98 . . . . 0.0 107.442 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -139.79 121.17 15.01 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -173.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 47.46 34.89 3.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.961 1.304 . . . . 0.0 111.723 -172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.1 t70 69.5 -3.76 1.54 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.8 2.44 . . . . 0.0 114.856 -175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.91 92.08 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 O-C-N 121.016 -1.053 . . . . 0.0 111.541 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 t -157.27 -8.73 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.435 0.694 . . . . 0.0 111.936 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 pm0 -60.73 -9.91 4.64 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.607 1.163 . . . . 0.0 111.225 160.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 100' ' ' VAL . 7.1 m-30 -55.57 -37.76 68.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.947 -1.096 . . . . 0.0 110.574 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.87 -1.13 45.9 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.474 1.512 . . . . 0.0 112.736 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -72.67 -16.76 61.69 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.012 1.406 . . . . 0.0 111.626 165.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.53 -59.65 1.53 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.81 153.08 27.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.84 157.6 45.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.426 ' HB3' HD12 ' A' ' 16' ' ' LEU . 36.2 tt0 -54.6 -22.56 13.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.943 1.697 . . . . 0.0 114.282 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 15' ' ' GLN . 5.6 mp -127.14 8.38 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.881 0.872 . . . . 0.0 111.954 -172.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.67 166.39 22.01 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.277 -0.89 . . . . 0.0 110.933 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -94.67 160.08 14.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.47 170.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.34 163.08 18.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.042 1.337 . . . . 0.0 109.24 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -80.23 158.5 26.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.455 0.702 . . . . 0.0 110.378 164.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 35' ' ' ALA . 72.1 mt -127.53 51.5 1.91 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.689 1.595 . . . . 0.0 111.09 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -59.34 126.7 28.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.66 121.1 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -63.84 139.56 58.78 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.457 1.48 . . . . 0.0 108.746 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.556 HD22 HG22 ' A' ' 59' ' ' THR . 35.7 mt -118.1 11.52 13.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.02 0.928 . . . . 0.0 112.421 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.88 -105.81 0.72 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.23 -71.99 0.74 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -159.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 t -116.72 87.76 2.76 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.31 -102.23 0.18 Allowed Glycine 0 CA--C 1.498 -0.969 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 163.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 m 68.26 142.67 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 126.913 2.085 . . . . 0.0 110.824 -153.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -96.5 143.12 27.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 163.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.82 102.41 4.56 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.65 -171.71 15.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.364 0.983 . . . . 0.0 112.446 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.0 m -110.6 144.75 39.01 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.277 1.831 . . . . 0.0 107.938 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -138.96 161.8 36.46 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.548 -0.72 . . . . 0.0 111.034 157.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.57 137.95 32.52 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 113.964 -1.471 . . . . 0.0 107.594 159.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.64 155.04 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -136.02 -22.42 1.39 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.028 1.731 . . . . 0.0 112.185 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -153.55 152.62 31.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 120.923 -1.111 . . . . 0.0 108.104 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.3 tp -156.42 122.2 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -145.48 79.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.96 -139.98 27.0 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.98 2.11 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 127.921 2.488 . . . . 0.0 114.617 168.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.25 132.27 56.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.999 1.727 . . . . 0.0 108.592 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.35 171.68 12.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 161.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 93' ' ' ALA . 15.6 m95 -134.15 144.18 48.38 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.426 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.23 177.37 5.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.926 1.29 . . . . 0.0 110.042 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -144.02 32.27 1.25 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 mt 47.99 -173.1 0.01 OUTLIER 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.51 1.148 . . . . 0.0 112.77 -162.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.82 -60.66 1.5 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.239 1.016 . . . . 0.0 108.27 161.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.03 170.57 12.49 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -164.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 63.4 -70.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.893 2.077 . . . . 0.0 110.565 -169.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -71.65 142.09 49.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.76 1.224 . . . . 0.0 109.414 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -151.95 155.74 33.77 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.864 1.266 . . . . 0.0 107.817 152.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.66 167.19 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.667 1.578 . . . . 0.0 111.111 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.28 156.67 39.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.67 2.247 . . . . 0.0 111.445 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.69 162.97 16.77 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.018 2.478 . . . . 0.0 110.413 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 50.14 21.74 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 168.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.556 HG22 HD22 ' A' ' 25' ' ' LEU . 85.4 m -114.77 -30.93 6.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.075 0.95 . . . . 0.0 111.368 -168.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mt -73.84 145.68 44.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.041 1.336 . . . . 0.0 109.704 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -148.46 162.54 39.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 86' ' ' LEU . 46.3 mt-10 -70.43 -1.93 12.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.178 1.391 . . . . 0.0 114.11 -168.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.62 6.98 9.67 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.153 1.835 . . . . 0.0 111.836 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.93 123.23 19.26 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.07 116.82 6.87 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.89 131.63 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 138.19 50.43 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.835 1.254 . . . . 0.0 108.297 -167.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.61 143.39 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 124.325 1.05 . . . . 0.0 109.098 -166.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.17 126.73 12.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 0.0 109.053 -174.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -152.26 161.45 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.287 1.435 . . . . 0.0 110.246 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -113.14 131.71 55.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.996 1.318 . . . . 0.0 110.238 -170.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -148.19 49.04 1.04 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 111.055 -163.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.63 -97.49 0.25 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.575 1.559 . . . . 0.0 109.407 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.82 0.29 9.98 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.83 1.681 . . . . 0.0 113.569 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.62 171.1 14.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.813 1.306 . . . . 0.0 111.937 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.78 109.66 21.33 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.208 2.203 . . . . 0.0 107.559 177.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -85.02 108.0 17.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.53 162.78 25.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 35.4 t -157.7 168.35 27.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.18 0.925 . . . . 0.0 109.631 -173.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.02 152.66 18.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.222 1.809 . . . . 0.0 107.517 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.18 -177.86 37.95 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -138.62 165.2 27.52 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.482 1.113 . . . . 0.0 109.949 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.74 -34.48 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 65.65 -66.85 0.15 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.342 1.857 . . . . 0.0 112.656 -175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.0 m -142.25 117.34 10.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.921 2.488 . . . . 0.0 106.402 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 3.4 tp -89.47 160.74 16.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -125.51 -56.12 1.51 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -148.39 175.61 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.71 23.31 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.198 1.399 . . . . 0.0 112.173 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -147.03 -6.59 0.49 Allowed 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 166.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -138.6 131.15 28.99 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 120.585 1.539 . . . . 0.0 107.208 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -166.13 158.91 14.8 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.138 1.375 . . . . 0.0 109.412 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . . . -80.49 175.63 10.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.917 1.287 . . . . 0.0 109.861 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.37 139.54 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.525 1.13 . . . . 0.0 108.408 158.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -93.93 111.77 23.53 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -72.55 139.54 47.59 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.61 139.59 50.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 123.708 0.63 . . . . 0.0 110.753 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.66 -88.97 1.18 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 124.441 1.02 . . . . 0.0 112.116 168.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 149.1 16.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.982 1.313 . . . . 0.0 110.119 -175.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG23 ' CD1' ' A' ' 9' ' ' TYR . 39.9 t -106.8 114.71 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 158.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.35 35.17 2.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 47.25 92.35 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.52 2.328 . . . . 0.0 114.247 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.86 -3.7 17.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -161.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -135.8 162.8 31.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -120.81 161.04 22.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.875 0.87 . . . . 0.0 110.274 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -101.04 137.08 39.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -134.59 62.65 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 119.566 1.075 . . . . 0.0 110.374 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 55.43 7.7 0.24 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 160.227 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -136.19 69.37 1.43 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.97 43.86 30.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.676 1.59 . . . . 0.0 112.3 168.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.48 91.51 2.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.211 1.005 . . . . 0.0 110.422 -172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.94 102.94 0.66 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.899 0.88 . . . . 0.0 109.972 171.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 82.78 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 121.162 -0.961 . . . . 0.0 112.557 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.7 m -136.7 6.83 2.97 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.83 -0.806 . . . . 0.0 111.309 159.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -82.93 -7.4 59.67 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.56 2.344 . . . . 0.0 113.525 -172.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -58.54 -46.63 86.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.468 0.707 . . . . 0.0 109.679 -168.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.61 -0.58 80.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.713 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -73.41 -28.86 62.23 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.573 1.686 . . . . 0.0 109.903 164.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' CE2' HG13 ' A' ' 100' ' ' VAL . 7.1 m-30 -107.16 -41.68 5.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.295 1.038 . . . . 0.0 110.416 -168.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.26 116.38 30.36 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -94.94 154.39 17.22 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -52.64 -23.68 6.99 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 127.033 2.133 . . . . 0.0 114.102 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -129.67 8.72 5.38 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.77 1.628 . . . . 0.0 111.397 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.13 175.85 4.25 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.301 -0.874 . . . . 0.0 110.36 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE3' ' CE1' ' A' ' 50' ' ' PHE . 47.3 mtpt -114.29 145.97 41.07 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.034 0.934 . . . . 0.0 108.588 168.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 153.02 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.823 0.849 . . . . 0.0 109.768 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -68.85 154.73 41.48 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.052 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.6 mt -129.6 21.91 5.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -158.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -52.51 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.346 1.458 . . . . 0.0 112.871 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.17 135.22 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 120.114 1.324 . . . . 0.0 108.13 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -82.1 125.08 30.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.18 13.81 24.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.341 1.056 . . . . 0.0 112.923 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.74 -144.55 15.43 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -83.73 -85.36 0.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.0 p -87.53 43.44 1.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.815 2.446 . . . . 0.0 111.566 -167.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.09 -91.49 0.76 Allowed Glycine 0 C--N 1.334 0.426 0 O-C-N 121.211 -0.93 . . . . 0.0 110.864 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . 0.282 0.0 OUTLIER 58.99 170.02 0.06 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.913 2.485 . . . . 0.0 114.462 -178.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -142.13 144.49 33.52 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.986 1.715 . . . . 0.0 108.563 173.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.86 136.76 48.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.24 -174.76 21.72 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.17 0.891 . . . . 0.0 110.896 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.09 146.55 45.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.309 1.043 . . . . 0.0 108.677 170.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.37 149.71 36.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.02 31.27 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.5 mt -75.32 155.93 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 164.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -133.91 -41.14 0.84 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.057 0.943 . . . . 0.0 111.759 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -141.56 153.76 45.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.835 1.254 . . . . 0.0 108.238 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 133.97 18.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -140.51 75.13 1.49 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.88 2.072 . . . . 0.0 107.589 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.95 -116.1 6.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.279 1.418 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.6 p -64.13 11.17 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.511 1.525 . . . . 0.0 114.966 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 117.1 11.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.17 166.28 15.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -128.82 155.92 44.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.33 1.052 . . . . 0.0 109.578 174.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.6 mt -147.46 150.66 35.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.721 2.008 . . . . 0.0 108.227 -163.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -150.04 130.39 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 164.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -57.35 157.92 6.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.107 2.563 . . . . 0.0 113.087 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE1' ' HE3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -78.75 -70.19 0.51 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.249 1.82 . . . . 0.0 112.113 -166.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 162.76 131.68 1.25 Allowed Glycine 0 CA--C 1.524 0.639 0 O-C-N 120.502 -1.374 . . . . 0.0 109.68 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.38 -3.84 2.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.037 2.935 . . . . 0.0 113.871 -171.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.89 34.87 1.57 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.764 1.226 . . . . 0.0 112.144 -167.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.2 161.17 78.19 Favored Pre-proline 0 N--CA 1.473 0.708 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 159.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.63 167.19 27.78 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.948 2.432 . . . . 0.0 111.849 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -62.81 161.73 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.129 1.886 . . . . 0.0 112.427 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.05 158.72 46.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.022 1.815 . . . . 0.0 111.169 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 49.22 22.64 0.68 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.658 1.983 . . . . 0.0 113.902 171.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -94.68 -46.98 6.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.075 1.75 . . . . 0.0 109.146 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.92 155.24 40.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.644 1.577 . . . . 0.0 109.496 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -145.72 171.38 14.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.275 1.03 . . . . 0.0 108.273 158.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -73.13 -7.2 50.29 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -166.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.65 2.9 27.62 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 116.936 -2.036 . . . . 0.0 111.679 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.46 138.88 58.55 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.326 1.563 . . . . 0.0 107.936 -167.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.3 64.22 3.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.973 1.368 . . . . 0.0 109.303 -155.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.52 136.68 23.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.862 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -87.13 174.38 8.67 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 123.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.421 1.488 . . . . 0.0 109.395 170.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -118.95 152.7 35.87 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.025 0.829 . . . . 0.0 109.477 167.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.92 142.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 108.54 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.93 113.16 15.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -156.5 170.58 22.02 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.36 14.19 25.65 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.92 -0.933 . . . . 0.0 115.178 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.25 5.3 82.92 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.946 1.873 . . . . 0.0 115.03 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.76 -168.01 2.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.572 1.549 . . . . 0.0 108.491 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.6 tp -99.99 125.77 46.07 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 163.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 100' ' ' VAL . 0.6 OUTLIER -92.32 141.02 29.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.37 1.468 . . . . 0.0 107.496 167.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.461 ' H ' HD11 ' A' ' 103' ' ' LEU . 7.6 tmm_? -145.01 121.89 11.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 160.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.7 t -111.39 166.71 10.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.843 0.83 . . . . 0.0 109.09 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.14 133.07 55.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.84 -167.29 15.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 113.1 -165.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.7 mmt-85 -137.37 171.0 15.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.519 1.528 . . . . 0.0 108.242 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.66 -30.18 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 72.24 -64.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.632 1.973 . . . . 0.0 111.531 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -148.35 123.64 10.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.455 2.302 . . . . 0.0 105.701 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.2 152.03 19.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 167.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.44 -47.46 2.34 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.234 0.614 . . . . 0.0 109.851 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -143.58 175.66 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -54.27 -20.95 7.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.29 11.24 4.55 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.86 115.24 13.42 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -163.3 168.42 20.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -173.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.74 178.63 6.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.099 1.76 . . . . 0.0 111.16 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 pt -144.05 145.84 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.979 1.311 . . . . 0.0 109.771 152.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.42 119.92 40.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 171.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.67 138.55 33.27 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.39 164.92 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.963 0.905 . . . . 0.0 109.857 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.55 8.61 63.38 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.408 -1.218 . . . . 0.0 115.426 165.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 tpt85 62.83 143.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.436 2.295 . . . . 0.0 111.855 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 77' ' ' CYS . 1.4 p -95.85 154.77 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 125.909 1.684 . . . . 0.0 110.182 170.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -150.4 -170.89 3.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 163.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -96.96 121.22 38.6 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.698 2.399 . . . . 0.0 105.884 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.461 HD11 ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.96 -10.13 7.17 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -171.26 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -139.0 163.59 31.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.077 1.351 . . . . 0.0 107.928 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -135.01 172.49 12.94 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -64.08 169.09 4.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.334 0.588 . . . . 0.0 110.053 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -108.75 60.9 0.6 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 163.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 55.17 30.45 14.51 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.985 0.914 . . . . 0.0 112.117 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.907 . . . . . . . . 0 0 . 1 stop_ save_